{"meta":{"query_hash":"b7d1b77a1ab4","filters":{"venue":"Drugs"},"cohort_total":213,"direct_labels_cover":0,"predictions_cover":213,"exported":213,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b7d1b77a1ab4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drugs"},"results":[{"id":"W1027163360","doi":"10.1007/s40265-015-0422-x","title":"Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Clostridium difficile; Fidaxomicin; Medicine; Vancomycin; Metronidazole; Epidemiology; Intensive care medicine; Incidence (geometry); Pharmacotherapy; Infection control; Disease; Internal medicine; Antibiotics; Pediatrics; Microbiology","score_opus":0.1530025530572249,"score_gpt":0.4150057551255378,"score_spread":0.26200320206831285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1027163360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007684053,0.9877125,0.0000017912341,0.00037760276,0.00027194407,0.0018607943,0.00035388736,0.00006356514,0.0016738434],"genre_scores_gemma":[0.000702454,0.996545,0.000033541397,0.00003824009,0.0006842566,0.00041394113,0.0004903317,0.000069153866,0.0010230707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969831,0.0003798185,0.0010444538,0.0006645136,0.00036201076,0.0005661093],"domain_scores_gemma":[0.9946347,0.0035652807,0.0005010179,0.0006359786,0.0002439672,0.0004190769],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060120504,0.00062011037,0.004062361,0.00045209003,0.000084031366,0.000017901226,0.000104023806,0.00060177164,0.000095609044],"category_scores_gemma":[0.0014827467,0.00045118135,0.00079726684,0.00042702007,0.00036923113,0.000051590985,0.00011157027,0.0003702018,0.00008358474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011087629,0.00072132883,0.00061706925,0.006691397,0.0007462098,0.000030707575,0.0001232995,4.6929614e-7,0.000003214748,0.00007791975,0.011008008,0.9798695],"study_design_scores_gemma":[0.0016668489,0.0018081068,0.000020688065,0.0031309351,0.0026998892,0.00010418584,0.00008960049,0.000011948085,0.00027705065,0.000022813154,0.9898591,0.00030880058],"about_ca_topic_score_codex":0.0010566538,"about_ca_topic_score_gemma":0.00001879786,"teacher_disagreement_score":0.9795607,"about_ca_system_score_codex":0.00096070225,"about_ca_system_score_gemma":0.0007723591,"threshold_uncertainty_score":0.999794},"labels":[],"label_agreement":null},{"id":"W114418843","doi":"10.2165/00003495-200464120-00001","title":"Biological Agents for Rheumatoid Arthritis","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Rheumatoid arthritis; Pharmacotherapy; Arthritis; Intensive care medicine; Internal medicine","score_opus":0.07007589361737611,"score_gpt":0.3673728519366236,"score_spread":0.2972969583192475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W114418843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031342126,0.9958211,0.000053422296,0.00009669711,0.00024018997,0.0021358293,0.00020220509,0.0001295834,0.0012895875],"genre_scores_gemma":[0.000041158983,0.9969249,0.00053843134,0.00007504345,0.00015170233,0.0007548044,0.00086151925,0.00007971204,0.00057277735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997913,0.000085006024,0.0005987011,0.0004923257,0.00031009546,0.0006008823],"domain_scores_gemma":[0.9988234,0.00021100036,0.00015253118,0.00040923528,0.00008997848,0.00031383912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030892438,0.00040404772,0.001992963,0.00020231112,0.00013635312,0.000056280405,0.00021765298,0.00037031478,0.0005091029],"category_scores_gemma":[0.0002501758,0.00028649438,0.00094786723,0.00019091232,0.00017780311,0.0000480583,0.00007405578,0.00039701434,0.00067652814],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002513045,0.00010598685,0.0000025501,0.0047829146,0.00021743213,0.00004672964,0.000072627314,1.6291123e-8,2.1380902e-7,0.0016498885,0.0033683577,0.98972815],"study_design_scores_gemma":[0.0016667313,0.00029414886,0.000002014709,0.047154367,0.0000095353025,0.00032549078,0.00002738917,5.2323924e-7,0.0000017542759,0.0006258521,0.9496336,0.00025857045],"about_ca_topic_score_codex":0.000017272901,"about_ca_topic_score_gemma":0.0000018948889,"teacher_disagreement_score":0.9894696,"about_ca_system_score_codex":0.00013508799,"about_ca_system_score_gemma":0.0005746036,"threshold_uncertainty_score":0.9999587},"labels":[],"label_agreement":null},{"id":"W1161070254","doi":"10.1007/s40265-015-0443-5","title":"A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Hemorrhagic cystitis; Radiation therapy; Cystoscopy; Urology; Surgery; Urinary system; Complication; Internal medicine; Chemotherapy; Cyclophosphamide","score_opus":0.07932815640015588,"score_gpt":0.38248011252988123,"score_spread":0.30315195612972534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1161070254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000070885244,0.93211985,0.000051084735,0.00032619035,0.00021790464,0.0014918247,0.000044857134,0.000029168785,0.06571202],"genre_scores_gemma":[0.0001173,0.9955634,0.000966242,0.00015514555,0.00023610056,0.00020033997,0.00018730939,0.000036850193,0.0025373462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986335,0.00008853826,0.00038874446,0.0002682915,0.0004226955,0.00019821106],"domain_scores_gemma":[0.99892676,0.00005424017,0.00018967797,0.00052476797,0.00005045513,0.000254093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002778792,0.00022091976,0.00087241526,0.00010860161,0.000037560134,0.000014040021,0.00014911308,0.0001736681,0.00003452521],"category_scores_gemma":[0.000039861454,0.00012038847,0.0002981931,0.00038819,0.00002781617,0.000024394301,0.00008627691,0.00027655423,0.00037487297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001323542,0.00023355265,2.5134116e-7,0.009710743,0.00053772837,0.000054706885,0.00009785457,4.7061573e-7,3.0225205e-8,0.0010820689,0.021333618,0.96693575],"study_design_scores_gemma":[0.00034316743,0.000047873356,0.000004748654,0.0036526877,0.0043635312,0.00012078089,0.00011914987,0.000018815697,6.3951535e-7,0.000008850042,0.99119216,0.00012758562],"about_ca_topic_score_codex":0.000029956533,"about_ca_topic_score_gemma":1.125131e-7,"teacher_disagreement_score":0.9698585,"about_ca_system_score_codex":0.000109179025,"about_ca_system_score_gemma":0.0003981586,"threshold_uncertainty_score":0.4909299},"labels":[],"label_agreement":null},{"id":"W1248577202","doi":"10.2165/11641160-000000000-00000","title":"Management of Bleeding in Patients Receiving Conventional or New Anticoagulants","year":2012,"lang":"en","type":"review","venue":"Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Anticoagulant; Intensive care medicine; Clotting factor; Resuscitation; Major bleeding; Anesthesia; Surgery; Atrial fibrillation; Internal medicine","score_opus":0.06856875756673375,"score_gpt":0.34879708797077874,"score_spread":0.280228330404045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1248577202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054862146,0.98590183,0.000011529797,0.000027498614,0.0006804111,0.0018218502,0.000012647389,0.000027584994,0.010968017],"genre_scores_gemma":[0.0016496299,0.99469775,0.00054856885,0.00003730681,0.000172512,0.00005441248,0.00018620244,0.000051520467,0.002602105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980499,0.000044346976,0.0007747266,0.00031314368,0.0004506392,0.00036725824],"domain_scores_gemma":[0.999082,0.000049875845,0.0003796761,0.00031083057,0.000037100566,0.00014050872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003351754,0.00029678442,0.0018872063,0.00034904096,0.0000249707,0.000012442371,0.0001395747,0.00013759742,0.0005951504],"category_scores_gemma":[0.0000123696245,0.0002259843,0.00029352607,0.00035209296,0.000024198198,0.0000712399,0.00019939036,0.0001826029,0.00012323343],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015307583,0.0008188738,0.0009727128,0.041733246,0.0006367568,0.00003551697,0.000107061955,1.444709e-7,1.7003046e-8,0.0007378628,0.002429732,0.95251274],"study_design_scores_gemma":[0.0014751299,0.00009640661,0.01951392,0.06381313,0.003342244,0.00000480926,0.000071843264,0.0000010226202,5.608738e-7,0.0000180501,0.91140944,0.00025347207],"about_ca_topic_score_codex":0.00004977698,"about_ca_topic_score_gemma":0.000002894889,"teacher_disagreement_score":0.9522593,"about_ca_system_score_codex":0.00017320605,"about_ca_system_score_gemma":0.00009538999,"threshold_uncertainty_score":0.9215372},"labels":[],"label_agreement":null},{"id":"W132865001","doi":"10.2165/00003495-200666002-00004","title":"Resolution of Severe Diarrhoea and Return to Work in a Patient Converted from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic??)","year":2006,"lang":"en","type":"article","venue":"Drugs","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Mycophenolate; Medicine; Enteric coated; Mycophenolic acid; Pharmacotherapy; Internal medicine; Transplantation","score_opus":0.0074920783094953,"score_gpt":0.23229367395914763,"score_spread":0.22480159564965232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W132865001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960003,0.00029158973,0.00003843941,0.0014311328,0.00013908194,0.00095008773,0.00012944383,0.00005429307,0.00096563355],"genre_scores_gemma":[0.9979199,0.000051807918,0.00074704713,0.00070741726,0.00008160427,0.00010044579,0.00015627599,0.000032223856,0.00020326654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979514,0.00010249351,0.00055438135,0.00045358398,0.00040194968,0.00053619273],"domain_scores_gemma":[0.99879223,0.00015916719,0.0001007934,0.0003920514,0.00015635173,0.00039943398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018775353,0.00022460571,0.000472587,0.0002979239,0.00004659492,0.000033304404,0.000108164604,0.00011160553,0.0002726863],"category_scores_gemma":[0.00022269074,0.00020613824,0.00006510708,0.0007639502,0.00004340552,0.00009288774,0.00016716731,0.00020960777,0.00009343606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020401284,0.0013233264,0.6777856,0.00039575904,0.0002097068,0.0004828686,0.014810885,0.00011453505,0.23470856,0.0000603782,0.03406235,0.01564477],"study_design_scores_gemma":[0.0055834926,0.0010856432,0.95556265,0.0011751426,0.00008307289,0.00001387366,0.0007306458,0.0007897509,0.029227797,0.00025632503,0.005022979,0.0004686395],"about_ca_topic_score_codex":0.0060833003,"about_ca_topic_score_gemma":0.00021457464,"teacher_disagreement_score":0.27777705,"about_ca_system_score_codex":0.00016180656,"about_ca_system_score_gemma":0.00007951554,"threshold_uncertainty_score":0.9196171},"labels":[],"label_agreement":null},{"id":"W1424849964","doi":"10.2165/11593730-000000000-00000","title":"Biosimilars of Biological Drug Therapies","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Biosimilar; Risk analysis (engineering); Medicine; Immunogenicity; Drug; Pharmacology; Intensive care medicine; Immune system; Immunology","score_opus":0.10087913348773116,"score_gpt":0.349562527575078,"score_spread":0.24868339408734685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1424849964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007784657,0.9935172,0.000010546931,0.000060606162,0.0006700474,0.0003347086,0.0001976025,0.000057972327,0.0051435097],"genre_scores_gemma":[0.00002850444,0.9966502,0.0006026501,0.00017125005,0.000043317483,0.00002846509,0.00008317368,0.00003039878,0.0023620476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756205,0.0007977711,0.0007431851,0.00047216652,0.000029495759,0.00039531637],"domain_scores_gemma":[0.99851835,0.00047467678,0.0004128721,0.0005064698,0.000055749635,0.000031883654],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006083546,0.00046150276,0.0021694836,0.00017674599,0.00006554337,0.0000067497626,0.0006251435,0.0010823202,0.0027960918],"category_scores_gemma":[0.000075948126,0.00026546372,0.00093745906,0.00026943977,0.000759275,0.000022680684,0.00019941683,0.0005917846,0.0003382288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014085675,0.00012236442,0.000005901209,0.0014461188,0.0006606467,0.0000017025443,0.00015833309,6.879328e-10,0.000035332247,0.0020329019,0.010020307,0.9855023],"study_design_scores_gemma":[0.00014323325,0.00007865229,0.0000049611926,0.0015382675,0.00051504286,0.000018834811,0.00005544397,1.7624124e-8,0.00035595387,0.0003893808,0.9965847,0.00031551087],"about_ca_topic_score_codex":0.000013453385,"about_ca_topic_score_gemma":9.4033015e-7,"teacher_disagreement_score":0.9865644,"about_ca_system_score_codex":0.000020532023,"about_ca_system_score_gemma":0.00008606008,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W1480461509","doi":"10.2165/11636220-000000000-00000","title":"Sedation for Critically Ill or Injured Adults in the Intensive Care Unit","year":2012,"lang":"en","type":"review","venue":"Drugs","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Foothills Medical Centre; University of Calgary","funders":"Alberta Innovates; Alberta Innovates - Health Solutions; University of Calgary; Canadian Anesthesiologists' Society; Heart and Stroke Foundation of Canada","keywords":"Sedation; Medicine; Sedative; Delirium; Intensive care medicine; Intensive care unit; Dexmedetomidine; Critically ill; Mechanical ventilation; Randomized controlled trial; Intensive care; MEDLINE; Anesthesia; Surgery","score_opus":0.09949290808970769,"score_gpt":0.3955438668134486,"score_spread":0.29605095872374093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480461509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022749606,0.99439013,0.000040041094,0.0008356808,0.00013221095,0.0031574413,0.000078395846,0.000022421122,0.0011161637],"genre_scores_gemma":[0.0015929417,0.9838167,0.00022865814,0.009376209,0.00045986538,0.0005870825,0.0027980523,0.000064123866,0.0010764047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998772,0.00017872454,0.00036335512,0.00022909314,0.0002013425,0.0002554594],"domain_scores_gemma":[0.9974513,0.0004642285,0.00010975942,0.00030810622,0.0015938836,0.00007269778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021196537,0.00024660997,0.00085178355,0.00012038786,0.000045915967,0.000012915716,0.00017308345,0.00022647719,0.00008005869],"category_scores_gemma":[0.0011197252,0.00012747792,0.00022750019,0.00022060313,0.000054605483,0.000052939773,0.000021959922,0.00029215612,0.00011262646],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015636427,0.000048498212,0.000044051798,0.014604041,0.000050375034,0.00003062111,0.0107857,3.0144471e-9,6.0978685e-8,0.00029658357,0.0013924977,0.9725912],"study_design_scores_gemma":[0.0006240242,0.00018294172,0.00018108686,0.00758391,0.00096492487,0.00004800572,0.020766776,0.0000016666422,5.925168e-7,0.000008919991,0.969488,0.00014909785],"about_ca_topic_score_codex":0.000021029407,"about_ca_topic_score_gemma":0.000016169148,"teacher_disagreement_score":0.9724421,"about_ca_system_score_codex":0.00007636294,"about_ca_system_score_gemma":0.00022034292,"threshold_uncertainty_score":0.5198399},"labels":[],"label_agreement":null},{"id":"W14899582","doi":"10.2165/11635740-000000000-00000","title":"Thrombolytic Therapy for Acute Ischaemic Stroke","year":2012,"lang":"en","type":"article","venue":"Drugs","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Ontario Brain Institute; University of Calgary","funders":"Alberta Innovates","keywords":"Medicine; Thrombolysis; Stroke (engine); Intensive care medicine; Fibrinolytic agent; Acute stroke; Tissue plasminogen activator; Ischaemic stroke; SAFER; Internal medicine; Myocardial infarction; Ischemia","score_opus":0.01915028886389957,"score_gpt":0.3109649841788531,"score_spread":0.2918146953149535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W14899582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92629313,0.001202246,0.0023934154,0.003282779,0.0005975574,0.0012308285,0.000042091084,0.00015697432,0.06480098],"genre_scores_gemma":[0.97302026,0.00021365995,0.0038312871,0.0030973891,0.00073925004,0.00013509265,0.00005486911,0.00004298511,0.018865237],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990244,0.000008057316,0.00016150145,0.00017449552,0.00020633113,0.00042519474],"domain_scores_gemma":[0.9993674,0.000050008126,0.000055489018,0.0003498502,0.000038774342,0.00013843694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017364902,0.0001483338,0.0002525647,0.00006749971,0.000046869678,0.000008886607,0.00010624134,0.000064048436,0.0002454597],"category_scores_gemma":[0.000017019962,0.00011883958,0.00013630379,0.000073569034,0.000041097945,0.000104563245,0.00005003148,0.00010485094,0.00018846939],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062499306,0.0005469455,0.02258956,0.000114178714,0.0022406233,0.000008619459,0.0044466853,6.255347e-7,0.13424312,0.001942561,0.77573663,0.05750546],"study_design_scores_gemma":[0.00501285,0.00029349854,0.010282829,0.00003938577,0.0005910994,0.00003494976,0.0008766474,0.0001379286,0.084531546,0.000043167984,0.8978799,0.00027617722],"about_ca_topic_score_codex":0.0000056604094,"about_ca_topic_score_gemma":8.711415e-8,"teacher_disagreement_score":0.12214329,"about_ca_system_score_codex":0.000069538866,"about_ca_system_score_gemma":0.000025253621,"threshold_uncertainty_score":0.48461378},"labels":[],"label_agreement":null},{"id":"W1527756626","doi":"10.2165/11585440-000000000-00000","title":"Drug-Resistant Tuberculosis","year":2011,"lang":"en","type":"article","venue":"Drugs","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Regimen; Tuberculosis; Adverse effect; Pharmacotherapy; Drug resistance; Intensive care medicine; Drug; Bedaquiline; Disease; Mycobacterium tuberculosis; Pharmacology; Surgery; Internal medicine; Pathology","score_opus":0.037385107576415146,"score_gpt":0.30448286132137475,"score_spread":0.2670977537449596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1527756626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.770517,0.00050615455,0.000018670828,0.0050858143,0.00011354599,0.00021880228,0.000008305953,0.00011486823,0.22341686],"genre_scores_gemma":[0.9921956,0.0001870822,0.0012529338,0.0028209207,0.0001428303,0.00003447921,0.000018739876,0.000021806813,0.0033256258],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99873114,0.00009613619,0.0002353031,0.00026550808,0.00021025803,0.0004616528],"domain_scores_gemma":[0.99907523,0.00009416475,0.000031934065,0.0003894093,0.000076318924,0.00033292608],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004349322,0.00012388249,0.00029635025,0.00011990476,0.00006232524,0.0000050587055,0.00011197472,0.00007594179,0.0017297711],"category_scores_gemma":[0.00025463782,0.00009441696,0.00014383723,0.00017455195,0.000110288674,0.00005452963,0.000058808146,0.00022370157,0.0012041462],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030925388,0.0015142986,0.26445132,0.00042755218,0.001007192,0.0006397947,0.011680375,8.531307e-7,0.03193239,0.023911346,0.6001962,0.06114619],"study_design_scores_gemma":[0.0027306434,0.00066757575,0.6994357,0.00013626584,0.00022217575,0.0001231759,0.0016715393,0.00024490658,0.027309386,0.0033638019,0.2635822,0.0005125976],"about_ca_topic_score_codex":0.0009842492,"about_ca_topic_score_gemma":0.00004082381,"teacher_disagreement_score":0.43498442,"about_ca_system_score_codex":0.0000551217,"about_ca_system_score_gemma":0.00005914181,"threshold_uncertainty_score":0.9995735},"labels":[],"label_agreement":null},{"id":"W1598581251","doi":"10.2165/11599470-000000000-00000","title":"The Cost Effectiveness of Human Papillomavirus Vaccines","year":2012,"lang":"en","type":"review","venue":"Drugs","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Providence Health Care Research Institute; Providence Health Care; BC Centre for Disease Control; University of British Columbia","funders":"","keywords":"Medicine; Human papillomavirus; Human papillomavirus vaccine; Virology; Pharmacotherapy; Immunology; Gardasil; Internal medicine; Cancer; Cervical cancer","score_opus":0.12372828497937456,"score_gpt":0.4621449820442727,"score_spread":0.33841669706489813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1598581251","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014478483,0.9642464,0.0000010574628,0.000014938705,0.00017565463,0.0013924825,0.000020769548,0.000018917794,0.034115322],"genre_scores_gemma":[0.0011866974,0.9968187,0.0000014156504,0.000011366506,0.00049619435,0.00029043504,0.00008731136,0.00004538039,0.0010624706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838483,0.0003365081,0.0003582396,0.00020326066,0.00038003494,0.00033713144],"domain_scores_gemma":[0.99799,0.001027204,0.0001247346,0.0005401777,0.00016242838,0.00015542726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011026785,0.00022333374,0.0013396353,0.00008266033,0.00012971288,0.000016104683,0.00025056925,0.00017133968,0.00078252185],"category_scores_gemma":[0.00007224133,0.0001148949,0.00045689745,0.00027972666,0.00009814935,0.00002272144,0.00012756993,0.00046166603,0.00014401376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049561666,0.000051839637,0.000040227762,0.04100068,0.00014360671,0.0000026534606,0.000021316273,2.9102927e-9,0.0000018876856,0.0005567638,0.00020108368,0.9579304],"study_design_scores_gemma":[0.0004706824,0.00009088616,0.0017155935,0.002931657,0.00079707225,0.000009852341,0.000011414683,8.869619e-8,0.0000260884,0.000052100113,0.9937825,0.00011204356],"about_ca_topic_score_codex":0.00010461119,"about_ca_topic_score_gemma":0.000011317494,"teacher_disagreement_score":0.9935814,"about_ca_system_score_codex":0.00014101453,"about_ca_system_score_gemma":0.00019748161,"threshold_uncertainty_score":0.8568065},"labels":[],"label_agreement":null},{"id":"W169459663","doi":"10.2165/00003495-200161040-00003","title":"Review of Macrolides and Ketolides","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Roxithromycin; Ketolide; Telithromycin; Microbiology; Clarithromycin; Erythromycin; Streptococcus pneumoniae; Macrolide Antibiotics; Azithromycin; Haemophilus influenzae; Antibiotics; Medicine; Chemistry; Biology","score_opus":0.043274835764260965,"score_gpt":0.3807761641455251,"score_spread":0.3375013283812642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W169459663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000034055859,0.98739684,0.0000011644872,0.00013200917,0.00009176462,0.00053429895,0.00001964799,0.00002971032,0.011791162],"genre_scores_gemma":[0.0000011199049,0.9977495,0.0000114502245,0.0009931194,0.00014296618,0.00004820011,0.000026370712,0.000026918724,0.0010003487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990243,0.00006782078,0.00047406403,0.00018846184,0.00010922014,0.00013617777],"domain_scores_gemma":[0.99922806,0.000089848276,0.00022292187,0.0002951028,0.00006146197,0.00010259789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017469388,0.00020840071,0.0016484311,0.00014283191,0.000033359775,0.000004787057,0.00005615696,0.00014417463,0.00013780834],"category_scores_gemma":[0.000101426675,0.00013821936,0.00036805987,0.00032127334,0.00008697716,0.00002100803,0.000035180332,0.00022751601,0.00005348447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[3.4235143e-7,0.000020698293,0.000011119146,0.29865333,0.00007415487,0.000012901486,0.0000072723783,8.869401e-10,7.240082e-7,0.00003581157,0.0021720869,0.69901156],"study_design_scores_gemma":[0.000062499865,0.000030650008,0.0000041195317,0.2607242,0.0012535808,0.000504234,0.0000030632282,5.473592e-8,6.479493e-7,0.0000060215525,0.7373277,0.00008324993],"about_ca_topic_score_codex":0.0000064051924,"about_ca_topic_score_gemma":4.4108816e-7,"teacher_disagreement_score":0.7351556,"about_ca_system_score_codex":0.000027801225,"about_ca_system_score_gemma":0.00017936034,"threshold_uncertainty_score":0.5636422},"labels":[],"label_agreement":null},{"id":"W186149320","doi":"10.2165/11595870-000000000-00000","title":"Current and Emerging Drug Treatment Options for Alzheimerʼs Disease","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pharmacotherapy; Drug; Disease; Current (fluid); Alzheimer's disease; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.10408147618995826,"score_gpt":0.41435526508169573,"score_spread":0.31027378889173746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W186149320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021975053,0.9945272,0.000007168535,0.00008449245,0.00018388891,0.0037565893,0.000988375,0.00008111299,0.00034918464],"genre_scores_gemma":[0.0000891158,0.99415255,0.00018149448,0.000012598621,0.00032887474,0.0026154954,0.0021830527,0.00009960169,0.00033720635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980617,0.000088942266,0.0004088247,0.00066032435,0.00023722117,0.0005429567],"domain_scores_gemma":[0.9978375,0.00013652598,0.00015619575,0.0005640723,0.00008833435,0.0012174111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010361397,0.0005697962,0.0013026745,0.00027166225,0.00021134254,0.000036078247,0.000105138075,0.000080215985,0.00013261991],"category_scores_gemma":[0.000027711296,0.00039144934,0.00085556455,0.00016056246,0.000106978885,0.00007449338,0.000075971475,0.00016852304,0.00019837968],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081861006,0.0008299784,0.0000506802,0.006527454,0.009951464,0.000044055087,0.00012088855,1.5426535e-8,3.0262872e-9,0.00044370524,0.0014561926,0.9804937],"study_design_scores_gemma":[0.0013783595,0.00015027772,0.00004248617,0.0054859584,0.026285004,0.000012014729,0.000025153495,0.000009672945,3.1877144e-7,0.00015098054,0.9661625,0.0002972825],"about_ca_topic_score_codex":0.00003832713,"about_ca_topic_score_gemma":0.0000022962906,"teacher_disagreement_score":0.9801964,"about_ca_system_score_codex":0.00021000019,"about_ca_system_score_gemma":0.00090329634,"threshold_uncertainty_score":0.99985373},"labels":[],"label_agreement":null},{"id":"W1964772192","doi":"10.2165/00003495-200464060-00004","title":"Current Issues in the Management of Urinary Tract Infections","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Pharmacotherapy; Urinary system; Current (fluid); Internal medicine","score_opus":0.04426529444297341,"score_gpt":0.3864096607318575,"score_spread":0.3421443662888841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964772192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009114301,0.97867846,0.000016542723,0.00019493945,0.00039919873,0.0022487603,0.000011672026,0.0000590122,0.01830027],"genre_scores_gemma":[0.00047962292,0.9978426,0.000121999365,0.000019348769,0.00013278176,0.0005606783,0.00010884388,0.00003921604,0.0006948774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982219,0.0001371117,0.0006861139,0.00032936642,0.0003768906,0.0002486435],"domain_scores_gemma":[0.9987851,0.000082011735,0.0002606181,0.00079622486,0.000030469073,0.000045579913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046977162,0.0003424482,0.00096877554,0.000614347,0.000060477756,0.000018136903,0.00025220416,0.00010612226,0.00012777605],"category_scores_gemma":[0.0000073816896,0.00023257555,0.0005244299,0.000969181,0.000063823376,0.000074222364,0.00010967944,0.00064887747,0.00021606858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000047567087,0.023210142,0.000042641128,0.078826465,0.00041784678,0.00030036457,0.00039157906,0.000009590079,2.9143785e-9,0.003530366,0.0006359861,0.8926303],"study_design_scores_gemma":[0.0003733432,0.0008936602,0.0005310578,0.034456246,0.0021914332,0.0003056866,0.00015921266,5.725891e-7,6.766273e-8,0.00008081589,0.9608361,0.00017177757],"about_ca_topic_score_codex":0.00006107994,"about_ca_topic_score_gemma":0.0000011751295,"teacher_disagreement_score":0.96020013,"about_ca_system_score_codex":0.0003481295,"about_ca_system_score_gemma":0.00010922095,"threshold_uncertainty_score":0.9484156},"labels":[],"label_agreement":null},{"id":"W1965009420","doi":"10.2165/00003495-200767140-00007","title":"Fluoroquinolones for the Treatment of Pulmonary Tuberculosis","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; BC Centre for Disease Control","funders":"","keywords":"Medicine; Moxifloxacin; Ethambutol; Pyrazinamide; Gatifloxacin; Levofloxacin; Tolerability; Rifampicin; Tuberculosis; Internal medicine; Culture conversion; Regimen; Bedaquiline; Adverse effect; Mycobacterium tuberculosis; Surgery; Antibiotics; Sputum; Pathology","score_opus":0.12201034200474559,"score_gpt":0.43324468431030594,"score_spread":0.31123434230556035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965009420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022162041,0.9947241,0.000026316875,0.0009473825,0.00019021121,0.0024851921,0.00013421515,0.000028418835,0.0014420019],"genre_scores_gemma":[0.00002058405,0.9962847,0.00019514695,0.00013713563,0.000630535,0.0007762555,0.0003486235,0.000053647876,0.0015533495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808216,0.00013321816,0.000684734,0.0003642875,0.00021275155,0.0005228503],"domain_scores_gemma":[0.99595684,0.0029143847,0.00018925793,0.00068357575,0.000101181,0.00015473927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053279224,0.00034700596,0.0021772347,0.00022539459,0.00007943378,0.0000047266044,0.00019572659,0.00037100282,0.000086627995],"category_scores_gemma":[0.00019985641,0.00016881943,0.0014221894,0.00024731143,0.00018520956,0.000016832251,0.000031150284,0.00018560699,0.00007830095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076028875,0.00030854784,0.000028230841,0.0073521417,0.0010726028,0.000015428715,0.000069125184,1.0223014e-7,0.0000010977383,0.00009180733,0.0034825997,0.9875023],"study_design_scores_gemma":[0.0002985225,0.0006166271,0.000057324225,0.0017428236,0.002193834,0.00010966533,0.000042166055,0.00003063346,0.000010544439,0.000020005706,0.9947499,0.00012793684],"about_ca_topic_score_codex":0.00017393098,"about_ca_topic_score_gemma":0.0000056600525,"teacher_disagreement_score":0.9912673,"about_ca_system_score_codex":0.00020711741,"about_ca_system_score_gemma":0.00019395433,"threshold_uncertainty_score":0.68842566},"labels":[],"label_agreement":null},{"id":"W1965225830","doi":"10.2165/00003495-200060020-00003","title":"Potential Novel Uses of Thalidomide","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Thalidomide; Medicine; Erythema nodosum; Multiple myeloma; Rheumatoid arthritis; Pyoderma gangrenosum; Dermatology; Cancer; Disease; Immunology; Internal medicine","score_opus":0.06488550715583498,"score_gpt":0.383350522487704,"score_spread":0.31846501533186905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965225830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008117694,0.98989975,0.0000074758073,0.000019759334,0.00007688501,0.00082760135,0.0002594837,0.000027340466,0.008800515],"genre_scores_gemma":[0.0002226965,0.9944274,0.0003760446,0.000016537024,0.00020261365,0.00005881175,0.00048370555,0.000048492213,0.0041637323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998521,0.00005379819,0.0004201802,0.000281225,0.00042889544,0.00029491747],"domain_scores_gemma":[0.9990791,0.00009792951,0.00014336326,0.00043941333,0.00005066098,0.00018955328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010058955,0.00027080107,0.0014914129,0.0002170623,0.000029092063,0.000010745645,0.00014197831,0.00018415543,0.0009050483],"category_scores_gemma":[0.000051377392,0.00018205546,0.00062831177,0.00018332413,0.000076365985,0.000028087787,0.000048768605,0.0002417473,0.00040286206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006541279,0.0002964481,0.000011020748,0.009487251,0.0005508665,0.00012509215,0.000023482242,8.713547e-8,0.0000020557995,0.00001951139,0.00058398466,0.9888348],"study_design_scores_gemma":[0.001503879,0.00008619009,0.000034518827,0.007334107,0.001085589,0.00015293303,0.0000073958104,0.0000034073598,0.000015278856,0.0000051593033,0.98964727,0.00012425907],"about_ca_topic_score_codex":0.00013870138,"about_ca_topic_score_gemma":0.0000011978998,"teacher_disagreement_score":0.9890633,"about_ca_system_score_codex":0.00007299556,"about_ca_system_score_gemma":0.0004094811,"threshold_uncertainty_score":0.9909644},"labels":[],"label_agreement":null},{"id":"W1966240579","doi":"10.2165/00003495-200060060-00007","title":"Current Recommendations for the Treatment of Genital Herpes","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Valaciclovir; Famciclovir; Aciclovir; Medicine; Foscarnet; Penciclovir; Herpes simplex virus; Asymptomatic; Intensive care medicine; Ganciclovir; Internal medicine; Immunology; Viral disease; Herpesviridae; Virus; Human cytomegalovirus","score_opus":0.09999097896334952,"score_gpt":0.42182045722408984,"score_spread":0.3218294782607403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966240579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013029284,0.99566257,0.000023929262,0.00012506626,0.00039805475,0.0019237647,0.0005052558,0.000024166864,0.0013241553],"genre_scores_gemma":[0.000012690032,0.9960159,0.00016864642,0.00000970227,0.00026190814,0.0011744545,0.0005897585,0.000032458312,0.0017344628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991942,0.000034106804,0.00036117245,0.00018589509,0.000079528814,0.00014510009],"domain_scores_gemma":[0.9991388,0.00029226305,0.0001302248,0.00034696868,0.000037447055,0.00005429686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004656197,0.00023071785,0.00078350585,0.00009278681,0.00011624062,0.000009671433,0.00005296859,0.00008563815,0.00041727108],"category_scores_gemma":[0.0000060906923,0.00011858988,0.0007580772,0.00014988006,0.00003755831,0.000016432063,0.000005553656,0.000057254398,0.00011666945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000066666203,0.0009950814,0.0000012781896,0.001011827,0.0006734933,6.992382e-7,0.00013644507,5.1698684e-8,1.2739648e-9,0.000041952426,0.0016803606,0.99545217],"study_design_scores_gemma":[0.00064640876,0.0002672128,0.0000015282047,0.0016761362,0.004069024,0.000012085509,0.000016611528,0.0000026527966,0.0000010797626,0.000015388456,0.99320805,0.00008384645],"about_ca_topic_score_codex":0.000048771333,"about_ca_topic_score_gemma":0.0000057267266,"teacher_disagreement_score":0.9953683,"about_ca_system_score_codex":0.00018904915,"about_ca_system_score_gemma":0.0001939871,"threshold_uncertainty_score":0.4835955},"labels":[],"label_agreement":null},{"id":"W1966435794","doi":"10.2165/11635660-000000000-00000","title":"Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections","year":2012,"lang":"en","type":"review","venue":"Drugs","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"Forest Laboratories","keywords":"Microbiology; Medicine; Cephalosporin; Enterococcus faecalis; Staphylococcus aureus; Bacterial pneumonia; Streptococcus pneumoniae; Methicillin-resistant Staphylococcus aureus; Vancomycin; Enterococcus faecium; Antibiotics; Biology; Bacteria","score_opus":0.029308340028212004,"score_gpt":0.32106770984662436,"score_spread":0.29175936981841233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966435794","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5286329,0.46796396,0.0000013563998,0.00007318395,0.00046447286,0.0015880947,0.0011318594,0.000019121355,0.00012509145],"genre_scores_gemma":[0.05155906,0.94627297,0.000106200845,0.00004054307,0.0007110342,0.000077101366,0.0011048776,0.000058204016,0.00007003196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979474,0.0006291412,0.00067139865,0.00023494342,0.00017307434,0.00034406205],"domain_scores_gemma":[0.9983967,0.0004196718,0.00036704034,0.000656349,0.000050302748,0.00010994648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025190957,0.0005166906,0.0018715532,0.00021992993,0.00015871531,0.000046068726,0.00017343413,0.0004020227,0.00008723107],"category_scores_gemma":[0.000028782788,0.00032553772,0.00025544738,0.00028812943,0.0003346238,0.00007728,0.000085156535,0.00038233373,0.0000029734279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031729403,0.00093802286,0.00016156575,0.0059851566,0.0007033311,0.000021249376,0.008811501,4.7600377e-8,0.0014904201,0.000040359995,0.00020111534,0.9813299],"study_design_scores_gemma":[0.0019736865,0.00061271637,0.0032450862,0.0017799513,0.0028763355,0.0002112004,0.0002016718,3.208628e-7,0.00007333162,0.000019571624,0.98872495,0.00028117554],"about_ca_topic_score_codex":0.0004640181,"about_ca_topic_score_gemma":0.0005709423,"teacher_disagreement_score":0.98852384,"about_ca_system_score_codex":0.00016185656,"about_ca_system_score_gemma":0.00016304976,"threshold_uncertainty_score":0.99991965},"labels":[],"label_agreement":null},{"id":"W1967712902","doi":"10.2165/11594300-000000000-00000","title":"Therapeutic Potential of Ginseng in the Management of Cardiovascular Disorders","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Ginseng; Medicine; Ginsenoside; Heart failure; Pharmacology; Traditional medicine; American ginseng; Cardiology; Alternative medicine; Pathology","score_opus":0.020197091009005047,"score_gpt":0.27751335339812616,"score_spread":0.2573162623891211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967712902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034613322,0.9968583,0.00033367693,0.0000067129963,0.000032675518,0.0005973671,0.000019338573,0.0000022233723,0.0018035517],"genre_scores_gemma":[0.03325578,0.9663678,0.00007717782,0.000013030449,0.000027289447,0.000121242534,0.00009729591,0.0000115643315,0.000028836115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917895,0.00015843817,0.00024326859,0.00022002278,0.00008387898,0.000115418086],"domain_scores_gemma":[0.9993199,0.000012149893,0.000112403475,0.000530049,0.000012783099,0.000012711251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028293047,0.00014931308,0.00045064196,0.00002884649,0.000017656717,0.0000028905558,0.00036177106,0.00014944,0.000005177994],"category_scores_gemma":[0.000002017705,0.00008595427,0.0006036813,0.00012080281,0.00008770683,4.9888826e-7,0.00007585422,0.00008838314,0.000002829691],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000030015356,0.00008549504,7.7237274e-7,0.0026014685,0.0006695473,6.571539e-7,0.000022364826,0.000009493698,0.000031492935,0.001350084,0.000021751197,0.99520385],"study_design_scores_gemma":[0.00010951079,0.000053419608,0.000039015504,0.00034976745,0.00057963235,0.0000017322146,0.00005194644,9.872907e-7,0.000026056974,0.00012225735,0.9985622,0.00010344148],"about_ca_topic_score_codex":0.000032081247,"about_ca_topic_score_gemma":0.0000012826372,"teacher_disagreement_score":0.99854046,"about_ca_system_score_codex":0.0000035346322,"about_ca_system_score_gemma":0.000016864633,"threshold_uncertainty_score":0.35051134},"labels":[],"label_agreement":null},{"id":"W1971739828","doi":"10.2165/00003495-200969030-00004","title":"Paediatric Painful Bladder Syndrome/Interstitial Cystitis","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Providence Health Care","funders":"","keywords":"Interstitial cystitis; Medicine; Urinary urgency; Urinalysis; Hydroxyzine; Amitriptyline; Urinary system; Abdominal pain; Urology; Enuresis; Overactive bladder; Internal medicine; Anesthesia; Pathology","score_opus":0.03922192377809979,"score_gpt":0.35879610837070164,"score_spread":0.31957418459260184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971739828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007679737,0.96533823,0.00001998539,0.00021132447,0.00036123564,0.0013709811,0.00014648568,0.0001556622,0.03238841],"genre_scores_gemma":[0.000096339965,0.9854169,0.00012457387,0.00019192007,0.0010001201,0.00010393739,0.00081667677,0.000107193155,0.01214237],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685055,0.00026460286,0.0006900387,0.00067875476,0.0007281668,0.00078790233],"domain_scores_gemma":[0.99826676,0.00027441076,0.00016327109,0.0007102109,0.000107259395,0.0004781115],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005035258,0.0005911784,0.0020857134,0.00067665154,0.00010964861,0.00007366895,0.0003292957,0.00048814758,0.0020146316],"category_scores_gemma":[0.00009947851,0.00046556475,0.0009492657,0.0007686695,0.00011054989,0.00008802886,0.00014715521,0.00119398,0.0028335967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023410348,0.00013792622,0.0000029457922,0.01176509,0.00030355877,0.003436468,0.00009991504,4.3458154e-8,3.4315228e-8,0.000027259035,0.028753314,0.95545006],"study_design_scores_gemma":[0.0005603792,0.0008947674,0.000016605627,0.005991456,0.001467441,0.004549913,0.000030163865,0.0000031355364,2.2216408e-7,0.000046147226,0.9860108,0.0004289581],"about_ca_topic_score_codex":0.00005222783,"about_ca_topic_score_gemma":0.0000018401806,"teacher_disagreement_score":0.9572575,"about_ca_system_score_codex":0.00024251151,"about_ca_system_score_gemma":0.00095369905,"threshold_uncertainty_score":0.9997796},"labels":[],"label_agreement":null},{"id":"W1972079818","doi":"10.2165/00003495-200767070-00006","title":"Comparative Review of the Carbapenems","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":644,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Doripenem; Ertapenem; Meropenem; Imipenem; Carbapenem; Microbiology; Cilastatin; Enterococcus faecium; Medicine; Biology; Antibiotics; Antibiotic resistance","score_opus":0.11739415539138064,"score_gpt":0.45396501980962234,"score_spread":0.3365708644182417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972079818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000017613264,0.9579736,0.0000028803759,0.000096630945,0.00026423833,0.0010425276,0.000019415565,0.000009519017,0.040589407],"genre_scores_gemma":[0.000023849558,0.9971869,0.0000517862,0.00071742566,0.00018074998,0.0000032747785,0.000052808376,0.000024473147,0.0017587548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987216,0.000066847126,0.0005672804,0.00018235986,0.0003007735,0.00016111102],"domain_scores_gemma":[0.99885666,0.00011523988,0.00036639065,0.0004728835,0.00011400728,0.00007481527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031213326,0.00022694576,0.0018630846,0.00005348235,0.000025763233,0.0000030075473,0.00022565479,0.00010441396,0.00017327128],"category_scores_gemma":[0.00003356688,0.00011959918,0.00067565974,0.0003850901,0.00010982458,0.000006086932,0.0000913293,0.00039843254,0.00009672713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000243133,0.00007657327,0.0000014468778,0.28188396,0.00021105843,0.000005218405,0.00006916919,3.3594876e-8,7.8441866e-7,0.00020595688,0.022735598,0.69480777],"study_design_scores_gemma":[0.00010130771,0.000015545962,0.000005466986,0.2078428,0.0017809228,0.000020963673,0.000005181078,0.0000011649458,0.000013435876,0.0000011687514,0.79012626,0.000085760395],"about_ca_topic_score_codex":0.0000059157314,"about_ca_topic_score_gemma":2.0267628e-7,"teacher_disagreement_score":0.76739067,"about_ca_system_score_codex":0.000038615857,"about_ca_system_score_gemma":0.00024115316,"threshold_uncertainty_score":0.4877113},"labels":[],"label_agreement":null},{"id":"W1972606475","doi":"10.2165/00003495-200565100-00002","title":"Tigecycline","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Tigecycline; Medicine; Pharmacodynamics; Linezolid; Antibiotics; Adverse effect; Pharmacology; Pneumonia; Pharmacokinetics; Internal medicine; Microbiology; Vancomycin; Staphylococcus aureus; Biology","score_opus":0.02176675668497814,"score_gpt":0.33364893815410823,"score_spread":0.3118821814691301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972606475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004236639,0.9930598,0.000032437223,0.000011591315,0.00025868122,0.00021554698,0.000047427853,0.000014856087,0.0063172714],"genre_scores_gemma":[0.000012803838,0.9853847,0.0005753122,0.00006883904,0.0014742862,0.000010775017,0.00080053875,0.00006273536,0.011610003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887955,0.000058391826,0.00033956574,0.00040383905,0.00009378665,0.00022487427],"domain_scores_gemma":[0.9991372,0.000011167163,0.00018008321,0.00058383663,0.000025112056,0.00006258116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010964764,0.00028360126,0.0006080637,0.000037521164,0.000031735555,0.000023389837,0.0003330878,0.00039549987,0.00014176409],"category_scores_gemma":[0.000035314468,0.00023547615,0.00033874356,0.00006806999,0.000059201375,9.54446e-7,0.00011726396,0.00013436227,0.00039027238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000025691975,0.000017491086,0.0000024529256,0.0009960099,0.00006198169,0.0000021434569,0.0000028601996,5.5011526e-8,0.000020398851,0.00002479856,0.009467525,0.9894017],"study_design_scores_gemma":[0.000060656348,0.000018207711,0.0000028373158,0.00094731245,0.00011139377,0.000013611653,0.0000027681351,1.4679493e-7,0.000024667526,0.0000028469494,0.99855685,0.00025867033],"about_ca_topic_score_codex":0.0000015066267,"about_ca_topic_score_gemma":0.000002630591,"teacher_disagreement_score":0.989143,"about_ca_system_score_codex":0.000021301625,"about_ca_system_score_gemma":0.00013952816,"threshold_uncertainty_score":0.9602439},"labels":[],"label_agreement":null},{"id":"W1973067762","doi":"10.2165/11532000-000000000-00000","title":"Can Improving Sleep Influence Sleep-Disordered Breathing?","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"","keywords":"Medicine; Insomnia; Sleep and breathing; Non-rapid eye movement sleep; Hypoventilation; Sleep (system call); Zolpidem; Anesthesia; Obesity hypoventilation syndrome; Sleep disorder; Sleep apnea; Obstructive sleep apnea; Internal medicine; Psychiatry; Respiratory system; Electroencephalography","score_opus":0.020651255180025745,"score_gpt":0.32980863884302813,"score_spread":0.3091573836630024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973067762","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002688214,0.9897027,0.000025060752,0.00028194796,0.00022591431,0.002115206,0.00007903857,0.0002310673,0.007070235],"genre_scores_gemma":[0.0011062961,0.9956444,0.0008145713,0.00027503935,0.0005174924,0.0001789619,0.0002795738,0.00019900658,0.0009846754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99572396,0.00023861112,0.0009072271,0.001061962,0.0010518389,0.0010163832],"domain_scores_gemma":[0.99716467,0.0002548694,0.00041816957,0.0013324361,0.00032519532,0.0005046516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052643585,0.0007884891,0.0024932378,0.00065089104,0.00018745997,0.00010720907,0.00065584824,0.00060313573,0.00018473755],"category_scores_gemma":[0.00063683384,0.0006575582,0.0007444874,0.0009715441,0.00020509568,0.00014650855,0.00029309714,0.0018130405,0.00041247072],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013788466,0.0000868922,0.000030075407,0.011826509,0.000238226,0.00020700444,0.0003001437,8.9411475e-7,0.0000061934384,0.0001076804,0.000057954927,0.9871246],"study_design_scores_gemma":[0.0012193926,0.00026425524,0.00016829073,0.0074004275,0.0017940387,0.0005186236,0.00014021917,0.00021323406,0.000010952522,0.00013012954,0.9872324,0.0009080234],"about_ca_topic_score_codex":0.0004962201,"about_ca_topic_score_gemma":0.000017876853,"teacher_disagreement_score":0.98717445,"about_ca_system_score_codex":0.0008069097,"about_ca_system_score_gemma":0.0004061817,"threshold_uncertainty_score":0.9995876},"labels":[],"label_agreement":null},{"id":"W1973968673","doi":"10.2165/11533040-000000000-00000","title":"Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae","year":2010,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":380,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Nitrofurantoin; Medicine; Intensive care medicine; Fosfomycin; Enterobacteriaceae; Antibiotics; Microbiology; Antibiotic resistance; Escherichia coli; Biology","score_opus":0.010537909936359328,"score_gpt":0.27470445539159594,"score_spread":0.2641665454552366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973968673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013566669,0.98096985,0.0002050507,0.000029746881,0.00097331847,0.0007356927,0.00011152886,0.00006979095,0.00333834],"genre_scores_gemma":[0.0013648365,0.99363685,0.0005135751,0.000035087243,0.0009192896,0.000049527916,0.00084554404,0.00014087526,0.002494415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803257,0.00010830601,0.00041719704,0.00086919527,0.00014776915,0.0004249613],"domain_scores_gemma":[0.9982344,0.000020322143,0.00036158157,0.0012135695,0.000050971896,0.00011917148],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018813398,0.0005311519,0.0008328975,0.00010300216,0.00013135771,0.00010864519,0.0003796012,0.00054776995,0.00009604368],"category_scores_gemma":[0.000051268526,0.00041142481,0.00031836482,0.000167222,0.00016027487,0.000006223368,0.00015676145,0.000492658,0.00010057533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013199874,0.00068678014,0.0014714719,0.0122209005,0.0013141795,0.000059988604,0.0001591013,0.0000010711783,0.0033019872,0.0004891909,0.0052628033,0.97490054],"study_design_scores_gemma":[0.00015283552,0.00015714842,0.00018582698,0.0018351224,0.0002653456,0.0001424673,0.00001060926,1.0816991e-7,0.00021161216,0.000008441923,0.996545,0.0004854675],"about_ca_topic_score_codex":0.000015777043,"about_ca_topic_score_gemma":0.000079654994,"teacher_disagreement_score":0.9912822,"about_ca_system_score_codex":0.000044699642,"about_ca_system_score_gemma":0.00030647955,"threshold_uncertainty_score":0.99983376},"labels":[],"label_agreement":null},{"id":"W1974236161","doi":"10.2165/00003495-200868001-00002","title":"Trends in Kidney Transplantation over the Past Decade","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Transplantation; Kidney transplantation; Immunosuppression; Azathioprine; Tacrolimus; Kidney; Surgery; Internal medicine; Disease","score_opus":0.03607397678006712,"score_gpt":0.3511537070343408,"score_spread":0.31507973025427366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974236161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055584733,0.98960304,0.0000097229795,0.00017874008,0.00016045303,0.00044391945,0.00019656702,0.00003159768,0.009320353],"genre_scores_gemma":[0.0001086616,0.9940833,0.000058185164,0.00036030254,0.00013263199,0.00008894665,0.002412402,0.000038619386,0.0027169704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987372,0.00008314224,0.00043989645,0.00026054154,0.0002737355,0.00020545963],"domain_scores_gemma":[0.999382,0.000120888326,0.00012424203,0.0002360873,0.000012823861,0.0001239291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055066022,0.0002969258,0.0008432216,0.0003533252,0.000052750536,0.000012719124,0.00010165089,0.00017819136,0.00019114635],"category_scores_gemma":[0.0000040050095,0.00016157106,0.0004883364,0.00050690316,0.000037088434,0.000043748485,0.000004271775,0.0003072809,0.00011094357],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004021542,0.00009446603,0.0007916909,0.008496478,0.00023111461,0.0004386622,0.00064606476,3.6060626e-7,5.2978553e-8,0.00006535479,0.0008522023,0.98834336],"study_design_scores_gemma":[0.0016123371,0.00003996677,0.0060249586,0.014956164,0.0011736612,0.00065327185,0.000008364929,0.0000016515394,6.112571e-7,0.0000038268045,0.97536355,0.00016165998],"about_ca_topic_score_codex":0.000068937276,"about_ca_topic_score_gemma":0.00000900712,"teacher_disagreement_score":0.98818165,"about_ca_system_score_codex":0.00009236424,"about_ca_system_score_gemma":0.00011850135,"threshold_uncertainty_score":0.65886766},"labels":[],"label_agreement":null},{"id":"W1976600789","doi":"10.2165/00003495-200767180-00002","title":"Guidelines for the Management of Lyme Disease","year":2007,"lang":"en","type":"article","venue":"Drugs","topic":"Vector-borne infectious diseases","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Lyme disease; Pharmacotherapy; Disease management; Intensive care medicine; Disease; Internal medicine; Virology","score_opus":0.025703443869779047,"score_gpt":0.30737647899494547,"score_spread":0.2816730351251664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976600789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90588903,0.049231708,0.02054302,0.005738584,0.004102993,0.0024882806,0.00038978088,0.00035459665,0.011261978],"genre_scores_gemma":[0.9957313,0.00010266625,0.00013526468,0.00054012774,0.000053051856,0.00004135561,0.000035361525,0.000010418815,0.0033504337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99946356,0.000014715427,0.0001995143,0.00011994636,0.000022693972,0.00017955653],"domain_scores_gemma":[0.99938834,0.00016426915,0.00006260517,0.00024480012,0.00012276087,0.000017225331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025726418,0.00007610233,0.00008786439,0.000033140295,0.000092158654,0.000003478555,0.00014889496,0.00003403551,0.00017933181],"category_scores_gemma":[0.000051021932,0.000051084233,0.00010364711,0.00006501628,0.00009397576,0.000020564592,0.000047126603,0.000032142674,0.00008938638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003080585,0.0014435644,0.029408423,0.00081823947,0.0057358914,0.000034265642,0.0011920788,0.00023992886,0.029721344,0.14709593,0.37940297,0.40182677],"study_design_scores_gemma":[0.0028761171,0.00010700152,0.16424264,0.00009123803,0.00084992877,0.00000659062,0.0015446413,0.000022362294,0.02416547,0.0021466522,0.80364597,0.0003014058],"about_ca_topic_score_codex":0.000035311845,"about_ca_topic_score_gemma":0.0000064913975,"teacher_disagreement_score":0.42424297,"about_ca_system_score_codex":0.000013891384,"about_ca_system_score_gemma":0.00001684549,"threshold_uncertainty_score":0.20831545},"labels":[],"label_agreement":null},{"id":"W1979208548","doi":"10.2165/00003495-200565150-00004","title":"Pharmacological Treatment of Ankylosing Spondylitis","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia; McMaster University","funders":"Spondylitis Association of America","keywords":"Medicine; Randomized controlled trial; Ankylosing spondylitis; Internal medicine; Placebo; Rheumatology; MEDLINE; Physical therapy; Alternative medicine","score_opus":0.0811452335208391,"score_gpt":0.40616622497221516,"score_spread":0.3250209914513761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979208548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029098822,0.98970366,3.4145194e-7,0.000045161367,0.00021516568,0.0010346653,0.0005801831,0.000047515674,0.008082344],"genre_scores_gemma":[0.00008998514,0.99613965,0.00028384602,0.000034107252,0.0005278133,0.00017528687,0.0005982142,0.00004221406,0.002108897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853545,0.00005879477,0.00052397815,0.00036718833,0.00020682233,0.00030777894],"domain_scores_gemma":[0.9992521,0.000114737704,0.00021158857,0.0002452495,0.000043512133,0.00013282192],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000045554123,0.0004128529,0.0023392674,0.00013181618,0.00006094747,0.000006849504,0.000059659866,0.00019494108,0.0014596895],"category_scores_gemma":[0.000010458199,0.00026895807,0.0008507531,0.00019489328,0.00009052548,0.000021490307,0.000035061053,0.00010353484,0.00015347719],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039929946,0.0007481145,0.000015230055,0.0014175513,0.0010022937,0.00033965107,0.000110528534,1.4583818e-8,3.502588e-7,0.00003858837,0.00035016297,0.9959376],"study_design_scores_gemma":[0.002108345,0.0008837397,0.0000165363,0.004074808,0.005172871,0.00025269255,0.000027220687,3.4399054e-7,0.000007014408,0.0000030090298,0.987285,0.00016840141],"about_ca_topic_score_codex":0.000028907227,"about_ca_topic_score_gemma":0.0000018966484,"teacher_disagreement_score":0.9957692,"about_ca_system_score_codex":0.00040940908,"about_ca_system_score_gemma":0.00013736199,"threshold_uncertainty_score":0.9999763},"labels":[],"label_agreement":null},{"id":"W1980049759","doi":"10.2165/00003495-200161140-00002","title":"Underutilisation of ACE Inhibitors in Patients with Congestive Heart Failure","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Heart failure; ACE inhibitor; Angiotensin-converting enzyme; Internal medicine; Intensive care medicine; Pharmacotherapy; Dose; MEDLINE; Emergency medicine; Cardiology; Blood pressure","score_opus":0.019961910363628925,"score_gpt":0.2886777781622897,"score_spread":0.26871586779866075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980049759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020405701,0.98911154,0.000008379109,0.0017204563,0.00014213799,0.0050827586,0.0000271457,0.000065653745,0.0018013831],"genre_scores_gemma":[0.004152961,0.99153525,0.0014233361,0.00008995212,0.00011236335,0.00016551216,0.00091696,0.00007599176,0.0015276746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878454,0.00007134778,0.00037538444,0.00028136704,0.00029652516,0.00019083044],"domain_scores_gemma":[0.9993558,0.00006324089,0.00016437857,0.00027171374,0.00007180005,0.00007305095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001220769,0.00026913857,0.0011137504,0.00026761403,0.000015978721,0.0000064921574,0.000044361255,0.00015847152,0.00006806986],"category_scores_gemma":[0.000021772315,0.00018162298,0.00013940885,0.00045037168,0.00005324653,0.00005615953,0.000030615596,0.00019026437,0.000050261486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009679391,0.00086110993,0.019771209,0.012035759,0.00046363578,0.000024038241,0.0005509316,0.0000010992139,4.1528015e-8,0.00017237944,0.028174134,0.93784887],"study_design_scores_gemma":[0.0014721311,0.0002872103,0.0012765281,0.011082905,0.00066353334,0.0000017299757,0.00010219984,4.8488516e-7,9.089851e-7,0.0000043068558,0.9849658,0.00014227208],"about_ca_topic_score_codex":0.000057265515,"about_ca_topic_score_gemma":0.000038208644,"teacher_disagreement_score":0.95679164,"about_ca_system_score_codex":0.00021718515,"about_ca_system_score_gemma":0.00015825643,"threshold_uncertainty_score":0.740637},"labels":[],"label_agreement":null},{"id":"W1983382084","doi":"10.1007/s40265-014-0212-x","title":"Teriflunomide and Its Mechanism of Action in Multiple Sclerosis","year":2014,"lang":"en","type":"review","venue":"Drugs","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":352,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharma; EMD Serono; Sanofi; Bayer HealthCare; Genentech; Else Kröner-Fresenius-Stiftung; Fresenius Medical Care North America; Deutsche Forschungsgemeinschaft; GlaxoSmithKline; Biogen; Teva Pharmaceutical Industries; Eli Lilly and Company","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Immune system; Mechanism of action; Adverse effect; Immunology; Pharmacology; Pyrimidine metabolism; Disease; Internal medicine; Fingolimod; Enzyme; In vitro; Biology; Biochemistry","score_opus":0.11878070727903658,"score_gpt":0.3515273827265237,"score_spread":0.2327466754474871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983382084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022394047,0.9960611,0.000009516841,0.000024304025,0.000054971268,0.0007067184,0.000007980676,0.000016044361,0.0008799849],"genre_scores_gemma":[0.005293306,0.9939184,0.000024843419,0.000018679952,0.0000373373,0.00007410877,0.000042207303,0.000032548895,0.00055856945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884623,0.00009625863,0.00048879505,0.00021634156,0.00017604743,0.00017632652],"domain_scores_gemma":[0.9994121,0.00008877497,0.0001844848,0.00022215497,0.000039665905,0.000052777337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003720968,0.00017290017,0.0012775087,0.00029100548,0.000025411966,0.0000074175737,0.000082506194,0.00022764248,0.000067684574],"category_scores_gemma":[0.00012855728,0.00014066839,0.00015292967,0.00016343157,0.000031782325,0.00005322524,0.00007001305,0.00030427254,0.00006206544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016485694,0.000034844103,0.000011173973,0.022899449,0.00003394823,0.0000021249796,0.00010804688,3.3540765e-8,0.00015966364,0.00019476969,0.000083548155,0.9764559],"study_design_scores_gemma":[0.0009008455,0.00008774276,0.00014416456,0.015535868,0.00015218246,0.000009314103,0.00008911939,0.00010901286,0.0002639367,0.000024441131,0.9825254,0.00015795439],"about_ca_topic_score_codex":0.000045139117,"about_ca_topic_score_gemma":0.0000055108317,"teacher_disagreement_score":0.98244184,"about_ca_system_score_codex":0.00005373102,"about_ca_system_score_gemma":0.00015661656,"threshold_uncertainty_score":0.573629},"labels":[],"label_agreement":null},{"id":"W1985627776","doi":"10.2165/00003495-200868001-00003","title":"Malignancy in Kidney Transplant Recipients","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Immunosuppression; Sirolimus; Malignancy; Temsirolimus; Calcineurin; Transplantation; Population; Kidney transplantation; Tacrolimus; Discovery and development of mTOR inhibitors; Oncology; Internal medicine; PI3K/AKT/mTOR pathway; Immunology; Biology","score_opus":0.03095871917603919,"score_gpt":0.3193619925432934,"score_spread":0.2884032733672542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985627776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050553976,0.9859463,3.23228e-7,0.000034568046,0.00037850183,0.00056508183,0.00022958413,0.000050064325,0.012745022],"genre_scores_gemma":[0.000042543037,0.9951202,0.00001458191,0.00022006452,0.00014560948,0.000063610016,0.0006503794,0.000053989603,0.0036889773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99854094,0.00006132267,0.0005039444,0.00033782073,0.00023598292,0.0003200082],"domain_scores_gemma":[0.9991265,0.000036110643,0.0001120469,0.00032040858,0.000014015446,0.00039091567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046455294,0.00031829096,0.0013058316,0.00028182563,0.000033289878,0.0000054201673,0.00012231813,0.0003945582,0.00018862147],"category_scores_gemma":[0.000030510344,0.00021997896,0.00053001026,0.00032968458,0.00004637853,0.000026252797,0.00001673126,0.00042837748,0.00054685294],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028380045,0.00033053753,0.0001674479,0.009823748,0.00017177196,0.0017651875,0.00023182078,3.614936e-8,1.7247669e-7,0.000031511026,0.010459419,0.97699],"study_design_scores_gemma":[0.00065408845,0.000027353912,0.00006893181,0.09073187,0.000647619,0.00032433844,0.0000025969732,7.085913e-7,6.2581654e-7,0.0000049794194,0.9073281,0.00020877748],"about_ca_topic_score_codex":0.000054050313,"about_ca_topic_score_gemma":7.5124547e-7,"teacher_disagreement_score":0.9767812,"about_ca_system_score_codex":0.00010438607,"about_ca_system_score_gemma":0.0006788358,"threshold_uncertainty_score":0.8970482},"labels":[],"label_agreement":null},{"id":"W1988335299","doi":"10.2165/00003495-200161080-00004","title":"Pharmacotherapy of Ectoparasitic Infections","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"RWTH Aachen University; Centre International de Recherche sur le Cancer","keywords":"Medicine; Pharmacotherapy; Scabies; Intensive care medicine; Adverse effect; Ivermectin; Permethrin; Drug; MEDLINE; Dermatology; Pharmacology; Veterinary medicine; Psychiatry; Biology","score_opus":0.06101477888708411,"score_gpt":0.4339364530541628,"score_spread":0.37292167416707867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988335299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040700554,0.97122085,0.000050966344,0.00003871945,0.000105511375,0.00044827387,0.00006565301,0.000050943785,0.027978394],"genre_scores_gemma":[0.00009680335,0.9981356,0.000039169845,0.00021027098,0.00007905718,0.00007533903,0.00021238283,0.000020601794,0.0011307584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999226,0.000046334124,0.00035485078,0.00013732068,0.000109219094,0.00012628379],"domain_scores_gemma":[0.999407,0.00010946929,0.00013835263,0.00018206345,0.000052455893,0.00011064787],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003161442,0.00015414662,0.000869472,0.00013519653,0.00003056936,0.000005967053,0.00005238143,0.00009432807,0.0014480024],"category_scores_gemma":[0.000028438033,0.00010880441,0.00049467635,0.0003637906,0.000053102194,0.000025839578,0.000009278258,0.00015362042,0.00029808376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002479962,0.00034407966,0.000052322368,0.00699471,0.00015550827,0.000025634654,0.00001758895,2.2331207e-7,4.366008e-7,0.000555916,0.0029118364,0.9889393],"study_design_scores_gemma":[0.00023710234,0.00004952979,0.000037630845,0.0027664816,0.0011663547,0.00015260253,0.0000063019697,0.000004091863,9.609971e-7,0.000060279774,0.9954249,0.00009374711],"about_ca_topic_score_codex":0.0000097945085,"about_ca_topic_score_gemma":1.7456449e-7,"teacher_disagreement_score":0.99251306,"about_ca_system_score_codex":0.000029564348,"about_ca_system_score_gemma":0.00017196566,"threshold_uncertainty_score":0.9994648},"labels":[],"label_agreement":null},{"id":"W1989886020","doi":"10.1007/s40265-013-0168-2","title":"Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":335,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; Health Sciences Centre; University of Manitoba","funders":"","keywords":"Tazobactam; Cephalosporin; Microbiology; Cephem; Medicine; Pseudomonas aeruginosa; Ceftazidime; Piperacillin; Antibiotics; Ceftriaxone; Beta-Lactamase Inhibitors; Pharmacology; Imipenem; Biology; Antibiotic resistance; Bacteria; Biochemistry","score_opus":0.019337001377061867,"score_gpt":0.27622892951490785,"score_spread":0.256891928137846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989886020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25376767,0.7324997,0.00063486106,0.000086148066,0.0011900326,0.005950205,0.0014467955,0.00018078565,0.004243774],"genre_scores_gemma":[0.066742346,0.9253002,0.0019928755,0.000067165565,0.0005722669,0.00026672558,0.0021870283,0.00028137097,0.0025900668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962974,0.0002627126,0.0007755203,0.0013950623,0.0005203709,0.0007489165],"domain_scores_gemma":[0.99687093,0.00012681255,0.0011290659,0.0012319196,0.00034734988,0.00029390134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002977159,0.0011329195,0.0017034849,0.00017426339,0.00020977968,0.00017157209,0.00062908075,0.00090302894,0.00003818406],"category_scores_gemma":[0.00018416379,0.00089150405,0.00053648534,0.00037056406,0.0004132844,0.00003352126,0.00027331323,0.0005880503,0.00012619885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009273118,0.0026558996,0.00012737881,0.01754009,0.0021895692,0.00011039749,0.00037916118,0.000004625158,0.0586509,0.00032514773,0.0041835513,0.912906],"study_design_scores_gemma":[0.0021937971,0.0006141022,0.00021093087,0.0052928776,0.00057597493,0.00003447358,0.00018962595,0.00002069012,0.007224497,0.000011493931,0.98174864,0.0018829049],"about_ca_topic_score_codex":0.00009003173,"about_ca_topic_score_gemma":0.000057470308,"teacher_disagreement_score":0.9775651,"about_ca_system_score_codex":0.00025544144,"about_ca_system_score_gemma":0.00059499784,"threshold_uncertainty_score":0.9993536},"labels":[],"label_agreement":null},{"id":"W1994080743","doi":"10.2165/00003495-200059001-00005","title":"Clinical Evidence with Montelukast in the Management of Chronic Childhood Asthma","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Montelukast; Medicine; Placebo; Asthma; Bronchoconstriction; Adverse effect; Leukotriene receptor; Quality of life (healthcare); Randomized controlled trial; Anesthesia; Salmeterol; Internal medicine; Pediatrics; Alternative medicine","score_opus":0.04219740496768754,"score_gpt":0.3728719501084492,"score_spread":0.33067454514076167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994080743","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033563658,0.9941036,0.000002631076,0.00006905419,0.000050830826,0.0014026616,0.000012065693,0.00001689578,0.0040066326],"genre_scores_gemma":[0.0008694669,0.9980221,0.000056931665,0.00016612183,0.00031867635,0.000120157434,0.000023903829,0.00003449486,0.0003881587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978752,0.000273832,0.00077505596,0.00038887016,0.0004525106,0.00023450675],"domain_scores_gemma":[0.99870026,0.00018654873,0.00026214294,0.00073386834,0.00002298641,0.00009420704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005077673,0.00029406016,0.0013072104,0.00010910941,0.000030012478,0.000010464543,0.00035890352,0.00014988704,0.00016000331],"category_scores_gemma":[0.00001231605,0.00014249179,0.00048444577,0.00039610345,0.00016704135,0.000040019535,0.000051006857,0.00048811757,0.00010459002],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032491243,0.00044057015,0.00007726585,0.015187088,0.00016774522,0.00026850493,0.00008464128,7.506007e-7,1.0025385e-9,0.00003217409,0.00038437464,0.9833244],"study_design_scores_gemma":[0.00051188393,0.0004930381,0.0035886907,0.09606702,0.0009763844,0.00005007451,0.00013685312,0.0000011017124,2.6441478e-8,0.000002177483,0.89803225,0.00014050542],"about_ca_topic_score_codex":0.0000065316544,"about_ca_topic_score_gemma":0.0000047825342,"teacher_disagreement_score":0.98318386,"about_ca_system_score_codex":0.000068069996,"about_ca_system_score_gemma":0.00063273445,"threshold_uncertainty_score":0.58106464},"labels":[],"label_agreement":null},{"id":"W1995586381","doi":"10.2165/11593790-000000000-00000","title":"Pharmacological Modulation of Arterial Stiffness","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiovascular Health and Disease Prevention","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Arterial stiffness; Medicine; Cardiology; Internal medicine; Glycation; Blood pressure; Pharmacology; Receptor","score_opus":0.06748616140121036,"score_gpt":0.3780397902019101,"score_spread":0.3105536288006997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995586381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080490526,0.99602616,0.000077966855,0.0000038366907,0.00051669887,0.0009444879,0.000031388616,0.00003220869,0.0015623239],"genre_scores_gemma":[0.0019007421,0.9968498,0.000051124924,0.000021903383,0.0005442419,0.00008288921,0.00042417276,0.00001827364,0.00010689738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895287,0.00012301322,0.0004120571,0.00020417891,0.0001730102,0.00013489224],"domain_scores_gemma":[0.99936026,0.000024263776,0.00018647319,0.00021114065,0.00005933148,0.00015851042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001769417,0.00015240978,0.0011141116,0.00009799578,0.000018154542,0.000002982217,0.000050817034,0.00019022496,0.00044732727],"category_scores_gemma":[0.000029806835,0.000115856485,0.00094086246,0.000114854505,0.000028087034,0.000023708833,0.000027358761,0.00013473953,0.000077762015],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116127696,0.000105612264,4.4313165e-7,0.018460676,0.00021780944,0.0000070417245,0.0000202761,6.617507e-8,0.0000050144145,0.000061420695,0.00021758061,0.98078793],"study_design_scores_gemma":[0.0011896724,0.000016133003,0.0005797595,0.0034600107,0.0049083056,0.00003114315,0.0000035750452,0.000007651546,0.0000012328398,0.000050693656,0.9896368,0.00011503485],"about_ca_topic_score_codex":0.000011573344,"about_ca_topic_score_gemma":1.0302451e-7,"teacher_disagreement_score":0.9894192,"about_ca_system_score_codex":0.000049334125,"about_ca_system_score_gemma":0.00028015874,"threshold_uncertainty_score":0.489792},"labels":[],"label_agreement":null},{"id":"W1996424927","doi":"10.2165/00003495-200969040-00004","title":"Intravenous Proton Pump Inhibitors","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Western University","funders":"AstraZeneca","keywords":"Medicine; Esomeprazole; Omeprazole; Pantoprazole; Gastric acid; Lansoprazole; Bolus (digestion); Peptic; Proton-pump inhibitor; Stress ulcer; Enteral administration; Ranitidine; Drug; Intensive care medicine; Gastroenterology; Anesthesia; Internal medicine; Pharmacology; Stomach; Peptic ulcer; Parenteral nutrition","score_opus":0.02735762979096468,"score_gpt":0.33704761347312157,"score_spread":0.3096899836821569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996424927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082624996,0.9858922,0.0000010630436,0.00002253382,0.0001810334,0.0030994408,0.000018844452,0.000104242645,0.010598056],"genre_scores_gemma":[0.0003969607,0.9939509,0.00012380564,0.00008920613,0.00051758415,0.00031025408,0.00035995012,0.000064429005,0.004186916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984212,0.000052333107,0.00044505016,0.0003993548,0.00031562927,0.00036643687],"domain_scores_gemma":[0.99908334,0.000026854857,0.00018937816,0.00043278435,0.000038354745,0.00022930239],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009972949,0.00043389216,0.0015791177,0.0001837328,0.000048640628,0.000022253917,0.00010659493,0.00028646825,0.0001007696],"category_scores_gemma":[0.000029836101,0.00029153706,0.0005191058,0.00021994511,0.00003337387,0.000031245505,0.00003106301,0.0004291517,0.0011014757],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000039877928,0.00023542948,0.000017618922,0.008058233,0.000159193,0.00089587027,0.00005114323,5.97785e-9,3.5883126e-8,0.000013183024,0.0003052897,0.99026],"study_design_scores_gemma":[0.0004904036,0.00044169952,0.000027198985,0.008080669,0.0013659159,0.00024325286,0.000002829581,1.2219103e-7,0.000012329783,0.00003146166,0.98919773,0.00010639749],"about_ca_topic_score_codex":0.0000055250753,"about_ca_topic_score_gemma":1.1094594e-7,"teacher_disagreement_score":0.9901536,"about_ca_system_score_codex":0.00022410793,"about_ca_system_score_gemma":0.00029329906,"threshold_uncertainty_score":0.9999537},"labels":[],"label_agreement":null},{"id":"W1996485133","doi":"10.2165/00003495-200363030-00002","title":"Treatment of Lupus Nephritis","year":2003,"lang":"en","type":"review","venue":"Drugs","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Kidney Foundation of Canada","keywords":"Medicine; Lupus nephritis; Systemic lupus erythematosus; Natural history; Pharmacotherapy; Intensive care medicine; Proteinuria; Disease; Immunology; Nephropathy; Internal medicine; Kidney; Endocrinology","score_opus":0.06308370758329739,"score_gpt":0.37674383238125525,"score_spread":0.31366012479795785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996485133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003326932,0.9685396,0.0000016275786,0.000017457762,0.0004575273,0.0017171297,0.00004902414,0.00003317886,0.029151194],"genre_scores_gemma":[0.0000037349967,0.95707476,0.0001416496,0.000008060049,0.00018558015,0.0002468732,0.000103144426,0.0000812171,0.042154986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979406,0.0001789582,0.00069280335,0.00035885547,0.0004904726,0.00033832446],"domain_scores_gemma":[0.9984749,0.00020833318,0.00023676695,0.0008006571,0.000096909156,0.00018245561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014303645,0.0003555639,0.0028124962,0.00029333084,0.00002382467,0.000009145159,0.00012705194,0.00030942587,0.00035992125],"category_scores_gemma":[0.000046360572,0.00023696628,0.0007872751,0.0003672856,0.00007627249,0.000016786666,0.000025194147,0.00014845848,0.00052066223],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000071444642,0.00016657142,0.00009440285,0.054840904,0.00036919912,0.00014930898,0.00035698636,3.2827228e-9,3.083416e-7,0.00011056581,0.0033147356,0.94058985],"study_design_scores_gemma":[0.000992547,0.0002668753,1.3179151e-7,0.021419045,0.00077508506,0.024002865,0.000100746096,3.5391724e-7,0.0000032611756,0.000006348732,0.9522914,0.00014130969],"about_ca_topic_score_codex":0.00004173707,"about_ca_topic_score_gemma":0.000001075379,"teacher_disagreement_score":0.9489767,"about_ca_system_score_codex":0.0005577331,"about_ca_system_score_gemma":0.0007336072,"threshold_uncertainty_score":0.96632046},"labels":[],"label_agreement":null},{"id":"W1997030483","doi":"10.2165/00003495-200262100-00004","title":"Metabolic and Additional Vascular Effects of Thiazolidinediones","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":292,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Insulin resistance; Rosiglitazone; Medicine; Pioglitazone; Metabolic syndrome; PPAR agonist; Peroxisome proliferator-activated receptor; Internal medicine; Endocrinology; Type 2 diabetes; Diabetes mellitus; Glucose homeostasis; Nuclear receptor; Inflammation; Bioinformatics; Receptor; Transcription factor; Biology","score_opus":0.009726374286928614,"score_gpt":0.25146682186682573,"score_spread":0.24174044757989713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997030483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003428635,0.9984189,0.000008488431,0.000004085807,0.00019402972,0.00034592365,0.000410175,0.000012149242,0.0002633622],"genre_scores_gemma":[0.00013045529,0.9972464,0.00015428943,0.000028425047,0.00045054907,0.00017080808,0.0015314082,0.000052353298,0.00023532953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987851,0.00014098221,0.00029910824,0.0004010829,0.00017778443,0.00019596764],"domain_scores_gemma":[0.99925774,0.00006475258,0.00020589611,0.00032223924,0.000057583675,0.000091762224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000082892795,0.00033381465,0.00089592417,0.00011006068,0.000043357024,0.000012408739,0.000181234,0.0004405224,0.00024281497],"category_scores_gemma":[0.00012832512,0.00027273688,0.0003775877,0.00014199517,0.00009673373,0.0000033235538,0.00012812638,0.0001741928,0.000026356412],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006547083,0.00014492463,0.0000035901728,0.014828817,0.0015104077,0.000003890945,0.000045943765,3.184173e-7,0.0031389103,0.00015823981,0.021490708,0.9586677],"study_design_scores_gemma":[0.00018164219,0.00004596147,0.0000018662782,0.001282331,0.00036175956,0.00001743897,0.0000028383063,5.1894307e-7,0.012370963,0.000008203653,0.9854675,0.00025899836],"about_ca_topic_score_codex":0.0000017998051,"about_ca_topic_score_gemma":1.5877359e-7,"teacher_disagreement_score":0.96397674,"about_ca_system_score_codex":0.000008411001,"about_ca_system_score_gemma":0.0000832678,"threshold_uncertainty_score":0.99997246},"labels":[],"label_agreement":null},{"id":"W1998158725","doi":"10.2165/00003495-200262070-00002","title":"Options for Induction Immunosuppression in Liver Transplant Recipients","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Basiliximab; Medicine; Daclizumab; Immunosuppression; Azathioprine; Adverse effect; Calcineurin; Transplantation; Liver transplantation; Tacrolimus; Pharmacology; Tolerability; Immunology; Internal medicine","score_opus":0.08672789145602479,"score_gpt":0.3657103711825928,"score_spread":0.27898247972656803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998158725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000092450835,0.99668735,0.00005483302,0.00002437093,0.00040840363,0.0016156997,0.00026177877,0.000030624888,0.00082449755],"genre_scores_gemma":[0.00025697227,0.99379754,0.0005003496,0.000018211003,0.00008889291,0.00038703287,0.0020272695,0.000040301256,0.002883439],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988005,0.000059411796,0.0004704523,0.00029703302,0.00017154422,0.00020102126],"domain_scores_gemma":[0.9994608,0.000100442376,0.00012947682,0.0002076617,0.00002915573,0.00007245725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009003184,0.00026122222,0.0008763177,0.00029523342,0.000055027132,0.000012478525,0.00006944138,0.00025691165,0.00014673785],"category_scores_gemma":[0.0000060309153,0.00018517982,0.00044102993,0.00020204781,0.000017128572,0.00006797289,0.0000051402476,0.00023361745,0.0001175062],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005444779,0.00030835174,0.00010263003,0.01169535,0.00020542694,0.000056852747,0.00039245383,6.0712574e-7,9.506717e-7,0.000057229245,0.000109789005,0.9870159],"study_design_scores_gemma":[0.0025713115,0.00014542553,0.00056216965,0.06992598,0.0021391676,0.00021124326,0.00001420095,0.000025207733,0.000006502518,0.000012990824,0.92412597,0.00025984633],"about_ca_topic_score_codex":0.000026962347,"about_ca_topic_score_gemma":0.0000024153878,"teacher_disagreement_score":0.9867561,"about_ca_system_score_codex":0.0001506304,"about_ca_system_score_gemma":0.00004633696,"threshold_uncertainty_score":0.7551414},"labels":[],"label_agreement":null},{"id":"W2000709950","doi":"10.2165/00003495-200059050-00004","title":"Pancreatic Cancer","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Pancreatic cancer; Cancer research; Cancer; Metastasis; Immunotherapy; Targeted therapy; Oncology; Internal medicine; Immunology","score_opus":0.027971764498118362,"score_gpt":0.3752909445037849,"score_spread":0.34731918000566653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000709950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038958646,0.99222696,7.826609e-7,0.000007886172,0.00006442826,0.00033183352,0.00023245541,0.0000084139465,0.007088271],"genre_scores_gemma":[0.00001558621,0.98835206,0.000013071678,0.000037728925,0.00038426404,0.00042892466,0.00081591634,0.00004277018,0.009909679],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990596,0.000054515353,0.0001580353,0.0003418194,0.000120068646,0.00026595598],"domain_scores_gemma":[0.99945706,0.000007475572,0.000055371627,0.0003629924,0.000015259477,0.00010182187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037442864,0.00022629218,0.00047771874,0.000041984764,0.000041477495,0.000022216005,0.00018983758,0.00016962404,0.0004363367],"category_scores_gemma":[0.0000062828904,0.00017399396,0.00029144823,0.000086375956,0.000035942277,7.959362e-7,0.000056677087,0.00010324866,0.00024734563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008198875,0.000021949367,0.000002959006,0.0011940298,0.0002591411,0.0000064507344,0.0000051486263,1.13698164e-7,0.0000015337783,0.0000021989804,0.007541761,0.99095654],"study_design_scores_gemma":[0.00014944891,0.00004512773,7.211643e-7,0.0011051241,0.00022408138,0.000008274189,0.000001398048,1.0954645e-7,0.000027200123,0.00000567405,0.99826586,0.00016695175],"about_ca_topic_score_codex":0.00035275938,"about_ca_topic_score_gemma":0.00006727869,"teacher_disagreement_score":0.9907896,"about_ca_system_score_codex":0.000050680923,"about_ca_system_score_gemma":0.00038830258,"threshold_uncertainty_score":0.70952684},"labels":[],"label_agreement":null},{"id":"W2000947329","doi":"10.2165/11535230-000000000-00000","title":"Minimizing Repolarization-Related Proarrhythmic Risk in Drug Development and Clinical Practice","year":2010,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Fondation Leducq; Heart and Stroke Foundation of Canada","keywords":"Proarrhythmia; Torsades de pointes; Afterdepolarization; Medicine; QT interval; hERG; Repolarization; Pharmacology; Drug development; Long QT syndrome; Cardiology; Internal medicine; Drug; Potassium channel; Electrophysiology","score_opus":0.01928364887580724,"score_gpt":0.3512573470904996,"score_spread":0.33197369821469236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000947329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068862895,0.98826236,0.0000040651053,0.000142523,0.0005545734,0.0013066834,0.0000055593573,0.000062298444,0.0027756658],"genre_scores_gemma":[0.00016063823,0.99328446,0.004584071,0.00013175892,0.00041509667,0.00009080684,0.00020390764,0.000059608756,0.0010696241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968336,0.0005993981,0.0013834215,0.00066917797,0.0001918499,0.000322515],"domain_scores_gemma":[0.9972968,0.0012253422,0.00081119733,0.0004311082,0.00008892338,0.00014660369],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016544133,0.00036020364,0.001831285,0.0002285846,0.00011855002,0.00002030071,0.00006741786,0.0007988253,0.0000151062095],"category_scores_gemma":[0.002338509,0.00029133452,0.0003254222,0.00036872443,0.00013112313,0.00009357336,0.0000936359,0.0028895326,0.00010858625],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044960845,0.00008262508,0.00006836573,0.0014833221,0.00031008336,0.0005350735,0.0005187412,1.2613309e-7,5.5056285e-7,0.00008381782,0.00014282462,0.9967295],"study_design_scores_gemma":[0.0006789727,0.000048820795,0.00028248373,0.0040473794,0.0013752797,0.0016731042,0.00005086589,0.0000069084654,0.0000021898927,0.000022547685,0.9915195,0.0002919373],"about_ca_topic_score_codex":0.000026890482,"about_ca_topic_score_gemma":0.000008682099,"teacher_disagreement_score":0.99643755,"about_ca_system_score_codex":0.00009718734,"about_ca_system_score_gemma":0.0011540622,"threshold_uncertainty_score":0.99995387},"labels":[],"label_agreement":null},{"id":"W2003140298","doi":"10.2165/00003495-200464140-00003","title":"Treatment of Erectile Dysfunction in Patients with Cardiovascular Disease","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Erectile dysfunction; Pharmacotherapy; Disease; Intensive care medicine; Internal medicine","score_opus":0.030773379094523615,"score_gpt":0.2841513024797722,"score_spread":0.2533779233852486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003140298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042495152,0.9963515,0.000023910992,0.000008114221,0.0004897204,0.0012930728,0.000036427366,0.000047919453,0.0013243953],"genre_scores_gemma":[0.0005279656,0.9971944,0.000022769615,0.000013834787,0.00012943546,0.00023383426,0.00040990688,0.00004417826,0.0014236743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985596,0.00005662575,0.000385138,0.00039239076,0.0004431776,0.00016307163],"domain_scores_gemma":[0.9990623,0.000039777682,0.00013591888,0.0005120941,0.00012285032,0.00012704202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053729676,0.00032968758,0.001671483,0.0002961619,0.00003605193,0.000005244263,0.000027211128,0.00010445237,0.0000899182],"category_scores_gemma":[0.000028681854,0.00020352782,0.00063294236,0.0004367441,0.000046668523,0.000035349367,0.0000129086,0.000101542704,0.00008025962],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042953645,0.00094073045,0.0038054434,0.0072671585,0.0020476931,0.00001975786,0.00012138776,0.000019360199,2.3039262e-9,0.00001468595,0.000093968534,0.9852403],"study_design_scores_gemma":[0.004566317,0.00090060383,0.005409144,0.0040708277,0.0045369067,0.000004063001,0.00005533239,3.7824464e-7,1.4158982e-7,0.0000015626781,0.9802805,0.00017423295],"about_ca_topic_score_codex":0.00014298463,"about_ca_topic_score_gemma":0.0000018247894,"teacher_disagreement_score":0.98506606,"about_ca_system_score_codex":0.00058309163,"about_ca_system_score_gemma":0.0003189411,"threshold_uncertainty_score":0.8299623},"labels":[],"label_agreement":null},{"id":"W2003266662","doi":"10.2165/00003495-200262170-00004","title":"Diagnosis and Management of Psoriatic Arthritis","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Canadian Institutes of Health Research; Arthritis Society; University Health Network","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Enthesitis; Rheumatoid arthritis; Psoriasis; Arthritis; Inflammatory arthritis; Polyarthritis; Dermatology; Ankylosis; Sacroiliitis; Sulfasalazine; Rheumatoid factor; Disease; Surgery; Internal medicine","score_opus":0.03821503565870255,"score_gpt":0.31437428154469904,"score_spread":0.2761592458859965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003266662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047413392,0.9923849,2.253272e-7,0.000033312044,0.00015003611,0.0009347813,0.00005852232,0.000018638177,0.006372144],"genre_scores_gemma":[0.00003980715,0.9981019,0.0002568166,0.000018258688,0.00006453974,0.00046584042,0.000046939545,0.000030910058,0.00097499334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901557,0.000020811392,0.0003598825,0.00025769664,0.00017660084,0.00016946613],"domain_scores_gemma":[0.99946105,0.0000524473,0.00014260944,0.00025307454,0.000019808882,0.00007102323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004328059,0.00023786214,0.0014035553,0.00008915615,0.00003907093,0.000006657298,0.00004138205,0.00008723772,0.000208788],"category_scores_gemma":[0.000006237388,0.00018661884,0.0002472405,0.00015134993,0.00005127292,0.00001508039,0.00007652936,0.00008315854,0.00008387935],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000017642651,0.0001280288,0.00003153097,0.022997942,0.0008465463,0.00021677143,0.000058480036,1.2596104e-9,4.9111043e-10,0.00014981112,0.0014916828,0.97407746],"study_design_scores_gemma":[0.0011224153,0.00010482489,0.00008101641,0.053244837,0.0022901946,0.00005470256,0.000041780426,1.0776401e-7,1.5786058e-7,0.0000138992245,0.94292843,0.00011761867],"about_ca_topic_score_codex":0.000015899426,"about_ca_topic_score_gemma":0.000002164609,"teacher_disagreement_score":0.9739598,"about_ca_system_score_codex":0.000040633106,"about_ca_system_score_gemma":0.000008901377,"threshold_uncertainty_score":0.7610095},"labels":[],"label_agreement":null},{"id":"W2004594777","doi":"10.2165/00003495-200161120-00005","title":"Endometriosis","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Endometriosis; Medicine; Infertility; Etiology; Pelvic pain; Gynecology; Endometrium; Uterus; Internal medicine; Surgery; Pregnancy","score_opus":0.0800474230095203,"score_gpt":0.408748061528627,"score_spread":0.32870063851910675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004594777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.926915e-7,0.9440062,0.0000039620977,0.000059881266,0.00010322065,0.0013779914,0.00006230842,0.00008208433,0.054303367],"genre_scores_gemma":[0.000005871114,0.98590934,0.00018482922,0.00006104827,0.0003142875,0.00038612893,0.00032251235,0.00007247088,0.012743515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979145,0.00010750784,0.00044330678,0.00041914854,0.0006235559,0.000491999],"domain_scores_gemma":[0.99627155,0.0025037846,0.00013144356,0.0006041476,0.000075455166,0.00041359768],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025397088,0.00038120995,0.002180199,0.0013986558,0.000053997308,0.000033065244,0.0001640845,0.00023192183,0.001215643],"category_scores_gemma":[0.0024043221,0.00024620374,0.0010849714,0.0026680783,0.000045883633,0.00003159337,0.00008480565,0.00047459014,0.002215344],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007882535,0.00021768738,0.000005909727,0.007886366,0.000636271,0.0003588456,0.000009285079,1.8657371e-9,2.662014e-8,0.00003524761,0.004168668,0.98667383],"study_design_scores_gemma":[0.00092533504,0.00020505808,0.0000013352585,0.006529678,0.0013067973,0.00029759423,0.000007298785,1.2408269e-7,0.000002018045,0.0000061449623,0.99054736,0.00017126238],"about_ca_topic_score_codex":0.000032711378,"about_ca_topic_score_gemma":8.575728e-7,"teacher_disagreement_score":0.9865025,"about_ca_system_score_codex":0.00041745914,"about_ca_system_score_gemma":0.00037062741,"threshold_uncertainty_score":0.99999905},"labels":[],"label_agreement":null},{"id":"W2005405935","doi":"10.2165/11632860-000000000-00000","title":"Assessment and Medication Management of Paediatric Obsessive-Compulsive Disorder","year":2012,"lang":"en","type":"article","venue":"Drugs","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Hospital for Sick Children","keywords":"Medicine; Pharmacotherapy; Psychiatry; Obsessive compulsive; Intensive care medicine; Tic disorder; Pediatrics; Psychotherapist; Tics; Psychology","score_opus":0.009313191940417713,"score_gpt":0.30810610132673794,"score_spread":0.29879290938632025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005405935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8918303,0.0064703533,0.0030141869,0.00077795616,0.0014851989,0.0006445932,0.000021001586,0.00007884884,0.09567753],"genre_scores_gemma":[0.9969111,0.00030304724,0.0018391705,0.00013819625,0.00014387135,0.000102096215,0.00004749281,0.00003245842,0.00048254096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998341,0.00015707243,0.00035947212,0.0003391173,0.00034065894,0.0004626566],"domain_scores_gemma":[0.99891835,0.00014703837,0.00030441923,0.00042050358,0.000052492156,0.00015718878],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002866259,0.0002120623,0.00028417338,0.00018672235,0.00008626105,0.0000127658095,0.00022275244,0.00009400616,0.001212529],"category_scores_gemma":[0.000008085492,0.00020096388,0.00007739554,0.00035562113,0.00016488953,0.00016859123,0.00014366086,0.00017016669,0.0001423793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003694788,0.0010028739,0.6496624,0.00018624427,0.00048260542,0.000008605627,0.007503886,0.000008852607,0.000050047387,0.1636447,0.0022950042,0.17511787],"study_design_scores_gemma":[0.0015123405,0.000055533168,0.9835555,0.000025748855,0.0001403656,0.0000044047833,0.010128697,0.000036467052,0.00002024101,0.001012291,0.0032849505,0.00022348974],"about_ca_topic_score_codex":0.00009955232,"about_ca_topic_score_gemma":0.0000023930745,"teacher_disagreement_score":0.3338931,"about_ca_system_score_codex":0.00006391815,"about_ca_system_score_gemma":0.000019659186,"threshold_uncertainty_score":0.9997005},"labels":[],"label_agreement":null},{"id":"W2005913125","doi":"10.2165/00003495-200565110-00001","title":"Drugs in Development for Hepatitis B","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AGE-WELL","keywords":"Lamivudine; Adefovir; Telbivudine; Entecavir; Medicine; HBeAg; Combination therapy; Hepatitis B; Pegylated interferon; Virology; Hepatitis B virus; Pharmacotherapy; Pharmacology; Immunology; Chronic hepatitis; Internal medicine; Virus; Ribavirin; HBsAg","score_opus":0.056396667292056384,"score_gpt":0.3614276505510224,"score_spread":0.305030983258966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005913125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004206541,0.9887079,0.000011695603,0.00013490107,0.0002579314,0.002194249,0.000059442682,0.000069248534,0.008522579],"genre_scores_gemma":[0.000026552563,0.9877002,0.004111269,0.00025294014,0.0004623604,0.001188338,0.00030476533,0.00009885785,0.0058546946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779356,0.00005071846,0.0008984974,0.0004702519,0.00030497563,0.0004819907],"domain_scores_gemma":[0.99902105,0.000248807,0.00020010756,0.00032766102,0.00008296268,0.00011939713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000362953,0.00044333967,0.0021933615,0.0003435164,0.00006728953,0.000014882124,0.00014989024,0.00026680733,0.00012651621],"category_scores_gemma":[0.00016169135,0.0003741688,0.0003534857,0.0002841909,0.00004578801,0.000040932002,0.00010191325,0.00031842222,0.00068190665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000041797084,0.00006642325,0.00030184526,0.011514802,0.00014319553,0.000011850161,0.0013498687,1.8475419e-8,1.5065561e-8,0.000059456215,0.006458523,0.98008984],"study_design_scores_gemma":[0.00049737474,0.00003410151,0.0002224445,0.015991159,0.0003180609,0.000010690166,0.000018647957,0.0000016678729,0.0000014206241,0.0000074485138,0.98255515,0.00034181756],"about_ca_topic_score_codex":0.00038909845,"about_ca_topic_score_gemma":0.0013810205,"teacher_disagreement_score":0.979748,"about_ca_system_score_codex":0.00082845433,"about_ca_system_score_gemma":0.0008479783,"threshold_uncertainty_score":0.999871},"labels":[],"label_agreement":null},{"id":"W2010025151","doi":"10.2165/00003495-200363040-00004","title":"Management of Insomnia in Patients With Chronic Obstructive Pulmonary Disease","year":2003,"lang":"en","type":"review","venue":"Drugs","topic":"Sleep and related disorders","field":"Psychology","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; COPD; Ipratropium bromide; Intensive care medicine; Population; Insomnia; Sleep disorder; Zopiclone; Bronchodilator; Internal medicine; Asthma; Psychiatry","score_opus":0.009391242436043166,"score_gpt":0.2740668925918704,"score_spread":0.2646756501558272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010025151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006171308,0.9544758,0.0000013407598,0.0000024133328,0.00046469187,0.0011443092,0.000048111437,0.000015892289,0.043230273],"genre_scores_gemma":[0.0009796475,0.99697596,0.000018570034,0.000010711264,0.000015506997,0.0002053545,0.00024655706,0.00006000527,0.0014876972],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99854046,0.00015246897,0.00039987682,0.00043227617,0.00019327113,0.00028165104],"domain_scores_gemma":[0.9991291,0.000025914378,0.00026016554,0.0004809069,0.000022718485,0.00008115327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052481177,0.00031007302,0.0006804671,0.00023974324,0.00002103945,0.0000041663143,0.00022168682,0.00020896798,0.00038657145],"category_scores_gemma":[0.0000013190848,0.00022954514,0.00016963789,0.00048251025,0.00009081433,0.000031771673,0.00004320526,0.00030504135,0.00018936477],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005517693,0.0006699035,0.0013448822,0.004905661,0.0009112586,0.0000980795,0.00014747347,0.000002110518,1.2532708e-10,0.0010822115,0.00011741628,0.99066585],"study_design_scores_gemma":[0.0017420161,0.000058683632,0.015746024,0.0069860606,0.0018200187,0.0000011444308,0.0001660838,2.8655518e-7,3.232456e-9,0.0001058377,0.9729666,0.0004072555],"about_ca_topic_score_codex":0.000019892756,"about_ca_topic_score_gemma":9.858859e-7,"teacher_disagreement_score":0.9902586,"about_ca_system_score_codex":0.00015929366,"about_ca_system_score_gemma":0.000067781984,"threshold_uncertainty_score":0.93605787},"labels":[],"label_agreement":null},{"id":"W2010355855","doi":"10.2165/00003495-200666090-00005","title":"Pharmacotherapy of Alcoholism in Patients with Co-morbid Psychiatric Disorders","year":2006,"lang":"en","type":"review","venue":"Drugs","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Psychiatry; Medicine; Anxiety; Bipolar disorder; Population; Schizophrenia (object-oriented programming); Olanzapine; Mood disorders; Alcohol dependence; Sertraline; Depression (economics); Pharmacotherapy; Mood; Antidepressant; Alcohol","score_opus":0.013158639686434687,"score_gpt":0.3306385004802578,"score_spread":0.31747986079382307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010355855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007842817,0.990047,0.0000024033159,0.000023795703,0.00009902281,0.0015070371,0.00011376829,0.00002367387,0.0073990617],"genre_scores_gemma":[0.0014261241,0.9969589,0.000092963295,0.00003254399,0.00005169681,0.00009095196,0.0010207058,0.00007565071,0.00025044815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986344,0.000058422254,0.00044960433,0.0003129845,0.00030652902,0.00023808074],"domain_scores_gemma":[0.9993313,0.000027422326,0.00024043747,0.0003077153,0.000027453618,0.00006568471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059390415,0.0003578666,0.0012491551,0.0003646274,0.000020522632,0.000004840217,0.00010324641,0.0001478914,0.000087015986],"category_scores_gemma":[0.0000013531671,0.0002377991,0.00029158496,0.0004704324,0.00005006477,0.00002798154,0.000009746803,0.00025218131,0.000031164287],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059486687,0.0014997785,0.069313124,0.0052274126,0.00027618872,0.0000011237452,0.00007572731,1.8117532e-7,1.3709979e-8,0.000013913058,0.0006256701,0.92290735],"study_design_scores_gemma":[0.0060925013,0.00027053998,0.019727664,0.0017843446,0.0011686265,0.0000016833606,0.0000051916836,3.081763e-7,5.460183e-7,0.000013327579,0.97070295,0.00023230785],"about_ca_topic_score_codex":0.00025733467,"about_ca_topic_score_gemma":0.00005458538,"teacher_disagreement_score":0.9700773,"about_ca_system_score_codex":0.000078931065,"about_ca_system_score_gemma":0.00016500619,"threshold_uncertainty_score":0.9697166},"labels":[],"label_agreement":null},{"id":"W2011019643","doi":"10.2165/00003495-200161070-00004","title":"Monotherapy versus Combination Therapy as First Line Treatment of Uncomplicated Arterial Hypertension","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Blood pressure; Pharmacotherapy; Combination therapy; Regimen; Adverse effect; Population; Antihypertensive drug; Drug; Intensive care medicine; Cardiology; Internal medicine; Pharmacology","score_opus":0.14514203928438177,"score_gpt":0.3625023986492613,"score_spread":0.21736035936487955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011019643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006066389,0.9949466,0.0000021512556,0.0006538124,0.0006382523,0.0013315033,0.000026091146,0.000081542996,0.0017134058],"genre_scores_gemma":[0.00045777648,0.9970719,0.000040664137,0.0002562855,0.00047308407,0.00013443395,0.00042284981,0.00006839249,0.0010746003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984359,0.0000739403,0.0005849483,0.0004096193,0.00028259552,0.00021297976],"domain_scores_gemma":[0.99854934,0.00026485202,0.00032247574,0.00054186693,0.0002334759,0.00008800177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006804098,0.0004601439,0.002792243,0.00018938916,0.0000984565,0.000011876106,0.00009165819,0.0003032394,0.00015912556],"category_scores_gemma":[0.000012967929,0.00029364816,0.00055857917,0.00030851536,0.00007347689,0.000027634747,0.000021079655,0.00011796373,0.00011317682],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010042745,0.001410698,0.0000017009156,0.0007561191,0.0019766039,0.00004550133,0.00019997681,1.0971448e-7,0.00001807716,0.00003229041,0.002961832,0.9915928],"study_design_scores_gemma":[0.010406866,0.002495774,0.000011866834,0.0020856995,0.0031824324,0.000078260106,0.000022643479,0.000004982606,0.00006417173,0.000020852076,0.98139894,0.00022750546],"about_ca_topic_score_codex":0.00016820608,"about_ca_topic_score_gemma":0.00000675318,"teacher_disagreement_score":0.9913653,"about_ca_system_score_codex":0.000054122138,"about_ca_system_score_gemma":0.00011806268,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W2011091397","doi":"10.1007/s40265-013-0145-9","title":"Should Mild COPD Be Treated? Evidence for Early Pharmacological Intervention","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; European Respiratory Society; GlaxoSmithKline; AstraZeneca; Pfizer","keywords":"Medicine; COPD; Spirometry; Pharmacotherapy; Intensive care medicine; Disease; Clinical trial; Smoking cessation; Airway obstruction; Pulmonary disease; Intervention (counseling); Internal medicine; Airway; Physical therapy; Asthma; Pathology; Surgery","score_opus":0.25025002197446633,"score_gpt":0.47592606020828776,"score_spread":0.22567603823382143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011091397","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001155272,0.989614,0.00003209185,0.0004465509,0.00036558378,0.0069402857,0.00028653024,0.00013915623,0.0010204919],"genre_scores_gemma":[0.00044049596,0.9816764,0.00016148247,0.00016772069,0.00082625885,0.0032168797,0.00062297255,0.0001196799,0.012768087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644434,0.0003405613,0.0008312757,0.00095414364,0.0007040068,0.00072563894],"domain_scores_gemma":[0.99744093,0.00083246833,0.00031226507,0.00056405674,0.00033024978,0.0005200503],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052461954,0.00060253346,0.0018528224,0.00031234213,0.00011580537,0.000077995704,0.00048482206,0.00051589543,0.0035773704],"category_scores_gemma":[0.00036106224,0.0004464864,0.0016683196,0.00041268705,0.00025014192,0.00023165313,0.00025111428,0.000900938,0.0006768196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017894848,0.00036547103,0.00009879224,0.041939586,0.0005546182,0.00007282029,0.000041283798,5.7710114e-8,0.000006001244,0.000044040607,0.024753567,0.9319448],"study_design_scores_gemma":[0.001653735,0.0003760734,0.00039028205,0.023006206,0.0038851367,0.00004515996,0.000041938318,0.00005833941,0.000023426282,0.000054021046,0.97003204,0.00043362644],"about_ca_topic_score_codex":0.00019048061,"about_ca_topic_score_gemma":0.0000021992525,"teacher_disagreement_score":0.94527847,"about_ca_system_score_codex":0.0011576836,"about_ca_system_score_gemma":0.0004729985,"threshold_uncertainty_score":0.9997987},"labels":[],"label_agreement":null},{"id":"W2012003343","doi":"10.1007/s40265-013-0026-2","title":"Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Leukemia; Refractory (planetary science); Myeloid leukemia; Oncology; Disease; Chemotherapy; Cancer; Childhood leukemia; Intensive care medicine; Internal medicine; Lymphoblastic Leukemia","score_opus":0.046610658832416364,"score_gpt":0.3592068213984452,"score_spread":0.3125961625660288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012003343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005842372,0.99389315,0.000010997058,0.00018172499,0.0008970888,0.001739919,0.000022232767,0.00017598066,0.0030204884],"genre_scores_gemma":[0.0000014803734,0.9452348,0.0012004555,0.00034036435,0.004250085,0.00024221219,0.00012961194,0.00017644909,0.048424583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997095,0.00016751737,0.0007153247,0.00072934036,0.0006685241,0.0006242894],"domain_scores_gemma":[0.9978851,0.0004931986,0.0003044629,0.0005030451,0.00012627705,0.0006879219],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023178909,0.0006423953,0.0016542433,0.00061925384,0.00017036965,0.00006792368,0.0002791157,0.00074392953,0.0014283174],"category_scores_gemma":[0.00009083598,0.00042283913,0.00026087038,0.0010351114,0.00007537737,0.0001427924,0.000164151,0.0013445447,0.001168155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038461418,0.000045640743,0.0000063693005,0.008433134,0.0003746742,0.00007674043,0.00028496096,6.8606303e-9,9.854796e-7,0.00000483186,0.062106993,0.9286272],"study_design_scores_gemma":[0.0023154207,0.000097338976,0.000024187664,0.0015956102,0.0022718888,0.00048105497,0.000051007675,0.0000058578607,0.0000012016493,0.0000044269073,0.9927393,0.00041271228],"about_ca_topic_score_codex":0.00010118601,"about_ca_topic_score_gemma":0.0000023901027,"teacher_disagreement_score":0.9306323,"about_ca_system_score_codex":0.003052585,"about_ca_system_score_gemma":0.012559978,"threshold_uncertainty_score":0.9998223},"labels":[],"label_agreement":null},{"id":"W2012123298","doi":"10.2165/00003495-200262150-00010","title":"Gefitinib","year":2002,"lang":"sl","type":"article","venue":"Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Gefitinib; Pharmacotherapy; Pharmacology; Internal medicine; Cancer; Epidermal growth factor receptor","score_opus":0.03679783711843848,"score_gpt":0.30342954578173936,"score_spread":0.2666317086633009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012123298","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47176164,0.02363052,0.0000018457799,0.011257257,0.002385308,0.00035868285,0.000050998064,0.00008595369,0.4904678],"genre_scores_gemma":[0.82582176,0.0025375937,0.00002900862,0.0031754875,0.0017002197,0.000020602367,0.000021885051,0.00002259569,0.16667084],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900573,0.000039977014,0.00018898066,0.00024267095,0.00015907515,0.00036353726],"domain_scores_gemma":[0.99943185,0.000088754736,0.000055409895,0.00020830204,0.000033404696,0.00018227473],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000641904,0.00016893871,0.00026643134,0.000066255074,0.00007176254,0.000013198556,0.00007428044,0.00010754025,0.050074603],"category_scores_gemma":[0.000010840291,0.00015530651,0.000119155855,0.00015091698,0.000080425816,0.000040181836,0.000027895352,0.00019853616,0.006575006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013027404,0.001071743,0.0051632626,0.000114997274,0.0003781252,0.0002888372,0.007491141,0.0000010463102,0.0009952489,0.0005458566,0.70318365,0.28063583],"study_design_scores_gemma":[0.006697835,0.0006114244,0.003296441,0.00009575291,0.0007790558,0.00004361206,0.0013554054,0.00059839233,0.0021667494,0.00007120407,0.9840343,0.00024983683],"about_ca_topic_score_codex":0.00010050116,"about_ca_topic_score_gemma":0.000006476415,"teacher_disagreement_score":0.3540601,"about_ca_system_score_codex":0.00011220916,"about_ca_system_score_gemma":0.000027103944,"threshold_uncertainty_score":0.9941985},"labels":[],"label_agreement":null},{"id":"W2014419865","doi":"10.2165/00003495-200666170-00001","title":"Potential of Aromatase Inhibitors for Ovulation and Superovulation Induction in Infertile Women","year":2006,"lang":"en","type":"review","venue":"Drugs","topic":"Ovarian function and disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Clomifene; Ovulation induction; Ovulation; Medicine; Letrozole; Gynecology; Estrogen; Anovulation; Adverse effect; Pregnancy; Endocrinology; Aromatase; Internal medicine; Biology; Hormone; Polycystic ovary; Insulin","score_opus":0.01883640610038124,"score_gpt":0.29445222465359183,"score_spread":0.2756158185532106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014419865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049907688,0.9456826,0.00034090743,0.00008235988,0.0006489052,0.0026460218,0.00015548815,0.00005784768,0.00047819232],"genre_scores_gemma":[0.03583117,0.95342255,0.0004932585,0.00007025663,0.0006214297,0.00046215302,0.00804341,0.000097409786,0.000958365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903387,0.000036177207,0.00047698748,0.00020289198,0.00012461844,0.00012544525],"domain_scores_gemma":[0.9995771,0.000034979188,0.0001762645,0.00012437536,0.0000412628,0.000046034424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018739949,0.0001497659,0.0005894317,0.00038793162,0.00002329694,0.000009759214,0.000017947084,0.00023225282,0.000035523673],"category_scores_gemma":[0.00005568754,0.0001351404,0.00010363185,0.0002296775,0.000028557684,0.000091027614,0.00001170086,0.00011151721,0.000003919362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011992151,0.0001789159,0.00025941152,0.012016065,0.000046857887,0.0000013047201,0.0002912081,0.000023703333,0.00002671035,0.00013831806,0.0014420674,0.9854555],"study_design_scores_gemma":[0.0028162126,0.00020507396,0.0029966147,0.0028517398,0.00043474595,0.00001742587,0.0003381,0.0002459653,0.000009416616,0.00021644105,0.98961,0.0002582495],"about_ca_topic_score_codex":0.00007600614,"about_ca_topic_score_gemma":0.0000046480473,"teacher_disagreement_score":0.98816794,"about_ca_system_score_codex":0.000111749105,"about_ca_system_score_gemma":0.0001098875,"threshold_uncertainty_score":0.55108654},"labels":[],"label_agreement":null},{"id":"W2014500898","doi":"10.1007/s40265-015-0365-2","title":"Preventive Analgesia and Novel Strategies for the Prevention of Chronic Post-Surgical Pain","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; York University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Chronic pain; Perioperative; Intensive care medicine; Analgesic; Central sensitization; Psychosocial; Quality of life (healthcare); Psychological intervention; Acute pain; Multimodal therapy; Physical therapy; Anesthesia; Nociception; Surgery; Psychiatry; Nursing","score_opus":0.04321788175516431,"score_gpt":0.3471312076987139,"score_spread":0.3039133259435496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014500898","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012279284,0.9929226,0.0035997215,0.00021046621,0.000025969228,0.0026027295,0.000010313349,0.00001519607,0.0006007232],"genre_scores_gemma":[0.00020301699,0.99507236,0.00019505374,0.000058500853,0.00022917768,0.00027126336,0.00018909706,0.000029183537,0.0037523403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988489,0.00020528912,0.00035592337,0.0002266026,0.00020645697,0.00015682854],"domain_scores_gemma":[0.99885184,0.00046192162,0.00027258246,0.0002561775,0.000102653124,0.000054813034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020198082,0.0002126113,0.0008770188,0.00007349055,0.00004096043,0.000019396213,0.000113879585,0.0001365242,0.000028118275],"category_scores_gemma":[0.000032958353,0.0001223528,0.00035830576,0.00011837361,0.00009332375,0.000038307062,0.000030245013,0.00013710663,0.000003740058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036225032,0.00011105574,0.0000024586734,0.02487869,0.00041696566,0.000005512415,0.00018506208,6.982902e-7,2.0163667e-7,0.0065273102,0.0014770189,0.9663588],"study_design_scores_gemma":[0.0005829554,0.00056740345,0.000020014446,0.006221812,0.0022860644,0.000028688055,0.0006421296,0.00012651634,1.16862225e-7,0.0003262989,0.98908234,0.000115657946],"about_ca_topic_score_codex":0.000013805733,"about_ca_topic_score_gemma":0.0000035619214,"teacher_disagreement_score":0.98760533,"about_ca_system_score_codex":0.000069016525,"about_ca_system_score_gemma":0.000524302,"threshold_uncertainty_score":0.49894023},"labels":[],"label_agreement":null},{"id":"W2016675546","doi":"10.2165/00003495-200059040-00005","title":"A Risk-Benefit Assessment of Pharmacological and Nonpharmacological Treatments for Nausea and Vomiting of Pregnancy","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Ondansetron; Nausea; Metoclopramide; Pregnancy; Vomiting; Pharmacotherapy; Intensive care medicine; Pharmacology; Randomized controlled trial; Anesthesia; Internal medicine","score_opus":0.06665601290362505,"score_gpt":0.4470213298078172,"score_spread":0.3803653169041922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016675546","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007453623,0.98794615,0.000031267984,0.00003069767,0.000064905464,0.0025483973,0.00038724198,0.000025164543,0.0015125276],"genre_scores_gemma":[0.0057244776,0.9919641,0.0012553093,0.000038058155,0.00007293577,0.0004662765,0.00010825994,0.000023076422,0.00034748373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998357,0.00010464233,0.0007062238,0.0003725578,0.00021079081,0.00024878175],"domain_scores_gemma":[0.9982907,0.00061466143,0.0006533988,0.00015506367,0.000058210564,0.0002279475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025774265,0.0003028393,0.0016839734,0.00012844786,0.000055502893,0.000005260176,0.00008865929,0.0002697321,0.00018016374],"category_scores_gemma":[0.000091155634,0.000198023,0.00027556857,0.0001255216,0.00016738189,0.000041878564,0.000050886487,0.00027923414,0.0000010124867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005563076,0.0004061195,0.0005968308,0.010371217,0.0009637673,0.000008941953,0.000095757074,1.06177275e-7,0.000012298965,0.000052292682,0.00009836324,0.98733866],"study_design_scores_gemma":[0.026394118,0.00502846,0.012836109,0.17489722,0.075615026,0.00034468333,0.000110342466,0.00044622069,0.00039574245,0.00029315616,0.702481,0.0011579568],"about_ca_topic_score_codex":0.0000055273154,"about_ca_topic_score_gemma":1.5038518e-7,"teacher_disagreement_score":0.9861807,"about_ca_system_score_codex":0.00006563956,"about_ca_system_score_gemma":0.0002460735,"threshold_uncertainty_score":0.80751437},"labels":[],"label_agreement":null},{"id":"W2018201647","doi":"10.1007/s40265-014-0293-6","title":"Antiepileptic Drugs for the Treatment of Agitation and Aggression in Dementia: Do They Have a Place in Therapy?","year":2014,"lang":"en","type":"review","venue":"Drugs","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"H. Lundbeck A/S; Pfizer","keywords":"Oxcarbazepine; Tolerability; Medicine; Levetiracetam; Topiramate; Dementia; Gabapentin; Lamotrigine; Psychiatry; Observational study; Aggression; Vigabatrin; Carbamazepine; Donepezil; Intensive care medicine; Adverse effect; Anticonvulsant; Epilepsy; Pharmacology; Alternative medicine; Disease; Internal medicine","score_opus":0.05138615566476509,"score_gpt":0.3946525175362661,"score_spread":0.34326636187150106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018201647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008414926,0.9881052,0.0000053768895,0.00030934368,0.00007727682,0.0029296372,0.000015748363,0.0000075603557,0.00013496228],"genre_scores_gemma":[0.0231696,0.97591513,0.000031430216,0.00014415117,0.0000711615,0.00057552394,0.00002287191,0.00001661032,0.00005348748],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989093,0.00016838314,0.00037791347,0.00024293666,0.00012706126,0.00017438162],"domain_scores_gemma":[0.9979555,0.0015894056,0.00023886102,0.0001365144,0.00004648488,0.000033214914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041852958,0.00023867263,0.0011910152,0.00012458839,0.000044985733,0.00001118716,0.00006027363,0.00011951104,0.0000065877643],"category_scores_gemma":[0.00009949771,0.000108179636,0.00019352081,0.000074036616,0.000065254535,0.000018904668,0.00002253218,0.00011708081,0.0000015141095],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012421049,0.00032932227,0.000107703934,0.0030767117,0.00026697593,0.0000034939005,0.0024589829,0.0000012891322,0.000005255244,0.000015783377,0.00015383786,0.9934564],"study_design_scores_gemma":[0.006812686,0.001894502,0.00035134726,0.024403883,0.0014204851,0.0000038762305,0.000564367,0.00028206207,0.0000330698,0.00016567492,0.9638374,0.00023063716],"about_ca_topic_score_codex":0.00005828119,"about_ca_topic_score_gemma":0.000023517883,"teacher_disagreement_score":0.9932258,"about_ca_system_score_codex":0.00008365385,"about_ca_system_score_gemma":0.000039975566,"threshold_uncertainty_score":0.44114378},"labels":[],"label_agreement":null},{"id":"W2022826620","doi":"10.2165/00003495-200868001-00004","title":"Pathogenesis and Management of Chronic Allograft Nephropathy","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Pathogenesis; Pharmacotherapy; Nephropathy; Chronic allograft nephropathy; Immunology; Pharmacology; Bioinformatics; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.030794799613438475,"score_gpt":0.3238280722218733,"score_spread":0.29303327260843487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022826620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037959642,0.9975156,0.0000222676,0.000009726963,0.000058404246,0.00065682636,0.000055734294,0.000018068451,0.001625368],"genre_scores_gemma":[0.000038557795,0.9977984,0.00062238297,0.000021245412,0.00003945562,0.00006332988,0.0002525777,0.000029785931,0.0011342838],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999096,0.000028892442,0.0003369817,0.00022707865,0.0001775643,0.00013352653],"domain_scores_gemma":[0.9995173,0.000030148565,0.00013845491,0.00022178241,0.000017224318,0.00007506581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030842217,0.00022771949,0.0009794069,0.00011070285,0.000027199483,0.000003644639,0.000050376548,0.000092074966,0.000031980657],"category_scores_gemma":[5.8130206e-7,0.00015594285,0.00031950383,0.0001396138,0.000060572063,0.000015350435,0.00002042551,0.00006600526,0.00003106415],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006002328,0.00007899838,0.00005387017,0.06141704,0.000765969,0.00042503813,0.000040218252,4.9956814e-8,2.260516e-7,0.000090360176,0.000029965746,0.93709224],"study_design_scores_gemma":[0.0008692054,0.000116504656,0.00045578182,0.02560652,0.002964908,0.00036493925,0.000009355176,7.7925785e-7,0.0000016762979,0.0000024830485,0.9694779,0.000129955],"about_ca_topic_score_codex":0.000007802743,"about_ca_topic_score_gemma":4.5081748e-7,"teacher_disagreement_score":0.9694479,"about_ca_system_score_codex":0.00005566055,"about_ca_system_score_gemma":0.00006013172,"threshold_uncertainty_score":0.6359165},"labels":[],"label_agreement":null},{"id":"W2023602620","doi":"10.2165/00003495-200565180-00009","title":"Tigecycline","year":2005,"lang":"en","type":"article","venue":"Drugs","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Tigecycline; Pharmacotherapy; Traditional medicine; Pharmacology; Antibiotics; Microbiology; Internal medicine; Biology","score_opus":0.012047133154302428,"score_gpt":0.30640781164521225,"score_spread":0.2943606784909098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023602620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87023216,0.000101439626,0.00003935197,0.0018318833,0.000056219997,0.00011721515,0.0000017080943,0.00007120516,0.12754878],"genre_scores_gemma":[0.9867018,0.000014742364,0.0008440668,0.0005441358,0.00022926381,0.000013402696,0.000011071874,0.000005361346,0.011636145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974865,0.0000027511883,0.000059596656,0.00006931741,0.000047356225,0.000072321935],"domain_scores_gemma":[0.9998102,0.000009200611,0.0000095535,0.00010254652,0.00001582233,0.000052687454],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000016755812,0.00003912826,0.00006182003,0.000026709966,0.000024839926,0.0000034414586,0.000010061823,0.000020240726,0.0012577919],"category_scores_gemma":[0.0000071492136,0.00002938936,0.000038478447,0.000057684723,0.000011536659,0.000022294627,0.000005806019,0.000037234775,0.0012068782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048662667,0.0009594912,0.28999427,0.00001289924,0.00014226222,0.000024746387,0.00026928273,0.000008523715,0.0014717308,0.0013825638,0.018702505,0.68698305],"study_design_scores_gemma":[0.0020407161,0.0001275955,0.15512161,0.000021837935,0.000066320594,0.00004004827,0.00003281996,0.00022796381,0.010819192,0.0001021404,0.8313244,0.0000753765],"about_ca_topic_score_codex":0.000018543484,"about_ca_topic_score_gemma":0.0000025367478,"teacher_disagreement_score":0.8126219,"about_ca_system_score_codex":0.000026638758,"about_ca_system_score_gemma":0.00000978249,"threshold_uncertainty_score":0.9996552},"labels":[],"label_agreement":null},{"id":"W2024196604","doi":"10.2165/00003495-200363200-00003","title":"Dual ACE and Neutral Endopeptidase Inhibitors","year":2003,"lang":"en","type":"review","venue":"Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Blood pressure; Internal medicine; Cardiology; Heart failure; ACE inhibitor; Neprilysin; Bradykinin; Angiotensin-converting enzyme; Population; Aldosterone","score_opus":0.026725863270189346,"score_gpt":0.30546557313898653,"score_spread":0.2787397098687972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024196604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001561606,0.96861833,2.4807994e-7,0.00006719757,0.00025287137,0.00097085553,0.000012966082,0.00005491074,0.029866477],"genre_scores_gemma":[0.00002087723,0.9750918,0.00013574977,0.00017160768,0.00021943655,0.00010134806,0.00017382568,0.00004648886,0.024038857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99895245,0.00004537926,0.00026463968,0.00033570913,0.00013098739,0.00027084866],"domain_scores_gemma":[0.9994095,0.00004332346,0.00009838581,0.00027188536,0.000014483052,0.00016239696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010772835,0.00033145302,0.0010146756,0.00014347766,0.000036811438,0.00003169104,0.00004052928,0.00012680788,0.00007765545],"category_scores_gemma":[0.000009747811,0.00023902151,0.00025295437,0.00014512271,0.000048795315,0.00004326305,0.00006474958,0.00017829343,0.00022328187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000023520702,0.00008935616,0.00000820126,0.0077084806,0.0002962848,0.00011636943,0.00006075854,8.757241e-9,9.3706284e-8,0.00051552523,0.018222038,0.97298056],"study_design_scores_gemma":[0.000606324,0.00010150751,0.000002898805,0.0041680643,0.002337263,0.000027125983,0.00002922588,1.5022766e-7,0.000003879327,0.000009381313,0.99252576,0.00018845196],"about_ca_topic_score_codex":0.0000060642647,"about_ca_topic_score_gemma":7.8519577e-7,"teacher_disagreement_score":0.97430366,"about_ca_system_score_codex":0.00008586433,"about_ca_system_score_gemma":0.00006740256,"threshold_uncertainty_score":0.97470146},"labels":[],"label_agreement":null},{"id":"W2025105082","doi":"10.2165/00003495-200161030-00005","title":"Does Allergen Immunotherapy Alter the Natural Course of Allergic Disorders?","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Medical Research Council","keywords":"Medicine; Immunology; Allergy; Immunotherapy; Allergen immunotherapy; Desensitization (medicine); Allergen; Immunoglobulin E; Asthma; House dust mite; Immune system; Antibody; Internal medicine","score_opus":0.014827769694644733,"score_gpt":0.30504803930342833,"score_spread":0.2902202696087836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025105082","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000106855114,0.99217767,0.000019139969,0.0008737026,0.0008740341,0.0009155669,0.000022665217,0.000039977527,0.0049703815],"genre_scores_gemma":[0.00077289256,0.9904637,0.000038934304,0.00032258293,0.00046122514,0.000036533747,0.00044146628,0.00008035207,0.0073823645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827915,0.00015405362,0.0006470612,0.00031095123,0.00034279347,0.0002660142],"domain_scores_gemma":[0.9986579,0.00014773633,0.00040788006,0.0006235756,0.00010545032,0.000057460642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021851886,0.00039323448,0.0013626909,0.00008224203,0.0000897575,0.000016810873,0.00023473607,0.00023194238,0.00058000296],"category_scores_gemma":[0.000017545282,0.00015936627,0.00070061744,0.0002629307,0.00014270352,0.000043996126,0.00004254118,0.00042691303,0.000048688948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028089113,0.00010805048,0.0000043515192,0.0013297902,0.0007547661,0.000012494153,0.00087839284,7.7126117e-7,0.0000013036906,0.00020388553,0.0038030886,0.99287504],"study_design_scores_gemma":[0.0004968889,0.000047862457,0.000032232514,0.0027703221,0.00032228456,0.000050883344,0.00026013632,0.000036841662,0.000001339268,0.00008912573,0.9956746,0.00021748651],"about_ca_topic_score_codex":0.000056569897,"about_ca_topic_score_gemma":0.000037072234,"teacher_disagreement_score":0.99265754,"about_ca_system_score_codex":0.000045722478,"about_ca_system_score_gemma":0.00020361168,"threshold_uncertainty_score":0.64987683},"labels":[],"label_agreement":null},{"id":"W2027729256","doi":"10.2165/00003495-200161030-00006","title":"The Myocardial Na+/H+ Exchanger","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Medical Research Council; Heart and Stroke Foundation of Canada","keywords":"Intracellular pH; Sodium–hydrogen antiporter; Amiloride; Paracrine signalling; Intracellular; Angiotensin II; Autocrine signalling; Endothelin receptor; Gene isoform; Cell biology; Medicine; Receptor; Chemistry; Pharmacology; Internal medicine; Endocrinology; Biology; Biochemistry; Sodium","score_opus":0.023435077160446644,"score_gpt":0.31529117656604233,"score_spread":0.2918560994055957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027729256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011197579,0.97565824,0.000001816859,0.00021127726,0.00091607583,0.00059838226,0.000011237378,0.000063336825,0.022528421],"genre_scores_gemma":[0.000009823311,0.98297834,0.0000078752355,0.00031808615,0.0037100108,0.00015949785,0.00011953553,0.00005335158,0.012643483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986526,0.0001640569,0.0002868449,0.00030911024,0.00018463036,0.00040278336],"domain_scores_gemma":[0.99885964,0.00029962452,0.00012389307,0.00057998294,0.000039055954,0.00009777233],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022816577,0.00030470177,0.0013790922,0.00006700149,0.00020013547,0.000018191617,0.0001201195,0.00034004232,0.00009047411],"category_scores_gemma":[0.00005756639,0.00016784974,0.0012280346,0.00028126314,0.0001322239,0.000016521826,0.00006363777,0.00068405044,0.0010269287],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001625445,0.0000085925385,1.8875782e-7,0.0009078598,0.00034586655,0.00019425733,0.000029062478,2.5164654e-8,2.7934965e-7,0.00017165835,0.019303337,0.9790226],"study_design_scores_gemma":[0.00016114225,0.00006969205,0.0000033130839,0.0014705586,0.0011581592,0.0008454611,0.000009296626,3.399354e-7,4.6938533e-7,0.00004421053,0.996072,0.00016538924],"about_ca_topic_score_codex":0.000005179261,"about_ca_topic_score_gemma":4.0401738e-7,"teacher_disagreement_score":0.9788572,"about_ca_system_score_codex":0.000087546,"about_ca_system_score_gemma":0.0002560362,"threshold_uncertainty_score":0.9997509},"labels":[],"label_agreement":null},{"id":"W2028261606","doi":"10.1007/s40265-013-0092-5","title":"The Optimal Management of Follicular Lymphoma: An Evolving Field","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"Pharmacyclics; Genentech; Celgene; Teva Pharmaceutical Industries; American Society of Hematology","keywords":"Medicine; Follicular lymphoma; Rituximab; Chemoimmunotherapy; Radioimmunotherapy; Bendamustine; Oncology; Tolerability; Internal medicine; Lymphoma; Vincristine; Cyclophosphamide; Immunology; Chemotherapy; Adverse effect","score_opus":0.02607585979887412,"score_gpt":0.32327577265854934,"score_spread":0.29719991285967523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028261606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002007599,0.98945445,0.0000052629885,0.00009716835,0.00017991231,0.0012800253,0.0000070881592,0.000028815386,0.008746538],"genre_scores_gemma":[0.00026629254,0.99621934,0.0008784439,0.000056392902,0.00011242815,0.0005447862,0.00007178171,0.000037209124,0.0018132998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998585,0.00006107702,0.00046358086,0.00031232467,0.00031504364,0.00026300916],"domain_scores_gemma":[0.9985904,0.00019459358,0.00023062919,0.00079962687,0.00006617571,0.00011853907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001683827,0.00030691733,0.0009988975,0.000060500963,0.000101011996,0.000049039045,0.00022987164,0.0001538544,0.000124594],"category_scores_gemma":[0.000013181688,0.00016209499,0.00055116083,0.00014120499,0.00003742278,0.00005388742,0.00011742409,0.00006311468,0.00015092778],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000042272472,0.00027818675,0.000011458171,0.0051175603,0.0009220085,0.00008644799,0.00004945355,1.102469e-7,2.6061224e-8,0.0008118318,0.003849542,0.98886913],"study_design_scores_gemma":[0.00077403954,0.00017743671,0.00007988996,0.008162773,0.0027136675,0.00003697607,0.00013974239,0.000013894938,0.000010440239,0.00001164072,0.9877285,0.0001510308],"about_ca_topic_score_codex":0.0001047867,"about_ca_topic_score_gemma":9.1018234e-7,"teacher_disagreement_score":0.9887181,"about_ca_system_score_codex":0.0001934317,"about_ca_system_score_gemma":0.000107511805,"threshold_uncertainty_score":0.6610042},"labels":[],"label_agreement":null},{"id":"W2029403749","doi":"10.2165/0003495-200868170-00002","title":"Mild to Moderate Crohn’s Disease","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Mesalazine; Budesonide; Crohn's disease; Disease; Sulfasalazine; Maintenance therapy; Inflammatory bowel disease; Natural history; Intensive care medicine; Internal medicine; Gastroenterology; Ulcerative colitis; Chemotherapy; Asthma","score_opus":0.01995303257022757,"score_gpt":0.2928080993935062,"score_spread":0.27285506682327865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029403749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058034464,0.99634916,0.00003672026,0.000018336872,0.00023758045,0.0007845132,0.00034900304,0.000030943604,0.001613404],"genre_scores_gemma":[0.00006739964,0.99303406,0.00009406486,0.00051656796,0.0006227218,0.00030757132,0.00090985966,0.00010665219,0.0043410854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998322,0.00011746426,0.00034983203,0.00065198523,0.00019232168,0.00036639458],"domain_scores_gemma":[0.9983635,0.0000072293165,0.0001143766,0.0008839517,0.000071262286,0.0005596709],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005931818,0.00044955598,0.00054950605,0.00008617104,0.00010684211,0.00003529279,0.00040225819,0.00024413357,0.000042636897],"category_scores_gemma":[0.00006618612,0.00041496745,0.0005783737,0.000089125795,0.00005113941,0.0000021303124,0.00023621325,0.00014033668,0.0007642874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004306695,0.00020193076,0.00001802014,0.010815265,0.00044860458,0.002937517,0.000114703405,0.00006589379,0.0000088079905,0.0001526081,0.19166158,0.7931444],"study_design_scores_gemma":[0.00012860895,0.000009226381,0.0001358658,0.00079829106,0.00015131159,0.000008566183,0.0000022219024,0.0000036013428,0.0000048914458,0.000008525353,0.99825263,0.00049625523],"about_ca_topic_score_codex":0.0000028187094,"about_ca_topic_score_gemma":0.000002407038,"teacher_disagreement_score":0.80659103,"about_ca_system_score_codex":0.000041545474,"about_ca_system_score_gemma":0.0006550934,"threshold_uncertainty_score":0.99983025},"labels":[],"label_agreement":null},{"id":"W2034091655","doi":"10.2165/00003495-200868001-00001","title":"The Evolution of Immunosuppressant Therapy in Renal Transplantation","year":2008,"lang":"en","type":"article","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Transplantation; Intensive care medicine; Kidney transplantation; Internal medicine","score_opus":0.016002404563374203,"score_gpt":0.2702323924178969,"score_spread":0.2542299878545227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034091655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957878,0.0008543703,0.000173251,0.00019119456,0.000046737074,0.00018512926,0.000008475139,0.00000974378,0.0027433066],"genre_scores_gemma":[0.9940272,0.005438029,0.000114810806,0.000024273822,0.000012087368,0.000012628197,0.00002894545,0.0000050317017,0.00033701904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994835,0.00002732122,0.00017765269,0.00007035251,0.00015455126,0.00008657076],"domain_scores_gemma":[0.99974936,0.00006709872,0.000040336006,0.000097041906,0.00002739742,0.00001877608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067272515,0.000055211098,0.00010065327,0.00004737439,0.000058191883,0.0000019888246,0.00003437272,0.000025466505,0.000014719353],"category_scores_gemma":[0.0000026512753,0.000032243333,0.00005381481,0.00010598879,0.00004845633,0.000038656333,0.0000011258576,0.000051790423,0.0000063453035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007068694,0.0008325819,0.8799505,0.00023307216,0.0003805785,0.00037391146,0.019106753,0.0001831916,0.060991023,0.0045088674,0.00010086364,0.026269926],"study_design_scores_gemma":[0.0044232425,0.00017059971,0.9733978,0.00012373908,0.00002224169,0.000114650844,0.00018472773,0.00006975882,0.021059744,0.0001275902,0.00026269726,0.000043200627],"about_ca_topic_score_codex":0.00029384738,"about_ca_topic_score_gemma":0.000013844818,"teacher_disagreement_score":0.09344727,"about_ca_system_score_codex":0.000040056642,"about_ca_system_score_gemma":0.000045267334,"threshold_uncertainty_score":0.13148451},"labels":[],"label_agreement":null},{"id":"W2034943103","doi":"10.2165/00003495-200969070-00001","title":"Novel Approaches for Pharmacological Management of Atrial Fibrillation","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Montreal Heart Institute","funders":"","keywords":"Medicine; Amiodarone; Dofetilide; Atrial fibrillation; Supraventricular arrhythmia; Proarrhythmia; Cardiology; Anti-Arrhythmia Agents; Drug; Sotalol; Sinus rhythm; Internal medicine; Intensive care medicine; Adverse effect; Ibutilide; Cardiac arrhythmia; Pharmacotherapy; Dronedarone; Pharmacology","score_opus":0.2732358529622797,"score_gpt":0.42379488410236377,"score_spread":0.15055903114008407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034943103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000059228832,0.98847157,0.0016739229,0.00019450278,0.00036518567,0.004083025,0.000034374938,0.000064334396,0.0051071495],"genre_scores_gemma":[0.00002395642,0.9859943,0.006935365,0.000020674686,0.002904048,0.00000915992,0.00055368035,0.000029629704,0.003529194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848247,0.00003179007,0.00069743,0.00032767194,0.00026762593,0.00019300655],"domain_scores_gemma":[0.99908227,0.00018663297,0.00043632658,0.000196856,0.000037108388,0.000060830927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032641744,0.00027798713,0.0014596542,0.00018022646,0.00004090971,0.00001305658,0.00010137809,0.00020622084,0.00005782965],"category_scores_gemma":[0.000022762377,0.00020545875,0.0014939507,0.00025531652,0.00002953252,0.000039906612,0.000059623995,0.000086847795,0.000020497991],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011992782,0.000005768127,0.0000062494178,0.013704397,0.00085460703,0.0000012484012,0.000014023246,0.000022552538,2.5702886e-7,0.0046154275,0.00058626995,0.9800693],"study_design_scores_gemma":[0.001802899,0.00010659009,0.000029201234,0.0018773254,0.007316139,0.0000034532698,0.000020783558,0.00013972432,0.0000011061634,0.000068669106,0.98845184,0.0001822961],"about_ca_topic_score_codex":7.369936e-7,"about_ca_topic_score_gemma":3.3334647e-8,"teacher_disagreement_score":0.98786557,"about_ca_system_score_codex":0.00007577484,"about_ca_system_score_gemma":0.00004497772,"threshold_uncertainty_score":0.83783644},"labels":[],"label_agreement":null},{"id":"W2038962385","doi":"10.2165/00003495-200767002-00005","title":"Clinical Results of If Current Inhibition by Ivabradine","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Ivabradine; Medicine; Cardiology; Coronary artery disease; Internal medicine; Tolerability; Heart failure; Angina; Heart rate; Contractility; Adverse effect; Myocardial infarction; Blood pressure","score_opus":0.11225787342870548,"score_gpt":0.47009098018204903,"score_spread":0.35783310675334357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038962385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058934966,0.99431556,0.000052939307,0.000077140285,0.0005605154,0.0008049913,0.00018497184,0.000036227728,0.003908693],"genre_scores_gemma":[0.000025696003,0.9963051,0.00007628458,0.00014032028,0.0011116803,0.000014223701,0.001829235,0.000041613504,0.00045585382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966977,0.00032823184,0.0017260524,0.00043366494,0.0005152323,0.00029911363],"domain_scores_gemma":[0.9983371,0.00022327174,0.0003623355,0.00065481063,0.000117283584,0.0003052319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003224336,0.00026096465,0.0025210723,0.00015656452,0.00002670768,0.000004754471,0.00006400231,0.00042996826,0.000027770708],"category_scores_gemma":[0.00021289164,0.00019748957,0.0015041796,0.00035369486,0.000080446625,0.000025131108,0.00003746037,0.0008539927,0.00022623868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002304358,0.00015846164,0.0000016974096,0.016100679,0.00013111538,0.00001794477,0.000029025485,5.4249085e-9,1.288076e-7,0.000011007457,0.058652516,0.92487437],"study_design_scores_gemma":[0.0011514344,0.00014862636,0.000013736013,0.017297084,0.0009699875,0.000058092148,0.000008644881,5.983227e-7,0.0000033435372,0.0000034848442,0.9802003,0.00014467986],"about_ca_topic_score_codex":0.000029125933,"about_ca_topic_score_gemma":6.53091e-7,"teacher_disagreement_score":0.9247297,"about_ca_system_score_codex":0.00010232196,"about_ca_system_score_gemma":0.0006566736,"threshold_uncertainty_score":0.8053391},"labels":[],"label_agreement":null},{"id":"W2040873599","doi":"10.2165/00003495-200565070-00002","title":"Bullous Pemphigoid","year":2005,"lang":"id","type":"review","venue":"Drugs","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"Bullous pemphigoid; Medicine; Autoantibody; Pemphigus vulgaris; Cicatricial pemphigoid; Immunology; Dermatology; Immune system; Pemphigoid; Antibody","score_opus":0.024711527956983777,"score_gpt":0.3257739759478527,"score_spread":0.3010624479908689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040873599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008295407,0.92717075,0.000005947578,0.0007161874,0.0017042686,0.0022326221,0.00016798724,0.00039879777,0.06752049],"genre_scores_gemma":[0.00071856414,0.871792,0.0001574029,0.0010267737,0.0039752116,0.000231834,0.0009477792,0.00040165245,0.12074876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935715,0.0003838905,0.0018924265,0.0014016652,0.0012671858,0.0014832916],"domain_scores_gemma":[0.9950092,0.00048798052,0.0010052581,0.0024761816,0.00025236618,0.00076904014],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00058161677,0.001561952,0.0043024695,0.00047523263,0.00029317915,0.00010773381,0.0010472285,0.0009780014,0.014856873],"category_scores_gemma":[0.0006218155,0.0013857065,0.0021127362,0.000701209,0.00040619046,0.00010272476,0.0004711963,0.0014654819,0.057698257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004926375,0.0007467153,0.000032310043,0.015890773,0.00077695004,0.0005622436,0.0005424871,7.489814e-7,0.0000018911455,0.00018751762,0.06591218,0.9152969],"study_design_scores_gemma":[0.0012963522,0.00017870532,0.00024067699,0.024067609,0.0062134713,0.00046309957,0.00020059137,0.0000073782053,0.0000031879492,0.000015753423,0.9661401,0.0011730553],"about_ca_topic_score_codex":0.00010118166,"about_ca_topic_score_gemma":0.0000032425858,"teacher_disagreement_score":0.91412383,"about_ca_system_score_codex":0.0009145719,"about_ca_system_score_gemma":0.0025001164,"threshold_uncertainty_score":0.9997129},"labels":[],"label_agreement":null},{"id":"W2047657005","doi":"10.2165/11631440-000000000-00000","title":"Epidemiology and Management of Kawasaki Disease","year":2012,"lang":"en","type":"review","venue":"Drugs","topic":"Kawasaki Disease and Coronary Complications","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Chinese Academy of Agricultural Sciences; Arthritis Society","keywords":"Kawasaki disease; Medicine; Aspirin; Vasculitis; Epidemiology; Systemic vasculitis; Disease; Macrophage activation syndrome; Internal medicine; Immunology; Pediatrics; Artery","score_opus":0.1282571116822686,"score_gpt":0.41013458331458624,"score_spread":0.28187747163231763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047657005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012384879,0.9923294,0.000026487347,0.0002069118,0.00006283362,0.0007668291,0.000066086635,0.000027048194,0.0065020006],"genre_scores_gemma":[0.0002155578,0.9970455,0.0003217971,0.00017616402,0.000116398245,0.00023626968,0.0003513442,0.000026484604,0.0015104531],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988777,0.00010093929,0.00045051175,0.00026599568,0.00008476066,0.00022010405],"domain_scores_gemma":[0.9986761,0.00014233837,0.0002032031,0.00057674735,0.000024394507,0.00037719053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018414341,0.00020299797,0.0011078801,0.00009765965,0.00003090532,0.0000010223481,0.00010035496,0.000079990576,0.00013077645],"category_scores_gemma":[0.000013641706,0.00015607775,0.00030533655,0.00012373242,0.00009146458,0.000023985156,0.000113723014,0.00011225639,0.000120393495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000107364995,0.00012999053,0.00038719288,0.047612272,0.00028308947,0.000011647766,0.000011111154,1.5488757e-8,6.72247e-9,0.012624091,0.0006954523,0.9382344],"study_design_scores_gemma":[0.00013932222,0.000015278009,0.0068542077,0.0063488735,0.00609034,0.000015201209,0.000012044969,0.0000013027162,1.2327184e-8,0.0002820763,0.9801199,0.00012143149],"about_ca_topic_score_codex":0.000003791375,"about_ca_topic_score_gemma":9.049588e-8,"teacher_disagreement_score":0.9794245,"about_ca_system_score_codex":0.0000308311,"about_ca_system_score_gemma":0.00007737399,"threshold_uncertainty_score":0.63646656},"labels":[],"label_agreement":null},{"id":"W2047723707","doi":"10.2165/00003495-200262170-00002","title":"Statins and Menopause","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Menopause; Pravastatin; Fluvastatin; Internal medicine; Clinical trial; Hormone replacement therapy (female-to-male); Lovastatin; Placebo; Cholesterol; Endocrinology; Simvastatin; Lipoprotein; Statin; Physiology; Testosterone (patch)","score_opus":0.03733087280325366,"score_gpt":0.32604547079497603,"score_spread":0.2887145979917224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047723707","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009753067,0.9907524,0.0000052843816,0.000045682995,0.0000831586,0.000852361,0.000027117649,0.000043509586,0.008180758],"genre_scores_gemma":[0.000003477737,0.9958142,0.00021652569,0.00013809116,0.00039361446,0.0000684806,0.00006322455,0.00004875084,0.003253642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988917,0.00007439882,0.00027306267,0.0002757394,0.00028131405,0.00020375787],"domain_scores_gemma":[0.9991829,0.000038689708,0.000085313804,0.00048081737,0.000025662259,0.00018665598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025988062,0.0002148948,0.0013991671,0.000085306165,0.000043101605,0.000015422913,0.00004660083,0.00015635096,0.00014488121],"category_scores_gemma":[0.000034441564,0.00014897785,0.00027712705,0.00012901342,0.000030058218,0.000019231806,0.00003759539,0.00029235473,0.0001589002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.142458e-7,0.000018447774,3.946537e-7,0.02202197,0.00019652197,0.000045621906,0.00009065144,1.6051361e-9,1.565159e-8,0.00005769363,0.0015293473,0.9760385],"study_design_scores_gemma":[0.0002916083,0.00006774745,0.0000032563619,0.005698317,0.0013122035,0.00024682764,0.00001764542,6.633429e-7,1.2670564e-7,0.0000056674326,0.992223,0.00013291887],"about_ca_topic_score_codex":0.000054771583,"about_ca_topic_score_gemma":0.0000010770608,"teacher_disagreement_score":0.9906937,"about_ca_system_score_codex":0.00006551102,"about_ca_system_score_gemma":0.00013725624,"threshold_uncertainty_score":0.607514},"labels":[],"label_agreement":null},{"id":"W2047794741","doi":"10.2165/00003495-200059050-00003","title":"Pharmacological Management of Intermittent Claudication","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Children's Hospital of Eastern Ontario; Agricultural Research Institute of Ontario; University of Ottawa","funders":"","keywords":"Medicine; Pentoxifylline; Intermittent claudication; Placebo; Claudication; Clinical trial; Ginkgo biloba; Physical therapy; Adverse effect; Pharmacotherapy; Internal medicine; Vascular disease; Pharmacology; Arterial disease; Alternative medicine","score_opus":0.04569416447861133,"score_gpt":0.37885352398363303,"score_spread":0.33315935950502173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047794741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042539185,0.9459975,0.000013434698,0.0001161824,0.00011432095,0.0014200803,0.000017803932,0.000064303764,0.052213863],"genre_scores_gemma":[0.00011998967,0.9941778,0.00023673972,0.0002793474,0.00009999126,0.00030697923,0.00024569037,0.000027358034,0.004506114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985486,0.00006819396,0.00055493513,0.0003440607,0.0002946715,0.00018951336],"domain_scores_gemma":[0.9992916,0.000014305001,0.00020358915,0.000349783,0.000019579453,0.00012113409],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010665448,0.0002578499,0.0009953941,0.00013410585,0.000019468287,0.000007827801,0.0001992438,0.00009075709,0.0025001392],"category_scores_gemma":[0.0000013641713,0.00018815292,0.00048166144,0.00020346887,0.00005677406,0.000024929817,0.00012221534,0.00016794336,0.0005749977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002240451,0.00028697104,0.0000010518968,0.022572923,0.000720027,0.00008601744,0.00001903059,1.5920696e-7,1.5432066e-7,0.00013268943,0.0072571095,0.96890146],"study_design_scores_gemma":[0.00038257224,0.00005978237,0.000067059984,0.010049717,0.004956899,0.000010346873,0.000019076182,0.0000068923414,6.3926325e-7,0.000017044556,0.9842846,0.0001453917],"about_ca_topic_score_codex":0.0000012227903,"about_ca_topic_score_gemma":2.904006e-8,"teacher_disagreement_score":0.9770275,"about_ca_system_score_codex":0.00016834785,"about_ca_system_score_gemma":0.000037696012,"threshold_uncertainty_score":0.9984117},"labels":[],"label_agreement":null},{"id":"W2048287611","doi":"10.1007/s40265-015-0352-7","title":"Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; Health Sciences Centre; University of Manitoba","funders":"","keywords":"Linezolid; Pharmacology; Prodrug; 23S ribosomal RNA; Microbiology; Medicine; In vivo; Staphylococcus aureus; Potency; Chemistry; Biology; Ribosome; Vancomycin; In vitro; Biochemistry; RNA; Bacteria; Gene","score_opus":0.0417442126434535,"score_gpt":0.3228652229552022,"score_spread":0.2811210103117487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048287611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015560802,0.97997946,0.00058537564,0.00013302117,0.00037031627,0.0048488663,0.0029694391,0.0003131189,0.009244299],"genre_scores_gemma":[0.002235219,0.9905785,0.002580935,0.0002489967,0.00061209674,0.00031094658,0.00087208493,0.00038693173,0.0021743462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99505895,0.00020479396,0.0009485162,0.0014187712,0.0012331448,0.001135812],"domain_scores_gemma":[0.99579346,0.0002731443,0.0010040207,0.001409867,0.00072581216,0.0007936914],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00061136024,0.0013889458,0.0042842473,0.00048505145,0.00021138847,0.000091433336,0.00046507583,0.00075693865,0.000018296741],"category_scores_gemma":[0.00018372579,0.0009844985,0.0010076256,0.0010545475,0.00045858874,0.0001413261,0.00025220806,0.0014621811,0.00021245441],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011414039,0.0013811403,0.00000582655,0.013867584,0.0013434142,0.0013313586,0.00054860645,0.0000027517133,0.0016017575,0.00009175762,0.0029059416,0.97577846],"study_design_scores_gemma":[0.0024170936,0.00039553727,0.00006540642,0.029767608,0.003333681,0.00020924123,0.000211258,0.000019283787,0.00019917346,0.0000030084282,0.96214527,0.0012334491],"about_ca_topic_score_codex":0.00013888263,"about_ca_topic_score_gemma":0.000048350892,"teacher_disagreement_score":0.974545,"about_ca_system_score_codex":0.0013350145,"about_ca_system_score_gemma":0.002374899,"threshold_uncertainty_score":0.9998861},"labels":[],"label_agreement":null},{"id":"W2048882628","doi":"10.2165/00003495-200868001-00006","title":"Sirolimus Use in Recipients of Expanded Criteria Donor Kidneys","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of British Columbia; Vancouver General Hospital; Western University","funders":"","keywords":"Medicine; Sirolimus; Pharmacotherapy; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.0894390122475382,"score_gpt":0.3843362855487541,"score_spread":0.2948972733012159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048882628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021063364,0.99535066,0.0000030788226,0.000012158573,0.00029936878,0.0008354763,0.00021956394,0.000022800154,0.0011505345],"genre_scores_gemma":[0.0005656441,0.99654585,0.0003543642,0.00007365763,0.00004778012,0.00005882921,0.0008017028,0.000040635157,0.001511528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850625,0.000084685955,0.0006817838,0.00028604447,0.00023884031,0.00020238501],"domain_scores_gemma":[0.99911994,0.00015277797,0.00022034941,0.00032843646,0.00004118243,0.00013732431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051684387,0.0002944685,0.0015977855,0.0003103538,0.00001812362,0.0000090495005,0.00008918812,0.0001912533,0.00011504442],"category_scores_gemma":[0.00003693377,0.00020953506,0.00043343427,0.00026238375,0.000037211805,0.000067942136,0.000015836255,0.00017734796,0.000073580624],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022631677,0.0009575566,0.011368093,0.04180245,0.0008628092,0.0010920253,0.0009833231,2.307828e-7,0.0000028258182,0.000030134575,0.00081047846,0.9418638],"study_design_scores_gemma":[0.004074497,0.00015612517,0.006071028,0.05485844,0.0010440245,0.00034594585,0.000010886708,0.0000015153477,0.000015007444,0.0000063254583,0.93311095,0.0003052526],"about_ca_topic_score_codex":0.00014169532,"about_ca_topic_score_gemma":0.0000038421736,"teacher_disagreement_score":0.9415585,"about_ca_system_score_codex":0.00009564321,"about_ca_system_score_gemma":0.00016076144,"threshold_uncertainty_score":0.85445917},"labels":[],"label_agreement":null},{"id":"W2049940696","doi":"10.2165/00003495-200464210-00002","title":"Topical Antibacterial Therapy for Acne Vulgaris","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Acne; Medicine; Pharmacotherapy; Dermatology; Intensive care medicine; Internal medicine","score_opus":0.04030622317457319,"score_gpt":0.3707486903519999,"score_spread":0.33044246717742676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049940696","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001593413,0.99623525,0.000028321903,0.00013854397,0.0007458009,0.0017025287,0.000047471596,0.000047087597,0.00089565123],"genre_scores_gemma":[0.000024460183,0.9938306,0.0002701016,0.0001605191,0.0015963776,0.00015310255,0.0006747612,0.000048002137,0.0032420284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907094,0.000025260599,0.00025528163,0.00029028775,0.00011100067,0.00024720965],"domain_scores_gemma":[0.9994397,0.000071301234,0.000092907736,0.00026471203,0.000025934458,0.00010544139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006946939,0.00029573255,0.001303328,0.00005807559,0.00007551464,0.000022902506,0.00007315313,0.00033758022,0.00013555607],"category_scores_gemma":[0.000013909273,0.00016665114,0.00062688626,0.00007186092,0.00002883476,0.000023665107,0.00002017439,0.00015429634,0.00008224906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006801357,0.0001824391,0.0000024664262,0.0071905227,0.00031553052,0.00002610515,0.000065451786,5.644915e-9,0.00000124584,0.000099888304,0.002106221,0.98994213],"study_design_scores_gemma":[0.0022711847,0.0005600058,0.000008938728,0.0068809045,0.0006925387,0.000039042512,0.0000035519145,1.9372102e-7,0.000011265402,0.000028322329,0.989339,0.00016503454],"about_ca_topic_score_codex":0.0000161413,"about_ca_topic_score_gemma":2.4802705e-7,"teacher_disagreement_score":0.9897771,"about_ca_system_score_codex":0.00008543703,"about_ca_system_score_gemma":0.00029150234,"threshold_uncertainty_score":0.6795836},"labels":[],"label_agreement":null},{"id":"W2051693645","doi":"10.2165/11534440-000000000-00000","title":"New Lipoglycopeptides","year":2010,"lang":"en","type":"review","venue":"Drugs","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":346,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Dalbavancin; Teicoplanin; Vancomycin; Microbiology; Staphylococcus aureus; Daptomycin; Pharmacology; Methicillin-resistant Staphylococcus aureus; Linezolid; Chemistry; Medicine; Biology; Bacteria","score_opus":0.028929472080892398,"score_gpt":0.3414561144664045,"score_spread":0.3125266423855121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051693645","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002586379,0.962755,0.00005285919,0.000072675895,0.00058400317,0.00081280764,0.000027879414,0.00012566711,0.03556649],"genre_scores_gemma":[5.3850675e-7,0.93983793,0.005680371,0.00017727027,0.0013090234,0.000023546223,0.00009773455,0.000116169336,0.052757397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837255,0.000031079657,0.0005148505,0.00044757084,0.00026769366,0.00036623247],"domain_scores_gemma":[0.9984371,0.00014100797,0.00025258775,0.00079368526,0.000062788204,0.00031279522],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013223983,0.00043896763,0.0019028474,0.00018125838,0.000049656537,0.000040018895,0.00027977058,0.00060148456,0.0009486908],"category_scores_gemma":[0.00014626964,0.00033203303,0.00077182095,0.00032327868,0.00008275721,0.000039287195,0.00008553872,0.0011160311,0.0028759649],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000076736305,0.000017152373,0.000001055499,0.00696966,0.00006194331,0.00004678507,0.000032988915,2.5360714e-9,0.000007173799,0.0001476602,0.07279426,0.91991365],"study_design_scores_gemma":[0.00020772313,0.000027442617,0.0000017160264,0.01689811,0.0009074232,0.00008232433,0.000006350333,7.508955e-8,0.000010463768,0.000026188834,0.9815463,0.000285901],"about_ca_topic_score_codex":0.000044417116,"about_ca_topic_score_gemma":0.000009321645,"teacher_disagreement_score":0.9196277,"about_ca_system_score_codex":0.00010237873,"about_ca_system_score_gemma":0.0012838349,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W2053107343","doi":"10.2165/00003495-200868001-00005","title":"Mechanisms and Management of Proteinuria in Kidney Transplant Patients","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Proteinuria; Sirolimus; Urology; Renal function; Kidney transplantation; Transplantation; Internal medicine; Glomerulosclerosis; Kidney","score_opus":0.02363974651473585,"score_gpt":0.2998636149460597,"score_spread":0.27622386843132385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053107343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011656688,0.99427056,0.000034255467,0.000013956393,0.00008449293,0.0027958886,0.00023390111,0.000015615049,0.0024347631],"genre_scores_gemma":[0.0002079447,0.99734443,0.0012061273,0.00003109173,0.0000048966963,0.00014795069,0.0005937096,0.000025668538,0.0004381951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989352,0.00003468887,0.00043593295,0.00023116797,0.0002259557,0.0001370403],"domain_scores_gemma":[0.9995773,0.000016787624,0.00012988033,0.0001516762,0.000015424028,0.00010894908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036955964,0.00022988746,0.00095302827,0.00015978831,0.0000149469015,0.0000029796906,0.000050928924,0.00010685644,0.000022950617],"category_scores_gemma":[0.0000011861857,0.00015967713,0.00017433139,0.00013955667,0.000020188463,0.000021703012,0.000008682192,0.00010113518,0.000013551527],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075533855,0.0004895096,0.0004860193,0.17914999,0.0007839981,0.0005247145,0.00043712126,5.5030032e-8,1.9482735e-7,0.0008817453,0.000022658587,0.81714845],"study_design_scores_gemma":[0.012791765,0.0005575683,0.0049161636,0.43128526,0.0042290622,0.00022156733,0.00003220858,0.000002434997,0.000022236969,0.00014249029,0.5451734,0.0006258459],"about_ca_topic_score_codex":0.000022236223,"about_ca_topic_score_gemma":7.1825366e-7,"teacher_disagreement_score":0.8165226,"about_ca_system_score_codex":0.000041868185,"about_ca_system_score_gemma":0.000047121674,"threshold_uncertainty_score":0.65114444},"labels":[],"label_agreement":null},{"id":"W2054828913","doi":"10.1007/s40265-013-0014-6","title":"Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Rheumatoid arthritis; Druggability; Context (archaeology); Kinase; Immunology; Inflammation; Proinflammatory cytokine; Arthritis; MAPK/ERK pathway; Methotrexate; p38 mitogen-activated protein kinases; Pharmacology","score_opus":0.026024606140518408,"score_gpt":0.2893558393361413,"score_spread":0.2633312331956229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054828913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005565632,0.99511546,0.000103677696,0.000013975226,0.0004293555,0.0026383975,0.00022735307,0.000035592955,0.0008796311],"genre_scores_gemma":[0.0004127096,0.98998886,0.00022461648,0.00007308706,0.00034664053,0.0025077362,0.0025447113,0.00011484627,0.0037868135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832684,0.00011383041,0.00042108403,0.0005972523,0.0001276354,0.00041335885],"domain_scores_gemma":[0.9989238,0.000027693788,0.0002814526,0.00054615684,0.00009783779,0.00012305635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011447282,0.0004782909,0.00087306777,0.00006528796,0.00010611567,0.000052645693,0.0003252603,0.000523592,0.0001353108],"category_scores_gemma":[0.00007055702,0.00039540435,0.0005305773,0.00007891367,0.000056616835,0.00000387444,0.000094838135,0.00014458939,0.0002292999],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015801388,0.0000465626,1.7175714e-7,0.0021400712,0.0002307817,0.0000028,0.000030048373,3.069748e-8,0.024116203,0.00020851308,0.0061015994,0.9671074],"study_design_scores_gemma":[0.00033765944,0.00024783815,9.318298e-8,0.0017275187,0.000041951076,0.00003217528,0.00001898076,3.5668765e-7,0.057495512,0.00011829586,0.9395239,0.00045572175],"about_ca_topic_score_codex":0.00003434322,"about_ca_topic_score_gemma":0.000003992626,"teacher_disagreement_score":0.9666517,"about_ca_system_score_codex":0.000019856305,"about_ca_system_score_gemma":0.00030967558,"threshold_uncertainty_score":0.9998498},"labels":[],"label_agreement":null},{"id":"W2056317617","doi":"10.1007/s40265-013-0013-7","title":"Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":423,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Avibactam; Ceftazidime; Ceftazidime/avibactam; Beta-Lactamase Inhibitors; Medicine; Pharmacokinetics; Pharmacology; Microbiology; Cephalosporin; Chemistry; Antibiotics; Biology; Pseudomonas aeruginosa; Bacteria","score_opus":0.02177261858170477,"score_gpt":0.29372918615663773,"score_spread":0.271956567574933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056317617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003864881,0.9910356,0.00013573773,0.000023482688,0.0009989067,0.0011446839,0.00014871302,0.000045210607,0.00260278],"genre_scores_gemma":[0.0011635364,0.9888637,0.00068012334,0.00006123824,0.00082145917,0.000091057955,0.0023395051,0.00014709188,0.0058322735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767494,0.000101880265,0.00069668685,0.0008037691,0.00026690745,0.00045578578],"domain_scores_gemma":[0.9981733,0.000034723427,0.0005610591,0.0009128294,0.00014984955,0.0001682576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021090645,0.0006200944,0.0010299821,0.00011712255,0.00009001763,0.00010225675,0.00051395525,0.00078347063,0.00012244223],"category_scores_gemma":[0.00009116075,0.0005464418,0.000511453,0.00019483762,0.00013367514,0.000010337771,0.00023338183,0.00030401614,0.0004382246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046074187,0.0008585536,0.00005898947,0.013260854,0.00064322597,0.000018244134,0.00008779455,2.6244567e-7,0.011011058,0.0007926764,0.04237271,0.93084955],"study_design_scores_gemma":[0.00040791466,0.00009494626,0.000019506368,0.0017227782,0.00022249078,0.000025257104,0.000023092529,0.0000013097799,0.00066667347,0.000013319194,0.9961943,0.00060840906],"about_ca_topic_score_codex":0.000016874388,"about_ca_topic_score_gemma":0.0000027160015,"teacher_disagreement_score":0.9538216,"about_ca_system_score_codex":0.00008536405,"about_ca_system_score_gemma":0.00030342853,"threshold_uncertainty_score":0.9996987},"labels":[],"label_agreement":null},{"id":"W2059072558","doi":"10.2165/00003495-200464010-00003","title":"First-Line Treatment Strategies to Improve Survival in Patients with Advanced Colorectal Cancer","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Irinotecan; Colorectal cancer; Oxaliplatin; Oncology; Chemotherapy; Internal medicine; Disease; Cetuximab; Cancer; Intensive care medicine","score_opus":0.018532480870473243,"score_gpt":0.325341864936809,"score_spread":0.30680938406633573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059072558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018621912,0.974371,0.0000015660471,0.00009810929,0.0005497533,0.004228866,0.0004581255,0.000058117093,0.0016125266],"genre_scores_gemma":[0.010181108,0.9861246,0.000099582976,0.00002248213,0.00014036182,0.002640104,0.0002544537,0.00007888591,0.00045846644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810785,0.000027804408,0.0004394855,0.00064925716,0.00032695246,0.00044865758],"domain_scores_gemma":[0.9992274,0.000067704656,0.00017103575,0.00025741805,0.000113110465,0.00016332975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000038821603,0.0006629117,0.0021860553,0.00017951328,0.00007986769,0.00002835768,0.00009005301,0.00014141096,0.000059538994],"category_scores_gemma":[0.000010973576,0.00039218503,0.0002500506,0.00043197355,0.00005417575,0.00006914197,0.00005653816,0.00018217773,0.000024763207],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010074292,0.00083161425,0.0011303629,0.0040865666,0.0008136581,0.00004968605,0.0009152353,0.0000512345,7.006218e-8,0.000021628595,0.000009758727,0.9910827],"study_design_scores_gemma":[0.013897948,0.014645666,0.01212167,0.024357792,0.002639297,0.00000255209,0.0003933341,0.0000010780747,0.000006174755,0.000017924629,0.93096596,0.0009505787],"about_ca_topic_score_codex":0.0014775506,"about_ca_topic_score_gemma":0.005176632,"teacher_disagreement_score":0.99013215,"about_ca_system_score_codex":0.0029964072,"about_ca_system_score_gemma":0.0010985355,"threshold_uncertainty_score":0.999853},"labels":[],"label_agreement":null},{"id":"W2059634850","doi":"10.2165/00003495-200464190-00003","title":"Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"U.S. Department of Veterans Affairs","keywords":"Medicine; Fibrate; Internal medicine; Bezafibrate; Fenofibrate; Metabolic syndrome; Abdominal obesity; Hypertriglyceridemia; Diabetes mellitus; Risk factor; Cholesterol; Gemfibrozil; Endocrinology; Triglyceride; Obesity","score_opus":0.0231935526228265,"score_gpt":0.30793954816706903,"score_spread":0.2847459955442425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059634850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052337246,0.99143,0.00002698669,0.000024116995,0.000032107568,0.002923339,0.00020316061,0.0000074379245,0.00011913031],"genre_scores_gemma":[0.026684942,0.97245395,0.00029943587,0.000021750568,0.00005459086,0.00024350191,0.00019494862,0.000027336157,0.000019554944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986981,0.00013957097,0.00042483318,0.00021498116,0.0003530026,0.00016948776],"domain_scores_gemma":[0.9989963,0.00010948441,0.00021519406,0.00057995185,0.000030361822,0.000068719004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044035044,0.00019497835,0.0011590014,0.00009908137,0.000027313925,0.0000029353703,0.00013644983,0.000070974806,0.000010005474],"category_scores_gemma":[0.00003527881,0.00011316825,0.00085362146,0.00023708427,0.000048477967,0.000020848162,0.00004140187,0.00014669244,0.0000018644233],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056240573,0.00022544399,0.00031923567,0.121682234,0.0007168959,0.000009667682,0.0012057311,0.0000027150859,3.5183007e-7,0.00040181944,0.000037921203,0.8753418],"study_design_scores_gemma":[0.0016927919,0.00026746918,0.050302096,0.04469386,0.0053693224,0.000011478136,0.0036138028,0.00000165179,0.00001751061,0.0006876826,0.893041,0.00030134968],"about_ca_topic_score_codex":0.000120095785,"about_ca_topic_score_gemma":8.809466e-7,"teacher_disagreement_score":0.89300305,"about_ca_system_score_codex":0.00007547737,"about_ca_system_score_gemma":0.00022606371,"threshold_uncertainty_score":0.46148676},"labels":[],"label_agreement":null},{"id":"W2062507310","doi":"10.2165/00003495-200565040-00004","title":"An Overview of Economic Evaluations for Drugs Used in Rheumatoid Arthritis","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"","keywords":"Medicine; Infliximab; Adalimumab; Rheumatoid arthritis; Etanercept; Quality-adjusted life year; Quality of life (healthcare); Antirheumatic Agents; Golimumab; Pharmacoeconomics; Intensive care medicine; Physical therapy; Cost effectiveness; Disease; Internal medicine; Risk analysis (engineering)","score_opus":0.088687636478896,"score_gpt":0.43036565504091906,"score_spread":0.34167801856202307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062507310","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006126081,0.99547,0.0000092427035,0.000113070804,0.00012815936,0.0026806998,0.00038966443,0.00004234501,0.00055419863],"genre_scores_gemma":[0.00063847046,0.996762,0.00049052597,0.000030852807,0.00013444127,0.00088761543,0.0008326263,0.00009833551,0.00012515808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99723166,0.00025913023,0.0012083824,0.00047950738,0.00035005124,0.00047124823],"domain_scores_gemma":[0.998204,0.00041394794,0.0003460143,0.00070608687,0.00010058328,0.00022940278],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011094755,0.00037597772,0.0024522548,0.0005664332,0.00006553123,0.00004187881,0.00028254517,0.00024494375,0.00071029115],"category_scores_gemma":[0.00010323655,0.00034634344,0.0006616855,0.00021438742,0.00013090548,0.00020032638,0.0000394387,0.00031922496,0.00018604826],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021706233,0.00016549534,0.000014624736,0.0037685758,0.0001298598,0.0000021072055,0.00059671723,0.0000018441776,9.826211e-7,0.002096135,0.00057252304,0.9926294],"study_design_scores_gemma":[0.0026465512,0.00022574364,0.000013274415,0.03313013,0.000024759136,0.00003760818,0.000163484,0.00012451549,0.0000058646037,0.0004098352,0.9629399,0.000278285],"about_ca_topic_score_codex":0.00013374838,"about_ca_topic_score_gemma":0.00027819726,"teacher_disagreement_score":0.9923511,"about_ca_system_score_codex":0.0002677716,"about_ca_system_score_gemma":0.0013755453,"threshold_uncertainty_score":0.99989885},"labels":[],"label_agreement":null},{"id":"W2064428940","doi":"10.2165/00003495-200363210-00002","title":"Newer Formulations of the Triptans","year":2003,"lang":"en","type":"review","venue":"Drugs","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Triptans; Sumatriptan; Zolmitriptan; Rizatriptan; Medicine; Migraine; Nausea; Anesthesia; Vomiting; Intensive care medicine; Internal medicine; Agonist","score_opus":0.07537286117795669,"score_gpt":0.38038940510317326,"score_spread":0.3050165439252166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064428940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000001873581,0.88950574,0.0000057163306,0.0001491251,0.000047096968,0.000470814,0.00001897739,0.000007995815,0.109792665],"genre_scores_gemma":[0.000010218192,0.93480057,0.00009730563,0.00013762068,0.000100608675,0.00002509558,0.0000152419425,0.000015932363,0.064797424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930185,0.000034281627,0.00030698944,0.000103998216,0.00014354577,0.00010934807],"domain_scores_gemma":[0.99938464,0.000060589857,0.00013474966,0.00033705274,0.00005465627,0.000028337774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009782177,0.00013477178,0.0008447303,0.000053387233,0.00005405135,0.0000019372374,0.00006957867,0.00009699407,0.0001571175],"category_scores_gemma":[0.00007551633,0.00006823084,0.0006215096,0.00025699107,0.00004046758,0.000009426742,0.000027666973,0.00018978497,0.000029685112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028046773,0.00009972748,0.000046273915,0.021813892,0.0005578179,0.0000017289598,0.0013428659,2.4944736e-8,2.4204576e-7,0.010572875,0.41550162,0.5500601],"study_design_scores_gemma":[0.00013452343,0.000013288894,0.000021631238,0.0034225222,0.0012306285,0.000009175897,0.00005540515,2.0801697e-7,3.5314167e-7,0.00007548185,0.9949782,0.00005858462],"about_ca_topic_score_codex":0.000014524727,"about_ca_topic_score_gemma":0.000008324583,"teacher_disagreement_score":0.5794766,"about_ca_system_score_codex":0.000029644243,"about_ca_system_score_gemma":0.00022048334,"threshold_uncertainty_score":0.27823728},"labels":[],"label_agreement":null},{"id":"W2065173886","doi":"10.2165/00003495-200868010-00004","title":"Antiretroviral Therapy","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Ritonavir; Medicine; Stavudine; Context (archaeology); Abacavir; Emtricitabine; Drug resistance; Antiretroviral therapy; Drug; Protease inhibitor (pharmacology); Lamivudine; Pharmacology; Intensive care medicine; Human immunodeficiency virus (HIV); Virology; Computational biology; Biology; Viral load; Virus; Genetics","score_opus":0.04814279697015873,"score_gpt":0.3389261771370195,"score_spread":0.2907833801668608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065173886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023195447,0.97890353,0.0000010103751,0.000110590874,0.0001908825,0.0007785047,0.0000127754,0.00010945987,0.019870073],"genre_scores_gemma":[0.0000045215975,0.91428113,0.0002861208,0.000091796705,0.00027605824,0.00008630554,0.00045917925,0.000067346555,0.08444757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986326,0.00004745138,0.0003793556,0.00035412982,0.00029883147,0.00028760586],"domain_scores_gemma":[0.99927723,0.00005166245,0.00013088752,0.00037961398,0.000030472858,0.00013012091],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005318391,0.00042208607,0.0015846211,0.00020961143,0.00007345889,0.0000127432695,0.00011177396,0.00022032493,0.00026142973],"category_scores_gemma":[0.000009576049,0.0002709382,0.0006331851,0.00027766215,0.00005276008,0.000030223813,0.000030481558,0.0002688328,0.0020097757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000065798667,0.00011493294,0.000057166693,0.0012416785,0.00037512594,0.00022966058,0.00022816748,8.9512847e-10,2.9476388e-8,0.00002854467,0.027620088,0.970098],"study_design_scores_gemma":[0.00069826574,0.00007085028,0.000007228422,0.003628133,0.00026748897,0.00024286479,0.000009640868,1.9851662e-7,0.000002051112,0.0000030683934,0.99483067,0.00023951607],"about_ca_topic_score_codex":0.000004788907,"about_ca_topic_score_gemma":1.5151807e-7,"teacher_disagreement_score":0.9698585,"about_ca_system_score_codex":0.00015274805,"about_ca_system_score_gemma":0.0005103561,"threshold_uncertainty_score":0.9999743},"labels":[],"label_agreement":null},{"id":"W2066074321","doi":"10.2165/00003495-200464190-00004","title":"Antiepileptic Drugs in the Treatment of Anxiety Disorders","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Pregabalin; Anxiety; Gabapentin; Lamotrigine; Medicine; Panic disorder; Pharmacotherapy; Psychiatry; Generalized anxiety disorder; Buspirone; Mood disorders; Anxiety disorder; Social anxiety; Epilepsy; Internal medicine; Alternative medicine","score_opus":0.04106096943222905,"score_gpt":0.37773535790226986,"score_spread":0.33667438847004083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066074321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027808495,0.97017187,0.00002885973,0.000061511215,0.0013333886,0.0021855182,0.00020966327,0.00006547213,0.025665607],"genre_scores_gemma":[0.0043936344,0.9921551,0.00007498068,0.00004917114,0.00028390743,0.0012875807,0.0003122744,0.00012896564,0.0013144246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996056,0.00064790953,0.0010148212,0.0010938237,0.00050083484,0.00068657723],"domain_scores_gemma":[0.99699605,0.00083474896,0.0007714244,0.0012045321,0.00009120049,0.00010204908],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003943105,0.0009124566,0.0019335533,0.00089332135,0.00011537744,0.000044387758,0.00084504555,0.0005406643,0.00055949227],"category_scores_gemma":[0.00006518283,0.00056523096,0.0010002158,0.002535626,0.00029203043,0.000094112176,0.000049634567,0.0004024783,0.0006441152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024330482,0.003016439,0.000961707,0.002499329,0.00044478313,0.0000063658085,0.011910211,2.9912405e-7,1.34954865e-8,0.0003609955,0.00084871874,0.9799268],"study_design_scores_gemma":[0.0015820179,0.00040577733,0.00055732444,0.0028160687,0.0009916339,0.000015998594,0.002703636,1.6056012e-7,6.1062343e-7,0.00074073195,0.9896988,0.0004871937],"about_ca_topic_score_codex":0.0005311085,"about_ca_topic_score_gemma":0.000028682633,"teacher_disagreement_score":0.9888501,"about_ca_system_score_codex":0.00039609696,"about_ca_system_score_gemma":0.00025468905,"threshold_uncertainty_score":0.9996799},"labels":[],"label_agreement":null},{"id":"W2067947520","doi":"10.2165/00003495-200666130-00005","title":"Cardiovascular Health and Aromatase Inhibitors","year":2006,"lang":"en","type":"review","venue":"Drugs","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Myocardial infarction; Disease; Internal medicine; Cancer; Oncology; Incidence (geometry); Clinical trial; Gynecology","score_opus":0.009769732726712194,"score_gpt":0.27342216586212703,"score_spread":0.26365243313541487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067947520","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001507053,0.9985889,0.0000073697965,0.00000997493,0.00016959499,0.00045242984,0.00006723326,0.000018357487,0.00053542864],"genre_scores_gemma":[0.000020064668,0.99671125,0.00006170752,0.000049897324,0.00041970555,0.000040413808,0.0023147557,0.000055416873,0.00032676398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864835,0.0001858184,0.00029580062,0.0004698123,0.00013099278,0.0002692517],"domain_scores_gemma":[0.99919504,0.000009683868,0.00012924364,0.0004802764,0.000012786416,0.00017295667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023995845,0.00031914137,0.0008798103,0.00006211856,0.000080252175,0.000023809855,0.00011553282,0.00044010158,9.4939367e-7],"category_scores_gemma":[0.000013901509,0.0002544227,0.00066350744,0.000094313735,0.00006181394,0.0000012163842,0.00011305243,0.00022073265,0.000027036345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002359275,0.000021516766,9.659807e-7,0.004310079,0.0005069683,0.0000139272015,0.000012584836,8.1719736e-7,0.0000047556805,0.000010860007,0.023440132,0.97167504],"study_design_scores_gemma":[0.00016153292,0.00009535682,1.783083e-7,0.0011011057,0.0002546961,0.000096358155,0.0000068188333,3.392407e-7,0.00004093827,0.0000029814487,0.997985,0.00025467473],"about_ca_topic_score_codex":0.0000463765,"about_ca_topic_score_gemma":5.989552e-7,"teacher_disagreement_score":0.9745449,"about_ca_system_score_codex":0.000022404663,"about_ca_system_score_gemma":0.00024075595,"threshold_uncertainty_score":0.9999908},"labels":[],"label_agreement":null},{"id":"W2069750059","doi":"10.2165/11319210-000000000-00000","title":"Pharmacotherapy and Weight-Loss Supplements for Treatment of Paediatric Obesity","year":2010,"lang":"en","type":"review","venue":"Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Child and Family Research Institute; University of British Columbia; BC Children's Hospital","funders":"","keywords":"Sibutramine; Medicine; Orlistat; Weight loss; Pharmacotherapy; Obesity; Overweight; Psychological intervention; Adverse effect; Intensive care medicine; Pediatrics; Internal medicine; Psychiatry","score_opus":0.03809831920995511,"score_gpt":0.3969230784000468,"score_spread":0.3588247591900917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069750059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046119825,0.9912869,0.0000054375832,0.000096585005,0.00041691633,0.0028140557,0.0005986707,0.00002954596,0.00013995366],"genre_scores_gemma":[0.00019452377,0.9965295,0.0004946685,0.000081415405,0.000494166,0.0005362872,0.0005684049,0.000043126438,0.0010578744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870527,0.000068086745,0.0004257835,0.00037975915,0.00013426032,0.0002868556],"domain_scores_gemma":[0.9990109,0.00024615106,0.00026272802,0.00024556956,0.000052526946,0.00018211239],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013097019,0.00040991098,0.0017670824,0.00018791978,0.00008854524,0.0000046206815,0.00008527844,0.00030660478,0.00028310122],"category_scores_gemma":[0.000005157548,0.0002788668,0.00052102713,0.00011643818,0.00008984718,0.000028446857,0.000022431943,0.00012380574,0.000021021635],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011622368,0.0017016215,0.0010299331,0.006900025,0.0011111456,0.000031905245,0.0002028784,6.1345924e-9,0.00001691263,0.000028678722,0.0015816827,0.987279],"study_design_scores_gemma":[0.0059562996,0.0006844994,0.000055610435,0.00039966378,0.0073485924,0.00004282594,0.0000038269914,0.0000017717047,0.0006284991,0.000032201617,0.98466146,0.00018472511],"about_ca_topic_score_codex":0.0000144149535,"about_ca_topic_score_gemma":0.000002234269,"teacher_disagreement_score":0.9870943,"about_ca_system_score_codex":0.00015150353,"about_ca_system_score_gemma":0.00024894802,"threshold_uncertainty_score":0.9999663},"labels":[],"label_agreement":null},{"id":"W2070074427","doi":"10.2165/00003495-200262120-00006","title":"The Ketolides","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Telithromycin; Ketolide; Microbiology; Streptococcus pneumoniae; Erythromycin; Chemistry; Biochemistry; Antibiotics; Biology","score_opus":0.05765043488422787,"score_gpt":0.360429234636641,"score_spread":0.3027787997524131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070074427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.344327e-7,0.95088565,6.1320986e-7,0.00025907913,0.00039849945,0.00031977374,0.0000052618116,0.00006170544,0.048068505],"genre_scores_gemma":[0.0000019595943,0.9782858,0.0000017238539,0.0001930025,0.00045396353,0.00007955564,0.000007402974,0.000027354141,0.020949276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99926406,0.000055530996,0.00024136402,0.00014076178,0.0001249413,0.00017333202],"domain_scores_gemma":[0.9992475,0.0001794309,0.00009094525,0.00037495428,0.000026881458,0.000080295424],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009663529,0.00016593744,0.0005925417,0.000066911445,0.00021330366,0.000026557831,0.00009555412,0.0001509839,0.000099174445],"category_scores_gemma":[0.000056005003,0.00007886389,0.00043477683,0.00019334267,0.000071848895,0.000012456386,0.000024519335,0.00035568263,0.0014623397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[1.8430701e-7,0.000016203468,0.000001671911,0.0017750518,0.000079320336,0.00001342483,0.000020224217,6.0151404e-9,1.1229454e-7,0.00014111045,0.008465452,0.98948723],"study_design_scores_gemma":[0.000053476542,0.000020644311,0.0000026829073,0.0028929075,0.00057222904,0.00018849366,0.000009582146,5.1044367e-7,1.4158407e-7,0.000009165961,0.9961662,0.00008390822],"about_ca_topic_score_codex":0.0000019179492,"about_ca_topic_score_gemma":8.488492e-7,"teacher_disagreement_score":0.9894033,"about_ca_system_score_codex":0.000055266646,"about_ca_system_score_gemma":0.00011174334,"threshold_uncertainty_score":0.99931514},"labels":[],"label_agreement":null},{"id":"W2074969992","doi":"10.2165/00003495-200161060-00008","title":"Desloratadine","year":2001,"lang":"en","type":"article","venue":"Drugs","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Medicine; Desloratadine; Pharmacotherapy; Traditional medicine; Pharmacology; Dermatology; Internal medicine","score_opus":0.009520128812159313,"score_gpt":0.26069722477461477,"score_spread":0.25117709596245547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074969992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875566,0.0010414444,0.00021375447,0.0009888224,0.0001769361,0.000117744305,0.000013160829,0.00003119781,0.00986037],"genre_scores_gemma":[0.99072164,0.00076433696,0.00045028533,0.0011651313,0.00020162901,0.000042839016,0.00013859523,0.000022078584,0.006493437],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932855,0.000021750104,0.00010986638,0.0002469778,0.00008196443,0.00021088304],"domain_scores_gemma":[0.99951816,0.000010313775,0.000038227896,0.00032649154,0.00002973296,0.000077078774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057029814,0.00012571215,0.00010258888,0.000026730593,0.00005246282,0.000016603415,0.00013647591,0.0000809671,0.00013102512],"category_scores_gemma":[0.00003526507,0.00011314689,0.000076367745,0.00007897845,0.00004030378,0.000002771978,0.00006965476,0.000037432324,0.0002349179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002128167,0.0006970539,0.55697954,0.000022905147,0.00044337838,0.00009555263,0.00035388608,0.00006126891,0.21278907,0.0009245001,0.17486194,0.0525581],"study_design_scores_gemma":[0.0010513148,0.00017191288,0.01703454,0.00000814173,0.000039757433,0.000027402819,0.00014884188,0.000012005419,0.20567088,0.00010700407,0.77543986,0.00028831422],"about_ca_topic_score_codex":0.000024422327,"about_ca_topic_score_gemma":0.000020390065,"teacher_disagreement_score":0.60057795,"about_ca_system_score_codex":0.000015814798,"about_ca_system_score_gemma":0.000023254372,"threshold_uncertainty_score":0.4613996},"labels":[],"label_agreement":null},{"id":"W2075634944","doi":"10.2165/00003495-200767170-00014","title":"Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia","year":2007,"lang":"en","type":"article","venue":"Drugs","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Imatinib; Refractory (planetary science); Philadelphia chromosome; Lymphoblastic Leukemia; Oncology; Internal medicine; Pharmacotherapy; Pediatrics; Leukemia; Genetics; Chromosomal translocation; Gene","score_opus":0.01332079583642018,"score_gpt":0.29007371630028644,"score_spread":0.27675292046386624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075634944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881664,0.00026128785,0.000056112178,0.0009311937,0.00027222282,0.000702625,0.000046445613,0.00015466503,0.009409058],"genre_scores_gemma":[0.9948747,0.000096418,0.00095337763,0.0009799963,0.00025418593,0.000037977075,0.00016250716,0.00007125923,0.0025695548],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977077,0.000046610774,0.0005842022,0.0005145619,0.00047405073,0.00067284086],"domain_scores_gemma":[0.9985023,0.00043696738,0.00016823593,0.0005309646,0.00007957332,0.0002819621],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034151637,0.00033761538,0.00054209784,0.00030600248,0.00007140202,0.000015002946,0.00015100499,0.00024541933,0.00059651263],"category_scores_gemma":[0.00017708015,0.00027231715,0.00012362874,0.0005588954,0.00012395436,0.0000952579,0.00007275529,0.00040575553,0.00041261388],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060556356,0.014815321,0.08517317,0.002681458,0.007940521,0.09595623,0.09728279,0.00021858398,0.3324621,0.0022819997,0.05470629,0.24592517],"study_design_scores_gemma":[0.17435308,0.008104429,0.5841504,0.0065058097,0.0029933252,0.0054403655,0.006153081,0.0036685157,0.18087435,0.0007004475,0.023396997,0.0036592388],"about_ca_topic_score_codex":0.0001598346,"about_ca_topic_score_gemma":0.000089636225,"teacher_disagreement_score":0.49897718,"about_ca_system_score_codex":0.0040010884,"about_ca_system_score_gemma":0.00087947724,"threshold_uncertainty_score":0.9999729},"labels":[],"label_agreement":null},{"id":"W2076233570","doi":"10.2165/11317030-000000000-00000","title":"Efflux-Mediated Drug Resistance in Bacteria","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":942,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Efflux; Drug resistance; Drug; Biology; Multiple drug resistance; Pharmacology; Bacteria; Drug discovery; Microbiology; Biochemistry; Genetics","score_opus":0.011298438079149703,"score_gpt":0.283172131083459,"score_spread":0.2718736930043093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076233570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014533183,0.9929515,0.000006857647,0.00004060165,0.00034687636,0.0005539252,0.00009609019,0.000026638852,0.004524171],"genre_scores_gemma":[0.00016700942,0.9880754,0.00084401795,0.000099051795,0.0003869814,0.000027871964,0.0018575536,0.000087169574,0.008454986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748725,0.00025631412,0.0007606344,0.00081562315,0.00018341676,0.0004967653],"domain_scores_gemma":[0.9984999,0.00005509561,0.00037117928,0.00091942615,0.000046517096,0.00010791779],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033492263,0.0005481688,0.0012280578,0.00013673687,0.000042180684,0.000057493315,0.00062973466,0.0005648698,0.000057439152],"category_scores_gemma":[0.00014824765,0.00050097285,0.00034235464,0.00030108896,0.00009900491,0.0000043158434,0.00012220468,0.00031323617,0.00018965836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002824764,0.00058283773,0.00031955066,0.029759485,0.0005572637,0.00020513465,0.00037103402,4.892802e-7,0.0023120674,0.00051765225,0.15446565,0.8106264],"study_design_scores_gemma":[0.00023436712,0.000015616763,0.00019283521,0.0044239,0.00006608119,0.000005074141,0.000008975181,1.1382211e-7,0.000058858954,0.000024359068,0.99445885,0.0005109476],"about_ca_topic_score_codex":0.00000676809,"about_ca_topic_score_gemma":0.00010580059,"teacher_disagreement_score":0.83999324,"about_ca_system_score_codex":0.00009483858,"about_ca_system_score_gemma":0.00032332612,"threshold_uncertainty_score":0.9997442},"labels":[],"label_agreement":null},{"id":"W2078776320","doi":"10.2165/00003495-200969070-00003","title":"Ceftaroline","year":2009,"lang":"pl","type":"review","venue":"Drugs","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Microbiology; Cephalosporin; Bacteroides fragilis; Medicine; Staphylococcus aureus; Penicillin binding proteins; Staphylococcus epidermidis; Antibiotics; Enterococcus faecalis; Penicillin; Biology; Bacteria","score_opus":0.026801562702451622,"score_gpt":0.3317347379774799,"score_spread":0.3049331752750283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078776320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057131372,0.9362189,0.00006896603,0.0007416987,0.0012436997,0.0018147974,0.00023814544,0.00015887551,0.05945775],"genre_scores_gemma":[0.0003532052,0.9501987,0.0006844342,0.0017968044,0.003034647,0.000034807977,0.00058596086,0.00017762584,0.04313378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949171,0.00023630378,0.0016431455,0.0011515648,0.0008081473,0.0012437553],"domain_scores_gemma":[0.996386,0.00036694508,0.00081979274,0.0015824174,0.00028127377,0.00056355284],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006452642,0.0011947853,0.0040374952,0.0004024891,0.0001768006,0.00007793246,0.00072538044,0.0010143351,0.002434263],"category_scores_gemma":[0.00038883853,0.0010248269,0.0014916073,0.0009464134,0.00029563202,0.00008692321,0.00014310754,0.0016914409,0.0113509055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007914293,0.00027494793,0.000014673423,0.013590813,0.00030011495,0.00039927225,0.00021046276,4.7233917e-7,0.000022327853,0.0003475224,0.08429785,0.9004624],"study_design_scores_gemma":[0.00085216976,0.00018619455,0.000055589273,0.035328846,0.0024820834,0.000078306024,0.00004771238,0.00000590663,0.000021354404,0.000062481646,0.96005756,0.0008218046],"about_ca_topic_score_codex":0.00004823886,"about_ca_topic_score_gemma":0.000007888771,"teacher_disagreement_score":0.8996406,"about_ca_system_score_codex":0.0005670546,"about_ca_system_score_gemma":0.0012505858,"threshold_uncertainty_score":0.9992202},"labels":[],"label_agreement":null},{"id":"W2083965012","doi":"10.2165/00003495-200060030-00003","title":"Immune Tolerance Therapy for Haemophilia","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Haemophilia; Intensive care medicine; Dosing; Complication; Haemophilia B; Pharmacotherapy; Haemophilia A; Factor IX; Surgery; Internal medicine","score_opus":0.07158676984139445,"score_gpt":0.3933388190161775,"score_spread":0.32175204917478306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083965012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036723282,0.9873733,0.0000013132851,0.00038774608,0.00018309822,0.003288803,0.000072124916,0.00007209095,0.0085847825],"genre_scores_gemma":[0.000009183876,0.95415545,0.0001583692,0.000094954245,0.0007618276,0.00069988077,0.000591163,0.00009517146,0.043433998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983059,0.0000564272,0.000456791,0.00043520026,0.00029878036,0.0004468867],"domain_scores_gemma":[0.9989026,0.00017981663,0.00009067249,0.00061253266,0.00006271096,0.00015166635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021756568,0.0003932608,0.001845286,0.00017982094,0.000102655096,0.000024773404,0.00020714758,0.00033195908,0.0006979139],"category_scores_gemma":[0.00001882566,0.00024500064,0.0010168817,0.0002633483,0.0000781083,0.00003103173,0.000020576817,0.0003467196,0.0006107064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000885013,0.0001572614,0.0000013734343,0.006836431,0.00025036104,0.000031052172,0.00007244556,2.3369012e-8,6.4308904e-7,0.000022690067,0.0035462785,0.9889929],"study_design_scores_gemma":[0.0014045005,0.000239875,0.0000034892453,0.007156136,0.00030891434,0.000042953256,0.000005080081,0.0000034735544,0.000015510977,0.000045334422,0.9905595,0.00021519233],"about_ca_topic_score_codex":0.00000919062,"about_ca_topic_score_gemma":1.9183729e-7,"teacher_disagreement_score":0.98877776,"about_ca_system_score_codex":0.000111166904,"about_ca_system_score_gemma":0.00044717366,"threshold_uncertainty_score":0.9990837},"labels":[],"label_agreement":null},{"id":"W2083968901","doi":"10.2165/00003495-200161001-00001","title":"An Overview of Fungal Infections","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":304,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Candida albicans; Incidence (geometry); Immunosuppression; Population; Intensive care medicine; Immunology; Aspergillosis; Dermatology; Biology; Microbiology; Environmental health","score_opus":0.1098644668487232,"score_gpt":0.44102854089089116,"score_spread":0.33116407404216797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083968901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047751168,0.99279654,0.0000010471158,0.000005563579,0.00010408286,0.0004459315,0.00012063125,0.00003399423,0.0064444453],"genre_scores_gemma":[0.00007484135,0.9982834,0.000021876169,0.000028551694,0.00014437884,0.000050678962,0.00040422103,0.000030393066,0.0009616766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992377,0.000044910565,0.00027011224,0.00018206528,0.00014157864,0.00012363441],"domain_scores_gemma":[0.9992456,0.000029875018,0.00013292939,0.00040046577,0.00003929853,0.00015186977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038035658,0.0001846971,0.000980624,0.00011642035,0.000025361236,0.000005592917,0.000053705517,0.00010986915,0.0005402597],"category_scores_gemma":[0.000011357262,0.00013189932,0.0005219805,0.00029844895,0.000022039232,0.000031802112,0.000015590113,0.00011023515,0.00017849797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002756952,0.0006667585,0.00036695122,0.012977583,0.00028043124,0.000043929365,0.0000103526645,1.9105263e-8,1.5671917e-8,0.00020181308,0.00040798396,0.9850414],"study_design_scores_gemma":[0.00032529313,0.00018027535,0.00023950097,0.009129294,0.0038778982,0.000077858575,0.0000050983595,3.9024079e-7,1.0631083e-7,0.000023051995,0.98605037,0.00009087844],"about_ca_topic_score_codex":0.00007404224,"about_ca_topic_score_gemma":0.0000027865908,"teacher_disagreement_score":0.9856424,"about_ca_system_score_codex":0.000063696185,"about_ca_system_score_gemma":0.00021838666,"threshold_uncertainty_score":0.5915465},"labels":[],"label_agreement":null},{"id":"W2085386233","doi":"10.2165/00003495-200464080-00001","title":"The Management of Hypertension in the Overweight and Obese Patient","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Overweight; Pharmacotherapy; Obesity; Internal medicine; Intensive care medicine","score_opus":0.03228219732939595,"score_gpt":0.31852711400397843,"score_spread":0.28624491667458246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085386233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017827933,0.9946896,2.0203505e-7,0.00031213652,0.00009552563,0.0009695677,0.0000040965433,0.000004759651,0.0021413346],"genre_scores_gemma":[0.001259046,0.99817574,0.000034413093,0.00021378994,0.000017399809,0.00008096027,0.000017647775,0.000007899618,0.00019307573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925303,0.000091939924,0.00023213458,0.00014462855,0.00015446283,0.00012382263],"domain_scores_gemma":[0.9995071,0.0001254931,0.000092783666,0.00023501844,0.000012878691,0.000026693877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018516486,0.00014341719,0.00046534705,0.000041171457,0.00006293867,0.0000040879927,0.00008641623,0.00007680286,0.000009073967],"category_scores_gemma":[0.0000030430367,0.000058445945,0.00011416007,0.00010725021,0.00006917423,0.000009875165,0.00006200565,0.00018305276,0.000015918979],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002086269,0.0003221864,0.000007999566,0.0077195875,0.00028498223,0.0003236073,0.00041991464,1.0992392e-7,9.999933e-8,0.0006957566,0.00048437977,0.9897205],"study_design_scores_gemma":[0.00067249325,0.00011119845,0.00030444894,0.0093598915,0.0016228467,0.00008146922,0.00018509587,7.2905834e-7,0.0000029572534,0.00010478543,0.9874941,0.00005998986],"about_ca_topic_score_codex":0.000013353862,"about_ca_topic_score_gemma":0.0000012879832,"teacher_disagreement_score":0.9896605,"about_ca_system_score_codex":0.000078409284,"about_ca_system_score_gemma":0.000046641486,"threshold_uncertainty_score":0.23833564},"labels":[],"label_agreement":null},{"id":"W2089068120","doi":"10.2165/00003495-200464010-00005","title":"The Glycylcyclines","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":306,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Tigecycline; Tetracycline; Minocycline; Microbiology; Efflux; Antimicrobial; Antibiotics; Medicine; Biology","score_opus":0.04072883456676513,"score_gpt":0.39530294476270794,"score_spread":0.3545741101959428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089068120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000132756,0.9906724,0.000007655686,0.00035725083,0.0004986104,0.0004581662,0.000007920165,0.000043059714,0.007953596],"genre_scores_gemma":[0.000014232225,0.99276584,0.00008409873,0.000108845095,0.0007082428,0.0000060575635,0.00006204455,0.000052320924,0.0061982996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901515,0.000023267683,0.00034318844,0.0001994691,0.0001887355,0.00023020407],"domain_scores_gemma":[0.9991979,0.00014498027,0.00012861483,0.00038236284,0.000042094045,0.00010406582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014609637,0.00022906627,0.00073125685,0.000046310157,0.00011364274,0.000033531716,0.00017894672,0.0001395563,0.0000375648],"category_scores_gemma":[0.000049763297,0.0001167423,0.0004454105,0.00016828076,0.00009274554,0.000007383469,0.00006188231,0.00037818777,0.00058081304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000036240276,0.00003201776,2.0196049e-7,0.006279545,0.00010356261,0.000019547773,0.000019299056,1.2432221e-7,6.67447e-8,0.00065941596,0.0030403459,0.98984224],"study_design_scores_gemma":[0.00025156562,0.000023019145,0.0000016224517,0.008846552,0.0010160026,0.000052356805,0.000007908223,0.0000026493183,9.2078454e-7,0.000043929813,0.98963046,0.00012301664],"about_ca_topic_score_codex":0.0000059289973,"about_ca_topic_score_gemma":2.3079224e-7,"teacher_disagreement_score":0.9897192,"about_ca_system_score_codex":0.000055100405,"about_ca_system_score_gemma":0.00030384675,"threshold_uncertainty_score":0.746537},"labels":[],"label_agreement":null},{"id":"W2089574993","doi":"10.1007/s40265-013-0105-4","title":"Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Medicine; Dopaminergic; Pharmacology; Levodopa; Dyskinesia; Amantadine; Serotonergic; Dopamine; Neuroscience; Parkinson's disease; Internal medicine; Psychology; Serotonin; Disease","score_opus":0.027414287080916776,"score_gpt":0.3132203201985601,"score_spread":0.28580603311764335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089574993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059719017,0.98853576,0.00003602719,0.000054114385,0.0003258254,0.008404786,0.0014502754,0.00006342928,0.00053260237],"genre_scores_gemma":[0.0026291253,0.9758623,0.00026704292,0.00021607625,0.00031580892,0.011592549,0.0015687312,0.00016456161,0.0073837885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974506,0.00006705887,0.00065953506,0.0008638554,0.00032452086,0.00063442264],"domain_scores_gemma":[0.99804,0.00013627122,0.00030605556,0.00069252297,0.000067347886,0.0007577934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000110098226,0.0007980575,0.0024485039,0.0003896478,0.00006785191,0.000040631523,0.00018752825,0.00025032356,0.00017417877],"category_scores_gemma":[0.000040767558,0.0005716758,0.0011454347,0.0002109972,0.000034691562,0.00008199066,0.00003742426,0.0001826724,0.0005603185],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033918425,0.0017870833,0.00054326706,0.011873154,0.0016450807,0.0005828699,0.00003551082,2.1464979e-7,0.0000013237967,0.000056235407,0.0021738498,0.9809622],"study_design_scores_gemma":[0.007880023,0.0002637431,0.0009353026,0.0064267884,0.007769964,0.000010274684,0.0000102558,0.00016237001,7.3518527e-7,0.0000816776,0.9760381,0.0004207593],"about_ca_topic_score_codex":0.00007495366,"about_ca_topic_score_gemma":0.0000026167222,"teacher_disagreement_score":0.98054147,"about_ca_system_score_codex":0.00060056464,"about_ca_system_score_gemma":0.0005548677,"threshold_uncertainty_score":0.9996735},"labels":[],"label_agreement":null},{"id":"W2090441507","doi":"10.1007/s40265-013-0176-2","title":"T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects","year":2014,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Department of Veterans Affairs","keywords":"Vedolizumab; Natalizumab; Medicine; Inflammatory bowel disease; Crohn's disease; Immunology; Leukocyte Trafficking; Disease; Inflammatory Bowel Diseases; Efalizumab; Inflammation; Chemokine; Tumor necrosis factor alpha; Pathology; Infliximab; Multiple sclerosis","score_opus":0.007414992976670643,"score_gpt":0.26253378202931754,"score_spread":0.2551187890526469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090441507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07504653,0.9237143,0.000002561341,0.000009011189,0.00024792756,0.00072623155,0.00003972088,0.000023466766,0.00019024726],"genre_scores_gemma":[0.013945285,0.9846696,0.000016643906,0.000017020044,0.00084907847,0.000097186115,0.00029733512,0.00006875612,0.00003905298],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981863,0.00018033436,0.00043200262,0.00070091884,0.00016829497,0.00033218705],"domain_scores_gemma":[0.99904007,0.000014211726,0.0002389855,0.0004251895,0.00003534457,0.00024622443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023344606,0.000497442,0.0005715806,0.00012424153,0.000081243175,0.00013482478,0.0001865933,0.00031237156,0.000004459822],"category_scores_gemma":[0.000017832788,0.00044118025,0.00016935618,0.000059129972,0.000116823176,0.000012213551,0.00017996563,0.00029207926,0.000008297903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121371435,0.00024350196,0.0037087635,0.14114706,0.000098088894,0.0003630213,0.00040890952,0.000011899415,0.00013900512,0.0013048612,0.0016749284,0.8507786],"study_design_scores_gemma":[0.0004948819,0.00002055492,0.0059036226,0.0030603241,0.00018913706,0.0000066428865,0.00008463672,0.000014056818,0.000007816155,0.000027771814,0.98956615,0.0006244313],"about_ca_topic_score_codex":7.648821e-7,"about_ca_topic_score_gemma":0.000004252062,"teacher_disagreement_score":0.9878912,"about_ca_system_score_codex":0.000026671743,"about_ca_system_score_gemma":0.00043057092,"threshold_uncertainty_score":0.999804},"labels":[],"label_agreement":null},{"id":"W2090738000","doi":"10.2165/00003495-200262120-00001","title":"Who Should Receive HMG CoA Reductase Inhibitors?","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McMaster University","funders":"Merck Canada","keywords":"Medicine; Myocardial infarction; Internal medicine; Pharmacotherapy; Diabetes mellitus; Statin; Cholesterol; Cardiology; HMG-CoA reductase; Dyslipidemia; Placebo; Disease; Endocrinology; Reductase; Alternative medicine","score_opus":0.06530291621394826,"score_gpt":0.34205484533847247,"score_spread":0.2767519291245242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090738000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012045296,0.97634226,0.0000032421447,0.00032605094,0.0007645118,0.0020853458,0.00008456406,0.00012629374,0.020255674],"genre_scores_gemma":[0.00000781015,0.9858924,0.00012152254,0.00041378572,0.0039922846,0.00021540833,0.0003734645,0.00014517884,0.008838115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968498,0.00026007317,0.00078497815,0.0007113327,0.0008651918,0.0005286234],"domain_scores_gemma":[0.9976249,0.00007166508,0.00028580189,0.0014518175,0.00012101778,0.0004448291],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073321216,0.00056181516,0.0031149618,0.000246557,0.00010957456,0.000036106383,0.0001929261,0.0006667931,0.0005111086],"category_scores_gemma":[0.00017369857,0.0004181868,0.0018997553,0.00053420546,0.000086485874,0.000056686593,0.00008873313,0.0011399336,0.00088684424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004896364,0.00006342041,4.5501335e-7,0.019103339,0.0003860403,0.0001483726,0.00014494649,2.6353828e-8,1.1155921e-7,0.0000436955,0.07041476,0.90968996],"study_design_scores_gemma":[0.0004935448,0.00009787429,0.0000010331646,0.022641059,0.0021711926,0.0004616741,0.000052715517,0.0000010264928,0.000006525091,0.0000096388985,0.9736879,0.000375835],"about_ca_topic_score_codex":0.00016685169,"about_ca_topic_score_gemma":0.0000021081394,"teacher_disagreement_score":0.9093141,"about_ca_system_score_codex":0.00035490547,"about_ca_system_score_gemma":0.0005356872,"threshold_uncertainty_score":0.9998911},"labels":[],"label_agreement":null},{"id":"W2095101592","doi":"10.2165/00003495-200868010-00005","title":"Pharmacological Treatment of Early Multiple Sclerosis","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"EMD Serono; IC Design Education Center; Teva Pharmaceutical Industries; Biogen","keywords":"Medicine; Multiple sclerosis; Pharmacotherapy; Intensive care medicine; Adverse effect; Disease; Fingolimod; Intervention (counseling); Internal medicine; Immunology; Psychiatry","score_opus":0.2802280657794406,"score_gpt":0.41739131604953694,"score_spread":0.13716325027009635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095101592","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011175346,0.99451303,0.0000012734059,0.00004012872,0.0001322978,0.0021861682,0.00018122731,0.000077471355,0.0017508408],"genre_scores_gemma":[0.0009256882,0.99653476,0.00031798,0.000016726908,0.00035724125,0.00064341637,0.00010592885,0.000060287548,0.0010379645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974822,0.00019088625,0.0007102327,0.00052334537,0.000603164,0.00049021124],"domain_scores_gemma":[0.99813294,0.00073977746,0.00026655814,0.0004392129,0.0001501476,0.0002713622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009078639,0.0005111351,0.0030359337,0.00026519343,0.00010547128,0.000009147907,0.0001910058,0.00027366506,0.00025008543],"category_scores_gemma":[0.0001967854,0.00031736368,0.001227609,0.0003898256,0.00032529797,0.000032637883,0.0001236727,0.00027477482,0.00027746646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006459266,0.00083776587,0.00019311388,0.0032311156,0.0011758528,0.000038230806,0.00037052375,7.215331e-8,0.000034008674,0.0000014531194,0.002594514,0.9914588],"study_design_scores_gemma":[0.0022126762,0.00095662905,0.0011349461,0.0048248437,0.0010836194,0.000021051632,0.00002286576,0.0000055153264,0.00008457592,3.121513e-7,0.9894206,0.00023236075],"about_ca_topic_score_codex":0.00015535203,"about_ca_topic_score_gemma":0.0000022595982,"teacher_disagreement_score":0.9912264,"about_ca_system_score_codex":0.000429963,"about_ca_system_score_gemma":0.0003160445,"threshold_uncertainty_score":0.9999278},"labels":[],"label_agreement":null},{"id":"W2100635876","doi":"10.2165/00003495-200262160-00005","title":"New Approaches to Atrial Fibrillation Management","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Mitacs; Heart and Stroke Foundation of Canada","keywords":"Medicine; Amiodarone; Atrial fibrillation; Sinus rhythm; Digitalis; Cardiology; Management of atrial fibrillation; Intensive care medicine; Population; Internal medicine; Sotalol; Digoxin; Heart failure","score_opus":0.08924184669275906,"score_gpt":0.30383974326204893,"score_spread":0.21459789656928988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100635876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000053252074,0.97806495,0.00006895336,0.00025717728,0.0003456554,0.0011976843,0.0000052414084,0.000059763086,0.019995268],"genre_scores_gemma":[0.0000061640403,0.9740202,0.0010739961,0.00006113538,0.0051971343,0.00001348623,0.0001609339,0.000036481182,0.01943046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892724,0.000057165536,0.00027496216,0.00036057766,0.00015277554,0.00022728936],"domain_scores_gemma":[0.99936455,0.00004586213,0.000086669446,0.00035560926,0.0000058293335,0.00014145735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000075332646,0.00024688645,0.0011218574,0.00016680076,0.000039802977,0.000010758594,0.000057329125,0.00020864788,0.00017036618],"category_scores_gemma":[0.000009752467,0.00019627421,0.00091397204,0.0002760047,0.000011032099,0.000017698074,0.000059618593,0.00020051308,0.0014244784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002198692,0.0000021045414,1.6164411e-7,0.002878101,0.00035171816,0.00004412197,0.000044234926,0.00000921768,1.8710471e-8,0.00091562484,0.011830131,0.9839026],"study_design_scores_gemma":[0.000271255,0.00008745524,0.000002992278,0.0020549446,0.0016073998,0.0000973763,0.0000036745953,0.000003643922,2.3029926e-7,0.000057180147,0.9956395,0.00017432062],"about_ca_topic_score_codex":0.000003608979,"about_ca_topic_score_gemma":1.2598441e-7,"teacher_disagreement_score":0.9838094,"about_ca_system_score_codex":0.00009843081,"about_ca_system_score_gemma":0.00006523135,"threshold_uncertainty_score":0.99935305},"labels":[],"label_agreement":null},{"id":"W2108405186","doi":"10.1007/s40265-014-0306-5","title":"Updated National and International Hypertension Guidelines: A Review of Current Recommendations","year":2014,"lang":"en","type":"review","venue":"Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Bayer HealthCare; Medical Research Council; American Heart Association; Sanofi; Chugai Pharmaceutical; Servier; Daiichi-Sankyo; Pfizer; AstraZeneca","keywords":"Medicine; Excellence; Blood pressure; Family medicine; Intensive care medicine; Nice; Clinical trial; Health care; Internal medicine; Political science","score_opus":0.2282544500303353,"score_gpt":0.455741269330621,"score_spread":0.2274868193002857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108405186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.1466535e-7,0.99024177,0.0000115538705,0.0057935817,0.0005701821,0.00046307768,0.00012704209,0.000027567938,0.002765091],"genre_scores_gemma":[8.269642e-7,0.9914659,0.00060934655,0.0050619394,0.00040864834,0.00007552256,0.0016330422,0.000023657929,0.00072111515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817604,0.00008418402,0.0009658747,0.0002963909,0.00037510824,0.00010242893],"domain_scores_gemma":[0.99749535,0.00017067134,0.00042628188,0.00021264619,0.0016248394,0.000070201975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053474447,0.00023813873,0.0019037185,0.00019748676,0.000045996065,0.000007218019,0.000102263526,0.00010374027,0.00042047544],"category_scores_gemma":[0.00055674766,0.00016350843,0.00029299632,0.00018138452,0.00004988149,0.00003742245,0.0001400385,0.00024353917,0.00007080671],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014986439,0.00003346564,3.6672571e-7,0.025027262,0.00024627167,6.352907e-7,0.00000528778,2.6783646e-9,8.6258204e-8,0.000093915995,0.46672714,0.50786406],"study_design_scores_gemma":[0.00023801034,0.00001527804,0.000001150395,0.16266233,0.0029500271,0.000119790675,0.0000054592447,0.000009038871,1.6709558e-7,0.00002062779,0.83386457,0.00011357324],"about_ca_topic_score_codex":0.000003466214,"about_ca_topic_score_gemma":3.8718764e-7,"teacher_disagreement_score":0.5077505,"about_ca_system_score_codex":0.000017154342,"about_ca_system_score_gemma":0.00021075521,"threshold_uncertainty_score":0.666768},"labels":[],"label_agreement":null},{"id":"W2132352181","doi":"10.2165/00003495-200767150-00002","title":"Recent Advances in the Pharmacological Management of Pain","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Pain management; Interventional pain management; Physical therapy; Psychiatry","score_opus":0.06403223199858148,"score_gpt":0.40404591138078483,"score_spread":0.34001367938220334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132352181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000042481356,0.9536485,0.000045044035,0.00017231132,0.00012563627,0.0014409594,0.0000022328663,0.000018517592,0.044542555],"genre_scores_gemma":[0.0000051803063,0.997787,0.00023819032,0.000775161,0.000115884635,0.00011248422,0.00005996758,0.000013592258,0.0008925257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984,0.0003262725,0.00047228183,0.00022845375,0.00034074057,0.00023225433],"domain_scores_gemma":[0.99920076,0.00032085748,0.00016882177,0.00025684555,0.000017201675,0.000035503133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002944145,0.00020439166,0.00076913624,0.00017526852,0.000018489282,0.0000057520297,0.00028919659,0.00009299068,0.00018930317],"category_scores_gemma":[0.000027126347,0.00011106506,0.00021328192,0.00053775,0.000049715876,0.000024067476,0.00007044967,0.0002956177,0.00004084854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014230062,0.00015316936,0.00001760131,0.015923696,0.000097469325,0.00015234288,0.00006959143,1.7119169e-7,1.0633671e-8,0.00046479743,0.004090251,0.97901666],"study_design_scores_gemma":[0.0003477844,0.000048232305,0.00005407065,0.0061894176,0.00080984953,8.4564965e-7,0.00030112968,0.0000039974157,1.3592769e-7,0.000039021405,0.9921019,0.000103627885],"about_ca_topic_score_codex":6.8753144e-7,"about_ca_topic_score_gemma":6.336342e-7,"teacher_disagreement_score":0.98801166,"about_ca_system_score_codex":0.0000691707,"about_ca_system_score_gemma":0.000020440431,"threshold_uncertainty_score":0.45291018},"labels":[],"label_agreement":null},{"id":"W2151168916","doi":"10.2165/00003495-200767040-00003","title":"The Diagnosis and Treatment of??Raynaud???s Phenomenon","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Iloprost; Vasospasm; Bosentan; Apremilast; Nifedipine; Adverse effect; Cardiology; Internal medicine; Anesthesia; Dermatology; Prostacyclin; Endothelin receptor; Psoriasis","score_opus":0.09794774049646297,"score_gpt":0.3665088360733924,"score_spread":0.2685610955769294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151168916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016206721,0.9937647,2.975321e-7,0.0000403439,0.00019323349,0.00096017943,0.000031044445,0.000020651454,0.004827476],"genre_scores_gemma":[0.000095726464,0.9977641,0.0000088906145,0.00001763104,0.00026436299,0.00020658287,0.000042911863,0.0000326285,0.0015671286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988587,0.000056083907,0.0004885806,0.00022496034,0.00018469762,0.00018700461],"domain_scores_gemma":[0.9986586,0.0005653682,0.00024588945,0.0003585781,0.000034162025,0.00013738793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015138187,0.00024796696,0.0011263854,0.000091835405,0.00008059749,0.000014582347,0.0000648607,0.00019534783,0.000032493324],"category_scores_gemma":[0.00002745743,0.00011266966,0.0003965381,0.00016960784,0.00010001751,0.000009548482,0.00001964185,0.00007477616,0.000032588778],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008792051,0.00013616313,0.00007373911,0.002711031,0.00044584423,0.000006666117,0.00017207618,7.437568e-9,9.3001425e-8,0.00006016649,0.0007433065,0.9956421],"study_design_scores_gemma":[0.00043029926,0.00018414689,0.000058788093,0.018582698,0.00256324,0.000022571203,0.00016461751,3.6818295e-7,0.0000022287259,0.0000040861805,0.977886,0.00010093693],"about_ca_topic_score_codex":0.00003794797,"about_ca_topic_score_gemma":0.0000011198196,"teacher_disagreement_score":0.99554116,"about_ca_system_score_codex":0.0001266358,"about_ca_system_score_gemma":0.00011941118,"threshold_uncertainty_score":0.45945355},"labels":[],"label_agreement":null},{"id":"W2151295088","doi":"10.2165/00003495-200060060-00006","title":"Can Antiarrhythmic Agents be Selected Based on Mechanism of Action?","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Drug; Drug action; Mechanism of action; Mechanism (biology); Gambit; Action (physics); Pharmacology; Anti-Arrhythmia Agents; Cardiology; Atrial fibrillation; Computer science","score_opus":0.029681390074495124,"score_gpt":0.323188965498077,"score_spread":0.2935075754235819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151295088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024423117,0.9878546,0.000011604382,0.0003607654,0.00056794134,0.00200872,0.00030461058,0.00018925648,0.006260168],"genre_scores_gemma":[0.0064719953,0.9901449,0.00003839633,0.00051158294,0.00047385614,0.00007821847,0.0008827695,0.00007729945,0.0013210006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982747,0.00021662052,0.0004437286,0.00044533837,0.00028058543,0.00033906417],"domain_scores_gemma":[0.9988715,0.0001298343,0.00026020597,0.0005453828,0.0000786727,0.000114411705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010590622,0.00039974763,0.0018913846,0.00032872445,0.0000692573,0.0000047218914,0.00008668362,0.00045115626,0.00062851026],"category_scores_gemma":[0.000037842598,0.00032694728,0.0007269108,0.00059215556,0.000053959757,0.000015354273,0.000014818657,0.0006573276,0.000104051214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019651682,0.00016979246,4.672899e-7,0.008685239,0.00060999533,0.0003790028,0.000060628372,0.000010064385,0.00006357011,0.0002341845,0.0036251827,0.9859654],"study_design_scores_gemma":[0.0009365204,0.0006645938,0.000017241766,0.007878043,0.0022806178,0.00036192246,0.0000063467887,0.000090919464,0.00046888713,0.00006451393,0.98680586,0.00042450952],"about_ca_topic_score_codex":0.000024888832,"about_ca_topic_score_gemma":0.000001775989,"teacher_disagreement_score":0.98554087,"about_ca_system_score_codex":0.00014296698,"about_ca_system_score_gemma":0.00079729897,"threshold_uncertainty_score":0.9999183},"labels":[],"label_agreement":null},{"id":"W2170978231","doi":"10.2165/00003495-200262060-00007","title":"Tamoxifen Resistant and Refractory Breast Cancer","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Tamoxifen; Medicine; Aromatase; Breast cancer; Exemestane; Aminoglutethimide; Anastrozole; Letrozole; Internal medicine; Oncology; Aromatase inhibitor; Antiestrogen; Adjuvant therapy; Megestrol acetate; Cancer; Hormonal therapy; Pharmacology","score_opus":0.011704291383928169,"score_gpt":0.28244718569975796,"score_spread":0.2707428943158298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170978231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003132994,0.99689627,5.4676366e-7,0.000026373666,0.00016106218,0.00024991468,0.0001313364,0.000014539713,0.0022066885],"genre_scores_gemma":[0.00017379812,0.9953003,0.000017371525,0.00004468223,0.0004074012,0.000059727998,0.0001749242,0.000059897753,0.0037618878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998898,0.00010006872,0.00022976003,0.00043252434,0.00010138978,0.00023820826],"domain_scores_gemma":[0.99935097,0.000014580037,0.00014829452,0.00033929048,0.000026952403,0.0001199306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089847,0.00030922136,0.0005448508,0.00004961989,0.00006590672,0.000023931761,0.00015413135,0.00058269803,0.000045935918],"category_scores_gemma":[0.000008706971,0.00023338995,0.00021679218,0.00008038402,0.000076684606,0.0000016847202,0.000109043765,0.00027886743,0.00003985993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016074657,0.000032837535,0.0000023736077,0.0019818197,0.00025298574,0.000016258846,0.000023090142,7.362153e-8,0.00032111735,0.000013421382,0.010831071,0.98650885],"study_design_scores_gemma":[0.00014208905,0.000056450455,0.00000466738,0.0016272648,0.00031383103,0.00008376854,0.000004215366,6.126845e-7,0.000036170044,0.0000023744683,0.99743783,0.0002907358],"about_ca_topic_score_codex":0.000023016053,"about_ca_topic_score_gemma":0.0000022035415,"teacher_disagreement_score":0.9866068,"about_ca_system_score_codex":0.00002947939,"about_ca_system_score_gemma":0.00009977586,"threshold_uncertainty_score":0.95173657},"labels":[],"label_agreement":null},{"id":"W2184974902","doi":"10.2165/00003495-200363150-00007","title":"Tenofovir Disoproxil Fumarate","year":2003,"lang":"sh","type":"letter","venue":"Drugs","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Tenofovir; Medicine; Pharmacotherapy; Pharmacology; Internal medicine; Virology; Human immunodeficiency virus (HIV)","score_opus":0.025287815416808336,"score_gpt":0.3020150207109723,"score_spread":0.27672720529416395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184974902","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012240664,0.013969112,0.000071935814,0.51998144,0.004036665,0.0034115617,0.0008413742,0.0002897919,0.44515747],"genre_scores_gemma":[0.006686027,0.0039738896,0.00014821543,0.410249,0.009978076,0.00024425352,0.0010411894,0.00047287287,0.56720644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920878,0.0004735611,0.0011355726,0.0016342024,0.00220049,0.0024683815],"domain_scores_gemma":[0.9961675,0.00035079638,0.00035323447,0.0020028106,0.00040985315,0.0007158003],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0011509951,0.00118294,0.0018190945,0.0007638023,0.0004731208,0.00033894723,0.0008102092,0.0019332097,0.023737688],"category_scores_gemma":[0.00021260632,0.0010260072,0.00081186736,0.0009500315,0.00059638394,0.00019387154,0.00031001883,0.0060836356,0.03605678],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023568989,0.00028042684,0.00084219564,0.0012176941,0.0005375984,0.0018464276,0.0008824534,9.289587e-7,0.0005441555,0.00018433298,0.9658594,0.027568655],"study_design_scores_gemma":[0.0026615588,0.0003344898,0.00057320436,0.000542657,0.00039413536,0.00008899218,0.00032964637,0.00007184852,0.00060032186,0.00023018352,0.9931115,0.0010614833],"about_ca_topic_score_codex":0.0011785044,"about_ca_topic_score_gemma":0.00004749287,"teacher_disagreement_score":0.122049,"about_ca_system_score_codex":0.0006974807,"about_ca_system_score_gemma":0.001215854,"threshold_uncertainty_score":0.99936247},"labels":[],"label_agreement":null},{"id":"W2204576307","doi":"10.2165/11318520-000000000-00000","title":"Refractory Gastro-Oesophageal Reflux Disease","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Reflux; Gastroenterology; Internal medicine; Gastro-; Heartburn; Refractory (planetary science); Cisapride; Proton-pump inhibitor; Gastroparesis; Disease; Gastric emptying; Ambulatory; Achalasia; Endoscopy; Esophagus; Stomach","score_opus":0.03665236786213808,"score_gpt":0.36293938006044085,"score_spread":0.32628701219830275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204576307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006392173,0.9897681,0.0000033672457,0.000032003405,0.00026673925,0.0010825904,0.00016065758,0.00019569052,0.008426959],"genre_scores_gemma":[0.0015568918,0.97808903,0.00038637363,0.0002818973,0.0008000171,0.000116811934,0.0016726464,0.00012967877,0.01696667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709195,0.0001331908,0.00069959846,0.00079359737,0.0006086695,0.0006729732],"domain_scores_gemma":[0.99744195,0.00007806867,0.00032886502,0.0010737934,0.00007167059,0.0010056753],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014977508,0.0007929322,0.002267749,0.00030973513,0.00010060752,0.00004038093,0.000245281,0.00029712,0.00039642237],"category_scores_gemma":[0.00008417249,0.0005714524,0.0011682684,0.00028554176,0.00007731128,0.0000920154,0.00007320059,0.0007387707,0.0022552432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031636315,0.00046874097,0.00014482821,0.005957941,0.00027545408,0.005763228,0.000022268136,2.8172696e-8,3.769683e-8,0.0000400693,0.002750657,0.9845451],"study_design_scores_gemma":[0.00090923643,0.000349076,0.0012717543,0.006464519,0.0038456155,0.00011517937,0.0000029202406,5.035576e-7,2.496192e-7,0.000039446863,0.98682225,0.000179274],"about_ca_topic_score_codex":0.0000029228206,"about_ca_topic_score_gemma":1.1562331e-7,"teacher_disagreement_score":0.9843658,"about_ca_system_score_codex":0.00042446537,"about_ca_system_score_gemma":0.0006845001,"threshold_uncertainty_score":0.99967366},"labels":[],"label_agreement":null},{"id":"W2215572913","doi":"10.2165/11585360-000000000-00000","title":"Non-Hormonal Treatment Strategies for Vasomotor Symptoms","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Vasomotor; Menopause; Estrogen; Hormone; Quality of life (healthcare); Depression (economics); Internal medicine","score_opus":0.09711939744794497,"score_gpt":0.39599387646300765,"score_spread":0.2988744790150627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215572913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006731698,0.98449826,0.000017568858,0.000029033064,0.00040573234,0.0048006093,0.0003700658,0.00007560697,0.009735818],"genre_scores_gemma":[0.00009307436,0.98934454,0.00045553644,0.00010849809,0.00060191454,0.0016602181,0.0009498749,0.00012428945,0.0066620763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800783,0.0000312504,0.00063557265,0.0005068646,0.00019157035,0.0006268795],"domain_scores_gemma":[0.9983815,0.0001190698,0.00032713305,0.00058438897,0.000072209856,0.0005156763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012448465,0.0006618721,0.002185321,0.00018280665,0.000120443845,0.00004234202,0.0001221622,0.00034212475,0.00025417202],"category_scores_gemma":[0.000010040887,0.00039718783,0.00020808434,0.00011735225,0.000045525147,0.000078218894,0.000023809987,0.00016074354,0.00039011845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009761909,0.00046992677,0.0000032196626,0.01897004,0.0012977931,0.000039713526,0.00032383399,9.434357e-9,4.5821312e-7,0.00058114924,0.0013148249,0.9769014],"study_design_scores_gemma":[0.0030957307,0.007080735,0.000011909735,0.0061420663,0.005141946,0.00007676113,0.000028653107,0.0000016322766,0.0000014073172,0.00011967118,0.97802,0.00027947858],"about_ca_topic_score_codex":0.00019558397,"about_ca_topic_score_gemma":0.0000052790156,"teacher_disagreement_score":0.9767052,"about_ca_system_score_codex":0.0005798892,"about_ca_system_score_gemma":0.0019917234,"threshold_uncertainty_score":0.999848},"labels":[],"label_agreement":null},{"id":"W2219541779","doi":"10.2165/11585280-000000000-00000","title":"Optimizing Therapy for Iron Overload in the Myelodysplastic Syndromes","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Deferasirox; Chelation therapy; Deferiprone; Clinical trial; Internal medicine; Deferoxamine; Adverse effect; Thalassemia; Intensive care medicine; Bone marrow","score_opus":0.04430918997115647,"score_gpt":0.31667618981949,"score_spread":0.2723669998483335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2219541779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005944317,0.9921705,0.000017678407,0.00014490435,0.00030516862,0.002067054,0.00001701474,0.000034578108,0.0051836465],"genre_scores_gemma":[0.000055839388,0.9981323,0.00018817275,0.00027431012,0.00010218062,0.00031735498,0.00010238128,0.00006362556,0.00076385465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864846,0.00008951948,0.00043438695,0.0003185262,0.00015579352,0.0003533054],"domain_scores_gemma":[0.99905,0.00031410126,0.00015858035,0.00039355722,0.00002354502,0.000060212133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034655648,0.00034321513,0.0011230194,0.00017282364,0.0000710315,0.000021047039,0.00023765322,0.00040763622,0.00007981529],"category_scores_gemma":[0.000046841058,0.00017999172,0.00049061596,0.00026181407,0.00006300027,0.00003120926,0.000023582277,0.0005281452,0.00007727799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000364005,0.00013430571,0.0000017567272,0.008205403,0.00011789327,0.00003192188,0.0022730283,0.0000011442546,1.584351e-7,0.00026286926,0.0015926692,0.9873425],"study_design_scores_gemma":[0.0009664115,0.00020775314,0.0000039626275,0.008902125,0.00050398585,0.00012943149,0.00036879,0.000010001373,1.6070207e-7,0.00003744064,0.98865986,0.00021005736],"about_ca_topic_score_codex":0.000033396136,"about_ca_topic_score_gemma":0.0000016054797,"teacher_disagreement_score":0.9871324,"about_ca_system_score_codex":0.00006301218,"about_ca_system_score_gemma":0.00020759352,"threshold_uncertainty_score":0.73398495},"labels":[],"label_agreement":null},{"id":"W2227579106","doi":"10.1007/s40265-015-0517-4","title":"Antidepressant Drugs for Postsurgical Pain: Current Status and Future Directions","year":2016,"lang":"en","type":"review","venue":"Drugs","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Chronic pain; Antidepressant; Analgesic; Adverse effect; Intensive care medicine; Dosing; Clinical trial; Acute pain; Anesthesia; Physical therapy; Psychiatry; Internal medicine; Anxiety","score_opus":0.024553397916522054,"score_gpt":0.327641121540552,"score_spread":0.30308772362402997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2227579106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006272199,0.9948907,0.00011102742,0.001059029,0.00035123964,0.001929305,0.000043922413,0.00009876796,0.0015097574],"genre_scores_gemma":[0.000004056499,0.99472094,0.00012343764,0.00036771162,0.0018249801,0.00038050846,0.00026472128,0.00006727303,0.0022463505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812543,0.00024802514,0.00042771004,0.00051145686,0.00025028462,0.00043711305],"domain_scores_gemma":[0.99846876,0.00060942024,0.00018752569,0.00040169092,0.00006827345,0.00026434637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007510425,0.00040130605,0.0013081522,0.00018542097,0.00013102726,0.000034148103,0.0000956981,0.00020755516,0.0001263482],"category_scores_gemma":[0.000046553312,0.00024264056,0.0005206485,0.00015135814,0.00007616886,0.000037663696,0.00004722624,0.00026347864,0.00005276094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020000687,0.00006732996,0.00007709155,0.0152658615,0.00015195008,0.000010549585,0.00015755076,2.2691924e-9,8.412287e-9,0.0011563438,0.014420542,0.96867275],"study_design_scores_gemma":[0.00054230355,0.00008384877,0.0000860136,0.010027154,0.001037593,0.000024304103,0.000091866175,0.0000032932758,3.9826872e-8,0.000052491574,0.9877615,0.0002895704],"about_ca_topic_score_codex":0.0000051446045,"about_ca_topic_score_gemma":3.4086216e-7,"teacher_disagreement_score":0.973341,"about_ca_system_score_codex":0.00008748357,"about_ca_system_score_gemma":0.00014389826,"threshold_uncertainty_score":0.9894595},"labels":[],"label_agreement":null},{"id":"W2237168606","doi":"10.2165/00003495-200666180-00010","title":"Recombinant Full-Length Parathyroid Hormone (1-84)","year":2006,"lang":"en","type":"article","venue":"Drugs","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Parathyroid hormone; Recombinant DNA; Pharmacotherapy; Endocrinology; Internal medicine; Calcium; Biology; Genetics","score_opus":0.006769616486914449,"score_gpt":0.2416573167543249,"score_spread":0.23488770026741043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2237168606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91638917,0.0135221435,0.000051851002,0.00090562657,0.00012191884,0.0002948677,0.000008565674,0.000111228976,0.06859462],"genre_scores_gemma":[0.9854102,0.00037635418,0.00055115664,0.00026237324,0.000102896556,0.000041530096,0.00012655433,0.00002712236,0.01310179],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99890685,0.000020021755,0.00023106072,0.00028586085,0.0002205203,0.0003356598],"domain_scores_gemma":[0.9994294,0.000023445305,0.000062810315,0.00032576837,0.0000430969,0.000115496514],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007618701,0.00018774893,0.00028007026,0.0000747527,0.00009382062,0.000019617411,0.00006505252,0.0000811174,0.000031417767],"category_scores_gemma":[0.000011130804,0.0001501511,0.000115921706,0.00017447502,0.000045418532,0.000066797955,0.000024511637,0.00011630971,0.0010385067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079949066,0.0035712686,0.011876299,0.000013770506,0.00022045788,0.00052423443,0.00055612816,0.000013739013,0.046876837,0.0052377917,0.9255167,0.0047932453],"study_design_scores_gemma":[0.033013016,0.0030351419,0.4900671,0.00004050499,0.00061273243,0.00038945282,0.0007377814,0.0008950082,0.007439325,0.009704848,0.45292196,0.0011431405],"about_ca_topic_score_codex":0.00027657728,"about_ca_topic_score_gemma":0.000015490876,"teacher_disagreement_score":0.47819078,"about_ca_system_score_codex":0.00006335426,"about_ca_system_score_gemma":0.000052037663,"threshold_uncertainty_score":0.9997393},"labels":[],"label_agreement":null},{"id":"W2242338668","doi":"10.2165/11595180-000000000-00000","title":"Biomarkers of Therapeutic Response in Patients with Chronic Obstructive Pulmonary Disease","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Providence Health Care","funders":"AstraZeneca","keywords":"Medicine; COPD; Exacerbation; Clinical trial; Internal medicine; Intensive care medicine; Pharmacology","score_opus":0.02413078821614477,"score_gpt":0.3051262331786052,"score_spread":0.28099544496246043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242338668","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014803408,0.9797042,0.0000015264707,0.000022074886,0.00012467655,0.0036304623,0.00050814054,0.000042761796,0.0011627754],"genre_scores_gemma":[0.03966659,0.9579662,0.00005032462,0.000021353788,0.00011123924,0.00048411143,0.0007713387,0.00025723776,0.000671578],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99589765,0.00075089466,0.0008251175,0.00096217357,0.0008354461,0.00072869204],"domain_scores_gemma":[0.99706435,0.0003527957,0.00046370074,0.0012989084,0.0002588958,0.00056136545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004113293,0.00071740523,0.0019862398,0.0009955894,0.000054037893,0.000011626076,0.00045658275,0.00027523423,0.00048236098],"category_scores_gemma":[0.00011240861,0.0005349457,0.0005807221,0.0011446142,0.0006837973,0.0001484866,0.00021380963,0.00070196117,0.000084457824],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014146929,0.0010384835,0.017281068,0.037207734,0.0007847659,0.00034353527,0.00013106139,2.9970224e-7,5.211784e-7,0.00006961495,0.000020559779,0.9289754],"study_design_scores_gemma":[0.00266628,0.00045288954,0.75927675,0.019686438,0.0020419504,0.000018535178,0.00007329868,0.0000134347365,0.0000010284948,0.000104289786,0.21497685,0.00068822666],"about_ca_topic_score_codex":0.0000727084,"about_ca_topic_score_gemma":0.000002851757,"teacher_disagreement_score":0.9282872,"about_ca_system_score_codex":0.0021163675,"about_ca_system_score_gemma":0.004067525,"threshold_uncertainty_score":0.9997102},"labels":[],"label_agreement":null},{"id":"W2266943560","doi":"10.1007/s40265-016-0545-8","title":"Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent","year":2016,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":319,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Saint-Boniface; St. Boniface Hospital; Health Sciences Centre; University of Manitoba","funders":"","keywords":"Pharmacokinetics; Tigecycline; Medicine; Volume of distribution; Pseudomonas aeruginosa; Pharmacology; Population; Microbiology; Antimicrobial; Bacteria; Biology","score_opus":0.02337602297000151,"score_gpt":0.3290274756530104,"score_spread":0.30565145268300886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266943560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007439887,0.99664193,0.0001744533,0.000029452316,0.00081026455,0.0007107543,0.00062622793,0.000013105572,0.00091943203],"genre_scores_gemma":[0.000008566582,0.9949976,0.00082769536,0.00021734885,0.0012137197,0.000021263035,0.0013669949,0.00009212338,0.0012546397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749154,0.00012824727,0.0012072643,0.00064867985,0.00019296177,0.00033129807],"domain_scores_gemma":[0.99766946,0.000039894865,0.0009543417,0.001096281,0.00013835484,0.00010169098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003814174,0.00050994195,0.0018044339,0.00006484414,0.000030531704,0.000014379979,0.000625825,0.00043582974,0.00015961201],"category_scores_gemma":[0.00019992805,0.00035591025,0.0008076766,0.00012486789,0.00013613186,0.0000033499914,0.00027702772,0.00013371358,0.00009806428],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003775116,0.00015242124,0.0000035773303,0.18621118,0.00040009356,0.0000028944767,0.0000041214475,4.6710182e-9,0.010175307,0.00004806465,0.029512502,0.77345204],"study_design_scores_gemma":[0.00023530876,0.00005234115,0.0000037997777,0.14039467,0.00028150328,0.000019983403,0.0000011548884,2.8509396e-8,0.0005644941,0.0000014850111,0.8581031,0.00034214449],"about_ca_topic_score_codex":0.0000036289953,"about_ca_topic_score_gemma":8.933351e-7,"teacher_disagreement_score":0.8285906,"about_ca_system_score_codex":0.00003131693,"about_ca_system_score_gemma":0.00032984786,"threshold_uncertainty_score":0.9998893},"labels":[],"label_agreement":null},{"id":"W2279230689","doi":"10.1007/s40265-015-0491-x","title":"Diagnosis and Management of Systemic Sclerosis: A Practical Approach","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Medicine; Scleroderma (fungus); Disease; Intensive care medicine; Interstitial lung disease; Systemic disease; Systemic inflammation; Multisystem disease; Autoimmunity; Multiple sclerosis; Pulmonary fibrosis; Autoimmune disease; Fibrosis; Dermatology; Lung; Pathology; Immunology; Inflammation; Internal medicine","score_opus":0.1548884206716103,"score_gpt":0.36918013149120665,"score_spread":0.21429171081959636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279230689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009849753,0.9930381,0.000006217199,0.000025720434,0.00016042883,0.0020654344,0.00004298022,0.0000502664,0.0045123207],"genre_scores_gemma":[0.000490634,0.9974956,0.0004914208,0.000020168703,0.00012236768,0.0008923911,0.00008704534,0.000057002708,0.00034336763],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978841,0.00016784469,0.0007759824,0.0004585793,0.00049334485,0.00022015673],"domain_scores_gemma":[0.99853563,0.00011377134,0.00044719927,0.00051043776,0.00009649888,0.0002964726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050016894,0.00033754166,0.0020462438,0.00016879202,0.000028559636,0.000021483238,0.000102811515,0.00036327823,0.000015860162],"category_scores_gemma":[0.00004025482,0.00022248863,0.00037457867,0.0003061137,0.00008901062,0.000039425468,0.0001271541,0.00023608927,0.000051168616],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013583576,0.0003127618,0.00002149161,0.18074149,0.0012031074,0.000023721643,0.00016014709,7.575675e-8,1.6348847e-7,0.00026003527,0.00840829,0.8088551],"study_design_scores_gemma":[0.0009491931,0.000066307024,0.000031569274,0.5042527,0.0134305945,0.00048658886,0.0015071678,0.000006090282,4.9553125e-7,0.0000033691595,0.47899562,0.0002703476],"about_ca_topic_score_codex":0.000013931203,"about_ca_topic_score_gemma":2.564478e-8,"teacher_disagreement_score":0.8085848,"about_ca_system_score_codex":0.00012575292,"about_ca_system_score_gemma":0.00021387724,"threshold_uncertainty_score":0.90728223},"labels":[],"label_agreement":null},{"id":"W2288852178","doi":"10.1007/s40265-015-0471-1","title":"Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Anesthesia Alternate Funds Association","keywords":"Medicine; Intensive care medicine; Intrathecal; Clinical Practice; Analgesic; Expert opinion; Refractory (planetary science); Anesthesia; Physical therapy","score_opus":0.03528943630869925,"score_gpt":0.34380135378461524,"score_spread":0.308511917475916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288852178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005693904,0.99576247,0.00004959045,0.0002507608,0.0005456961,0.0024598057,0.00002140439,0.00007419367,0.00083040685],"genre_scores_gemma":[0.0000042715574,0.9919817,0.00014342157,0.000095215924,0.0058245556,0.00028679296,0.0004621191,0.0000602826,0.001141682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985379,0.000109512504,0.0003430957,0.00043785095,0.00025164604,0.00032002016],"domain_scores_gemma":[0.9990259,0.0000969912,0.00019470617,0.0003961578,0.0000765906,0.00020967833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010285353,0.00037223115,0.0012289007,0.00016743697,0.00005277298,0.000034942103,0.00013328738,0.00022962983,0.000030277819],"category_scores_gemma":[0.00006520616,0.00026439675,0.00027185766,0.00018003561,0.000051970626,0.00004464671,0.000061164224,0.0004347331,0.000031760494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011498867,0.000053299304,0.000008027229,0.040876072,0.00010304408,0.000008469597,0.00009110613,3.7342263e-9,3.445187e-8,0.0005287694,0.060281474,0.8980382],"study_design_scores_gemma":[0.0006536795,0.0002557315,0.000024231416,0.0059369034,0.0011405796,0.0000026163648,0.000036959587,0.000029678973,6.236848e-8,0.000101467595,0.9915549,0.00026316638],"about_ca_topic_score_codex":0.0000010455632,"about_ca_topic_score_gemma":0.0000014674052,"teacher_disagreement_score":0.93127346,"about_ca_system_score_codex":0.0003325875,"about_ca_system_score_gemma":0.0004817208,"threshold_uncertainty_score":0.9999808},"labels":[],"label_agreement":null},{"id":"W241406582","doi":"10.2165/00003495-200767180-00005","title":"Treatment of Lysosomal Storage Disorders","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Lysosomal storage disorders; Enzyme replacement therapy; Medicine; Substrate reduction therapy; Intensive care medicine; Lysosomal storage disease; Disease; Orphan drug; Reimbursement; Fabry disease; Clinical trial; Pathology; Bioinformatics; Health care","score_opus":0.061845232560002635,"score_gpt":0.392680393069236,"score_spread":0.3308351605092334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W241406582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018062505,0.97582114,0.000017840022,0.000047436562,0.00017183762,0.0018457894,0.00006416502,0.00006655194,0.021784645],"genre_scores_gemma":[0.00020464038,0.99282646,0.00013844119,0.000013013087,0.00022338917,0.00012336837,0.00033367466,0.00012351057,0.006013506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997299,0.000114343806,0.0007264545,0.00053767004,0.00074523425,0.00057729485],"domain_scores_gemma":[0.99832284,0.00023851419,0.00027231296,0.00079675077,0.00009156035,0.00027803972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016125347,0.0005437777,0.0025538704,0.0005817363,0.000056936115,0.000012824452,0.0002363811,0.0004396257,0.00046803593],"category_scores_gemma":[0.000066904926,0.00039072038,0.0012163512,0.0007235829,0.00019972135,0.00004144467,0.00006891741,0.00030017298,0.0003401776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004795907,0.0007440912,0.000048027625,0.012354704,0.00044814468,0.00012298768,0.00028941536,1.1754411e-7,4.1996574e-7,0.00012762891,0.00020516267,0.9856113],"study_design_scores_gemma":[0.0011819425,0.0007918423,0.000021797665,0.0024603133,0.0009928835,0.00006514145,0.000102333164,0.0000029739742,0.00000305901,0.000019248704,0.99408054,0.00027793046],"about_ca_topic_score_codex":0.0002273959,"about_ca_topic_score_gemma":0.000019290976,"teacher_disagreement_score":0.9938754,"about_ca_system_score_codex":0.000647326,"about_ca_system_score_gemma":0.0006543751,"threshold_uncertainty_score":0.99985445},"labels":[],"label_agreement":null},{"id":"W2420878420","doi":"10.1007/s40265-016-0600-5","title":"Psychosis in Parkinson’s Disease: Epidemiology, Pathophysiology, and Management","year":2016,"lang":"en","type":"review","venue":"Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Psychosis; Quetiapine; Medicine; Clozapine; Antipsychotic; Parkinson's disease; Psychiatry; Schizophrenia (object-oriented programming); Disease; Neuroscience; Psychology; Internal medicine","score_opus":0.04300202841631938,"score_gpt":0.3562318025215395,"score_spread":0.3132297741052201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420878420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008970588,0.9963476,0.00001238282,0.00034614466,0.00025657838,0.0015011047,0.00026276935,0.000055975917,0.0011277264],"genre_scores_gemma":[0.0001220844,0.99611825,0.00046285315,0.0006173291,0.0001473763,0.0011912232,0.0002564129,0.00006472889,0.0010197507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744344,0.00033517572,0.0006090262,0.0009686707,0.00013126252,0.0005124021],"domain_scores_gemma":[0.9983677,0.00023111673,0.0002504682,0.00066204305,0.00001574474,0.00047290028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035097348,0.00053566776,0.0020966243,0.00034501695,0.000050251438,0.0000067178803,0.00014124908,0.00026064948,0.00011185235],"category_scores_gemma":[0.000056015902,0.00034058304,0.00045383122,0.00018124485,0.00010724077,0.000036594047,0.00014392418,0.0002028273,0.00033467147],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059425744,0.0002250037,0.0008468427,0.010248994,0.00036896276,0.00037277045,0.000009769358,8.161723e-9,4.2129937e-8,0.0008041404,0.0019541418,0.9851099],"study_design_scores_gemma":[0.0010960044,0.00005441579,0.008409489,0.019764211,0.0014050622,0.000009799626,0.000006597154,0.0000015676112,3.3321978e-8,0.0025375504,0.96642876,0.00028653955],"about_ca_topic_score_codex":0.000016240065,"about_ca_topic_score_gemma":0.0000016567406,"teacher_disagreement_score":0.98482335,"about_ca_system_score_codex":0.00019752872,"about_ca_system_score_gemma":0.0000702945,"threshold_uncertainty_score":0.99990463},"labels":[],"label_agreement":null},{"id":"W2490949941","doi":"10.1007/s40265-016-0624-x","title":"Erratum to: Psychosis in Parkinson’s Disease: Epidemiology, Pathophysiology, and Management","year":2016,"lang":"en","type":"erratum","venue":"Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Psychosis; Epidemiology; Disease; Pathophysiology; Pharmacotherapy; Parkinson's disease; Psychiatry; Intensive care medicine; Pathology","score_opus":0.019529352863979273,"score_gpt":0.3025946316710802,"score_spread":0.2830652788071009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490949941","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08258331,0.25347757,0.00056066085,0.10468523,0.12762687,0.022848075,0.0077999705,0.0015467429,0.39887157],"genre_scores_gemma":[0.09581758,0.18186913,0.004338603,0.034596637,0.0043196916,0.0052587446,0.003704798,0.00052113563,0.66957366],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671125,0.0002301432,0.000564333,0.0014071859,0.00026470653,0.00082239776],"domain_scores_gemma":[0.9977599,0.00010738517,0.00020282636,0.00093659956,0.000046571375,0.0009467158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037310645,0.0006425176,0.0012276464,0.0005166181,0.00008576805,0.000014064008,0.00021543584,0.00048204366,0.0001365057],"category_scores_gemma":[0.00012058854,0.00047935362,0.00025932153,0.00023761639,0.00011894807,0.00005163224,0.00025114475,0.00047423743,0.000356808],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005245703,0.00038092007,0.009668567,0.00061217236,0.00033490252,0.0006540436,0.00006818182,1.8535296e-7,0.000008631738,0.00043648522,0.9487965,0.038514815],"study_design_scores_gemma":[0.0015491212,0.00014242013,0.25442103,0.0015228668,0.0003583195,0.000003667855,0.000030375175,0.000012929768,0.0000012873052,0.0069256234,0.7346873,0.00034506604],"about_ca_topic_score_codex":0.000076688935,"about_ca_topic_score_gemma":0.000024318677,"teacher_disagreement_score":0.2707021,"about_ca_system_score_codex":0.0002740837,"about_ca_system_score_gemma":0.00011139632,"threshold_uncertainty_score":0.9997658},"labels":[],"label_agreement":null},{"id":"W2508060336","doi":"10.1007/s40265-016-0628-6","title":"Second-Line Treatment of Non-Small Cell Lung Cancer: New Developments for Tumours Not Harbouring Targetable Oncogenic Driver Mutations","year":2016,"lang":"en","type":"review","venue":"Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Ontario Clinical Oncology Group; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Cancer research; Oncology; Mutation; Cell culture; Pharmacotherapy; Cancer; Internal medicine; Gene; Biology; Genetics","score_opus":0.031521627619089235,"score_gpt":0.3615598605783705,"score_spread":0.33003823295928125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508060336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008111242,0.99028945,0.0004682903,0.00011640805,0.00058777,0.00397443,0.0017552597,0.00004529092,0.0019520033],"genre_scores_gemma":[0.00044193663,0.9325159,0.005604106,0.00005440066,0.0004585237,0.0016912255,0.0013431463,0.00012444827,0.05776628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980272,0.000024734369,0.00075314,0.0005353817,0.00020503877,0.00045452386],"domain_scores_gemma":[0.9984608,0.00016720966,0.0005562882,0.0003637898,0.00016736485,0.00028454047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006430837,0.0005274036,0.0016746214,0.00026889195,0.00013361308,0.000019720885,0.00013884762,0.00018395347,0.000514608],"category_scores_gemma":[0.000009841346,0.00036215901,0.00068013335,0.00021090398,0.00003340798,0.00007703868,0.000030109915,0.00009030637,0.0000502668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049168884,0.00057090266,0.00030289186,0.0149037205,0.0031674092,0.000023006949,0.0020933186,0.000009124905,0.00006305949,0.000023315491,0.0030502693,0.97574383],"study_design_scores_gemma":[0.0049907626,0.0002484941,0.00009481622,0.008574128,0.008756067,0.000008075368,0.00003905206,0.00001350003,0.0018182008,0.000009062899,0.97507775,0.00037010587],"about_ca_topic_score_codex":0.00029795,"about_ca_topic_score_gemma":0.00007379198,"teacher_disagreement_score":0.9753737,"about_ca_system_score_codex":0.0016592151,"about_ca_system_score_gemma":0.0050178985,"threshold_uncertainty_score":0.99988306},"labels":[],"label_agreement":null},{"id":"W2558544919","doi":"10.1007/s40265-016-0667-z","title":"Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia","year":2016,"lang":"en","type":"review","venue":"Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; Health Sciences Centre; University of Manitoba","funders":"","keywords":"Ketolide; Telithromycin; Streptococcus pneumoniae; Microbiology; Medicine; Biology; Pharmacology; Antibiotics","score_opus":0.09072066963484758,"score_gpt":0.3764393947325712,"score_spread":0.2857187250977236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558544919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005784308,0.9921362,0.00015258531,0.00050830696,0.0013455487,0.0033254852,0.0010045957,0.00007799694,0.0008708929],"genre_scores_gemma":[0.00014270029,0.9962703,0.00003203116,0.00008656374,0.0008906483,0.0009874976,0.00014866337,0.000079702964,0.0013618708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984902,0.00018072473,0.000662752,0.00019080691,0.00015768946,0.00031782294],"domain_scores_gemma":[0.9972633,0.0012226839,0.00039214152,0.0008881039,0.0001134623,0.000120291625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002300778,0.00043011492,0.0018557148,0.00014755741,0.00034934675,0.000018847832,0.00021199932,0.00029212006,0.00006805889],"category_scores_gemma":[0.000062876956,0.00020037801,0.0011729255,0.0001596367,0.00022183248,0.000034134013,0.000040928906,0.00015111745,0.000050003102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003739932,0.0008591965,0.000002776017,0.0052420646,0.0010435999,0.0000020165721,0.0006235402,3.4543874e-8,0.002011461,0.00007685873,0.00042049176,0.9896806],"study_design_scores_gemma":[0.001570289,0.0009795998,0.00003403136,0.004529892,0.002551211,0.00009737282,0.00007401643,8.0001706e-7,0.00008275918,0.000009177658,0.98988205,0.00018882118],"about_ca_topic_score_codex":0.00006401749,"about_ca_topic_score_gemma":0.000011376303,"teacher_disagreement_score":0.98949176,"about_ca_system_score_codex":0.00026891945,"about_ca_system_score_gemma":0.000499572,"threshold_uncertainty_score":0.8171178},"labels":[],"label_agreement":null},{"id":"W2570488703","doi":"10.1007/s40265-016-0685-x","title":"Genotype 3 Infection: The Last Stand of Hepatitis C Virus","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Hepatitis C virus research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences","keywords":"Steatosis; Medicine; Hepatocellular carcinoma; Hepatitis C virus; Cirrhosis; Microsomal triglyceride transfer protein; Hepatitis C; Genotype; Internal medicine; Virology; Gastroenterology; Immunology; Virus; Biology; Cholesterol; Genetics; Gene","score_opus":0.1354607030590377,"score_gpt":0.43468187803377967,"score_spread":0.299221174974742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570488703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007470594,0.9539077,0.000009161976,0.00006225831,0.00031073636,0.0009951098,0.00017847412,0.00002883791,0.04443297],"genre_scores_gemma":[0.00014009308,0.9952785,0.000027562397,0.000028104552,0.00049031404,0.000100824895,0.00007139408,0.00006218362,0.0038010303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813044,0.00021088167,0.0004959642,0.0002782244,0.00059895765,0.00028554222],"domain_scores_gemma":[0.99788684,0.00021738921,0.00036005778,0.0011868429,0.00022116202,0.00012773326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005742286,0.00025770615,0.0013860748,0.0001808169,0.00018252025,0.00004896167,0.0003171703,0.0002625284,0.0006584173],"category_scores_gemma":[0.0004685615,0.00015787475,0.0004277769,0.00022004276,0.00026407486,0.000054987115,0.00017289568,0.0006703791,0.0007660668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000056998388,0.000033860408,0.0006824986,0.010358382,0.00021351766,0.000033255626,0.00010292776,2.4560963e-8,4.4241477e-7,0.000053633303,0.006478971,0.98203677],"study_design_scores_gemma":[0.000190911,0.00010515681,0.0004772952,0.0070942044,0.00042961913,0.000024436142,0.0000016467761,0.000001911625,0.000006329552,0.000011119878,0.9915289,0.00012844097],"about_ca_topic_score_codex":0.004453195,"about_ca_topic_score_gemma":0.0012461683,"teacher_disagreement_score":0.98504996,"about_ca_system_score_codex":0.00017765723,"about_ca_system_score_gemma":0.001101177,"threshold_uncertainty_score":0.9846494},"labels":[],"label_agreement":null},{"id":"W2573216598","doi":"10.1007/s40265-017-0690-8","title":"Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Chimeric antigen receptor; Medicine; Immunotherapy; CD19; Cell therapy; Immunology; Lymphoma; Chronic lymphocytic leukemia; B cell; Cancer research; Clinical trial; T cell; Leukemia; Antigen; Oncology; Stem cell; Internal medicine; Immune system; Biology; Antibody","score_opus":0.15225248355467466,"score_gpt":0.40610138065618046,"score_spread":0.2538488971015058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573216598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034595453,0.98672205,0.0000022186332,0.00014788233,0.0004270382,0.0012362095,0.00025979598,0.000045080025,0.0077001695],"genre_scores_gemma":[0.00020649642,0.97885334,0.0005249958,0.000023127563,0.00047480894,0.00007750855,0.0006649536,0.00016066179,0.019014077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965591,0.0003903142,0.0009581715,0.00077299273,0.0006716276,0.00064781297],"domain_scores_gemma":[0.9971857,0.00042104776,0.00077945896,0.0012974517,0.0001246585,0.00019170372],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010181979,0.00052698085,0.003053017,0.00045538033,0.00009751887,0.000050983454,0.0007332276,0.0004896784,0.003206335],"category_scores_gemma":[0.00021359161,0.00044785265,0.00078935025,0.00039740693,0.00022553676,0.00006897914,0.00027345488,0.0010566968,0.00051208714],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050141687,0.00022022809,0.00008634125,0.010319764,0.0002150022,0.000049022827,0.0009780335,3.2691966e-7,0.040690243,0.0000047048716,0.003221155,0.94416505],"study_design_scores_gemma":[0.00082332874,0.00006937983,0.0000179171,0.011887444,0.00023368374,0.000002452245,0.00027952937,0.0000050366853,0.006152862,0.000014023147,0.98015636,0.00035796317],"about_ca_topic_score_codex":0.0015868768,"about_ca_topic_score_gemma":0.000018624909,"teacher_disagreement_score":0.9769352,"about_ca_system_score_codex":0.0002184319,"about_ca_system_score_gemma":0.00085198076,"threshold_uncertainty_score":0.99979734},"labels":[],"label_agreement":null},{"id":"W2589910009","doi":"10.1007/s40265-017-0693-5","title":"Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Drug; Inflammatory bowel disease; Therapeutic drug monitoring; Pharmacology; Immunogenicity; Monoclonal antibody; Antibody; Pharmacokinetics; Dosing; Immunology; Therapeutic index; Sensitization; Pharmacotherapy; Therapeutic approach; Disease; Internal medicine","score_opus":0.08333870628314687,"score_gpt":0.41256987934238293,"score_spread":0.32923117305923605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589910009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071861345,0.9969149,0.000009670601,0.00015232713,0.0003105326,0.00090274244,0.00006588152,0.000025027886,0.0009002967],"genre_scores_gemma":[0.0008103475,0.99696094,0.00038610818,0.00005784616,0.000023482995,0.00004772914,0.00007622744,0.000028445389,0.0016088991],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972697,0.000830006,0.0008621146,0.00056211016,0.00009486896,0.00038119708],"domain_scores_gemma":[0.9982568,0.0002819046,0.0007262592,0.00063647237,0.000050825103,0.000047709982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011256484,0.0004582856,0.0016219753,0.00025241196,0.00014622594,0.000052097195,0.00035648275,0.00039378376,0.000050984778],"category_scores_gemma":[0.00008126993,0.00033716613,0.00041573506,0.00011588837,0.0006768404,0.00016731839,0.0004464544,0.0005144114,0.0000297641],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004088608,0.00024787473,0.0019205216,0.049082354,0.0011257622,0.000093132134,0.000083798834,5.3635876e-8,0.000012604098,0.004718544,0.00047491805,0.9421995],"study_design_scores_gemma":[0.00045250077,0.00002849117,0.013026398,0.03556083,0.0018139434,0.000017258557,0.00008058471,0.0000024641079,0.0000147989085,0.0005448051,0.94799834,0.00045956945],"about_ca_topic_score_codex":0.0000083115,"about_ca_topic_score_gemma":0.0000068199984,"teacher_disagreement_score":0.9475234,"about_ca_system_score_codex":0.00004069832,"about_ca_system_score_gemma":0.00016186721,"threshold_uncertainty_score":0.99990803},"labels":[],"label_agreement":null},{"id":"W2590483831","doi":"10.1007/s40265-017-0712-6","title":"The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Pfizer","keywords":"Medicine; Heartburn; Intensive care medicine; Medical prescription; Proton-pump inhibitor; Internal medicine; Disease; Pharmacology; Reflux","score_opus":0.13534627224506862,"score_gpt":0.3962835822762063,"score_spread":0.2609373100311377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590483831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096656644,0.99200225,9.348955e-7,0.00020459034,0.00009247456,0.006536394,0.00012038259,0.000012755922,0.000063631705],"genre_scores_gemma":[0.00277847,0.9961564,0.00007410881,0.00013155959,0.000085557265,0.00037781228,0.000062317216,0.000043111482,0.00029067774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757904,0.00037727566,0.00097464374,0.00037119858,0.00044615055,0.0002516861],"domain_scores_gemma":[0.9964134,0.0006549253,0.0011689654,0.0013956621,0.00023832986,0.00012873438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010493316,0.00040036027,0.0019470898,0.000063274616,0.00015850678,0.000041906034,0.0002665079,0.0001640889,0.000017558603],"category_scores_gemma":[0.00082093,0.00018029578,0.00044230506,0.00010591801,0.00046362827,0.00009385177,0.000089669826,0.0003203024,0.000008720024],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000134056,0.00016641522,0.00062588206,0.123401865,0.0005680616,0.000062635496,0.000073759875,5.6215317e-8,7.267689e-7,0.000030161587,0.00027713287,0.87465924],"study_design_scores_gemma":[0.0011081429,0.0005351066,0.00052545534,0.21687347,0.0069134203,0.000063533225,0.000008223319,0.000005066057,0.000028292872,0.000014935959,0.77377784,0.00014653933],"about_ca_topic_score_codex":0.000081244565,"about_ca_topic_score_gemma":0.0000034824734,"teacher_disagreement_score":0.87451273,"about_ca_system_score_codex":0.0000715405,"about_ca_system_score_gemma":0.0004909516,"threshold_uncertainty_score":0.73522484},"labels":[],"label_agreement":null},{"id":"W2593485868","doi":"10.1007/s40265-017-0717-1","title":"The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; Pfizer","keywords":"Biosimilar; Medicine; Clinical trial; Terminology; Risk analysis (engineering); Intensive care medicine; Internal medicine","score_opus":0.09806852305771535,"score_gpt":0.36849101172204035,"score_spread":0.270422488664325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593485868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000044271114,0.99401575,0.000004084226,0.0003177706,0.00029565772,0.00025384783,0.00015126793,0.000019964671,0.0049372236],"genre_scores_gemma":[0.00006595623,0.9975688,0.0001619685,0.00007583801,0.000039856324,0.000024149625,0.00007856531,0.000017877317,0.001967032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861574,0.00043069953,0.00043974342,0.0002733236,0.00003517806,0.00020528956],"domain_scores_gemma":[0.9980306,0.00060542,0.0004761947,0.0008134845,0.000052781696,0.000021499704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008183816,0.00021733785,0.00081144937,0.00007114199,0.00036635494,0.000034416833,0.0004155644,0.0006207761,0.00006524892],"category_scores_gemma":[0.00028894952,0.0001247619,0.00025187826,0.00007312236,0.000834646,0.000026391535,0.00011713551,0.00043280888,0.00004798506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000038776234,0.000023283774,0.0000014709708,0.0010660214,0.0002544672,0.0000011912383,0.00006793334,4.6966925e-10,0.00003637059,0.016663792,0.006880315,0.9750013],"study_design_scores_gemma":[0.00010706425,0.000020771422,0.000029033015,0.0012652572,0.000540268,0.000027300295,0.00008727413,4.8408314e-8,0.00019672076,0.0007907465,0.9967913,0.00014422709],"about_ca_topic_score_codex":0.000009177495,"about_ca_topic_score_gemma":0.0000059515687,"teacher_disagreement_score":0.98991096,"about_ca_system_score_codex":0.00001757473,"about_ca_system_score_gemma":0.000118872944,"threshold_uncertainty_score":0.5087642},"labels":[],"label_agreement":null},{"id":"W2623416369","doi":"10.1007/s40265-017-0758-5","title":"A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Winnipeg Regional Health Authority","funders":"","keywords":"Sevelamer; Hyperphosphatemia; Medicine; Phosphate binder; Kidney disease; Calcium; Phosphate; Internal medicine; Endocrinology; Intensive care medicine; Biochemistry; Chemistry","score_opus":0.08931779627646652,"score_gpt":0.4222005470744976,"score_spread":0.3328827507980311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623416369","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008203544,0.9935015,7.837181e-8,0.00024899107,0.00020702458,0.003255033,0.00027186068,0.000025301251,0.0024820457],"genre_scores_gemma":[0.00006158638,0.99386925,0.000022427004,0.0004648461,0.00007899754,0.0006961001,0.0014502613,0.00006895375,0.003287571],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978841,0.00010971072,0.00074782624,0.00050268014,0.00036828913,0.00038738208],"domain_scores_gemma":[0.99792814,0.000029443005,0.00069321896,0.0008830582,0.00005137539,0.00041479085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002341864,0.0005074113,0.002397583,0.00015851884,0.000057756006,0.000019652425,0.00029948264,0.00015980049,0.00035536458],"category_scores_gemma":[0.000087558445,0.00032914136,0.0005311192,0.00025817417,0.00017755994,0.00008336324,0.00011616748,0.00026572973,0.00020272323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011609922,0.0006116521,0.00033935325,0.2539798,0.0005890185,0.00038301756,0.00002197554,4.8732525e-9,5.3139527e-8,0.00002990412,0.073423475,0.67050564],"study_design_scores_gemma":[0.002250605,0.00011027772,0.00008983337,0.2439619,0.002290633,0.000008133523,0.000004585357,6.9685984e-7,3.9062795e-7,0.0000013102109,0.75106776,0.000213891],"about_ca_topic_score_codex":0.0001001258,"about_ca_topic_score_gemma":0.000008297328,"teacher_disagreement_score":0.67764425,"about_ca_system_score_codex":0.0009358395,"about_ca_system_score_gemma":0.0027346318,"threshold_uncertainty_score":0.9999161},"labels":[],"label_agreement":null},{"id":"W2744053002","doi":"10.1007/s40265-017-0798-x","title":"Erratum to: A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Winnipeg Regional Health Authority","funders":"","keywords":"Medicine; Intensive care medicine; Pharmacotherapy; Kidney disease; Pharmacology; Internal medicine","score_opus":0.08011405828288129,"score_gpt":0.41797205663274545,"score_spread":0.3378579983498642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744053002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011927709,0.99051726,1.2716768e-7,0.0005334542,0.000364615,0.0041570207,0.0002884537,0.000027681199,0.004099476],"genre_scores_gemma":[0.00009649286,0.98924744,0.0000363304,0.00072159996,0.000089610316,0.000950563,0.0011861529,0.000076952376,0.0075948434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760085,0.00011101803,0.0007859393,0.00058660854,0.0004621426,0.0004534255],"domain_scores_gemma":[0.9977334,0.000026096417,0.0005744672,0.0009792645,0.00006375767,0.0006229895],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024977437,0.00055619614,0.002490863,0.00019890185,0.000063964995,0.000025965515,0.00035112505,0.00016703551,0.00027427232],"category_scores_gemma":[0.00012051195,0.0003697395,0.00049789425,0.00037021286,0.00012748937,0.00008206306,0.00015115541,0.00029184256,0.0002877528],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017458056,0.00070327043,0.00029209477,0.1897916,0.0006125148,0.0005070897,0.000044669585,1.307445e-8,1.5332263e-7,0.000031540952,0.2612778,0.54656464],"study_design_scores_gemma":[0.0018537971,0.00017189313,0.00014686653,0.21610299,0.0018969388,0.0000072675284,0.0000065438585,5.3449685e-7,5.629687e-7,0.0000016226574,0.7795522,0.00025878273],"about_ca_topic_score_codex":0.00009885555,"about_ca_topic_score_gemma":0.000013755117,"teacher_disagreement_score":0.5463059,"about_ca_system_score_codex":0.0010212556,"about_ca_system_score_gemma":0.002903287,"threshold_uncertainty_score":0.9998754},"labels":[],"label_agreement":null},{"id":"W2749275095","doi":"10.1007/s40265-017-0796-z","title":"Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Antibody; Lymphoma; Immune system; Immunology; Cancer research; Antibody therapy; Clinical trial; Tumor microenvironment; Monoclonal antibody; Oncology; Internal medicine","score_opus":0.10697743891577456,"score_gpt":0.4122133735040457,"score_spread":0.30523593458827114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749275095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011209801,0.96865934,2.3890416e-7,0.0002701609,0.00021712646,0.0010709438,0.000041660485,0.000060469367,0.0285591],"genre_scores_gemma":[0.013193582,0.98320085,0.000017858503,0.00016722397,0.000277614,0.00023424222,0.00020841774,0.00007817459,0.0026220514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976516,0.00014968522,0.0006400651,0.0006696802,0.0003766338,0.000512359],"domain_scores_gemma":[0.99822134,0.00021179412,0.0003598614,0.00097432284,0.000043696724,0.00018900816],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020889117,0.000640165,0.003017807,0.00029033716,0.00011497541,0.00012807247,0.00029771827,0.00048125163,0.0001252416],"category_scores_gemma":[0.000047863992,0.00042518668,0.00076144387,0.00015767271,0.00017251141,0.00007777739,0.00009814156,0.00021251646,0.0009695565],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015412932,0.00081099087,0.00065560004,0.0038081463,0.00048458908,0.0011011319,0.00008650127,4.1363712e-8,1.8603963e-7,0.0009623052,0.0008077604,0.9912673],"study_design_scores_gemma":[0.0021168012,0.0002195526,0.0072793197,0.014527089,0.0015291204,0.00032103067,0.00004452353,0.000003935351,0.000004876086,0.000116244686,0.97345513,0.00038239942],"about_ca_topic_score_codex":0.0002710439,"about_ca_topic_score_gemma":0.000023195249,"teacher_disagreement_score":0.99088496,"about_ca_system_score_codex":0.00048583915,"about_ca_system_score_gemma":0.0012215215,"threshold_uncertainty_score":0.99982},"labels":[],"label_agreement":null},{"id":"W2751007471","doi":"10.1007/s40265-017-0804-3","title":"Clinical Assessment and Management of Delirium in the Palliative Care Setting","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Bruyère; University of Ottawa","funders":"","keywords":"Delirium; Medicine; Palliative care; Intensive care medicine; Neurocognitive; Distress; Population; Sedation; Psychiatry; Nursing; Cognition; Anesthesia; Clinical psychology","score_opus":0.1358180847303014,"score_gpt":0.5052551552721194,"score_spread":0.36943707054181796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751007471","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005971124,0.96545756,0.000014287252,0.00050921686,0.00016800231,0.001790799,0.0000450026,0.0000065550144,0.03194887],"genre_scores_gemma":[0.0005754066,0.9960639,0.0003761072,0.0024396335,0.0000698841,0.00011177748,0.00022794837,0.000026754347,0.00010860888],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982848,0.00031880892,0.00061532157,0.00032550667,0.00027463658,0.0001808958],"domain_scores_gemma":[0.99642456,0.0004764956,0.00046264898,0.0004596219,0.0021374277,0.000039235816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070373336,0.00024269783,0.0011912192,0.000117006726,0.00005477321,0.00001750084,0.00021152403,0.0001643937,0.000008595607],"category_scores_gemma":[0.00072136964,0.00015297197,0.0003483099,0.00008195004,0.00018963104,0.000019506968,0.00014767134,0.00061134173,0.000007081357],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064191613,0.000035278965,0.0009260694,0.023056641,0.00029613925,0.00010894549,0.0009708653,8.1087865e-9,4.555659e-9,0.00021477329,0.001171159,0.9732137],"study_design_scores_gemma":[0.0008006742,0.000121103105,0.009668372,0.052019298,0.0020613302,0.0000046922773,0.042677518,0.000002057451,6.391575e-8,0.00001631935,0.89245063,0.00017793816],"about_ca_topic_score_codex":0.000013888819,"about_ca_topic_score_gemma":0.0000071271497,"teacher_disagreement_score":0.97303575,"about_ca_system_score_codex":0.0000926251,"about_ca_system_score_gemma":0.00019330696,"threshold_uncertainty_score":0.6238016},"labels":[],"label_agreement":null},{"id":"W2751789708","doi":"10.1007/s40265-017-0807-0","title":"Pharmacological Management of Gestational Diabetes Mellitus","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Glycemic; Gestational diabetes; Hypoglycemia; Metformin; Insulin; Incretin; Fetal macrosomia; Pregnancy; Insulin glargine; Postprandial; Diabetes mellitus; Neonatal hypoglycemia; Insulin lispro; Intensive care medicine; Type 2 diabetes; Internal medicine; Endocrinology; Gestation","score_opus":0.11394671550315888,"score_gpt":0.4370689747843489,"score_spread":0.32312225928119004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751789708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002649596,0.96931916,0.00000841949,0.00012663913,0.000121861114,0.0012960829,0.00010402465,0.00002471792,0.028972624],"genre_scores_gemma":[0.00006447099,0.9899463,0.0010665919,0.00005754607,0.00009160842,0.0003583243,0.0008261466,0.000025724004,0.0075632795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816114,0.00007466042,0.00044092027,0.00032469747,0.000655649,0.0003429081],"domain_scores_gemma":[0.99891436,0.00015977498,0.00028977776,0.00034238058,0.000117648146,0.00017607409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034841624,0.00024165929,0.0010383092,0.00020997306,0.00006907985,0.000026440082,0.0003009809,0.00009970075,0.0005740522],"category_scores_gemma":[0.00003759879,0.0001794466,0.0004017733,0.00011034587,0.00013852268,0.000046920897,0.00020431324,0.0002343622,0.00028872408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000066295606,0.00016441413,0.0000063967627,0.051152106,0.0012089361,0.00005592118,0.000009432202,3.7292546e-7,2.994132e-7,0.0027470652,0.0047648116,0.9398836],"study_design_scores_gemma":[0.0004597471,0.00008686505,0.0003342826,0.0075021195,0.0017839309,0.0000012038083,0.000014224661,0.000009977988,0.0000030868632,0.00021052676,0.98945284,0.0001412138],"about_ca_topic_score_codex":0.0000019433116,"about_ca_topic_score_gemma":6.82803e-8,"teacher_disagreement_score":0.984688,"about_ca_system_score_codex":0.00009583972,"about_ca_system_score_gemma":0.000137565,"threshold_uncertainty_score":0.73176193},"labels":[],"label_agreement":null},{"id":"W2768181348","doi":"10.1007/s40265-017-0830-1","title":"Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"NHLBI Division of Intramural Research; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Battelle","keywords":"Medicine; Drug repositioning; Intensive care medicine; Repurposing; Middle East respiratory syndrome coronavirus; Middle East respiratory syndrome; Clinical trial; Context (archaeology); Drug development; Drug; Coronavirus; Coronavirus disease 2019 (COVID-19); Pharmacology; Infectious disease (medical specialty); Disease; Pathology","score_opus":0.1819002405095236,"score_gpt":0.40881700471606247,"score_spread":0.22691676420653886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768181348","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004159666,0.991466,0.0000942853,0.00009031247,0.0005202231,0.0028135453,0.00063352514,0.00008596909,0.00013646949],"genre_scores_gemma":[0.0014002285,0.9916235,0.0001837249,0.0042692963,0.0005091794,0.0013325867,0.00008315059,0.00026248037,0.00033580864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689835,0.00016382395,0.00067728455,0.0009728286,0.0005942649,0.0006934733],"domain_scores_gemma":[0.9979666,0.00019366032,0.00039686044,0.0010512419,0.00022083928,0.00017080373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000830657,0.00070439297,0.0020031093,0.0005417535,0.0005818243,0.00022612177,0.00045893362,0.0004954822,0.0000125265715],"category_scores_gemma":[0.00008323533,0.0005515773,0.0005517213,0.00018988934,0.0005048078,0.00021269411,0.00027806524,0.0008733797,0.000043069515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015500357,0.00035003253,0.00008442106,0.026337672,0.0020608406,0.00031908453,0.00055585324,2.9234998e-8,0.00015175654,0.00025617803,0.00061524694,0.9691139],"study_design_scores_gemma":[0.0019476776,0.000497104,0.00023711893,0.007160687,0.0017946202,0.001463053,0.000082557766,0.000008268892,0.000005005509,0.000090657224,0.9861566,0.0005566794],"about_ca_topic_score_codex":0.000010247473,"about_ca_topic_score_gemma":0.0000032187154,"teacher_disagreement_score":0.98554134,"about_ca_system_score_codex":0.00016880716,"about_ca_system_score_gemma":0.001079388,"threshold_uncertainty_score":0.9996936},"labels":[],"label_agreement":null},{"id":"W2775239537","doi":"10.1007/s40265-017-0851-9","title":"Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":374,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Diagnostic Services Manitoba; University of Manitoba","funders":"","keywords":"Acinetobacter baumannii; Klebsiella pneumoniae; Imipenem; Microbiology; Medicine; Enterobacteriaceae; Meropenem; Pseudomonas aeruginosa; Avibactam; Stenotrophomonas maltophilia; Carbapenem; Biology; Antibiotics; Antibiotic resistance; Escherichia coli; Bacteria; Biochemistry; Genetics","score_opus":0.04268241867347237,"score_gpt":0.355640474932519,"score_spread":0.3129580562590466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775239537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004194881,0.9872466,0.000041677707,0.000086666216,0.00088418974,0.0009962721,0.0004103629,0.000036445537,0.0061029512],"genre_scores_gemma":[0.0064423275,0.9856335,0.0005806271,0.000077053344,0.00071501546,0.000070546084,0.0014577452,0.00017005228,0.004853142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971936,0.00013887136,0.0007436638,0.0010936093,0.00027616735,0.0005541009],"domain_scores_gemma":[0.9970329,0.00006619519,0.00084006914,0.0016333417,0.0001704949,0.00025704323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003505044,0.0007821125,0.0014611549,0.00013311123,0.00040131155,0.0003312618,0.0008952134,0.00063541776,0.000044132074],"category_scores_gemma":[0.00022989367,0.0007077337,0.0004303903,0.00011020282,0.00039588014,0.000020374222,0.0006086418,0.00039103866,0.000077973295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006495543,0.00059115153,0.00009446895,0.008101425,0.0009491113,0.000041802443,0.00009602317,5.353199e-7,0.007842869,0.0014864632,0.009318002,0.9714132],"study_design_scores_gemma":[0.0010354053,0.00008282799,0.00008140334,0.0022869727,0.000498835,0.00006016863,0.000026958154,0.000002221884,0.00039891133,0.000016995651,0.9946956,0.0008136834],"about_ca_topic_score_codex":0.000070275266,"about_ca_topic_score_gemma":0.00005958696,"teacher_disagreement_score":0.9853776,"about_ca_system_score_codex":0.000071485025,"about_ca_system_score_gemma":0.0004965985,"threshold_uncertainty_score":0.99953735},"labels":[],"label_agreement":null},{"id":"W2795962307","doi":"10.1007/s40265-018-0898-2","title":"Role of Methotrexate in the Management of Psoriatic Arthritis","year":2018,"lang":"en","type":"review","venue":"Drugs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Methotrexate; Psoriasis; Rheumatoid arthritis; Arthritis; Placebo-controlled study; Enthesitis; Internal medicine; Placebo; Dermatology; Pathology; Alternative medicine","score_opus":0.02660489395612581,"score_gpt":0.34112442539587745,"score_spread":0.31451953143975164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795962307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020824667,0.98755306,0.0000023542925,0.000029238121,0.00004403715,0.0009088851,0.000022932554,0.000006648876,0.0112245735],"genre_scores_gemma":[0.0004356347,0.99867296,0.00050860876,0.000011267134,0.00004412198,0.000116581854,0.000032447493,0.000022014969,0.00015637926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983267,0.00027338858,0.0005796478,0.00017751422,0.00042984297,0.00021286799],"domain_scores_gemma":[0.99906355,0.00014068864,0.0002169265,0.00048563536,0.000051695806,0.000041521205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009085202,0.00016547518,0.0011566222,0.00019801916,0.000018033094,0.000008190224,0.0002599575,0.000076056655,0.00014914804],"category_scores_gemma":[0.000026352618,0.00010068095,0.00029356644,0.0003573767,0.0001404064,0.000025345384,0.00006106718,0.00019525384,0.00005828519],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000113338065,0.00008479365,0.0000018618996,0.010630881,0.0003043287,0.00001753955,0.00077855313,9.501536e-9,4.5238298e-7,0.0015996775,0.00023102193,0.98633957],"study_design_scores_gemma":[0.000632589,0.00013056368,0.000024923973,0.046532456,0.000061020604,0.000024712634,0.0006212852,0.0000014953332,0.000009662405,0.0008304299,0.95105416,0.000076723845],"about_ca_topic_score_codex":0.00005124563,"about_ca_topic_score_gemma":0.000009059701,"teacher_disagreement_score":0.9862628,"about_ca_system_score_codex":0.000019167617,"about_ca_system_score_gemma":0.000076384575,"threshold_uncertainty_score":0.410565},"labels":[],"label_agreement":null},{"id":"W2802609592","doi":"10.1007/s40265-018-0910-x","title":"Correction to: Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations","year":2018,"lang":"en","type":"erratum","venue":"Drugs","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Diagnostic Services Manitoba; University of Manitoba","funders":"","keywords":"Meropenem; Medicine; Heading (navigation); Microbiology; Biology; Antibiotics; Geography; Antibiotic resistance","score_opus":0.01253244302557519,"score_gpt":0.3019576257687935,"score_spread":0.28942518274321827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802609592","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1778527,0.0023457105,0.00084868906,0.016476588,0.26776096,0.0057509365,0.0007798791,0.00088491384,0.52729964],"genre_scores_gemma":[0.51283604,0.0012965446,0.0009757447,0.0032598367,0.008275081,0.000039062616,0.0021612465,0.00032540134,0.47083107],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969427,0.00005376316,0.0006552728,0.0009755533,0.0007087118,0.0006639839],"domain_scores_gemma":[0.9973784,0.00015422782,0.0003207027,0.0007281606,0.00068491104,0.00073359394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032036632,0.00068912265,0.0009195036,0.0005028064,0.00032605708,0.00017909214,0.00027088897,0.00043959136,0.00043027787],"category_scores_gemma":[0.0003242182,0.0006687243,0.00020938671,0.0005830918,0.00023853217,0.0001175807,0.00032235516,0.0013483864,0.0004276163],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015516223,0.00066285545,0.000075524804,0.0001937776,0.00017947727,0.000025749094,0.0005021397,0.0000043048567,0.008780782,0.00015441714,0.9849895,0.0042762957],"study_design_scores_gemma":[0.0062274905,0.0008408746,0.0047110724,0.0014236426,0.0010550376,0.00012308835,0.00024151096,0.0038917286,0.0051499624,0.000023992488,0.975285,0.0010266115],"about_ca_topic_score_codex":0.00047356734,"about_ca_topic_score_gemma":0.00010399715,"teacher_disagreement_score":0.33498332,"about_ca_system_score_codex":0.00024022296,"about_ca_system_score_gemma":0.000503573,"threshold_uncertainty_score":0.9995764},"labels":[],"label_agreement":null},{"id":"W2888994582","doi":"10.1007/s40265-018-0971-x","title":"Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology","year":2018,"lang":"en","type":"review","venue":"Drugs","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunology; Medicine; Innate immune system; Unfolded protein response; Tumor necrosis factor alpha; Inflammation; Immune system; Endoplasmic reticulum; Biology; Cell biology","score_opus":0.010830699091991974,"score_gpt":0.2610095401965357,"score_spread":0.25017884110454375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888994582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02627289,0.96994984,0.000011012959,0.0003795197,0.00034483502,0.0026762646,0.0002364443,0.00003259426,0.00009660572],"genre_scores_gemma":[0.0027254075,0.9944959,0.0004753424,0.00027690252,0.0008346738,0.00032459514,0.00055565196,0.00007738852,0.00023411354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868006,0.00006676022,0.0003343992,0.00048471068,0.0001331748,0.0003009293],"domain_scores_gemma":[0.99909955,0.00020643589,0.00019023246,0.0002627495,0.00010978895,0.00013123642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010205958,0.00041989295,0.0010487742,0.000112061345,0.00031205823,0.00003236728,0.0000591592,0.00016614956,0.000016123462],"category_scores_gemma":[0.00005439186,0.0002187982,0.00014759057,0.0001828442,0.00014592553,0.0000602872,0.000088413864,0.00014901852,0.000009776399],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018844628,0.000051940755,0.00016452247,0.0006148204,0.00036236367,0.000003166529,0.0023756288,1.197771e-8,0.0000010206915,0.00005914636,0.0026195694,0.99355936],"study_design_scores_gemma":[0.0033284395,0.002020252,0.0014190624,0.0039814757,0.000547698,0.000015453923,0.00027906685,6.1234715e-7,0.0000017392132,0.0006048485,0.9875108,0.00029055245],"about_ca_topic_score_codex":0.000030283596,"about_ca_topic_score_gemma":0.000019616371,"teacher_disagreement_score":0.9932688,"about_ca_system_score_codex":0.00004186779,"about_ca_system_score_gemma":0.00007735197,"threshold_uncertainty_score":0.8922332},"labels":[],"label_agreement":null},{"id":"W2889874928","doi":"10.1007/s40265-018-0977-4","title":"Elagolix: First Global Approval","year":2018,"lang":"en","type":"review","venue":"Drugs","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endometriosis; Hormone antagonist; Clinical trial; Gonadotropin-releasing hormone; Pharmacotherapy; Hormone; Pharmacology; Internal medicine; Luteinizing hormone; Endocrine system","score_opus":0.060296668668761516,"score_gpt":0.4022300389948175,"score_spread":0.341933370326056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889874928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000043628706,0.9464745,0.0000050259723,0.00009665916,0.00019194328,0.0013099671,0.00012922946,0.00007368317,0.051714636],"genre_scores_gemma":[0.00001474911,0.9946617,0.00034499558,0.000048585916,0.0007924342,0.00024507544,0.0003718234,0.000040020055,0.0034806214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802786,0.00007277949,0.0003738823,0.00046078683,0.0005743628,0.00049032544],"domain_scores_gemma":[0.9984394,0.00034563872,0.00012012883,0.0006120073,0.0000931658,0.00038970797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022787302,0.0003657658,0.0015256411,0.00018894419,0.0000813422,0.00003483672,0.00020190288,0.00025204883,0.00039264024],"category_scores_gemma":[0.00063058286,0.00023379356,0.00076395384,0.00078152184,0.00011099573,0.000028037071,0.00013014104,0.00027658392,0.0044959686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017123371,0.00021414149,0.00001484631,0.013351337,0.00060128927,0.00015524022,0.000017148961,2.1812079e-9,2.452567e-9,0.00013404354,0.023822377,0.9616724],"study_design_scores_gemma":[0.00078014797,0.0002939028,0.000006062068,0.006540566,0.0008494059,0.00021060163,0.0000076263054,5.791838e-7,4.942818e-7,0.000022246759,0.9911232,0.00016515816],"about_ca_topic_score_codex":0.00005753046,"about_ca_topic_score_gemma":0.00001144159,"teacher_disagreement_score":0.96730083,"about_ca_system_score_codex":0.0006038212,"about_ca_system_score_gemma":0.0005246161,"threshold_uncertainty_score":0.9962791},"labels":[],"label_agreement":null},{"id":"W2892402399","doi":"10.1007/s40265-018-0975-6","title":"Human Papillomavirus Vaccines: Successes and Future Challenges","year":2018,"lang":"en","type":"review","venue":"Drugs","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Royal Victoria Hospital; Jewish General Hospital","funders":"","keywords":"Medicine; Human papillomavirus; Pharmacotherapy; Virology; Intensive care medicine; Internal medicine","score_opus":0.0839744224305002,"score_gpt":0.4185726180101321,"score_spread":0.33459819557963194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892402399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000066543935,0.9269367,7.4485264e-8,0.00070973125,0.00018432835,0.0005333492,0.000021622947,0.000059519767,0.071548015],"genre_scores_gemma":[0.000024000963,0.9912028,0.000011227446,0.00010729612,0.0064277994,0.00009057459,0.00008178464,0.00006545219,0.001989073],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983781,0.00007582831,0.0003377999,0.0005140355,0.00035583286,0.00033837822],"domain_scores_gemma":[0.9989058,0.00007732577,0.00009392805,0.0005030287,0.00015609505,0.00026386886],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023287292,0.00034399104,0.0014884897,0.00018185671,0.00011887482,0.00004172646,0.00019555227,0.0003576694,0.0034667507],"category_scores_gemma":[0.000024494462,0.00022704294,0.00025258152,0.00020284802,0.00009195875,0.000044858207,0.00015797607,0.00051094894,0.00019511774],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009783267,0.00003658411,0.0000024573258,0.049657255,0.00011154581,0.00002374277,0.00014696157,1.0691407e-10,4.384545e-8,0.00045838914,0.0036716429,0.9458816],"study_design_scores_gemma":[0.00043048002,0.00018869566,0.00024917128,0.0022375204,0.0005089457,0.00004813478,0.00014248693,6.091679e-8,6.138708e-7,0.00008438972,0.9958874,0.0002220763],"about_ca_topic_score_codex":0.00005850347,"about_ca_topic_score_gemma":0.000059962047,"teacher_disagreement_score":0.99221575,"about_ca_system_score_codex":0.00007119085,"about_ca_system_score_gemma":0.000187273,"threshold_uncertainty_score":0.9974442},"labels":[],"label_agreement":null},{"id":"W2906917595","doi":"10.1007/s40265-018-1032-1","title":"Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancer","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Nivolumab; Medicine; Pembrolizumab; Immune checkpoint; Blockade; Cancer; Oncology; Ipilimumab; Internal medicine; Atezolizumab; Immunotherapy; Microsatellite instability; Chemotherapy","score_opus":0.03974246553099459,"score_gpt":0.3481894594858245,"score_spread":0.30844699395482994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906917595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008225032,0.9959686,1.2850975e-7,0.00013734763,0.00043043334,0.0015086252,0.000056808494,0.000009209491,0.001066385],"genre_scores_gemma":[0.0004880388,0.99760264,0.00001152599,0.000053152846,0.00028313685,0.0002836294,0.00009231083,0.00003341322,0.0011521676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985062,0.00009885595,0.0007015337,0.00023672369,0.00023378828,0.00022290862],"domain_scores_gemma":[0.9990461,0.00008031479,0.00032327618,0.0005014419,0.00002185288,0.000027011421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024534718,0.00030019318,0.0014639924,0.00015087353,0.000017432472,0.000008189452,0.00014770913,0.0001527582,0.00015808306],"category_scores_gemma":[0.0000038522403,0.00015420362,0.0009261345,0.00032132532,0.0000741029,0.000017989272,0.000011436749,0.00016866197,0.0000253632],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013232788,0.0002758242,0.00003877275,0.005201685,0.00031355655,0.000017146753,0.0012932535,8.674527e-8,0.000012687872,0.00000307986,0.00020115638,0.99251044],"study_design_scores_gemma":[0.0015729637,0.0005120991,0.00018359652,0.009165459,0.0007816395,0.00002396007,0.00015828462,3.562569e-7,0.000094113064,0.0000011969373,0.98739827,0.000108063985],"about_ca_topic_score_codex":0.0010424341,"about_ca_topic_score_gemma":0.00002589411,"teacher_disagreement_score":0.9924024,"about_ca_system_score_codex":0.00048776262,"about_ca_system_score_gemma":0.00043192194,"threshold_uncertainty_score":0.6288241},"labels":[],"label_agreement":null},{"id":"W2912739876","doi":"10.1007/s40265-018-1024-1","title":"l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Merz Pharmaceuticals; King's College London; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Medicine; Hepatic encephalopathy; Randomized controlled trial; Cirrhosis; Internal medicine; Portosystemic shunt; Portal hypertension; Meta-analysis; Transjugular intrahepatic portosystemic shunt; Concomitant; Lactulose; Gastroenterology; Intensive care medicine","score_opus":0.2483490198769808,"score_gpt":0.4534745076328866,"score_spread":0.2051254877559058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912739876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012820697,0.9857993,0.00007563253,0.00007020634,0.00010491202,0.012414133,0.0010105845,0.000016536904,0.0003804508],"genre_scores_gemma":[0.003619675,0.9916637,0.00017796429,0.00005689098,0.000076919605,0.0025294155,0.0011734279,0.000034606837,0.00066743256],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99302256,0.0022775452,0.0036902737,0.00044253634,0.00036637322,0.00020068874],"domain_scores_gemma":[0.98424864,0.012921707,0.0022086373,0.00033674677,0.00018293524,0.000101319674],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0091346055,0.0004597655,0.027700007,0.0005454724,0.000021192565,0.000021291498,0.0000943131,0.00019605432,0.000039750084],"category_scores_gemma":[0.0022174811,0.00023410052,0.0052641802,0.00022235514,0.000069558824,0.000071372146,0.000010973984,0.0001640779,0.000010202706],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5246653,0.00035832333,0.0000071414743,0.14458875,0.257925,0.000038987357,0.0030537406,0.000007957752,0.000013653621,0.00017125582,0.00015118875,0.0690187],"study_design_scores_gemma":[0.36556238,0.0000847736,0.0000018646192,0.0045416765,0.6241847,0.0000030106855,0.000038012233,0.00006399698,0.0000183736,0.000100061705,0.005232493,0.00016858728],"about_ca_topic_score_codex":0.00011381522,"about_ca_topic_score_gemma":0.00000730266,"teacher_disagreement_score":0.36625975,"about_ca_system_score_codex":0.000025601788,"about_ca_system_score_gemma":0.0003264581,"threshold_uncertainty_score":0.9867348},"labels":[],"label_agreement":null},{"id":"W2912906332","doi":"10.1007/s40265-019-1055-2","title":"Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":429,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"","keywords":"Cephalosporin; Siderophore; Microbiology; Bacilli; Carbapenem; Multiple drug resistance; Medicine; Gram; Drug resistance; Pharmacotherapy; Antibiotics; Biology; Bacteria; Internal medicine","score_opus":0.02029146034473697,"score_gpt":0.281665191329291,"score_spread":0.2613737309845541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912906332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08321029,0.9108536,0.000037228743,0.000025813917,0.00027458204,0.0027780293,0.0005706947,0.000052550375,0.0021971771],"genre_scores_gemma":[0.035554063,0.96014416,0.00091352407,0.0000661218,0.00026830097,0.00014070593,0.00054260116,0.00024427936,0.002126219],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605745,0.00033636088,0.0007005834,0.0016742806,0.00045735892,0.00077394815],"domain_scores_gemma":[0.99718493,0.00015184825,0.0008283073,0.0013801417,0.0001787625,0.0002760372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028058363,0.0011648152,0.0021251864,0.00013640102,0.00019184874,0.00015551833,0.00054905977,0.0007770121,0.00001969099],"category_scores_gemma":[0.0001109171,0.0008964518,0.00047034334,0.0002832137,0.00045185102,0.000016398599,0.00037985624,0.00052678934,0.000045902656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024623624,0.00061415305,0.0003030338,0.038680676,0.0033757028,0.00037715782,0.0005815347,0.000008464054,0.034391273,0.00020014684,0.001730338,0.91727513],"study_design_scores_gemma":[0.0011960164,0.0005822992,0.00042184553,0.0064296084,0.00084390736,0.000031873184,0.00030149697,0.0000052076325,0.0021767132,0.000012760351,0.9863127,0.0016855611],"about_ca_topic_score_codex":0.0001478316,"about_ca_topic_score_gemma":0.00028267523,"teacher_disagreement_score":0.98458236,"about_ca_system_score_codex":0.00016578787,"about_ca_system_score_gemma":0.00068727485,"threshold_uncertainty_score":0.99934864},"labels":[],"label_agreement":null},{"id":"W2913170138","doi":"10.1007/s40265-018-1021-4","title":"l-Ornithine l-Aspartate (LOLA) for the Treatment of Hepatic Encephalopathy in Cirrhosis: Novel Insights and Translation to the Clinic","year":2019,"lang":"en","type":"editorial","venue":"Drugs","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cirrhosis; Hepatic encephalopathy; Pharmacotherapy; Translation (biology); Pharmacology; Encephalopathy; Internal medicine; Gastroenterology; Biochemistry; Chemistry","score_opus":0.019951941008156737,"score_gpt":0.2967060380770968,"score_spread":0.27675409706894005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913170138","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4220318,0.019883106,0.0018336654,0.003012166,0.53552604,0.0143962875,0.0026172241,0.00006673665,0.0006330104],"genre_scores_gemma":[0.7679606,0.0194541,0.0002394552,0.00022852683,0.20750098,0.0010802244,0.0023952557,0.00007896928,0.0010618704],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989096,0.000039324324,0.00034873508,0.00025671965,0.00031264033,0.00013300825],"domain_scores_gemma":[0.9977871,0.0016803576,0.00012390527,0.00025736587,0.00009891702,0.000052342075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001889245,0.00018576976,0.00037126237,0.00009861553,0.00005098488,0.000013722604,0.000081220736,0.00016772645,0.000006977219],"category_scores_gemma":[0.000021867032,0.00009795451,0.00011838691,0.00012525279,0.000033328935,0.00004747817,0.0000034920072,0.00012650267,0.000013561947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028094761,0.004915821,0.011010153,0.010646515,0.006807009,0.00003894501,0.622713,0.0004979439,0.002047965,0.00017159455,0.14003848,0.17301777],"study_design_scores_gemma":[0.024820978,0.0047898344,0.022798328,0.002411628,0.010295927,0.0000018290548,0.0020594092,0.0022743242,0.001052967,0.00020668938,0.92872983,0.0005582259],"about_ca_topic_score_codex":0.00025646,"about_ca_topic_score_gemma":0.00028123838,"teacher_disagreement_score":0.7886914,"about_ca_system_score_codex":0.0000490113,"about_ca_system_score_gemma":0.00020247774,"threshold_uncertainty_score":0.39944687},"labels":[],"label_agreement":null},{"id":"W2914015239","doi":"10.1007/s40265-018-1017-0","title":"Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Astrocytosis; Basal ganglia; Medicine; Hepatic encephalopathy; Neuroinflammation; Neuroscience; Pathophysiology; Cirrhosis; Pathology; Neuropathology; Central nervous system; Internal medicine; Inflammation; Biology","score_opus":0.0241786274564175,"score_gpt":0.31176151096361937,"score_spread":0.28758288350720185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914015239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052872263,0.993327,0.0000024268593,0.000023935303,0.00016244757,0.00068693596,0.00005166664,0.000021309763,0.000437009],"genre_scores_gemma":[0.0031465022,0.9958508,0.000029575001,0.00022095833,0.00007918161,0.00010738136,0.00043430598,0.000025597614,0.000105705854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988768,0.00016263359,0.0003186318,0.00036479678,0.00008557885,0.00019155242],"domain_scores_gemma":[0.99945277,0.00012675782,0.00010262726,0.00022811696,0.000017768847,0.00007197166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010366507,0.00021818478,0.0011937491,0.00020528016,0.000014221206,0.0000050969243,0.00005796701,0.00024095112,0.000028409655],"category_scores_gemma":[0.000006521764,0.00017008823,0.00015051784,0.00013952954,0.00004806647,0.000037135494,0.000021820557,0.00024358692,0.00021298809],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028988597,0.00007600864,0.0005742535,0.047551427,0.00011753167,0.0008711823,0.0009177271,3.735288e-8,0.000004713539,0.00013420657,0.000014403468,0.94970953],"study_design_scores_gemma":[0.01060573,0.002052189,0.022241076,0.16411088,0.046528,0.0023457122,0.00072314835,0.00007710252,0.000010920169,0.003867399,0.74438745,0.0030503613],"about_ca_topic_score_codex":0.000021876518,"about_ca_topic_score_gemma":0.000002131331,"teacher_disagreement_score":0.94665915,"about_ca_system_score_codex":0.000035944086,"about_ca_system_score_gemma":0.00017442212,"threshold_uncertainty_score":0.6935997},"labels":[],"label_agreement":null},{"id":"W2914471002","doi":"10.1007/s40265-019-1065-0","title":"Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital","funders":"","keywords":"Myasthenia gravis; Medicine; Immunology; Rituximab; Autoantibody; Immunopathology; Eculizumab; Autoimmune disease; Antibody; Complement system","score_opus":0.024503490715655232,"score_gpt":0.3147896148112093,"score_spread":0.2902861240955541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914471002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02444637,0.97118664,0.0000010954025,0.000023589624,0.0008825106,0.002531075,0.00018605523,0.00019241309,0.0005502557],"genre_scores_gemma":[0.000731276,0.99673975,0.000119132244,0.000051305622,0.00018007183,0.00021929701,0.0009567774,0.00016127239,0.0008411159],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964688,0.00046788005,0.0010175068,0.0008343566,0.0004353214,0.00077616767],"domain_scores_gemma":[0.998118,0.0002498402,0.00043964424,0.0008567524,0.00007099994,0.0002647679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039975593,0.00092389097,0.0036580295,0.0006199062,0.00006566843,0.00007943842,0.00022226371,0.00038381337,0.00010283679],"category_scores_gemma":[0.000038475875,0.000641739,0.0006344621,0.0006069411,0.00013215942,0.00006084152,0.00013956301,0.0008763495,0.00020141285],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005801077,0.00024604533,0.00019508455,0.014555557,0.00030429874,0.000037109825,0.00075287244,2.2061471e-7,0.000044332683,0.000047172867,0.00063169294,0.9831276],"study_design_scores_gemma":[0.0029358375,0.0001420678,0.0005287196,0.020067565,0.00082812237,0.000023500548,0.00004090879,0.00003153222,0.000009494365,0.000014941538,0.9747671,0.0006102211],"about_ca_topic_score_codex":0.00017978526,"about_ca_topic_score_gemma":0.000007695559,"teacher_disagreement_score":0.98251736,"about_ca_system_score_codex":0.00021789312,"about_ca_system_score_gemma":0.00037557769,"threshold_uncertainty_score":0.9996034},"labels":[],"label_agreement":null},{"id":"W2922206637","doi":"10.1007/s40265-019-01085-1","title":"Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Vulvodynia; Pharmacotherapy; MEDLINE; Pharmacology; Intensive care medicine; Dermatology; Internal medicine; Surgery","score_opus":0.26400019203152686,"score_gpt":0.4159392501684312,"score_spread":0.15193905813690434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922206637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033477249,0.98332727,0.0000150403375,0.00010437022,0.00073012954,0.0014541118,0.00002863343,0.000062320956,0.013943348],"genre_scores_gemma":[0.00048826207,0.9899611,0.00008367481,0.00013999674,0.00039649924,0.0002501635,0.00008990476,0.000025511847,0.008564894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985024,0.00009307206,0.0004895873,0.00048114918,0.00021250069,0.00022133796],"domain_scores_gemma":[0.9990961,0.00032896874,0.00021032865,0.00016129373,0.000050525967,0.00015281167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010038598,0.00040841853,0.0022954906,0.00014981795,0.00005762829,0.000008726257,0.000052154806,0.00029984376,0.0005820847],"category_scores_gemma":[0.000021916758,0.00022879627,0.0003881919,0.00020542445,0.00015553186,0.000023631317,0.00006816733,0.0002171884,0.00024442605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001615581,0.00072822534,0.00007733275,0.0053245192,0.0016529093,0.000032771943,0.00016288205,2.1133691e-7,0.00000774126,0.000054761433,0.0040089875,0.9877881],"study_design_scores_gemma":[0.0019504726,0.0014316529,0.000070296584,0.00037154922,0.006948826,0.00011828599,0.00016878624,0.000017431817,0.000010403331,0.0000020754565,0.98871946,0.00019072891],"about_ca_topic_score_codex":0.0000051454317,"about_ca_topic_score_gemma":8.196733e-8,"teacher_disagreement_score":0.98759735,"about_ca_system_score_codex":0.00012139918,"about_ca_system_score_gemma":0.0001210541,"threshold_uncertainty_score":0.93300414},"labels":[],"label_agreement":null},{"id":"W2937068696","doi":"10.1007/s40265-019-01110-3","title":"The Clinician’s Guide to Proton Pump Inhibitor Related Adverse Events","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Adverse effect; Proton-pump inhibitor; Intensive care medicine; Harm; Number needed to harm; Relative risk; Internal medicine; Confidence interval; Psychology; Number needed to treat","score_opus":0.03520317018572185,"score_gpt":0.39282732221688,"score_spread":0.35762415203115816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937068696","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068604626,0.97340006,8.6393385e-7,0.00018066721,0.0017062539,0.0120535595,0.000067907895,0.00011675509,0.011787892],"genre_scores_gemma":[0.000226638,0.89061785,0.00009505925,0.00020998695,0.00030481964,0.0009166117,0.0002427302,0.00010882835,0.10727745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721783,0.00016688542,0.0010438499,0.0005677207,0.00050463725,0.00049908756],"domain_scores_gemma":[0.9980392,0.00016155097,0.00040848125,0.0009943827,0.00009760668,0.00029877617],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004890606,0.00049026223,0.0014945752,0.0001380998,0.00012487064,0.000011547085,0.00028130252,0.00035256543,0.000081392696],"category_scores_gemma":[0.00027652548,0.0002688939,0.0008259721,0.00031617848,0.00003301692,0.0000431947,0.00015575528,0.000567733,0.010592441],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003942218,0.00019533001,0.0004768761,0.0059731402,0.0007284744,0.0002718469,0.000098520424,1.8772509e-7,1.1965848e-7,0.00002207837,0.0047721895,0.9874218],"study_design_scores_gemma":[0.0010429752,0.0003346715,0.00016751689,0.008848786,0.0015187154,0.00004187309,0.0000140403135,5.3083994e-7,0.000002935922,0.000010481085,0.9878986,0.00011890103],"about_ca_topic_score_codex":0.000010009553,"about_ca_topic_score_gemma":6.7201836e-7,"teacher_disagreement_score":0.9873029,"about_ca_system_score_codex":0.00036555578,"about_ca_system_score_gemma":0.0004972057,"threshold_uncertainty_score":0.99997634},"labels":[],"label_agreement":null},{"id":"W2944756121","doi":"10.1007/s40265-019-01115-y","title":"Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Pfizer","keywords":"Erlotinib; Medicine; Gefitinib; Lung cancer; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Oncology; Pharmacology; Cancer; Erlotinib Hydrochloride; EGFR inhibitors; Internal medicine","score_opus":0.026113738060411805,"score_gpt":0.38656500292374024,"score_spread":0.36045126486332846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944756121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018592787,0.94257504,0.0000050343824,0.000096140364,0.0002337361,0.0028022982,0.00007073616,0.000008114307,0.05402298],"genre_scores_gemma":[0.00021077521,0.99087894,0.00029962405,0.00014447847,0.000061440915,0.00089484284,0.00018407496,0.000033253495,0.0072925626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900025,0.000034859768,0.00035870867,0.00024798684,0.00017963884,0.00017854462],"domain_scores_gemma":[0.99920523,0.00006667808,0.00021302194,0.0004562582,0.000028148415,0.000030680018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108277694,0.00021529956,0.0008364461,0.00009801787,0.000020758587,0.000007301421,0.00017843614,0.000079000325,0.000085856285],"category_scores_gemma":[0.0000010875376,0.00012528773,0.00024161389,0.00026284007,0.000016403968,0.000021172676,0.000039948656,0.00018101414,0.000031311585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000754277,0.00018801489,0.00006695051,0.07255857,0.00062308967,0.000034511406,0.001168355,0.0000066991274,1.7572529e-7,0.00014541592,0.0013117628,0.9238889],"study_design_scores_gemma":[0.0014784288,0.000036945476,0.0001273226,0.025619363,0.005977525,0.0000032241255,0.00061851286,0.0000054921375,0.0000015547372,0.000003513591,0.96600133,0.00012679945],"about_ca_topic_score_codex":0.00009169438,"about_ca_topic_score_gemma":0.000007658942,"teacher_disagreement_score":0.96468955,"about_ca_system_score_codex":0.0002117567,"about_ca_system_score_gemma":0.0002652498,"threshold_uncertainty_score":0.51090854},"labels":[],"label_agreement":null},{"id":"W2950843447","doi":"10.1007/s40265-019-01152-7","title":"Damoctocog Alfa Pegol: A Review in Haemophilia A","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Haemophilia; Certolizumab pegol; Haemophilia A; Interim analysis; Haemophilia B; Dosing; Internal medicine; Surgery; Clinical trial; Adalimumab","score_opus":0.12454883995485991,"score_gpt":0.44268258544071537,"score_spread":0.3181337454858555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950843447","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000032318549,0.969329,9.803086e-8,0.0014009866,0.00016167632,0.0065291994,0.00003238501,0.00005111725,0.022492293],"genre_scores_gemma":[0.0000024768133,0.9657501,0.000042208645,0.0003309089,0.00025447656,0.0006941814,0.0005764104,0.00009878209,0.03225043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970327,0.00023806695,0.0008262842,0.00068107375,0.0006285265,0.00059334596],"domain_scores_gemma":[0.9982106,0.00021531363,0.0001789599,0.0010699546,0.00007711481,0.00024805768],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005143077,0.0005409038,0.0036767838,0.00045394464,0.000030873547,0.00001902659,0.00031101526,0.00040103678,0.00095413876],"category_scores_gemma":[0.0001925705,0.0003472451,0.0009389596,0.00091178104,0.000071657494,0.000051467112,0.00015529533,0.0009735625,0.005711399],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006581079,0.00013220191,0.000019893723,0.22482288,0.0001225394,0.0004698228,0.00003572318,2.403849e-9,5.0801376e-8,0.000021353006,0.012689593,0.76167935],"study_design_scores_gemma":[0.0005416335,0.00008629273,0.0000059499275,0.2264211,0.0010657081,0.00020778608,0.0000051881157,9.707945e-7,2.39395e-7,0.0000126010245,0.77142537,0.00022714681],"about_ca_topic_score_codex":0.000036649446,"about_ca_topic_score_gemma":0.0000039620522,"teacher_disagreement_score":0.7614522,"about_ca_system_score_codex":0.00034270828,"about_ca_system_score_gemma":0.0010343981,"threshold_uncertainty_score":0.9999591},"labels":[],"label_agreement":null},{"id":"W2951843738","doi":"10.1007/s40265-019-01141-w","title":"A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pregnancy; Infliximab; Adalimumab; Inflammatory bowel disease; Adverse effect; Ustekinumab; Context (archaeology); Discontinuation; Breastfeeding; Vedolizumab; Disease; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.06273772206705708,"score_gpt":0.33915724890318627,"score_spread":0.2764195268361292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951843738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048724394,0.99095386,0.00006638457,0.00023024458,0.00011219955,0.0023611467,0.000025922596,0.0001191231,0.0012586528],"genre_scores_gemma":[0.0070557008,0.99094653,0.00019886682,0.00042228366,0.0001476815,0.0004233946,0.000106734464,0.000041525167,0.000657297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826777,0.00014015246,0.00040018966,0.0006393976,0.00017533675,0.00037714213],"domain_scores_gemma":[0.9987877,0.00006293964,0.00019705994,0.00027783206,0.00004336864,0.0006310719],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020544481,0.0004093938,0.0009383449,0.00020079345,0.000093689014,0.000035028366,0.00015270044,0.00020915674,0.00004037844],"category_scores_gemma":[0.00007292498,0.00028301193,0.00016535635,0.00015913142,0.00014896765,0.00007080566,0.0001426281,0.00037858545,0.00002454012],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014075277,0.00019311692,0.0008147961,0.024721015,0.00031316758,0.00006165971,0.00066605693,6.036601e-7,0.000060132297,0.00015105342,0.0002466592,0.972631],"study_design_scores_gemma":[0.01673175,0.0009542498,0.034432117,0.22266339,0.0075457273,0.0011191865,0.0006644326,0.00039565892,0.00006432663,0.00016406007,0.7116594,0.0036057122],"about_ca_topic_score_codex":0.0000021303465,"about_ca_topic_score_gemma":4.177139e-8,"teacher_disagreement_score":0.96902525,"about_ca_system_score_codex":0.00006372347,"about_ca_system_score_gemma":0.00019446868,"threshold_uncertainty_score":0.9999622},"labels":[],"label_agreement":null},{"id":"W2954563654","doi":"10.1007/s40265-019-01156-3","title":"Perioperative Pain Management in Morbid Obesity","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Perioperative; Intensive care medicine; Opioid; Population; Analgesic; Adverse effect; Anesthesia; Internal medicine","score_opus":0.04225692084307678,"score_gpt":0.3328268487754298,"score_spread":0.29056992793235303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954563654","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013811219,0.9488132,0.00004509636,0.00015658821,0.000056346034,0.0026543268,0.0000012946514,0.000040989755,0.04821836],"genre_scores_gemma":[0.000015469175,0.95133436,0.00033090505,0.0014782597,0.00008796758,0.00020963594,0.00012997289,0.000044651508,0.0463688],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819463,0.00041367966,0.00039598218,0.00044675093,0.00026859847,0.00028035307],"domain_scores_gemma":[0.99916023,0.00010439313,0.00010865218,0.0005364432,0.000017814315,0.00007245733],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011709265,0.00034745104,0.0014071136,0.0002691451,0.000030326988,0.000022364318,0.00018153047,0.00015941772,0.00029447902],"category_scores_gemma":[0.000014490522,0.0002646535,0.00033236813,0.0002938767,0.000030963816,0.0000287473,0.00007405966,0.00032147462,0.0013088627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009810203,0.000115755836,0.00014625725,0.035959255,0.00019400545,0.00035570207,0.00026651155,4.881822e-7,4.9366293e-9,0.0016816416,0.0035235449,0.95774704],"study_design_scores_gemma":[0.0003320244,0.000080559446,0.00020669714,0.010859027,0.0007274343,0.000008992794,0.00031857242,0.000022288179,2.8594384e-8,0.000009183183,0.9871889,0.00024634344],"about_ca_topic_score_codex":0.000024930683,"about_ca_topic_score_gemma":0.0000024134526,"teacher_disagreement_score":0.9836653,"about_ca_system_score_codex":0.00023743871,"about_ca_system_score_gemma":0.00007639631,"threshold_uncertainty_score":0.99998057},"labels":[],"label_agreement":null},{"id":"W2958757303","doi":"10.1007/s40265-019-01169-y","title":"Innovations in Oral Therapies for Inflammatory Bowel Disease","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Ulcerative colitis; Vedolizumab; Infliximab; Drug development; Tofacitinib; Internal medicine; Adverse effect; Pharmacology; Drug; Disease; Rheumatoid arthritis","score_opus":0.023645301406845717,"score_gpt":0.3107230209837264,"score_spread":0.28707771957688066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958757303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020089787,0.99504226,0.00003786206,0.000024745326,0.00032418926,0.001776857,0.00044041642,0.000022385042,0.0003223183],"genre_scores_gemma":[0.00033520235,0.9931804,0.00012008255,0.00020094933,0.00036209,0.0010522916,0.0027897723,0.00011506972,0.001844132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984757,0.00010597176,0.00049921894,0.00048228886,0.00012271655,0.00031415082],"domain_scores_gemma":[0.99886876,0.000028849236,0.0002206165,0.0006773784,0.00010007551,0.00010434258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024927137,0.00036950252,0.00048389527,0.00018077334,0.000051370822,0.00003583526,0.0003478764,0.00028977226,0.000022335342],"category_scores_gemma":[0.000115818555,0.00034166,0.00039468223,0.000121570556,0.00006677274,0.000006015785,0.00011784543,0.00014876034,0.00008601207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048750095,0.00037719886,0.0027770482,0.07428234,0.00088697806,0.0001279223,0.00030372775,0.000039504444,0.000059155154,0.0069022984,0.02541607,0.88834023],"study_design_scores_gemma":[0.00041494507,0.000014996693,0.0009144006,0.0009415091,0.00016930276,8.3356855e-7,0.000018794546,0.000007807885,0.000001937582,0.000090722846,0.997013,0.0004118033],"about_ca_topic_score_codex":0.000001447407,"about_ca_topic_score_gemma":0.000009848685,"teacher_disagreement_score":0.9715969,"about_ca_system_score_codex":0.00005013539,"about_ca_system_score_gemma":0.0009070656,"threshold_uncertainty_score":0.99990356},"labels":[],"label_agreement":null},{"id":"W2966058539","doi":"10.1007/s40265-019-01173-2","title":"Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary; Robarts Clinical Trials","funders":"AbbVie; AstraZeneca; Amgen","keywords":"Eosinophilic esophagitis; Mepolizumab; Medicine; Immunology; Omalizumab; Antibody; Eosinophil; Disease; Internal medicine; Asthma; Immunoglobulin E","score_opus":0.061181478543082264,"score_gpt":0.379496866581606,"score_spread":0.3183153880385237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966058539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011053007,0.987906,0.0000038985177,0.0010082804,0.0005679054,0.009163545,0.000743097,0.000026077629,0.0005701864],"genre_scores_gemma":[0.000024189074,0.9890017,0.000058947742,0.00065613136,0.00024693116,0.00086900813,0.00010139706,0.000119560864,0.008922168],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973808,0.00019307398,0.0011956294,0.00042147795,0.00048096103,0.0003280419],"domain_scores_gemma":[0.99612206,0.0009814912,0.001094829,0.0015161454,0.00021299817,0.0000724912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036579717,0.0005597999,0.0031987794,0.00010089089,0.00006312948,0.0000088343495,0.00050150213,0.000120848,0.00019135395],"category_scores_gemma":[0.00006285866,0.00025690996,0.0019871648,0.00042526211,0.0002996698,0.000037129383,0.00005020514,0.00020836518,0.000081184866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001728251,0.0002381156,0.0000052693463,0.10258511,0.0012016072,0.0000025278425,0.00025558355,2.0056892e-7,0.0000034342165,0.000038884722,0.007812679,0.8878393],"study_design_scores_gemma":[0.0010138197,0.00041891355,0.000013181229,0.06297479,0.008177815,0.000052127558,0.000007877181,0.0000022713864,0.00017109762,0.000034189696,0.9269633,0.00017060047],"about_ca_topic_score_codex":0.000020102647,"about_ca_topic_score_gemma":0.0000017897831,"teacher_disagreement_score":0.91915065,"about_ca_system_score_codex":0.00018107689,"about_ca_system_score_gemma":0.0005419498,"threshold_uncertainty_score":0.9999883},"labels":[],"label_agreement":null},{"id":"W2968953218","doi":"10.1007/s40265-019-01180-3","title":"Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":327,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Calgary Laboratory Services","keywords":"Enterobacteriaceae; Medicine; Epidemiology; Molecular epidemiology; Pharmacotherapy; Intensive care medicine; Broad spectrum; Microbiology; Internal medicine; Biology; Genetics; Escherichia coli; Genotype","score_opus":0.03453368455422437,"score_gpt":0.32819340572051364,"score_spread":0.29365972116628924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968953218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022774028,0.9747619,0.00007524345,0.0001507357,0.000565696,0.00089303125,0.0002147687,0.000029790632,0.0005348256],"genre_scores_gemma":[0.0016543336,0.99401337,0.0005329378,0.00019743037,0.0003142658,0.00005816645,0.0016750976,0.00011062041,0.0014437751],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686664,0.0005247972,0.0006566392,0.0013013989,0.00009068211,0.00055985636],"domain_scores_gemma":[0.99797726,0.00008203159,0.00044723472,0.0013228667,0.000025134861,0.00014547852],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003738692,0.0006755273,0.00156216,0.00011821498,0.00008621255,0.00004091693,0.00029698166,0.0005344412,0.000047879417],"category_scores_gemma":[0.000114135946,0.00054161117,0.00047363146,0.00008544983,0.00014818717,0.00000446989,0.00017736424,0.00020710805,0.00019240398],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000242224,0.000530977,0.0006199563,0.0068785395,0.002380446,0.00008284846,0.00011500908,0.000008067693,0.001515159,0.004841595,0.0028615594,0.9799236],"study_design_scores_gemma":[0.00030174805,0.00040663016,0.00022146558,0.001478505,0.00045107378,0.000060572474,0.000010348275,0.0000015896583,0.00019670377,0.00006677991,0.996295,0.0005095987],"about_ca_topic_score_codex":0.000012054527,"about_ca_topic_score_gemma":0.000004674285,"teacher_disagreement_score":0.9934334,"about_ca_system_score_codex":0.0001316663,"about_ca_system_score_gemma":0.00016636407,"threshold_uncertainty_score":0.9997035},"labels":[],"label_agreement":null},{"id":"W2991537174","doi":"10.1007/s40265-019-01227-5","title":"Treating Persistent Pain After Breast Cancer Surgery","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Toronto General Hospital; St. Michael's Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Perioperative; Complication; Cancer pain; Cancer; Neuropathic pain; Surgery; Breast surgery; Anesthesia; Internal medicine","score_opus":0.0407063059616526,"score_gpt":0.30341835160262703,"score_spread":0.26271204564097445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991537174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024137455,0.99653184,0.0000044260273,0.00051007554,0.0001002839,0.000738791,0.000011987184,0.000046566358,0.0020318783],"genre_scores_gemma":[0.00007800544,0.9752154,0.000021678901,0.001975925,0.00047686667,0.00032546752,0.00012451723,0.00006807441,0.02171411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984385,0.00027727452,0.00037405864,0.00035809426,0.00025856582,0.0002935438],"domain_scores_gemma":[0.9988694,0.0004028895,0.00018124863,0.00040808003,0.00003344671,0.000104891966],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008934408,0.000330845,0.001531764,0.000167107,0.000031676387,0.000021270136,0.0000781864,0.00016250723,0.0010863786],"category_scores_gemma":[0.000017996086,0.00023238226,0.0012746934,0.00016774937,0.00002594046,0.000023276965,0.000026496584,0.00020522141,0.0004596294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013139621,0.000032324933,0.0030326045,0.04007999,0.0003225866,0.00008661861,0.00012979149,1.7324584e-7,2.9043832e-9,0.0000042591837,0.012236452,0.94406205],"study_design_scores_gemma":[0.00007654761,0.000012289692,0.00040815372,0.031039534,0.0025168755,0.00006187227,0.00011105271,0.000012614506,4.5172523e-9,3.7079488e-7,0.96553147,0.00022923647],"about_ca_topic_score_codex":0.000096556985,"about_ca_topic_score_gemma":0.000001772925,"teacher_disagreement_score":0.953295,"about_ca_system_score_codex":0.00021636469,"about_ca_system_score_gemma":0.00024140895,"threshold_uncertainty_score":0.9998268},"labels":[],"label_agreement":null},{"id":"W3001005446","doi":"10.1007/s40265-020-01257-4","title":"Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"","keywords":"Bioavailability; Pharmacokinetics; Cmax; Pharmacology; Medicine; Oral administration; Tetracycline; Minocycline; Efflux; Chemistry; Antibiotics; Biochemistry","score_opus":0.02617763870321694,"score_gpt":0.3066871564532287,"score_spread":0.28050951775001176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001005446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020870697,0.9959017,0.0003759101,0.000051055616,0.0003515263,0.00057745614,0.00021119195,0.000026814014,0.00041729803],"genre_scores_gemma":[0.0014309355,0.9937764,0.0024589107,0.00014311852,0.0005139087,0.000006292718,0.0008900735,0.000110425426,0.0006699524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978744,0.00009282286,0.0006279554,0.00086570653,0.00016257651,0.00037655083],"domain_scores_gemma":[0.9988131,0.000032687778,0.0003459023,0.0005677219,0.00004117739,0.00019938986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001848662,0.00055017637,0.001332695,0.00007322248,0.00006729809,0.00007235951,0.00039023804,0.0004898407,0.000017495406],"category_scores_gemma":[0.0001480562,0.0004758744,0.00032973452,0.0001835437,0.00019242999,0.0000031214995,0.00035445,0.00028757233,0.000052837902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000220856,0.0001167322,0.000027815226,0.0054773837,0.00032280415,0.000031087064,0.000046368925,1.1869411e-7,0.001389163,0.000046287918,0.0008254768,0.9916947],"study_design_scores_gemma":[0.00029313963,0.0001421535,0.00008541196,0.0012008578,0.0003974508,0.0000857572,0.000028029153,0.0000037618763,0.00013523317,0.0000039776683,0.99711394,0.0005102578],"about_ca_topic_score_codex":0.000016504906,"about_ca_topic_score_gemma":0.0000066553994,"teacher_disagreement_score":0.9962885,"about_ca_system_score_codex":0.00003593494,"about_ca_system_score_gemma":0.00020969115,"threshold_uncertainty_score":0.9997693},"labels":[],"label_agreement":null},{"id":"W3001438287","doi":"10.1007/s40265-019-01245-3","title":"Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Family Medicine; Western University","funders":"Novo Nordisk; Novo Nordisk Fonden; Steno Diabetes Center Copenhagen","keywords":"Liraglutide; Medicine; Insulin degludec; Hypoglycemia; Type 2 diabetes; Regimen; Glycemic; Insulin; Glucagon-like peptide 1 receptor; Diabetes mellitus; Intensive care medicine; Internal medicine; Endocrinology; Insulin glargine; Agonist","score_opus":0.057567502740075806,"score_gpt":0.34438592346030833,"score_spread":0.2868184207202325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001438287","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030613306,0.98684967,0.0000038211874,0.00040312318,0.00011842562,0.0014710256,0.000015143344,0.00009516896,0.007982274],"genre_scores_gemma":[0.0033629532,0.9895079,0.0052341423,0.0009324902,0.00024014083,0.00015998779,0.0002874791,0.00007388638,0.00020100044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979713,0.00017193268,0.00082456996,0.00051529694,0.00020587686,0.00031101218],"domain_scores_gemma":[0.9983731,0.0008333829,0.00029167676,0.00026874722,0.000061324106,0.00017176614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037756024,0.00036727858,0.0017706295,0.00017346974,0.00007594443,0.00007967576,0.00006591872,0.00016958141,0.00007639779],"category_scores_gemma":[0.00053637126,0.00027801684,0.00014978112,0.00031691897,0.00007203664,0.0000972423,0.00012450088,0.00048613304,0.00007152415],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011145398,0.0001676831,0.018441994,0.0071960622,0.00065563316,0.00014020916,0.0007317177,3.6636044e-7,2.0325776e-7,0.0005189767,0.001465634,0.9706704],"study_design_scores_gemma":[0.0026361507,0.0008777524,0.002642819,0.0214937,0.0039122347,0.000017771616,0.00026755754,0.00015668587,0.0000017770395,0.00026047605,0.9670709,0.00066218135],"about_ca_topic_score_codex":0.000020439877,"about_ca_topic_score_gemma":0.00010195666,"teacher_disagreement_score":0.9700082,"about_ca_system_score_codex":0.00008429029,"about_ca_system_score_gemma":0.000390608,"threshold_uncertainty_score":0.9999672},"labels":[],"label_agreement":null},{"id":"W3003887243","doi":"10.1007/s40265-020-01256-5","title":"The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Celltrion; Celltrion Healthcare","keywords":"Biosimilar; Medicine; Immune system; Pharmacotherapy; Intensive care medicine; Pharmacology; Immunology; Internal medicine","score_opus":0.021357099851742094,"score_gpt":0.3110286671542852,"score_spread":0.28967156730254306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003887243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015127228,0.9952234,0.0000017808686,0.0007417313,0.0016069792,0.00053298625,0.0016468756,0.00008675886,0.00014435359],"genre_scores_gemma":[0.000020390735,0.9987144,0.000058637543,0.00023196368,0.00026978005,0.0000544077,0.0003307932,0.000060248312,0.00025940116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689853,0.0007056186,0.0011338146,0.00052745204,0.0000935645,0.00064101716],"domain_scores_gemma":[0.9971312,0.0012405814,0.0007367071,0.0007079872,0.000105981984,0.00007750511],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052868645,0.0005889109,0.0020562366,0.00006743111,0.00037321096,0.00004786149,0.0010154765,0.0010687644,0.00013075907],"category_scores_gemma":[0.00024229039,0.00033568393,0.001134516,0.00047003472,0.00067174586,0.00005098842,0.00050670485,0.0010092243,0.00018919108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037935308,0.000041895848,0.000008582299,0.0026461594,0.000800694,0.000007312483,0.000117694675,4.6871218e-8,0.000028455257,0.0004163711,0.0037318312,0.992163],"study_design_scores_gemma":[0.00029478598,0.00005201015,0.000040886673,0.0023523665,0.0008367814,0.000017235878,0.00028878523,4.859996e-7,0.00012652286,0.000036279318,0.99558526,0.00036857682],"about_ca_topic_score_codex":0.0000029730718,"about_ca_topic_score_gemma":0.0000036282802,"teacher_disagreement_score":0.9918535,"about_ca_system_score_codex":0.000052293006,"about_ca_system_score_gemma":0.00023940322,"threshold_uncertainty_score":0.9999095},"labels":[],"label_agreement":null},{"id":"W3014098355","doi":"10.1007/s40265-020-01297-w","title":"Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Eculizumab; Medicine; Neuromyelitis optica; Spectrum disorder; Internal medicine; Intensive care medicine; Pediatrics; Immunology; Antibody; Complement system; Psychiatry","score_opus":0.06214246099619297,"score_gpt":0.3835801699538946,"score_spread":0.32143770895770163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014098355","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.208187e-7,0.9764352,0.0000026457062,0.008547319,0.00010624081,0.0032376396,0.00006902378,0.000085697146,0.011515738],"genre_scores_gemma":[0.000003571641,0.99720097,0.0001334153,0.00074930757,0.0003439901,0.0006347312,0.0001636308,0.000107905646,0.0006624916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966067,0.00032124386,0.0009369287,0.00079878356,0.0006980717,0.0006382688],"domain_scores_gemma":[0.9983523,0.00035337807,0.00018824925,0.0007278142,0.000052805502,0.00032543528],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032232283,0.0005866328,0.0039927773,0.00023813362,0.000051754178,0.0000269296,0.00035485253,0.00016016432,0.00061487366],"category_scores_gemma":[0.0016746876,0.00042236203,0.0008106211,0.0010936415,0.00012632695,0.000046866902,0.00042824086,0.0011493773,0.0012216833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000609214,0.00005718079,0.00000636753,0.14635609,0.00012379752,0.0002878109,0.00006324928,1.5291322e-8,6.2440044e-8,0.000042413867,0.008570227,0.8444867],"study_design_scores_gemma":[0.00044723705,0.00009040408,0.000066565066,0.14122763,0.00044279188,0.00004900272,0.000014168064,0.000005362254,6.348902e-8,0.000005444421,0.85738456,0.00026678544],"about_ca_topic_score_codex":0.00008999804,"about_ca_topic_score_gemma":0.00002207694,"teacher_disagreement_score":0.8488143,"about_ca_system_score_codex":0.00027149232,"about_ca_system_score_gemma":0.00050099543,"threshold_uncertainty_score":0.9998228},"labels":[],"label_agreement":null},{"id":"W3016167110","doi":"10.1007/s40265-020-01296-x","title":"Are Generic Drugs Used in Cardiology as Effective and Safe as their Brand-name Counterparts? A Systematic Review and Meta-analysis","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; McGill University; Université Laval; Institut National de Santé Publique du Québec","funders":"Université du Québec à Trois-Rivières","keywords":"Medicine; Meta-analysis; Confidence interval; MEDLINE; Brand names; Subgroup analysis; Systematic review; Internal medicine; Relative risk; Randomized controlled trial; Emergency medicine","score_opus":0.10560598533298951,"score_gpt":0.34000375411428563,"score_spread":0.23439776878129612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016167110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064906664,0.9911708,0.000011180361,0.0009864268,0.00006792884,0.0029894044,0.001445179,0.000019697596,0.0032444664],"genre_scores_gemma":[0.0025558514,0.9901236,0.0000070654837,0.0056672194,0.000064803535,0.0012269861,0.00006904329,0.00006429983,0.0002211139],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959981,0.0004725143,0.001955001,0.001099568,0.000043026517,0.00043182608],"domain_scores_gemma":[0.99643004,0.0008139717,0.0018297276,0.00062061264,0.000025066562,0.00028060362],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0015839282,0.0007209779,0.016060315,0.0005578126,0.000068789486,0.00013679368,0.00038395036,0.0003155195,0.0002907402],"category_scores_gemma":[0.00030854772,0.0005900285,0.002228522,0.00073442364,0.00011994317,0.00012056155,0.00022546419,0.0005075572,0.00069605384],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010397309,0.00004771667,0.00007450912,0.8054777,0.17788291,0.000059484988,0.0010324375,0.000008629595,1.1899969e-8,0.010735439,0.0005183217,0.0041524745],"study_design_scores_gemma":[0.0003617984,0.0000375788,0.000012647351,0.0043909247,0.2264098,0.00005628815,0.000045638597,0.00016454817,7.8580904e-8,0.0018372054,0.76585245,0.0008310813],"about_ca_topic_score_codex":0.00015758029,"about_ca_topic_score_gemma":0.000017207363,"teacher_disagreement_score":0.8010867,"about_ca_system_score_codex":0.00021185224,"about_ca_system_score_gemma":0.000057258265,"threshold_uncertainty_score":0.9996551},"labels":[],"label_agreement":null},{"id":"W3031883039","doi":"10.1007/s40265-020-01333-9","title":"Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases","year":2020,"lang":"en","type":"erratum","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biosimilar; Medicine; Immune system; Pharmacotherapy; Intensive care medicine; Immunology; Internal medicine","score_opus":0.010567851533116044,"score_gpt":0.26147632977104385,"score_spread":0.2509084782379278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031883039","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036935988,0.36377776,0.00009871364,0.04579029,0.5649326,0.002513428,0.0082558915,0.000692058,0.010245713],"genre_scores_gemma":[0.10199978,0.072553575,0.0013919013,0.06900632,0.04017459,0.0008937062,0.026284816,0.001365555,0.6863298],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99753267,0.0004169301,0.0007169272,0.00060569186,0.00013247978,0.0005953089],"domain_scores_gemma":[0.99817175,0.00042213887,0.0004479317,0.00066685054,0.00020065263,0.000090700836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003987705,0.0005012208,0.00088587054,0.00010434402,0.00031344363,0.000044476506,0.0008158031,0.0012268955,0.00036653166],"category_scores_gemma":[0.0004536131,0.00033713883,0.00049020146,0.00053525675,0.0003388239,0.000058470156,0.00047522056,0.0018864624,0.00025021055],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001971868,0.00006261425,0.00013135478,0.00013179448,0.00038302867,0.000004382934,0.00079383096,0.000003960691,0.001725354,0.00004024233,0.9704727,0.026053546],"study_design_scores_gemma":[0.0004089918,0.00014911685,0.0051899212,0.00039388897,0.000260266,0.000009641793,0.0013003276,0.00002261386,0.003872469,0.000020418918,0.98796743,0.00040488923],"about_ca_topic_score_codex":0.000030217752,"about_ca_topic_score_gemma":0.00006263372,"teacher_disagreement_score":0.67608404,"about_ca_system_score_codex":0.0000637121,"about_ca_system_score_gemma":0.00020086081,"threshold_uncertainty_score":0.9999081},"labels":[],"label_agreement":null},{"id":"W3036195168","doi":"10.1007/s40265-020-01323-x","title":"Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial","year":2020,"lang":"en","type":"article","venue":"Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Boehringer Ingelheim","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Atrial fibrillation; Warfarin; Dabigatran; Cardiology; Pharmacotherapy; Internal medicine; Randomized controlled trial; Myocardial infarction","score_opus":0.035380281358436835,"score_gpt":0.29127684671531356,"score_spread":0.2558965653568767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036195168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036354,0.00007754017,0.00002797723,0.0020594972,0.00021446479,0.0070444257,0.000036427256,0.0000711084,0.00010501937],"genre_scores_gemma":[0.9983087,0.00004607163,0.00008733195,0.00019760057,0.0008117317,0.000015299061,0.00033641257,0.000042598218,0.0001542495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997339,0.00029512457,0.00079616637,0.00046139068,0.00086693966,0.00024136352],"domain_scores_gemma":[0.9987441,0.00010875202,0.0004857114,0.00037579937,0.00019280973,0.000092865725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032341873,0.00029494445,0.0008059407,0.00028600456,0.00008513632,0.00004383943,0.00011560758,0.00013090127,0.00015869408],"category_scores_gemma":[0.00008539072,0.00017730608,0.00057936786,0.001255373,0.00009386218,0.00019370459,0.00005182296,0.00020052891,0.000003079765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4323645,0.00006917991,0.550499,0.000042930034,0.0012360227,0.000007675103,0.0043166173,0.0009980868,0.00041708085,0.000016757385,0.000020822006,0.010011312],"study_design_scores_gemma":[0.16067454,0.010828436,0.8192909,0.000130291,0.0011051227,0.000005378217,0.0007452872,0.0021084365,0.0015539295,0.000011928221,0.0031581935,0.0003875944],"about_ca_topic_score_codex":0.00016516146,"about_ca_topic_score_gemma":0.00008352274,"teacher_disagreement_score":0.27168995,"about_ca_system_score_codex":0.00009537854,"about_ca_system_score_gemma":0.00009670872,"threshold_uncertainty_score":0.7230332},"labels":[],"label_agreement":null},{"id":"W3037306288","doi":"10.1007/s40265-020-01348-2","title":"Ripretinib: First Approval","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PDGFRA; Medicine; GiST; Imatinib; PDGFRB; Tyrosine kinase; Receptor tyrosine kinase; Tyrosine-kinase inhibitor; Platelet-derived growth factor receptor; Imatinib mesylate; Sunitinib; Targeted therapy; Cancer research; Growth factor receptor; Pharmacology; Oncology; Internal medicine; Cancer; Stromal cell; Receptor; Growth factor; Biology","score_opus":0.06558843503017232,"score_gpt":0.3746732657524908,"score_spread":0.3090848307223185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037306288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014901875,0.97993237,0.000006415586,0.0005458912,0.000055723413,0.0011123542,0.00004717472,0.00010671181,0.01819188],"genre_scores_gemma":[0.000014013129,0.9960738,0.0010163967,0.000052729712,0.00037753675,0.00018236376,0.0002992664,0.00006723307,0.0019166988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984523,0.00005371999,0.00032020072,0.0004205452,0.0003843388,0.00036888983],"domain_scores_gemma":[0.99888575,0.00013620133,0.0001064638,0.0003572431,0.00004332917,0.0004710371],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000100597455,0.00034005666,0.0014108177,0.000095830146,0.00005365141,0.000025681411,0.00015340584,0.000074427444,0.00028254322],"category_scores_gemma":[0.00023991616,0.00023005072,0.00059368357,0.00025041137,0.000063323474,0.000016802887,0.00010794729,0.0005611927,0.0029624607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023670018,0.000118629534,0.000012459194,0.020597393,0.0001948991,0.0019566433,0.00004346046,7.0474737e-9,2.6313879e-8,0.00008734749,0.005958409,0.97100705],"study_design_scores_gemma":[0.00039884745,0.0004258007,0.000003795827,0.012361495,0.00071633945,0.0012449219,0.000015371486,0.0000033241113,5.654262e-7,0.000009786445,0.98468906,0.00013072263],"about_ca_topic_score_codex":0.000018709494,"about_ca_topic_score_gemma":9.572105e-7,"teacher_disagreement_score":0.9787306,"about_ca_system_score_codex":0.00017188278,"about_ca_system_score_gemma":0.000446976,"threshold_uncertainty_score":0.9978138},"labels":[],"label_agreement":null},{"id":"W3037838896","doi":"10.1007/s40265-020-01338-4","title":"Strategies for the Prevention and Treatment of Iatrogenic Withdrawal from Opioids and Benzodiazepines in Critically Ill Neonates, Children and Adults: A Systematic Review of Clinical Studies","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; Mount Sinai Hospital; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Sinai Health System; McGill University Health Centre","funders":"Université de Montréal","keywords":"Medicine; Psychological intervention; Methadone; Population; Clonidine; Intensive care medicine; MEDLINE; Buprenorphine; CINAHL; Randomized controlled trial; Systematic review; Data extraction; Emergency medicine; Opioid; Psychiatry; Anesthesia; Internal medicine","score_opus":0.03910036800117463,"score_gpt":0.39396514750711337,"score_spread":0.35486477950593875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037838896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010773386,0.9912049,0.000012488883,0.0005702433,0.000046798563,0.0066249263,0.00044467722,0.000007322225,0.000011287609],"genre_scores_gemma":[0.0005675231,0.99756175,0.00019092725,0.0008119068,0.000059158105,0.00048412514,0.00028920898,0.000027508597,0.000007912449],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975999,0.00032439022,0.0014068432,0.00038154513,0.00015552358,0.00013176954],"domain_scores_gemma":[0.99425644,0.002276599,0.0005055585,0.00019943582,0.0027001663,0.00006178905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033919432,0.0003339376,0.0039515235,0.000077726705,0.000026294549,0.000010493464,0.000063802254,0.00012705511,0.000002573225],"category_scores_gemma":[0.008050121,0.0001871225,0.00052191655,0.00012318915,0.0003720879,0.00004141258,0.00005336197,0.0001338737,3.4201975e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009597037,0.000092360686,0.000112386326,0.8217404,0.0031001323,0.0000044835174,0.00081484125,2.8177944e-9,7.771923e-8,0.00018660825,0.00009718546,0.17375556],"study_design_scores_gemma":[0.00248875,0.0017403336,0.00034993122,0.9556517,0.023904163,0.0000537985,0.013211638,0.000007827649,5.8267307e-7,0.00019430996,0.002191277,0.00020567031],"about_ca_topic_score_codex":0.00007790446,"about_ca_topic_score_gemma":0.00004518911,"teacher_disagreement_score":0.17354989,"about_ca_system_score_codex":0.000030140178,"about_ca_system_score_gemma":0.00027282225,"threshold_uncertainty_score":0.96373284},"labels":[],"label_agreement":null},{"id":"W3049193001","doi":"10.1007/s40265-020-01380-2","title":"Satralizumab: First Approval","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neuromyelitis optica; Drug approval; Drug development; Clinical trial; Pediatrics; Intensive care medicine; Internal medicine; Pharmacology; Immunology; Drug; Antibody","score_opus":0.05343999566156591,"score_gpt":0.35716890198382145,"score_spread":0.3037289063222555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049193001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.836286e-7,0.96051717,0.000006052914,0.00048163484,0.00011131478,0.0010011281,0.000015906331,0.000124081,0.03774183],"genre_scores_gemma":[0.0000031167176,0.99273896,0.0000637699,0.00012823388,0.00032673986,0.00013006965,0.00025637366,0.000091905655,0.0062608467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981598,0.00006560502,0.00056995946,0.00041178532,0.00042753303,0.00036527682],"domain_scores_gemma":[0.9990226,0.00006702969,0.00014991229,0.00051923114,0.000043312477,0.0001979011],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016100633,0.00035017057,0.0020188484,0.0001510929,0.00009100429,0.00003220147,0.00027148583,0.00030872508,0.0008471368],"category_scores_gemma":[0.00010381967,0.00026460204,0.0007593761,0.00039011176,0.000093479495,0.000046860285,0.00014638253,0.00081759866,0.003893329],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010859427,0.000032641234,0.0000015265757,0.030664086,0.00017736609,0.00013773175,0.00017871319,1.6090242e-8,4.0404668e-8,0.00017746253,0.02368308,0.94493645],"study_design_scores_gemma":[0.0003730306,0.000079227524,0.0000023596021,0.0057560867,0.00044883805,0.000081926126,0.00006156485,0.0000066692737,3.7134583e-7,0.000009497727,0.99294865,0.00023176888],"about_ca_topic_score_codex":0.000017556555,"about_ca_topic_score_gemma":9.098445e-7,"teacher_disagreement_score":0.9692656,"about_ca_system_score_codex":0.00012447045,"about_ca_system_score_gemma":0.00089846423,"threshold_uncertainty_score":0.9999806},"labels":[],"label_agreement":null},{"id":"W3082442646","doi":"10.1007/s40265-020-01389-7","title":"Decitabine/Cedazuridine: First Approval","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Decitabine; Medicine; Myelodysplastic syndromes; Cytidine deaminase; International Prognostic Scoring System; Internal medicine; Chronic myelomonocytic leukemia; Oncology; Pharmacology; Bone marrow; Immunology","score_opus":0.048028227437345174,"score_gpt":0.3567413463387515,"score_spread":0.3087131189014063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082442646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000021984379,0.9730286,0.000025949063,0.0016683688,0.00024110937,0.0017057848,0.00007469875,0.00022283169,0.02303046],"genre_scores_gemma":[0.000003099881,0.9893153,0.00086116,0.00031912417,0.0018650788,0.00027715287,0.00057143567,0.0002105552,0.006577109],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969661,0.000107435204,0.00069505884,0.000828843,0.0007579246,0.0006445868],"domain_scores_gemma":[0.9977848,0.00039383612,0.00020287572,0.0009068347,0.00011774947,0.00059393345],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033816925,0.0006216041,0.0027993917,0.00030807182,0.00010149325,0.000050909395,0.000565976,0.00050397246,0.0005829227],"category_scores_gemma":[0.00059641374,0.0004665825,0.0009438785,0.0009869295,0.00012657393,0.000057546215,0.00040680057,0.0016642517,0.0055934605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024721376,0.000043150594,0.0000011402109,0.027588436,0.00029805244,0.00054396415,0.000110662164,3.8263543e-8,2.2488287e-7,0.00016417481,0.10318499,0.86804044],"study_design_scores_gemma":[0.0007228301,0.00010737796,9.84441e-7,0.007281247,0.0010111252,0.0004657517,0.000032435928,0.000030718893,0.000002085284,0.000009655286,0.98996234,0.00037344042],"about_ca_topic_score_codex":0.000028058781,"about_ca_topic_score_gemma":0.0000013732746,"teacher_disagreement_score":0.88677734,"about_ca_system_score_codex":0.0009185672,"about_ca_system_score_gemma":0.002285727,"threshold_uncertainty_score":0.99977857},"labels":[],"label_agreement":null},{"id":"W3090684381","doi":"10.1007/s40265-020-01411-y","title":"Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Trastuzumab; Pertuzumab; Lapatinib; Medicine; Biosimilar; Neratinib; Trastuzumab emtansine; Metastatic breast cancer; Breast cancer; Oncology; Targeted therapy; Internal medicine; Cancer; Pharmacology","score_opus":0.05352402178422109,"score_gpt":0.3772090738336325,"score_spread":0.3236850520494114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090684381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003361546,0.9895042,3.4770483e-7,0.008130469,0.00017552213,0.0014627782,0.00007530428,0.000020417141,0.00029480894],"genre_scores_gemma":[0.0005944364,0.9981077,0.00009120777,0.00014245191,0.0005398564,0.0002778914,0.00007455746,0.000047716883,0.00012418692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981926,0.00021706709,0.0005370312,0.00043103797,0.00035544796,0.00026681824],"domain_scores_gemma":[0.9992365,0.00017097972,0.0002054391,0.00023175988,0.000060957736,0.00009431807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054401904,0.00029055873,0.0013207983,0.00017744073,0.00004961928,0.000016321284,0.00011465543,0.00012766448,0.00007296966],"category_scores_gemma":[0.00009844833,0.00016589202,0.000119917866,0.0005147506,0.00013307242,0.000025485637,0.0000669347,0.00043710324,0.000015245488],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110687084,0.000028925613,0.0002682915,0.0072251554,0.00020716403,0.00003252092,0.0013070572,0.0000052684372,0.0000066191315,0.000016227037,0.0017392155,0.9890529],"study_design_scores_gemma":[0.0012307254,0.00007858114,0.000065633445,0.010491379,0.00026035236,0.00005663903,0.00020204234,0.00003943335,0.000040798783,0.000004105729,0.9873838,0.00014650669],"about_ca_topic_score_codex":0.00093690405,"about_ca_topic_score_gemma":0.000025772428,"teacher_disagreement_score":0.9889064,"about_ca_system_score_codex":0.0028887296,"about_ca_system_score_gemma":0.0016268037,"threshold_uncertainty_score":0.75539273},"labels":[],"label_agreement":null},{"id":"W3105434842","doi":"10.1007/s40265-020-01429-2","title":"TRPV1-Targeted Drugs in Development for Human Pain Conditions","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Crohn's and Colitis Canada; Canada Excellence Research Chairs, Government of Canada","keywords":"TRPV1; Nociceptor; Medicine; Capsaicin; Chronic pain; Transient receptor potential channel; Neuropathic pain; Analgesic; Resiniferatoxin; Nociception; Noxious stimulus; Anesthesia; Pharmacology; Internal medicine; Receptor; Physical therapy","score_opus":0.0501895548727496,"score_gpt":0.36418053419243646,"score_spread":0.31399097931968684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105434842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033680222,0.99482405,0.00018904422,0.0001631445,0.00012666559,0.003109701,0.0001654784,0.00010339515,0.0012848207],"genre_scores_gemma":[0.00036028246,0.98067975,0.0042757024,0.00060131476,0.0002137405,0.0028459434,0.008170059,0.00013656178,0.002716619],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981581,0.00016414977,0.0006441153,0.00047013196,0.00021640965,0.00034711524],"domain_scores_gemma":[0.9990881,0.00023137151,0.00019574282,0.00025016358,0.000040068102,0.00019451874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000562718,0.00040766338,0.0015945202,0.00024610767,0.00012415272,0.000016511214,0.00012632515,0.00024070461,0.00016401616],"category_scores_gemma":[0.00009921972,0.00033439105,0.00038695827,0.00028251158,0.000021785196,0.000025978481,0.00003826098,0.00026384814,0.00016781874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008172223,0.0002752798,0.000007624315,0.010683533,0.00046743543,0.00008140209,0.0009859342,2.8491689e-8,0.0000034757077,0.0011674735,0.002543503,0.98377615],"study_design_scores_gemma":[0.0013380215,0.000112273345,0.000015362799,0.007886421,0.00056750124,0.0000061083956,0.00012972209,0.00000509262,0.000016346468,0.00033667227,0.98930556,0.00028090258],"about_ca_topic_score_codex":0.000015975249,"about_ca_topic_score_gemma":0.000008993519,"teacher_disagreement_score":0.98676205,"about_ca_system_score_codex":0.00041657352,"about_ca_system_score_gemma":0.00057271577,"threshold_uncertainty_score":0.99991083},"labels":[],"label_agreement":null},{"id":"W3107470768","doi":"10.1007/s40265-020-01443-4","title":"Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Veterinary medicine and infectious diseases","field":"Veterinary","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Manitoba Health; University of Manitoba","funders":"","keywords":"Bacteria; Medicine; Antibiotics; Protein subunit; Chemistry; Microbiology; Pharmacology; Biology; Biochemistry","score_opus":0.19314762598001795,"score_gpt":0.39461964294737595,"score_spread":0.201472016967358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107470768","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01527179,0.9801882,0.000038364837,0.00010686917,0.0006308765,0.0021671448,0.0013928949,0.00007829388,0.00012559137],"genre_scores_gemma":[0.0071168607,0.99111676,0.00006494686,0.0000717648,0.0005073954,0.00044957586,0.0005100726,0.000090220215,0.000072372655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983565,0.00033988425,0.0006310115,0.00026505505,0.00013485721,0.00027269623],"domain_scores_gemma":[0.9979557,0.0009279596,0.0003410996,0.00059528474,0.00004862996,0.00013133489],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017447185,0.00050289655,0.0017528444,0.00007897324,0.00027000095,0.000039655733,0.00031998096,0.00016739777,0.00007393278],"category_scores_gemma":[0.00007213193,0.00031508438,0.00053304224,0.00014264864,0.00020466391,0.000053802854,0.000118968994,0.00017177891,0.000014643848],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004345811,0.00087392546,8.3354763e-7,0.006669595,0.00060057524,0.000031777825,0.0028369902,6.934436e-8,0.00013196736,0.000027946799,0.0002493175,0.98814243],"study_design_scores_gemma":[0.0012820106,0.011905265,0.000026359248,0.0010006849,0.0019204202,0.00042695127,0.00035214648,0.000026367883,0.0000023739474,0.0000091630955,0.98279214,0.00025612238],"about_ca_topic_score_codex":0.00036098686,"about_ca_topic_score_gemma":0.000010219385,"teacher_disagreement_score":0.9878863,"about_ca_system_score_codex":0.00009309468,"about_ca_system_score_gemma":0.00019652436,"threshold_uncertainty_score":0.99993014},"labels":[],"label_agreement":null},{"id":"W3120183576","doi":"10.1007/s40265-020-01460-3","title":"Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministère de l'Agriculture, des Pêcheries et de l'Alimentation; Western University; University of Calgary","funders":"","keywords":"Medicine; Vedolizumab; Primary sclerosing cholangitis; Immunology; Inflammatory bowel disease; Erythema nodosum; Ulcerative colitis; Crohn's disease; Episcleritis; Scleritis; Pyoderma gangrenosum; Pathology; Uveitis; Disease","score_opus":0.015130346059062215,"score_gpt":0.29102815214469335,"score_spread":0.27589780608563114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120183576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005051447,0.9934246,0.000011791455,0.000012727444,0.00011152828,0.00046445572,0.00015855503,0.000017458693,0.0007474433],"genre_scores_gemma":[0.00060312025,0.99679935,0.00011381449,0.000063499094,0.0002413935,0.00022535244,0.0012336335,0.00007136974,0.00064844824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833894,0.00022172257,0.00043439024,0.0005696611,0.00014048604,0.00029477765],"domain_scores_gemma":[0.9989823,0.00003231522,0.00015080177,0.0005035586,0.000060518116,0.00027048687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016215084,0.00036124437,0.00034474753,0.000118490396,0.0000611689,0.000058949525,0.00019713044,0.00019888063,0.000041921776],"category_scores_gemma":[0.00021957651,0.00037511025,0.0002387928,0.000060504757,0.00011504497,0.0000051407214,0.0001983252,0.00021721092,0.000033469027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001333809,0.00034176625,0.006018664,0.04426506,0.00033079853,0.015448251,0.00034908648,0.00002186915,0.000024556948,0.003508922,0.0045383335,0.9250193],"study_design_scores_gemma":[0.00043796602,0.00001541788,0.011617784,0.005261907,0.0003156837,0.0001380835,0.0000781464,0.000014510346,9.325385e-7,0.000056885692,0.98139614,0.0006665588],"about_ca_topic_score_codex":0.000003021633,"about_ca_topic_score_gemma":0.000016684427,"teacher_disagreement_score":0.9768578,"about_ca_system_score_codex":0.00004719619,"about_ca_system_score_gemma":0.0009889257,"threshold_uncertainty_score":0.99987006},"labels":[],"label_agreement":null},{"id":"W3132622150","doi":"10.1007/s40265-021-01474-5","title":"MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Institute of Infection and Immunity; Canadian Institutes of Health Research","keywords":"microRNA; Coronavirus; Virus; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Coronavirus disease 2019 (COVID-19); Computational biology; Biology; Disease; Gene; Infectious disease (medical specialty); Genetics","score_opus":0.06736692272377537,"score_gpt":0.3338339917871777,"score_spread":0.26646706906340234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132622150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071433093,0.9969855,0.00010386728,0.00007672393,0.00029674912,0.00073369953,0.0001549936,0.0000338423,0.0009002721],"genre_scores_gemma":[0.00067123363,0.9908944,0.00019268724,0.00073383586,0.0006819106,0.000100205194,0.0051188143,0.00012712949,0.0014797817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976576,0.00035244384,0.0005439663,0.0008650369,0.00020572198,0.00037525772],"domain_scores_gemma":[0.99850214,0.00004662953,0.00038010694,0.0007977097,0.00005384393,0.00021955668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025062417,0.0005610661,0.0009136558,0.00010887906,0.00011979205,0.00008920341,0.00040702187,0.0007013702,0.000044203847],"category_scores_gemma":[0.00015586732,0.00046320926,0.00073307793,0.00027866705,0.00014769734,0.000004441497,0.00026652092,0.00024249656,0.00007359213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038957573,0.000173341,0.0000060994357,0.009183126,0.0007297535,0.000053613403,0.00012401327,0.0000063734437,0.0028726368,0.00009112543,0.008924996,0.97779596],"study_design_scores_gemma":[0.0002576603,0.000037231897,5.442854e-7,0.000967664,0.00040937928,0.000051799678,0.00008531688,0.000003987576,0.0018432171,0.000012157201,0.9957669,0.00056416163],"about_ca_topic_score_codex":0.0000072997204,"about_ca_topic_score_gemma":0.000005849226,"teacher_disagreement_score":0.98684186,"about_ca_system_score_codex":0.00015048229,"about_ca_system_score_gemma":0.0020525798,"threshold_uncertainty_score":0.99978197},"labels":[],"label_agreement":null},{"id":"W3182349977","doi":"10.1007/s40265-021-01557-3","title":"Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Ottawa Hospital; Montreal Heart Institute; University of Ottawa; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Dosing; Extracorporeal membrane oxygenation; Intensive care medicine; Antimicrobial; Observational study; Pharmacodynamics; Pharmacokinetics; Pharmacotherapy; Critically ill; Pharmacology; Internal medicine","score_opus":0.030081681397663027,"score_gpt":0.353210350668757,"score_spread":0.32312866927109396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182349977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023784844,0.9939753,0.000012648449,0.00046133096,0.00022613272,0.004230231,0.00018764874,0.000045284723,0.0006236056],"genre_scores_gemma":[0.0008288591,0.9964874,0.0004802147,0.0008864303,0.00016450138,0.00004749087,0.00069017615,0.00013028776,0.00028463578],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9948491,0.0004564521,0.0030202323,0.0006249807,0.00056777155,0.00048147773],"domain_scores_gemma":[0.99653786,0.00043208367,0.00094017276,0.0008025479,0.0010384488,0.0002488863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008420445,0.00065479113,0.00641023,0.00040003538,0.00004020959,0.000029034803,0.00039517359,0.00029969757,0.000248352],"category_scores_gemma":[0.00088194665,0.0005507227,0.0009552487,0.00094750855,0.00011780482,0.00004823343,0.00016677055,0.0007238516,0.00004222136],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016450826,0.00048468448,0.0000018084348,0.9885469,0.0003691925,0.0003819408,0.00009885456,8.875298e-7,0.00018804557,0.00006710859,0.00047686452,0.009367251],"study_design_scores_gemma":[0.0017097937,0.000046473382,0.0000073246897,0.95215625,0.008575753,0.00051081204,0.000025158795,0.000054905624,0.00037144343,0.0000010718214,0.0360572,0.0004838207],"about_ca_topic_score_codex":0.000012874871,"about_ca_topic_score_gemma":0.0000020435868,"teacher_disagreement_score":0.03639067,"about_ca_system_score_codex":0.0001309302,"about_ca_system_score_gemma":0.0003983971,"threshold_uncertainty_score":0.9996944},"labels":[],"label_agreement":null},{"id":"W3190984048","doi":"10.2165/00003495-200262050-00004","title":"Fetal Pharmacotherapy","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; Hospital for Sick Children; Mount Sinai Hospital; SickKids Foundation","funders":"National Institutes of Health","keywords":"Medicine; Pharmacotherapy; Fetus; Pregnancy; Intensive care medicine; Modalities; Toxoplasmosis; Obstetrics; Pediatrics; Immunology; Psychiatry","score_opus":0.0823380204129916,"score_gpt":0.4167268515802221,"score_spread":0.3343888311672305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190984048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.4019828e-7,0.9593846,0.00001761725,0.00015697777,0.00034003213,0.0005519024,0.000021081023,0.00009490222,0.03943255],"genre_scores_gemma":[0.000002669924,0.9759252,0.000071524824,0.00063809246,0.0005874861,0.0000744704,0.000109417146,0.000045916782,0.022545213],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989971,0.000047234356,0.00030491597,0.00021533553,0.00022644096,0.00020896515],"domain_scores_gemma":[0.99922955,0.000053887397,0.00014737267,0.0003294482,0.00001991079,0.00021983434],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010555354,0.00022754508,0.00096462923,0.00012985757,0.000029336914,0.00000738131,0.000114533505,0.00017743523,0.0031997303],"category_scores_gemma":[0.000029883566,0.00015938678,0.00042432957,0.00018945236,0.000041573985,0.000032392152,0.000012101488,0.000362377,0.0017247393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000204005,0.00005754126,3.3669298e-7,0.0060641384,0.00013119743,0.000020063959,0.000099432,1.5196706e-9,3.65532e-7,0.000016750817,0.024613075,0.96899503],"study_design_scores_gemma":[0.00050220493,0.000027403874,5.777097e-7,0.018621497,0.0007754245,0.00017697309,0.0000040769846,0.0000025189513,0.000002973165,0.00000336175,0.97974545,0.00013751668],"about_ca_topic_score_codex":0.0000019991944,"about_ca_topic_score_gemma":2.8864607e-8,"teacher_disagreement_score":0.9688575,"about_ca_system_score_codex":0.00007373397,"about_ca_system_score_gemma":0.00020654917,"threshold_uncertainty_score":0.9990525},"labels":[],"label_agreement":null},{"id":"W3194275796","doi":"10.1007/s40265-021-01581-3","title":"Reply to Zhang and Zhu “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”","year":2021,"lang":"en","type":"letter","venue":"Drugs","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Zhàng; microRNA; Pharmacotherapy; Virology; Pharmacology; Antiviral drug; Antiviral therapy; Drug; Virus; Internal medicine; Biology; Disease; Infectious disease (medical specialty)","score_opus":0.03243220776557968,"score_gpt":0.26826948033941367,"score_spread":0.235837272573834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194275796","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42708945,0.007172476,0.00053042406,0.56039166,0.0008364819,0.0015877304,0.00041737966,0.00010007654,0.0018742732],"genre_scores_gemma":[0.06496683,0.00032841816,0.00053119025,0.92246395,0.003186612,0.00007972038,0.0044207578,0.0001435657,0.003878953],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997841,0.00018676075,0.0003356166,0.0009836006,0.00023794181,0.00041509335],"domain_scores_gemma":[0.9987871,0.000038277693,0.00018919498,0.0007329331,0.00007043507,0.0001820318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019286606,0.000431059,0.000348115,0.00011846905,0.00012944352,0.00012845962,0.00026305357,0.00072702,0.000024743147],"category_scores_gemma":[0.0001649425,0.0004044475,0.00017904936,0.00017060283,0.00013632934,0.0000057235957,0.000302429,0.0003993422,0.000022396413],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119446064,0.000036758614,0.00009755366,0.00038341363,0.00022302143,0.00015915994,0.00033567872,0.000013378977,0.16844398,0.0000056161016,0.8257914,0.0043905545],"study_design_scores_gemma":[0.00037593144,0.0000732044,0.000041499374,0.00006475423,0.000079283825,0.000039123188,0.00016141872,0.000014053661,0.07250344,0.000030771203,0.92609847,0.00051806576],"about_ca_topic_score_codex":0.00003323815,"about_ca_topic_score_gemma":0.0000083289515,"teacher_disagreement_score":0.36212263,"about_ca_system_score_codex":0.000094291,"about_ca_system_score_gemma":0.00054950867,"threshold_uncertainty_score":0.99984074},"labels":[],"label_agreement":null},{"id":"W3195782509","doi":"10.1007/s40265-021-01596-w","title":"Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease","year":2021,"lang":"en","type":"erratum","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministère de l'Agriculture, des Pêcheries et de l'Alimentation; Western University; University of Calgary","funders":"","keywords":"Vedolizumab; Medicine; Inflammatory bowel disease; Pharmacotherapy; Internal medicine; Gastroenterology; Dermatology; Disease","score_opus":0.005440132270510036,"score_gpt":0.2369808581589856,"score_spread":0.23154072588847555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195782509","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8982916,0.0043846946,0.00030585093,0.0005943482,0.0414131,0.001648212,0.00060071994,0.00012496304,0.052636508],"genre_scores_gemma":[0.45563474,0.0010659996,0.0005148691,0.0020737816,0.006224633,0.0007823513,0.012275068,0.0003627479,0.52106583],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983846,0.00012444064,0.00031240485,0.00064525503,0.00020703116,0.00032626858],"domain_scores_gemma":[0.9988958,0.000020428735,0.00010599901,0.00047302258,0.00014089777,0.00036382585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013796148,0.00031751426,0.00014472503,0.00015527393,0.00008929255,0.000080738006,0.00016850395,0.0002233042,0.000056555928],"category_scores_gemma":[0.0005634393,0.0003860546,0.00010251495,0.00006911869,0.000080471415,0.000006451779,0.00019200308,0.0003975679,0.000034431832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029121747,0.00008879609,0.01544337,0.0003612426,0.000038178452,0.002028657,0.00031754252,0.00012629776,0.00080220716,0.00009135536,0.9788688,0.0015423717],"study_design_scores_gemma":[0.00064829737,0.000052740776,0.8116769,0.0006586028,0.00007421662,0.00006876705,0.0003920237,0.0005528387,0.00006698992,0.00007296457,0.18500361,0.0007320408],"about_ca_topic_score_codex":0.000025792177,"about_ca_topic_score_gemma":0.00038841102,"teacher_disagreement_score":0.79623353,"about_ca_system_score_codex":0.000077506,"about_ca_system_score_gemma":0.0009855168,"threshold_uncertainty_score":0.99985915},"labels":[],"label_agreement":null},{"id":"W3197659737","doi":"10.1007/s40265-021-01593-z","title":"Belumosudil: First Approval","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Systemic therapy; Intensive care medicine; Internal medicine; Cancer","score_opus":0.04729427697079658,"score_gpt":0.33894574865560045,"score_spread":0.2916514716848039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197659737","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019740678,0.9741662,0.00008963249,0.000091371076,0.0003368176,0.00075498555,0.000032312822,0.000088958725,0.024437746],"genre_scores_gemma":[0.0000028714326,0.99328923,0.0008003992,0.00007417793,0.00033698586,0.0001195995,0.0010199846,0.00008204341,0.0042746784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841607,0.000062661195,0.00051649497,0.00041670844,0.0003404208,0.00024766344],"domain_scores_gemma":[0.99897116,0.00020237413,0.00013845805,0.0004873105,0.000057366444,0.00014335553],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018142114,0.00031586626,0.0017262076,0.00011277663,0.0000493944,0.00002106553,0.00010899647,0.00032079598,0.00064839504],"category_scores_gemma":[0.000031873875,0.00025965765,0.0005637784,0.00026549931,0.000035949848,0.000021899408,0.0000266931,0.0003574487,0.0010950774],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000024496676,0.00007509128,0.000003945801,0.11099688,0.0002514603,0.0003639865,0.00043326023,5.1752743e-8,1.5643651e-7,0.00037116802,0.0038839788,0.8836176],"study_design_scores_gemma":[0.00028182688,0.000019757415,0.0000012269807,0.036815245,0.0019407966,0.00079252734,0.000049428814,0.000001795373,0.00000455125,0.000003090135,0.95988023,0.00020954474],"about_ca_topic_score_codex":0.000010768733,"about_ca_topic_score_gemma":0.0000020654422,"teacher_disagreement_score":0.9559962,"about_ca_system_score_codex":0.000102738944,"about_ca_system_score_gemma":0.0004282489,"threshold_uncertainty_score":0.9999856},"labels":[],"label_agreement":null},{"id":"W3211648887","doi":"10.1007/s40265-021-01602-1","title":"Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Chronic pain; Fibromyalgia; Cannabis; Headaches; Psychiatry; Addiction; Neurology; Intensive care medicine; Physical therapy","score_opus":0.028610056612344177,"score_gpt":0.3635209370357215,"score_spread":0.33491088042337736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211648887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002525201,0.9748895,0.000006321526,0.022770258,0.00015206343,0.0013997481,0.00006202719,0.0000151558315,0.00045239215],"genre_scores_gemma":[0.00009498663,0.9934371,0.000013690287,0.0007256167,0.00038738703,0.000804724,0.00029588165,0.00005750335,0.0041831075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99580693,0.0008833587,0.0008678443,0.00055147306,0.0013803123,0.00051009236],"domain_scores_gemma":[0.998303,0.00028191754,0.00019471417,0.00066796987,0.00017680746,0.00037561648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019073983,0.00048651136,0.002510518,0.000419894,0.00006299983,0.000025213274,0.0002674007,0.00043071556,0.00047435262],"category_scores_gemma":[0.0010845998,0.0002607114,0.0005283012,0.0008802091,0.0004423895,0.00001690282,0.000042917425,0.00052893884,0.0000050444983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023303879,0.00051299983,0.00006296028,0.012409319,0.00013044689,0.0006779628,0.00091649103,2.1674147e-7,1.8673315e-7,0.000041729938,0.09343529,0.8917891],"study_design_scores_gemma":[0.0013470836,0.00094809785,0.000096098636,0.01216828,0.000695658,0.00015792895,0.0005723976,0.00006844955,0.0000020171312,0.0000036407764,0.9837389,0.00020146766],"about_ca_topic_score_codex":0.001563763,"about_ca_topic_score_gemma":0.0008126453,"teacher_disagreement_score":0.8915876,"about_ca_system_score_codex":0.0003775696,"about_ca_system_score_gemma":0.004397035,"threshold_uncertainty_score":0.9999845},"labels":[],"label_agreement":null},{"id":"W3212182787","doi":"10.1007/s40265-021-01631-w","title":"Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Botulinum toxin; Pharmacology; Anesthesia; Intensive care medicine; Internal medicine","score_opus":0.14034393168162412,"score_gpt":0.39819710387262913,"score_spread":0.257853172191005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212182787","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000631218,0.99576616,0.00026563468,0.0001327457,0.00046528137,0.0015965009,0.000093122806,0.000044124754,0.0015733275],"genre_scores_gemma":[0.0002744395,0.99702275,0.0011213034,0.00014932225,0.00013255113,0.00007127155,0.000396371,0.00007077671,0.00076119334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976237,0.000086302796,0.0011950141,0.00049944565,0.0003170514,0.00027849668],"domain_scores_gemma":[0.9978868,0.0003888499,0.0007325428,0.00053248345,0.0003478999,0.000111436544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030683205,0.00039583613,0.0026169464,0.00021436163,0.00003752459,0.0000063286143,0.00016542069,0.00084150815,0.00014100026],"category_scores_gemma":[0.00037639253,0.0002970786,0.0012398191,0.0008757449,0.00007590162,0.000048854658,0.00008295291,0.00047291105,0.000012748761],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017501618,0.00078495976,0.000003169567,0.06931257,0.000696031,0.000007777958,0.0001768615,0.000010819778,0.000056800018,0.0046417597,0.0009465256,0.92318773],"study_design_scores_gemma":[0.0015424718,0.0010202564,0.000015766642,0.015492992,0.0022854859,0.000117647716,0.000048361268,0.00011517036,0.000037253496,0.00021157356,0.978827,0.0002860213],"about_ca_topic_score_codex":0.000008036245,"about_ca_topic_score_gemma":0.0000015690719,"teacher_disagreement_score":0.9778805,"about_ca_system_score_codex":0.000054557568,"about_ca_system_score_gemma":0.0004631006,"threshold_uncertainty_score":0.99994814},"labels":[],"label_agreement":null},{"id":"W3215398075","doi":"10.1007/s40265-021-01636-5","title":"Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"W. M. Keck Foundation","keywords":"Medicine; Fluvoxamine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pharmacotherapy; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Intensive care medicine; Betacoronavirus; Pandemic; Virology; Psychiatry; Internal medicine; Disease; Outbreak; Infectious disease (medical specialty); Fluoxetine","score_opus":0.16758524708011996,"score_gpt":0.4518696597222465,"score_spread":0.28428441264212656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215398075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017199338,0.9975238,0.0003012642,0.000019586,0.00045408355,0.0014336684,0.00006754768,0.0000035864134,0.00002447297],"genre_scores_gemma":[0.000103872495,0.9986461,0.000049806447,0.000059149672,0.0002502669,0.00068137253,0.00013590966,0.000017735285,0.000055825734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881905,0.00018410147,0.00042446435,0.00030178248,0.000119585704,0.00015100767],"domain_scores_gemma":[0.99886423,0.00024214738,0.0003654857,0.0003499172,0.00014931492,0.000028924753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030442516,0.0002468532,0.0010011848,0.000020926735,0.00003220168,0.000005698335,0.00017371257,0.00013439023,0.000021370955],"category_scores_gemma":[0.0002513253,0.00013800467,0.00089154765,0.00014453424,0.000045198896,0.0000018951071,0.00007663266,0.000067385365,0.0000033781696],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007928236,0.00011855128,3.896506e-7,0.047190737,0.00020903528,3.881649e-7,0.0000070829815,6.436318e-8,0.0052885315,0.00003298727,0.0021377695,0.94500655],"study_design_scores_gemma":[0.00013285133,0.0007128043,6.430895e-7,0.040568948,0.0009956354,0.0000036458262,5.868939e-7,6.778226e-7,0.042203147,0.0000032286234,0.9152601,0.00011775316],"about_ca_topic_score_codex":0.0000120836985,"about_ca_topic_score_gemma":0.0000011036547,"teacher_disagreement_score":0.9448888,"about_ca_system_score_codex":0.000032003438,"about_ca_system_score_gemma":0.00019467126,"threshold_uncertainty_score":0.56276673},"labels":[],"label_agreement":null},{"id":"W363749682","doi":"10.2165/00003495-200565090-00004","title":"Traditional and Newer Therapeutic Options for Psoriatic Arthritis","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Krembil Foundation","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Pathogenesis; Arthritis; Disease; Tumor necrosis factor alpha; Inflammatory arthritis; Inflammation; Immunology; Clinical trial; Dermatology; Intensive care medicine; Internal medicine","score_opus":0.06488033340554322,"score_gpt":0.29955361725219976,"score_spread":0.23467328384665653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W363749682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012305937,0.996693,0.000040054503,0.000069459784,0.000935109,0.00071421964,0.001060473,0.000047573798,0.00042781766],"genre_scores_gemma":[0.000041871142,0.9928027,0.00021548432,0.00006240766,0.00034683233,0.0006679406,0.0025274095,0.000035479734,0.0032998899],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989493,0.00014290362,0.00031372232,0.00031847146,0.00002287147,0.00025276706],"domain_scores_gemma":[0.99921906,0.00041773266,0.00013240344,0.00018377464,0.000023809735,0.00002321771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011896736,0.0003019872,0.0008195656,0.000117596275,0.00019702064,0.000019614497,0.000111780944,0.00041505936,0.00046524472],"category_scores_gemma":[0.000010989693,0.00024498568,0.00037981954,0.00007618463,0.000083578954,0.000049065202,0.000011657732,0.00013861929,0.0003424091],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007273794,0.000082083876,2.174397e-7,0.00037370477,0.0006190107,7.447734e-7,0.0000807486,3.685577e-8,0.0000022666286,0.004283887,0.0023305763,0.99221945],"study_design_scores_gemma":[0.00093286525,0.00007203807,0.00000918192,0.000856294,0.0014018583,0.000095272975,0.00001648995,1.9925322e-7,0.0000035033393,0.00055485003,0.9958164,0.00024105472],"about_ca_topic_score_codex":0.0000034559,"about_ca_topic_score_gemma":0.0000049291884,"teacher_disagreement_score":0.9934858,"about_ca_system_score_codex":0.00004265054,"about_ca_system_score_gemma":0.00010940789,"threshold_uncertainty_score":0.99902266},"labels":[],"label_agreement":null},{"id":"W36416826","doi":"10.2165/00003495-200767140-00005","title":"Drugs for the Perioperative Control of Hypertension","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Pharmacotherapy; Perioperative; Intensive care medicine; Pharmacology; Internal medicine; Anesthesia","score_opus":0.06763410134101555,"score_gpt":0.3513217376158047,"score_spread":0.28368763627478916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W36416826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005398953,0.9887495,0.00027608994,0.0006760539,0.00023326436,0.002157498,0.000033757333,0.000022656022,0.007845798],"genre_scores_gemma":[0.00015630927,0.99103695,0.00009006435,0.0011699476,0.0004082862,0.00013880485,0.000055042947,0.000047664525,0.0068969205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851406,0.000104479404,0.00055046915,0.0002563971,0.0003273246,0.0002472567],"domain_scores_gemma":[0.99462897,0.0044912673,0.00018338204,0.00040926927,0.0001900323,0.00009706912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077418063,0.00030445354,0.003225371,0.00009587242,0.000078942234,0.000011918738,0.00012491997,0.00025603292,0.000054578944],"category_scores_gemma":[0.0002460125,0.00014413432,0.002287307,0.00016613353,0.00017395405,0.00001831359,0.000018080293,0.0002549136,0.00003613292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010085748,0.0000415534,0.000004217303,0.004044392,0.00050094613,0.000027913653,0.00033312547,1.6013769e-7,7.7489534e-7,0.003160104,0.0006225297,0.99116343],"study_design_scores_gemma":[0.001244532,0.00008592053,0.00001208655,0.0019690713,0.0032976307,0.00012403684,0.00021283048,0.000012682265,0.0000024643127,0.0000015857238,0.9928851,0.00015205817],"about_ca_topic_score_codex":0.0000147065175,"about_ca_topic_score_gemma":3.2482905e-7,"teacher_disagreement_score":0.99226254,"about_ca_system_score_codex":0.000051572082,"about_ca_system_score_gemma":0.00021182362,"threshold_uncertainty_score":0.5877627},"labels":[],"label_agreement":null},{"id":"W4210391151","doi":"10.1007/s40265-021-01666-z","title":"Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Tolerability; Heart failure; Ejection fraction; Guideline; Intensive care medicine; Internal medicine; Population; Pharmacotherapy; Cardiology; Adverse effect; Pathology","score_opus":0.03752179838557585,"score_gpt":0.3217152077680374,"score_spread":0.28419340938246157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210391151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002657507,0.9877611,0.0000047864346,0.00090460206,0.00024683567,0.0037540034,0.000030982716,0.00015113286,0.0068808342],"genre_scores_gemma":[0.0004939597,0.98805285,0.0012406136,0.00004399586,0.00016694401,0.0010622231,0.0012065183,0.00008327162,0.007649622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826545,0.0001541425,0.0004911155,0.00048913754,0.00038584988,0.00021432106],"domain_scores_gemma":[0.9988535,0.00010635967,0.00034451537,0.0005410065,0.00003992992,0.000114712224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001249179,0.00044197487,0.0018137114,0.00032416396,0.00009864519,0.0000113226115,0.000053803033,0.00010686385,0.00060916546],"category_scores_gemma":[0.000008750099,0.0002993446,0.00049009046,0.00040901414,0.00003758953,0.00010181095,0.00002677579,0.00019973221,0.00007252482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023988503,0.001052412,0.000046516932,0.0068134833,0.0012885809,0.00007322813,0.00031273637,0.0000011190588,0.000007660261,0.000020292824,0.050364286,0.9397798],"study_design_scores_gemma":[0.0016806542,0.0012486859,0.0000069641474,0.0025313527,0.0017343482,0.00004478811,0.0007881802,7.3589194e-7,0.000049873892,0.0000016408688,0.991693,0.00021973602],"about_ca_topic_score_codex":0.00014564004,"about_ca_topic_score_gemma":0.000007107867,"teacher_disagreement_score":0.94132876,"about_ca_system_score_codex":0.0007577189,"about_ca_system_score_gemma":0.0004461006,"threshold_uncertainty_score":0.9999459},"labels":[],"label_agreement":null},{"id":"W4220973253","doi":"10.1007/s40265-022-01688-1","title":"Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"","keywords":"Microbiology; Antimicrobial; Penicillin binding proteins; Medicine; Antibiotics; Stenotrophomonas maltophilia; Cephalosporin; Enterococcus faecium; Bacteria; Penicillin; Biology; Pseudomonas aeruginosa","score_opus":0.03217992979468121,"score_gpt":0.3241709958498625,"score_spread":0.29199106605518127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220973253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11796267,0.87743413,0.00009458775,0.00003401194,0.00047577382,0.002707952,0.0011542058,0.000015518433,0.000121128665],"genre_scores_gemma":[0.005993067,0.9909978,0.0007258429,0.000021632863,0.00022589942,0.00039094302,0.0010447878,0.000076921184,0.0005231062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984601,0.00017687735,0.00045286192,0.0005373406,0.000101166865,0.0002716442],"domain_scores_gemma":[0.99875915,0.00014251364,0.0002502089,0.00070090994,0.000040961473,0.00010625346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020624252,0.00037901112,0.00084428216,0.00006832479,0.00022587067,0.0000480755,0.00030001547,0.00018089559,0.000089905276],"category_scores_gemma":[0.0000411461,0.00026538793,0.00031686175,0.00011178502,0.0000951736,0.00000510724,0.00010469082,0.0000796769,0.0000025525087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023921285,0.0022152998,0.000026850179,0.0017073231,0.00047989842,0.000021256445,0.00040709955,0.0000035593362,0.0013720043,0.000050211544,0.00021464832,0.99326265],"study_design_scores_gemma":[0.000317945,0.0038943423,0.00053345907,0.00018551842,0.0004787982,0.00009916618,0.00015450221,0.0000023832047,0.00018684959,0.000003050507,0.99385244,0.0002915658],"about_ca_topic_score_codex":0.00011060907,"about_ca_topic_score_gemma":0.00008423532,"teacher_disagreement_score":0.9936378,"about_ca_system_score_codex":0.000087669825,"about_ca_system_score_gemma":0.00022949575,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W4223567640","doi":"10.1007/s40265-022-01696-1","title":"Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Sexuality, Behavior, and Technology","field":"Psychology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Karolinska Institutet","keywords":"Paraphilia; Psychiatry; Medicine; Comorbidity; Anxiety; Distress; Clinical psychology; Libido; Sexual behavior","score_opus":0.11686110352792967,"score_gpt":0.4537111908426252,"score_spread":0.3368500873146955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223567640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005325856,0.98843586,0.000006614777,0.00022771707,0.0011486238,0.007548321,0.0011419707,0.00028077143,0.00067755685],"genre_scores_gemma":[0.000009519606,0.96471274,0.00004579973,0.00030675632,0.00020718825,0.025175985,0.001802861,0.00012766171,0.007611482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99607885,0.0006250153,0.00096344185,0.0013874461,0.00022620274,0.00071904704],"domain_scores_gemma":[0.9977598,0.00072952657,0.00050757127,0.00079872576,0.000038529717,0.00016582542],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034202647,0.0008717941,0.0029094142,0.00024503932,0.0003229376,0.00002523588,0.0005929026,0.00056201924,0.0053385706],"category_scores_gemma":[0.000038633727,0.0006856341,0.0005844354,0.00040566723,0.00029488702,0.00003423582,0.0003199732,0.00065835874,0.00011846443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016015692,0.0017963791,0.00012139311,0.0046787625,0.00035333462,0.00007590457,0.00031707794,8.039133e-9,8.7197286e-8,0.0015795765,0.0023986024,0.98866284],"study_design_scores_gemma":[0.0014048294,0.0013175035,0.000026995747,0.00054652727,0.007950853,0.00023402434,0.0006284266,3.656448e-7,5.158374e-8,0.000031035655,0.98719126,0.0006681277],"about_ca_topic_score_codex":0.0002536686,"about_ca_topic_score_gemma":0.00004061018,"teacher_disagreement_score":0.98799473,"about_ca_system_score_codex":0.0002311992,"about_ca_system_score_gemma":0.00012300098,"threshold_uncertainty_score":0.99955946},"labels":[],"label_agreement":null},{"id":"W4223580441","doi":"10.1007/s40265-022-01707-1","title":"Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Waterloo; Montfort Hospital; University of British Columbia; Ottawa Hospital","funders":"","keywords":"Medicine; Systematic review; Common Terminology Criteria for Adverse Events; Interquartile range; Adverse effect; Incidence (geometry); Data extraction; MEDLINE; Internal medicine; Oncology; Intensive care medicine","score_opus":0.1008775101479818,"score_gpt":0.3539215827697252,"score_spread":0.2530440726217434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223580441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023023855,0.9921495,5.499065e-7,0.00001667447,0.00034494876,0.00600804,0.00006459359,0.00003979936,0.001352872],"genre_scores_gemma":[0.00001740639,0.9959492,0.000024191575,0.00006122106,0.00006746951,0.001086925,0.0004530829,0.0000887985,0.0022516937],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953959,0.0008483456,0.0024212862,0.00038230166,0.00067299337,0.0002791628],"domain_scores_gemma":[0.99582046,0.00028924266,0.0028341387,0.00090950466,0.000066379835,0.00008025607],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024828452,0.0005316019,0.0054642074,0.0002247725,0.00006499917,0.000004263272,0.00028411695,0.00020359358,0.0010500832],"category_scores_gemma":[0.00039151643,0.00032954096,0.0019710213,0.0009986159,0.00006127106,0.0000509339,0.0000964099,0.00046550683,0.000048027763],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094279174,0.00025569843,0.000003046977,0.87702113,0.0019767315,0.000031427877,0.00030566493,3.0496928e-8,0.000003078463,0.000004785483,0.000396962,0.119907185],"study_design_scores_gemma":[0.0007713664,0.00017485664,0.0000052310556,0.4373972,0.0031877842,0.00007228033,0.00007843395,2.3639927e-7,0.000002804814,0.0000011427715,0.5581019,0.00020677222],"about_ca_topic_score_codex":0.00007838769,"about_ca_topic_score_gemma":0.0000030668675,"teacher_disagreement_score":0.5577049,"about_ca_system_score_codex":0.0008069808,"about_ca_system_score_gemma":0.0005105863,"threshold_uncertainty_score":0.99991566},"labels":[],"label_agreement":null},{"id":"W4235055282","doi":"10.1007/s40265-017-0719-z","title":"Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview","year":2017,"lang":"en","type":"erratum","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Inflammatory bowel disease; Pharmacotherapy; Drug; Antibody; Incidence (geometry); Disease; Biological drugs; Pharmacology; Immunology; Intensive care medicine; Internal medicine","score_opus":0.030616717790005837,"score_gpt":0.34854795751473017,"score_spread":0.3179312397247243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235055282","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17045307,0.6458716,0.00023887132,0.017449375,0.048370346,0.0075351885,0.0010004847,0.00035277952,0.108728305],"genre_scores_gemma":[0.197335,0.36257145,0.0031957496,0.0020567724,0.00046053188,0.00019841015,0.00082967494,0.00018438807,0.43316802],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733424,0.0005401211,0.0007140808,0.0007276211,0.00015653971,0.0005274202],"domain_scores_gemma":[0.9983599,0.00013853467,0.0005286386,0.0007810573,0.00010796546,0.00008391156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010125382,0.0004953228,0.0009404001,0.0003196056,0.00020314417,0.00008143672,0.0004468917,0.0006033212,0.00006659176],"category_scores_gemma":[0.00013786415,0.0004117704,0.00023658665,0.00013421984,0.00064992154,0.00019441934,0.00062616356,0.0009375423,0.00003450109],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005507643,0.00084251934,0.027631236,0.010162357,0.002179288,0.00034458347,0.00079440244,0.0000013166906,0.0021338172,0.0068364465,0.91983473,0.028688554],"study_design_scores_gemma":[0.0010091814,0.000103121776,0.43491614,0.008172512,0.0008092526,0.000011768841,0.00042713256,0.000022269904,0.00044026406,0.002070177,0.5511725,0.00084568484],"about_ca_topic_score_codex":0.000027928343,"about_ca_topic_score_gemma":0.00004816761,"teacher_disagreement_score":0.4072849,"about_ca_system_score_codex":0.00005128831,"about_ca_system_score_gemma":0.00020836991,"threshold_uncertainty_score":0.9998334},"labels":[],"label_agreement":null},{"id":"W4248311589","doi":"10.2165/00003495-200464110-00008","title":"The Management of Hypertension in the Overweight and Obese Patient","year":2004,"lang":"en","type":"article","venue":"Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Overweight; Pharmacotherapy; Obesity; Intensive care medicine; Weight management; Internal medicine","score_opus":0.011819959847611973,"score_gpt":0.25127476589534564,"score_spread":0.23945480604773367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248311589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907937,0.0010663136,0.0000015028526,0.0044053695,0.000044018358,0.00023190009,5.932248e-7,0.0000037623743,0.0034528088],"genre_scores_gemma":[0.997952,0.00081699406,0.00008572526,0.0010393203,0.000007704378,0.000013104407,0.0000015581472,0.0000019393508,0.00008167059],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99967945,0.000019252944,0.000073219635,0.00006246602,0.00009159581,0.0000740491],"domain_scores_gemma":[0.99982023,0.000033437675,0.000017696799,0.00010310781,0.000009294866,0.000016211412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094488205,0.000040412775,0.00006241555,0.000013941559,0.000052068375,0.0000020343562,0.00003159219,0.00001606797,0.0000049563596],"category_scores_gemma":[0.0000017919353,0.000018191271,0.000017363851,0.000049094393,0.00004606574,0.000011442535,0.00002411004,0.000051355477,0.000006579687],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004551336,0.016484112,0.08045878,0.0012288954,0.0024525018,0.0072662686,0.09781533,0.00023231497,0.010919567,0.12319354,0.015571896,0.63982546],"study_design_scores_gemma":[0.010776038,0.00086810277,0.91839445,0.0003504072,0.0004988183,0.00013130976,0.007822065,0.00006418249,0.018815875,0.0054554855,0.03668616,0.00013712511],"about_ca_topic_score_codex":0.000025273956,"about_ca_topic_score_gemma":0.0000039169363,"teacher_disagreement_score":0.8379356,"about_ca_system_score_codex":0.000023111203,"about_ca_system_score_gemma":0.0000075238045,"threshold_uncertainty_score":0.074181855},"labels":[],"label_agreement":null},{"id":"W4281252334","doi":"10.1007/s40265-022-01722-2","title":"New Topical Therapies in Development for Atopic Dermatitis","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Dupilumab; Roflumilast; Intensive care medicine; Apremilast; Dermatology; Disease; Calcineurin; Drug development; Ruxolitinib; Adverse effect; Drug; Pharmacology; Psoriasis; Surgery; Internal medicine; Transplantation","score_opus":0.04522105744302725,"score_gpt":0.3383699868870051,"score_spread":0.29314892944397786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281252334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003366043,0.99646586,0.000029070303,0.0003599263,0.0002238336,0.0007300798,0.0000068744353,0.00003136358,0.0021193428],"genre_scores_gemma":[0.000023930503,0.99396825,0.0008589327,0.0005717536,0.00009654978,0.00046287253,0.0002712922,0.000020996711,0.0037254493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910605,0.000056704375,0.00035283712,0.0001916896,0.000114785485,0.00017792199],"domain_scores_gemma":[0.9994892,0.00018304637,0.00006731843,0.00017204204,0.00000723992,0.000081163256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060439314,0.00017034265,0.0008633647,0.000119667704,0.000055593926,0.0000074350023,0.00011503066,0.00013189777,0.0011762313],"category_scores_gemma":[0.000045103472,0.00013725592,0.00021722876,0.000102951635,0.00001748116,0.00001896957,0.000048090467,0.00019447938,0.000044129716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027940193,0.000038713068,0.00024271096,0.006959045,0.000092061266,0.000059784674,0.00043729806,5.9636367e-9,1.120616e-9,0.00025873983,0.026610265,0.9652986],"study_design_scores_gemma":[0.00044998288,0.00001014561,0.00039292182,0.0017425484,0.00016660444,0.00009475754,0.00005249954,2.77322e-7,4.143626e-7,0.00012619467,0.9968348,0.00012885105],"about_ca_topic_score_codex":0.000006463476,"about_ca_topic_score_gemma":0.0000070095352,"teacher_disagreement_score":0.97022456,"about_ca_system_score_codex":0.00011271163,"about_ca_system_score_gemma":0.0008146476,"threshold_uncertainty_score":0.99973685},"labels":[],"label_agreement":null},{"id":"W4281898190","doi":"10.1007/s40265-022-01726-y","title":"Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Myasthenia gravis; Adverse effect; Eculizumab; Clinical trial; Pharmacotherapy; Immunology; Pharmacology; Antibody; Intensive care medicine; Internal medicine; Complement system","score_opus":0.07444458558377065,"score_gpt":0.373637324116084,"score_spread":0.2991927385323134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281898190","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013137737,0.98581487,0.0000057741745,0.00012960423,0.00044211568,0.0015362275,0.00028366086,0.000071435396,0.010402553],"genre_scores_gemma":[0.00004482374,0.9933462,0.00031068208,0.00058306695,0.0018430516,0.0002183698,0.00051986915,0.00012148742,0.0030124374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99730146,0.00032477034,0.00076476,0.0006276636,0.00059414713,0.00038721348],"domain_scores_gemma":[0.9984273,0.00015134027,0.000542936,0.0006303731,0.000054836873,0.0001932269],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003349314,0.0006107238,0.0028632572,0.00032838402,0.00010186265,0.00001670535,0.00032972303,0.00021839338,0.018690348],"category_scores_gemma":[0.000019678437,0.00035626194,0.00090242585,0.0005697008,0.00013055484,0.000020006615,0.000063287465,0.00052763923,0.00010700238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005483829,0.00037364307,0.00001276306,0.0018565307,0.0006147575,0.00011423476,0.0002226357,2.503634e-7,0.000013734988,0.0005569,0.008658747,0.9870274],"study_design_scores_gemma":[0.002224755,0.0010733502,0.0000070594588,0.001956494,0.0010306409,0.00011559971,0.000031655654,8.074063e-7,0.000029614343,0.00004115808,0.9931203,0.00036858025],"about_ca_topic_score_codex":0.00003273368,"about_ca_topic_score_gemma":7.9486415e-7,"teacher_disagreement_score":0.9866588,"about_ca_system_score_codex":0.00011576742,"about_ca_system_score_gemma":0.00026599894,"threshold_uncertainty_score":0.99988896},"labels":[],"label_agreement":null},{"id":"W4285587068","doi":"10.1007/s40265-022-01747-7","title":"Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Levodopa; Dyskinesia; Parkinson's disease; Physical medicine and rehabilitation; Disease; Quality of life (healthcare); Intensive care medicine; Internal medicine","score_opus":0.029926289269795955,"score_gpt":0.29602218998937174,"score_spread":0.2660959007195758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285587068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041327998,0.99175286,0.000052672385,0.00030042266,0.00023609765,0.0045012045,0.0023788272,0.00006984566,0.00029477477],"genre_scores_gemma":[0.0012121837,0.9866287,0.00059602153,0.0010014595,0.00027525992,0.0062549477,0.002744853,0.00012624463,0.0011603034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764144,0.00015626464,0.00052774366,0.0008190559,0.00043828695,0.00041719014],"domain_scores_gemma":[0.9981496,0.00042735893,0.00028304037,0.00041045612,0.00003788428,0.000691668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002836885,0.00053862954,0.0015509841,0.0003356575,0.0001374967,0.000044033648,0.00015372336,0.00015809014,0.00017198699],"category_scores_gemma":[0.00016650485,0.00046184027,0.000526327,0.00023661582,0.000077091754,0.00007591422,0.00007946084,0.00028717113,0.000018262343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052102725,0.00068206934,0.0005414606,0.017078573,0.000784492,0.00017865005,0.0002098875,8.6989854e-7,8.5522174e-7,0.0016580313,0.0016932872,0.9766508],"study_design_scores_gemma":[0.0054974086,0.000121095945,0.0004245247,0.00222057,0.0024628022,0.000009978642,0.000042967433,0.00036768726,1.8312682e-7,0.00073425745,0.98775667,0.00036185764],"about_ca_topic_score_codex":0.000032521948,"about_ca_topic_score_gemma":0.0000017918967,"teacher_disagreement_score":0.98606336,"about_ca_system_score_codex":0.00036785245,"about_ca_system_score_gemma":0.0010916607,"threshold_uncertainty_score":0.99978334},"labels":[],"label_agreement":null},{"id":"W4296027776","doi":"10.1007/s40265-022-01773-5","title":"Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Versus Arthritis; Università degli Studi di Palermo; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Osteoarthritis; Multimodal therapy; Physical therapy; Quality of life (healthcare); Knee pain; Pharmacotherapy; Psychological intervention; Multidisciplinary approach; Intensive care medicine; Physical medicine and rehabilitation; Alternative medicine; Surgery; Internal medicine; Pathology","score_opus":0.014340027231513426,"score_gpt":0.2693155871649119,"score_spread":0.25497555993339843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296027776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05852141,0.91393596,0.000059154692,0.00009884103,0.00044830455,0.022235857,0.0013422043,0.0001524937,0.0032057965],"genre_scores_gemma":[0.06719639,0.7995252,0.06501428,0.00067843305,0.00022591687,0.049411293,0.013554368,0.0011092862,0.0032848555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972287,0.00022700384,0.000773242,0.0006855537,0.00063933124,0.00044618858],"domain_scores_gemma":[0.9987673,0.00009486181,0.00022608611,0.00054728356,0.00007846409,0.00028601673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016929918,0.0005312391,0.0014625862,0.0006319908,0.00010707457,0.000017873703,0.00014375222,0.00011828551,0.00015319887],"category_scores_gemma":[0.00001995309,0.00045540096,0.00025856172,0.0008040802,0.000019012792,0.000070575465,0.00030324128,0.00018866132,0.000037404385],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005553285,0.0008490903,0.00005054423,0.0026556582,0.00014247854,0.00022940269,0.004490437,0.00004479917,2.5091404e-7,0.000061014733,0.000090973655,0.99083],"study_design_scores_gemma":[0.038633496,0.061060145,0.00021414274,0.10867472,0.0029272246,0.00004511527,0.036850296,0.00007645798,0.000020611446,0.00008792767,0.74825776,0.0031521202],"about_ca_topic_score_codex":0.000022096068,"about_ca_topic_score_gemma":0.000069561305,"teacher_disagreement_score":0.9876779,"about_ca_system_score_codex":0.00039056735,"about_ca_system_score_gemma":0.00013332098,"threshold_uncertainty_score":0.9997898},"labels":[],"label_agreement":null},{"id":"W4307250618","doi":"10.1007/s40265-022-01797-x","title":"Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection","year":2022,"lang":"en","type":"article","venue":"Drugs","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Victoria","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Placebo; Clinical endpoint; Internal medicine; Adverse effect; Diarrhea; Randomized controlled trial; Intention-to-treat analysis; Gastroenterology","score_opus":0.026048548276320364,"score_gpt":0.32775974972869437,"score_spread":0.301711201452374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307250618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799342,0.00094869355,0.0017078526,0.00041236205,0.00010602875,0.016423287,0.00006282686,0.000020783682,0.00038394786],"genre_scores_gemma":[0.99520355,0.0005074998,0.000058893995,0.000013135443,0.00012093301,0.0034852363,0.00027154613,0.000024539115,0.00031468898],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967596,0.0004697643,0.0011998445,0.0004282482,0.00081310055,0.0003294622],"domain_scores_gemma":[0.9966998,0.0020002546,0.0005749461,0.00042081162,0.00020310993,0.00010108831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032458093,0.00025353814,0.001830528,0.0007653692,0.00020711252,0.00002093278,0.00013614516,0.000083729174,0.00015462398],"category_scores_gemma":[0.00031551538,0.00016614936,0.00068686577,0.0015703299,0.00020981711,0.00005887763,0.00011544937,0.00041793214,2.7407984e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98063815,0.0033696566,0.00013272956,0.00017870219,0.0023892168,0.0000035396204,0.0009323022,0.0010801156,0.001527725,0.000074156575,0.00005129744,0.0096224295],"study_design_scores_gemma":[0.97893757,0.0037086504,0.0000848083,0.000086459244,0.0041226363,0.0000070740875,0.0004826423,0.007403383,0.004794841,0.000015810143,0.00020446873,0.00015166943],"about_ca_topic_score_codex":0.00049164006,"about_ca_topic_score_gemma":0.000118687385,"teacher_disagreement_score":0.015269308,"about_ca_system_score_codex":0.0002568904,"about_ca_system_score_gemma":0.0004548043,"threshold_uncertainty_score":0.67753744},"labels":[],"label_agreement":null},{"id":"W4308369849","doi":"10.1007/s40265-022-01805-0","title":"Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection","year":2022,"lang":"en","type":"erratum","venue":"Drugs","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Victoria","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Placebo; Clostridioides; Pharmacotherapy; Double blind; Randomized controlled trial; Internal medicine; Intensive care medicine; Alternative medicine; Pathology","score_opus":0.024358580413731075,"score_gpt":0.3212606948621724,"score_spread":0.29690211444844133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308369849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.812722,0.013726692,0.004328473,0.0020461772,0.031468302,0.10916759,0.00037678285,0.00019267555,0.025971286],"genre_scores_gemma":[0.8715834,0.0095754545,0.00008156555,0.000045784738,0.0026636773,0.01585315,0.008040761,0.00021050342,0.09194573],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940546,0.0007462111,0.0022297348,0.0009041089,0.0015181692,0.00054717815],"domain_scores_gemma":[0.9939178,0.002861371,0.0015858447,0.00083524786,0.000619168,0.00018054295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004330066,0.00062932144,0.0042248,0.0018288807,0.00026229912,0.0000972208,0.00027330828,0.0005081363,0.00048444996],"category_scores_gemma":[0.0010351563,0.00041995355,0.0015649406,0.0027856235,0.0003817047,0.00015339839,0.00017815352,0.0016866003,5.114859e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9288875,0.0037289115,0.000032569424,0.0006420924,0.0061878287,0.00000638347,0.000644612,0.00026882903,0.0000384925,0.000015533891,0.04926867,0.010278597],"study_design_scores_gemma":[0.9670981,0.0041697947,0.00003487978,0.00050862046,0.011770923,0.0000139779995,0.00041355187,0.0040300223,0.00019021521,0.000011077361,0.011406315,0.0003524893],"about_ca_topic_score_codex":0.0012180939,"about_ca_topic_score_gemma":0.0005553305,"teacher_disagreement_score":0.09331444,"about_ca_system_score_codex":0.0006560169,"about_ca_system_score_gemma":0.0017571817,"threshold_uncertainty_score":0.99982524},"labels":[],"label_agreement":null},{"id":"W4311672195","doi":"10.1007/s40265-022-01817-w","title":"The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Bedaquiline; Context (archaeology); Linezolid; Medicine; Tuberculosis; Intensive care medicine; Pandemic; Pharmacology; Coronavirus disease 2019 (COVID-19); Mycobacterium tuberculosis; Disease; Biology; Pathology; Infectious disease (medical specialty); Vancomycin","score_opus":0.07595104663412834,"score_gpt":0.38811534592005165,"score_spread":0.3121642992859233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311672195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000830261,0.990251,0.000015379721,0.0026734846,0.00022197106,0.0048307143,0.0007920549,0.000029564431,0.0003555565],"genre_scores_gemma":[0.00013438537,0.99354005,0.00011869452,0.0003599937,0.00027854813,0.0033267278,0.00033168236,0.00007314813,0.0018367891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970496,0.00032428806,0.00086393295,0.00064222893,0.0004007799,0.0007191682],"domain_scores_gemma":[0.99119014,0.007101489,0.0002916487,0.0010233535,0.00007938649,0.00031398135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014231218,0.00046593734,0.0020011466,0.00017666623,0.0004928288,0.000029392473,0.00036359183,0.00020148093,0.00014884878],"category_scores_gemma":[0.0006725505,0.00021685606,0.00079247373,0.00035641057,0.00022902335,0.000023579323,0.00017718428,0.00036650788,0.000008793148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021587088,0.00014729692,0.000064413776,0.0019770702,0.0013751639,0.0000045054403,0.0011018636,7.505896e-7,0.000004308393,0.000050587147,0.006668802,0.9883894],"study_design_scores_gemma":[0.0011572498,0.00097387313,0.00009460174,0.0006821226,0.0016823726,0.000086613996,0.0005365773,0.00004677973,0.000005441709,0.000012615464,0.99452525,0.00019648208],"about_ca_topic_score_codex":0.0013749505,"about_ca_topic_score_gemma":0.00026688195,"teacher_disagreement_score":0.98819286,"about_ca_system_score_codex":0.00046420257,"about_ca_system_score_gemma":0.00044370114,"threshold_uncertainty_score":0.88431334},"labels":[],"label_agreement":null},{"id":"W4353015627","doi":"10.1007/s40265-023-01859-8","title":"The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"Sleep and related disorders","field":"Psychology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Meta-analysis; Randomized controlled trial; Tolerability; Confidence interval; Insomnia; Placebo; Primary Insomnia; Systematic review; Relative risk; Internal medicine; Psychiatry; MEDLINE; Sleep disorder; Adverse effect; Alternative medicine","score_opus":0.14544743302878824,"score_gpt":0.43565685232434453,"score_spread":0.2902094192955563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353015627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000031782986,0.98637474,0.00003001256,0.00003397927,0.00022091306,0.01218286,0.00012943984,0.000023713494,0.0010011795],"genre_scores_gemma":[0.0000718593,0.99696386,0.000006997266,0.00003486479,0.00001796977,0.0024869728,0.00006495179,0.000037548933,0.0003149586],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9636277,0.03135621,0.003937875,0.0005151442,0.00029574428,0.00026734156],"domain_scores_gemma":[0.93447506,0.060488578,0.0040401034,0.0007842485,0.0001456163,0.000066404835],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02823165,0.0005676706,0.039219644,0.0003267005,0.0001251208,0.00002375286,0.0003434005,0.00036198893,0.00010571169],"category_scores_gemma":[0.0016760889,0.00025377295,0.0062356945,0.002153568,0.0004892941,0.000024921266,0.00010394128,0.00035199846,0.000023815923],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010073539,0.000032609987,7.8669494e-8,0.36348888,0.62951833,7.767026e-7,0.0011468786,0.0000051020975,1.987753e-9,0.0018300707,0.00021875412,0.0027511765],"study_design_scores_gemma":[0.011632427,0.000020000642,4.9842123e-7,0.06585731,0.9159006,0.0000023229995,0.00042319106,0.0000059649883,1.8006528e-8,0.00018204298,0.005764466,0.00021115474],"about_ca_topic_score_codex":0.0000869533,"about_ca_topic_score_gemma":0.0000088692395,"teacher_disagreement_score":0.2976316,"about_ca_system_score_codex":0.000020941841,"about_ca_system_score_gemma":0.000058777678,"threshold_uncertainty_score":0.9999915},"labels":[],"label_agreement":null},{"id":"W4378171864","doi":"10.1007/s40265-023-01872-x","title":"New Pharmacologic Approaches to the Treatment of Bipolar Depression","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of Ottawa; Université de Montréal; McGill University; University of British Columbia","funders":"","keywords":"Lurasidone; Bipolar disorder; Medicine; Randomized controlled trial; Antidepressant; Mood; Atypical depression; Mood disorders; Psychiatry; Schizophrenia (object-oriented programming); Internal medicine; Anxiety; Antipsychotic","score_opus":0.30201206338410325,"score_gpt":0.36725527057051566,"score_spread":0.06524320718641241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378171864","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033159187,0.9973039,0.000018355606,0.00014412738,0.00035045078,0.0012146471,0.000047520996,0.00009387063,0.0007939627],"genre_scores_gemma":[0.000025324674,0.99550414,0.000045628494,0.00011653086,0.00016393504,0.00016815256,0.000008285356,0.00003740542,0.0039306227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864185,0.0002148339,0.0002657652,0.00043755525,0.00020775943,0.00023223858],"domain_scores_gemma":[0.99893516,0.00045238345,0.00015380829,0.00035978836,0.0000033542847,0.00009548379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008096076,0.0002629857,0.0006158852,0.00012442916,0.00008504193,0.00002452402,0.0005327182,0.00010134618,0.000072852396],"category_scores_gemma":[0.000059639737,0.00013185854,0.00034470123,0.0006576496,0.0000387577,0.00002433482,0.000087702705,0.0001019079,0.00064919604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034354816,0.00007643009,3.607708e-7,0.0006726432,0.000016127142,0.00000343921,0.00043481257,0.000003539838,0.000023743589,0.00007844311,0.0036414494,0.9950456],"study_design_scores_gemma":[0.00014935173,0.00007119568,0.0000015950518,0.00045097555,0.00010565764,0.0000023187067,0.000034778237,0.000004958877,0.0011366244,0.00003706401,0.99787146,0.00013402561],"about_ca_topic_score_codex":0.000028813616,"about_ca_topic_score_gemma":0.0000035061266,"teacher_disagreement_score":0.99491155,"about_ca_system_score_codex":0.00005004955,"about_ca_system_score_gemma":0.00012161425,"threshold_uncertainty_score":0.8344318},"labels":[],"label_agreement":null},{"id":"W4379094806","doi":"10.1007/s40265-023-01882-9","title":"Targeting IL-23 for IBD: Rationale and Progress to Date","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"","keywords":"Medicine; Ustekinumab; Ulcerative colitis; Interleukin 23; Inflammatory bowel disease; Crohn's disease; Psoriasis; Disease; Immunology; Clinical trial; Internal medicine; Gastroenterology; Immune system; Interleukin 17; Adalimumab","score_opus":0.05452225443549843,"score_gpt":0.3243609393276801,"score_spread":0.2698386848921817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379094806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056909346,0.9959768,0.00001276689,0.000074879004,0.0008003207,0.0016402636,0.0012509549,0.00009185705,0.0000952365],"genre_scores_gemma":[0.0000038665585,0.9770507,0.00036301816,0.000029636829,0.0001638895,0.0014851785,0.007584984,0.000051314986,0.013267378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888366,0.00011425939,0.00030401893,0.00039149422,0.000022602053,0.00028393135],"domain_scores_gemma":[0.9993008,0.00032660403,0.0001370784,0.00017287553,0.00003772749,0.000024930374],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002576456,0.0002642424,0.0007625739,0.00012962695,0.00018082662,0.000022628066,0.00014953988,0.0002858509,0.00004114837],"category_scores_gemma":[0.00005786286,0.00020705776,0.00021796471,0.00014662194,0.0000435743,0.0000305655,0.00009381342,0.000090723,0.0012706202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017684197,0.0000259081,0.0000035691257,0.0027483818,0.0006332298,0.0000028094005,0.00026606876,8.9848186e-8,0.000017685263,0.0002722093,0.018704247,0.9773081],"study_design_scores_gemma":[0.00032627155,0.00004565091,0.0000021656185,0.0010856349,0.0006791825,0.0000100436,0.000048485395,2.225266e-7,0.000034136156,0.000027861033,0.9975251,0.00021525325],"about_ca_topic_score_codex":0.0000036433403,"about_ca_topic_score_gemma":0.00000229856,"teacher_disagreement_score":0.97882086,"about_ca_system_score_codex":0.000019438416,"about_ca_system_score_gemma":0.00008223098,"threshold_uncertainty_score":0.999507},"labels":[],"label_agreement":null},{"id":"W4385564760","doi":"10.1007/s40265-023-01923-3","title":"Recent Advances in Antiarrhythmic Drug Therapy","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; ZonMw; European Commission; Danmarks Frie Forskningsfond; Universitätsklinikum Essen","keywords":"Medicine; Repurposing; Drug development; Intensive care medicine; Drug; Atrial fibrillation; Anti-Arrhythmia Agents; Cardiac electrophysiology; Cardiac arrhythmia; Torsades de pointes; Ventricular fibrillation; Cardiology; Pharmacology; Internal medicine; QT interval; Electrophysiology","score_opus":0.029735199168989385,"score_gpt":0.3505080686278434,"score_spread":0.320772869458854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385564760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020880377,0.9958144,3.0011475e-7,0.00020249626,0.00061356724,0.0010242221,0.000018123445,0.00013655108,0.0019815774],"genre_scores_gemma":[0.000009041944,0.9963105,0.000013072889,0.00019578879,0.00090219727,0.00021303359,0.00022495446,0.00008869304,0.002042763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820644,0.00019413732,0.000496503,0.00049999036,0.00018198001,0.0004209729],"domain_scores_gemma":[0.9990455,0.0002234249,0.00017274122,0.00044353292,0.000035454905,0.0000793554],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027340124,0.00037489043,0.0020428384,0.00032180664,0.00004405739,0.000008070824,0.00010028756,0.00020101895,0.00010371063],"category_scores_gemma":[0.000049721555,0.00027664733,0.0005726131,0.0007873863,0.00007163201,0.000058382288,0.000044110464,0.0007613843,0.00092332036],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036828544,0.00002639438,0.0000018163968,0.0032630942,0.000094721196,0.00051800604,0.00008001881,8.389398e-7,5.7228135e-7,0.000051937088,0.0013392974,0.99458647],"study_design_scores_gemma":[0.00044408214,0.00005303985,0.0000122842885,0.007820677,0.00013575339,0.00020264849,0.000015747924,0.0000010168961,0.0000032165185,0.00013799536,0.99092776,0.00024580257],"about_ca_topic_score_codex":0.000005061435,"about_ca_topic_score_gemma":0.0000057875923,"teacher_disagreement_score":0.99434066,"about_ca_system_score_codex":0.0001230832,"about_ca_system_score_gemma":0.00035964244,"threshold_uncertainty_score":0.9999686},"labels":[],"label_agreement":null},{"id":"W4386945070","doi":"10.1007/s40265-023-01934-0","title":"Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; DNA repair; Drug resistance; Cancer; Cancer research; Homologous recombination; Poly ADP ribose polymerase; Tumor microenvironment; Disease; Polymerase; Biology; Internal medicine; DNA; Genetics","score_opus":0.07922667141945612,"score_gpt":0.4102456523476324,"score_spread":0.3310189809281763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945070","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022287963,0.9944177,0.000005244336,0.001038443,0.0011438353,0.0012021791,0.0010754768,0.000088635294,0.0010061808],"genre_scores_gemma":[0.0000044650865,0.99390274,0.000098029894,0.000043647757,0.0030349563,0.0011764581,0.00075112766,0.000072419985,0.00091617316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984427,0.00007662724,0.000581121,0.00041352396,0.00026653745,0.00021945749],"domain_scores_gemma":[0.9989626,0.000075459546,0.0003168614,0.00039437765,0.00009003292,0.00016068116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000078397374,0.0003740756,0.0014610934,0.00025308153,0.00007222479,0.000014376492,0.000045562618,0.00022355953,0.00040743864],"category_scores_gemma":[0.0000035569956,0.00028285314,0.00039712034,0.00046811765,0.00010822065,0.000039936298,0.000023432984,0.00021123218,0.00006851902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016620317,0.00014783889,0.000004292695,0.010041485,0.00032808306,0.000016676428,0.00047223317,1.3458886e-7,0.0000010323547,0.0012718466,0.0033170218,0.98438275],"study_design_scores_gemma":[0.0013686944,0.00015090258,0.000014431989,0.012189511,0.0013459582,0.000058802118,0.00007121022,0.0000011714321,0.000011108467,0.00016101156,0.9844184,0.00020879968],"about_ca_topic_score_codex":0.000043597836,"about_ca_topic_score_gemma":0.000008029385,"teacher_disagreement_score":0.98417395,"about_ca_system_score_codex":0.00048152456,"about_ca_system_score_gemma":0.00057992496,"threshold_uncertainty_score":0.9999624},"labels":[],"label_agreement":null},{"id":"W4387948572","doi":"10.1007/s40265-023-01950-0","title":"Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Universitätsklinikum Essen","keywords":"Nintedanib; Medicine; Pirfenidone; Idiopathic pulmonary fibrosis; Clinical trial; Intensive care medicine; Disease; Drug development; Clinical endpoint; Internal medicine; Lung; Drug; Pharmacology","score_opus":0.03746512349581604,"score_gpt":0.3395187922293471,"score_spread":0.30205366873353107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387948572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011268754,0.9944902,0.00000460014,0.0002269784,0.0011905415,0.0021504483,0.0013356464,0.00017599987,0.0004143335],"genre_scores_gemma":[0.000033771044,0.9901477,0.000039952873,0.000023563163,0.005970438,0.0010810515,0.0015056771,0.0001527588,0.0010450971],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792343,0.00007055283,0.00059364404,0.0007185455,0.00024338788,0.00045040622],"domain_scores_gemma":[0.9988429,0.00010900918,0.00021974435,0.00042115786,0.00007387102,0.00033335038],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016673403,0.00063069846,0.0020479714,0.00025738688,0.00015699268,0.000048678856,0.00012451995,0.00036489675,0.000033736753],"category_scores_gemma":[0.000018271781,0.00044283885,0.0012120641,0.00026392256,0.000057423782,0.00005584301,0.00008171852,0.0002773345,0.000121418925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033328222,0.00017046185,0.0000037012574,0.07530436,0.00023273217,0.00006615663,0.000080715596,1.8959932e-8,4.2565074e-7,0.00018992776,0.0019292006,0.92168903],"study_design_scores_gemma":[0.00044328792,0.0015423227,0.000009511143,0.03527696,0.0041376846,0.00013946972,0.00009667746,0.00004750277,3.1189194e-7,0.000043408116,0.9578732,0.00038962997],"about_ca_topic_score_codex":0.000010524828,"about_ca_topic_score_gemma":7.600653e-7,"teacher_disagreement_score":0.95594406,"about_ca_system_score_codex":0.00020083123,"about_ca_system_score_gemma":0.00042552935,"threshold_uncertainty_score":0.99980235},"labels":[],"label_agreement":null},{"id":"W4391754408","doi":"10.1007/s40265-024-02005-8","title":"Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression","year":2024,"lang":"en","type":"erratum","venue":"Drugs","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of Ottawa; Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Pharmacotherapy; Depression (economics); Bipolar disorder; Psychiatry; MEDLINE; Psychotherapist; Intensive care medicine; Psychology; Lithium (medication)","score_opus":0.0630032793385217,"score_gpt":0.2979588516626277,"score_spread":0.234955572324106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391754408","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005352589,0.7834789,0.00008215439,0.009151504,0.06945181,0.0027085647,0.00012394204,0.00023930316,0.13422853],"genre_scores_gemma":[0.0124193905,0.017905388,0.00012712141,0.00023754183,0.0040137386,0.00025867435,0.00064744847,0.000082258164,0.96430844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875706,0.000046781,0.00024118017,0.00043118827,0.00029957117,0.00022420919],"domain_scores_gemma":[0.9992303,0.00004745811,0.00007865983,0.00044334965,0.000024771301,0.00017542478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006107029,0.00033795438,0.0004914065,0.00015064239,0.000077393284,0.00002104103,0.000117456926,0.00027152654,0.00030247885],"category_scores_gemma":[0.000008188709,0.00017636595,0.00031972706,0.00029464957,0.000034750494,0.00001658669,0.00004569718,0.000369246,0.00037117553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008122455,0.0005292898,0.00047951107,0.00010198838,0.00051753916,0.000009432705,0.0022048366,0.0000040163363,0.000010711794,0.000007684418,0.733196,0.26285776],"study_design_scores_gemma":[0.00077907194,0.0009023183,0.0014756866,0.0002332,0.0018540168,0.000034294917,0.0002474806,0.00015274563,0.0010979513,0.00003108529,0.99305016,0.00014198513],"about_ca_topic_score_codex":0.0005299921,"about_ca_topic_score_gemma":0.00014703882,"teacher_disagreement_score":0.8300799,"about_ca_system_score_codex":0.00023492379,"about_ca_system_score_gemma":0.00036878634,"threshold_uncertainty_score":0.7191995},"labels":[],"label_agreement":null},{"id":"W4392236254","doi":"10.1007/s40265-024-02008-5","title":"Eplontersen: First Approval","year":2024,"lang":"en","type":"article","venue":"Drugs","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transthyretin; Medicine; Amyloidosis; Polyneuropathy; Pharmacology; Antisense therapy; Internal medicine; Oligonucleotide; Biochemistry; Gene; Biology","score_opus":0.0075525067745106055,"score_gpt":0.2517355677165025,"score_spread":0.2441830609419919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392236254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650798,0.00839891,0.0004221505,0.005590545,0.001115165,0.00034776283,0.000070315335,0.00019029561,0.018785063],"genre_scores_gemma":[0.9929414,0.00040895812,0.00036478342,0.0005508909,0.00032292024,0.000079368874,0.00010433099,0.000037167152,0.005190203],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991846,0.000018178614,0.000122243,0.0003627624,0.00009861908,0.00021358409],"domain_scores_gemma":[0.9995807,0.000021442072,0.000019575573,0.00029437884,0.000016603866,0.000067334695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006689582,0.00015222178,0.00010879944,0.000038006703,0.0000551033,0.000051618943,0.00013354853,0.00009637277,0.000075596254],"category_scores_gemma":[0.000023816016,0.00013156705,0.00014454643,0.00007495074,0.000049383107,0.000003631944,0.00009216006,0.00006231659,0.00035715834],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021272124,0.0008069207,0.05260999,0.0005582948,0.0020863544,0.00035107913,0.0032271377,0.00009689042,0.09941864,0.005781433,0.7520888,0.08276175],"study_design_scores_gemma":[0.00044713603,0.00013769422,0.0017614752,0.00004180884,0.00006232765,0.000022222019,0.0002621603,0.00009680054,0.08294724,0.000076365955,0.9138689,0.000275838],"about_ca_topic_score_codex":0.000027418204,"about_ca_topic_score_gemma":0.000026599624,"teacher_disagreement_score":0.16178015,"about_ca_system_score_codex":0.000025587566,"about_ca_system_score_gemma":0.00003757734,"threshold_uncertainty_score":0.5365149},"labels":[],"label_agreement":null},{"id":"W4399193083","doi":"10.1007/s40265-024-02038-z","title":"Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions","year":2024,"lang":"en","type":"review","venue":"Drugs","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Centre for Addiction and Mental Health; Health Sciences Centre; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital; York University; University of Toronto","funders":"","keywords":"Medicine; Postpartum depression; Breastfeeding; Sertraline; Postpartum period; Psychiatry; Intensive care medicine; Tolerability; Behavioral activation; Antidepressant; Depression (economics); Pregnancy; Adverse effect; Pediatrics; Pharmacology","score_opus":0.14346525389096457,"score_gpt":0.5070232233612373,"score_spread":0.36355796947027275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399193083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002210376,0.99636227,5.0597487e-7,0.0001916929,0.0009813966,0.0015979437,0.00029792433,0.000040102394,0.00050606206],"genre_scores_gemma":[0.000024846782,0.9984879,0.000022455444,0.00008843916,0.00032334012,0.00018548993,0.00021587935,0.00003799373,0.0006136881],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997719,0.00021213036,0.0011649537,0.00040343855,0.00020934413,0.0002911457],"domain_scores_gemma":[0.99868363,0.00015890661,0.0003319797,0.00044360026,0.000038633567,0.00034322546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042881494,0.00037750838,0.0022081318,0.000106550346,0.000045028217,0.000008782018,0.00007734685,0.0001608944,0.00012671776],"category_scores_gemma":[0.000045334975,0.00020881549,0.0009633397,0.00013905967,0.00007459191,0.000025709787,0.00011159364,0.00042138447,0.00015828732],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014067518,0.00012356578,0.000064520354,0.47316006,0.00012167042,0.000019561225,0.000017632454,5.3056554e-10,1.8743387e-9,0.0000140866405,0.0012414152,0.52522343],"study_design_scores_gemma":[0.00013564674,0.0002430911,0.000064689826,0.48832688,0.0025952992,0.00018695118,7.8733285e-7,6.319864e-7,1.6395533e-7,0.00000677964,0.5083593,0.000079775724],"about_ca_topic_score_codex":0.000023370856,"about_ca_topic_score_gemma":6.778544e-7,"teacher_disagreement_score":0.5251436,"about_ca_system_score_codex":0.00016200315,"about_ca_system_score_gemma":0.0005899611,"threshold_uncertainty_score":0.85152483},"labels":[],"label_agreement":null},{"id":"W4399707657","doi":"10.1007/s40265-024-02051-2","title":"Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians","year":2024,"lang":"en","type":"review","venue":"Drugs","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Biogen","keywords":"Spinal muscular atrophy; SMA*; Medicine; Clinical trial; Physical medicine and rehabilitation; Physical therapy; Disease; Intensive care medicine; Pathology","score_opus":0.09045282201644811,"score_gpt":0.44300561900128715,"score_spread":0.35255279698483905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024616975,0.99160063,0.00046650934,0.00014548954,0.00010557528,0.0058191875,0.00006774227,0.000045797868,0.0017244233],"genre_scores_gemma":[0.000025717456,0.98940027,0.0032840876,0.00003460425,0.00022834477,0.0037960396,0.0006162052,0.00011402487,0.0025007175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790734,0.0001490791,0.0005944285,0.000637871,0.0002934037,0.00041787085],"domain_scores_gemma":[0.9990991,0.00006552009,0.00007950533,0.00056855526,0.000039378632,0.00014797907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002556945,0.00039414552,0.0015750445,0.0004371504,0.00004647965,0.000033044176,0.00014728981,0.00023717308,0.00002187345],"category_scores_gemma":[0.000059785405,0.00026818595,0.0014434906,0.00046034454,0.00006674203,0.0000141823675,0.000053658103,0.0003810301,0.00015536454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023020706,0.0004829493,8.7182514e-7,0.046601646,0.00046024218,0.000083355015,0.00011130055,0.0000014251341,2.8371468e-7,0.000299374,0.00026084724,0.9516747],"study_design_scores_gemma":[0.0010666572,0.0008132458,0.0000026962796,0.005189826,0.0038999284,0.00010232022,0.00013807515,0.0002964021,1.2650474e-7,0.000054149994,0.98823214,0.00020442784],"about_ca_topic_score_codex":0.000032926477,"about_ca_topic_score_gemma":0.000004280329,"teacher_disagreement_score":0.9879713,"about_ca_system_score_codex":0.0002677411,"about_ca_system_score_gemma":0.00085531897,"threshold_uncertainty_score":0.99997705},"labels":[],"label_agreement":null},{"id":"W4402036755","doi":"10.1007/s40265-024-02082-9","title":"Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination","year":2024,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Manitoba Health; University of Manitoba","funders":"Biomedical Advanced Research and Development Authority","keywords":"Cefepime; Meropenem; Pseudomonas aeruginosa; Cephalosporin; Microbiology; Efflux; Medicine; Pharmacology; Biology; Imipenem; Antibiotic resistance; Antibiotics; Bacteria; Biochemistry; Genetics","score_opus":0.020420994014872736,"score_gpt":0.3101739363660325,"score_spread":0.2897529423511598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402036755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00087095244,0.9932016,0.00008394401,0.000034342873,0.0017308518,0.0006816078,0.00031627942,0.00006430887,0.003016082],"genre_scores_gemma":[0.0015455788,0.9873656,0.0002855828,0.000053500225,0.0012785197,0.000048847454,0.002262566,0.00018003426,0.0069797835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976438,0.00007707008,0.00067843776,0.00091643445,0.0002718034,0.00041241932],"domain_scores_gemma":[0.9985957,0.000027487837,0.00033399032,0.0008087657,0.00009561413,0.0001384058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002601677,0.0006329874,0.00097592204,0.00013886533,0.000069138245,0.00013054446,0.00045686006,0.00073539774,0.000046494602],"category_scores_gemma":[0.00008358858,0.0005393571,0.00061315397,0.0002870989,0.000114413146,0.000006667656,0.00027208985,0.00038630702,0.00046693068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010704252,0.0010555614,0.000026247717,0.057845704,0.0018423165,0.00015481253,0.00021997635,3.475221e-7,0.010083469,0.0045404593,0.120634116,0.8034899],"study_design_scores_gemma":[0.0002456234,0.00008514798,0.000004810066,0.0039153732,0.00065890205,0.000040283983,0.00002468455,0.0000019091108,0.00033339192,0.000029219069,0.9940847,0.00057593477],"about_ca_topic_score_codex":0.0000073902697,"about_ca_topic_score_gemma":0.000004180549,"teacher_disagreement_score":0.8734506,"about_ca_system_score_codex":0.000113796996,"about_ca_system_score_gemma":0.00040300834,"threshold_uncertainty_score":0.9997058},"labels":[],"label_agreement":null},{"id":"W4404312631","doi":"10.1007/s40265-024-02111-7","title":"The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab","year":2024,"lang":"en","type":"review","venue":"Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Merck","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Pharmacotherapy; Intensive care medicine; Immunotherapy; Cancer","score_opus":0.12585733132406987,"score_gpt":0.4139733711353599,"score_spread":0.2881160398112901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404312631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016611438,0.9793614,1.8488815e-7,0.000059238027,0.00040908117,0.0023285768,0.000023528934,0.000012956549,0.0011935993],"genre_scores_gemma":[0.047991894,0.95115346,0.0000016141801,0.000024969331,0.000052628446,0.0001621543,0.0000149986145,0.000030912783,0.0005673482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983622,0.0003427916,0.00072948734,0.00021208187,0.00022234592,0.0001311138],"domain_scores_gemma":[0.9989289,0.00016392121,0.00035612125,0.00046147147,0.000070769696,0.000018782961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058998505,0.00019534091,0.0009002714,0.00012465048,0.000050419105,0.000010904415,0.00019085575,0.00017891203,0.000013318877],"category_scores_gemma":[0.000040678315,0.00008619826,0.00029474037,0.0009709594,0.00011650238,0.000014929889,0.0000791221,0.00036585104,0.0000020569844],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024410081,0.00038177692,0.000006582359,0.004955279,0.00038526664,0.0001993562,0.0033397372,1.2394462e-7,0.000005235201,0.00001871151,0.0003463639,0.9901175],"study_design_scores_gemma":[0.0019577355,0.0005027645,0.00001563855,0.0053640828,0.00096364494,0.00080951763,0.006647028,0.000015354064,0.000016843367,0.000005915359,0.9836034,0.00009803849],"about_ca_topic_score_codex":0.00057905045,"about_ca_topic_score_gemma":0.00048323412,"teacher_disagreement_score":0.99001944,"about_ca_system_score_codex":0.00022128176,"about_ca_system_score_gemma":0.0010588268,"threshold_uncertainty_score":0.35150632},"labels":[],"label_agreement":null},{"id":"W4410076578","doi":"10.1007/s40265-025-02183-z","title":"Differentiating IL-23 Inhibitors in Crohn’s Disease","year":2025,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Crohn's disease; Pharmacotherapy; Interleukin 23; Crohn disease; Disease; Internal medicine; Immunology; Pharmacology; Gastroenterology; Interleukin 17; Inflammation","score_opus":0.009250379546394055,"score_gpt":0.2783835885818696,"score_spread":0.26913320903547555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410076578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028738028,0.9942099,0.0000067970327,0.000008140047,0.0004360586,0.0007049588,0.00028791785,0.000023882258,0.0014485382],"genre_scores_gemma":[0.00089163403,0.99384755,0.000020225807,0.00008280679,0.00042318302,0.00028867766,0.0016795555,0.000058530077,0.002707817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981535,0.0002132761,0.00052523596,0.0006051662,0.00015481291,0.00034797328],"domain_scores_gemma":[0.99893093,0.000028657803,0.00019305217,0.0006259604,0.000036349935,0.00018503233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001440381,0.00042207778,0.00059686805,0.00017530621,0.000058634774,0.00004378658,0.000345739,0.00030299296,0.000024386376],"category_scores_gemma":[0.0002276429,0.0003979269,0.0005252216,0.00015723868,0.000048779137,0.0000028154661,0.00033890008,0.00022959054,0.00006721654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006508376,0.00017487384,0.0008853777,0.042580917,0.00016614882,0.00071589823,0.00005608335,0.0000038538196,0.000010039393,0.0001473361,0.0065597612,0.9486346],"study_design_scores_gemma":[0.0003122385,0.0000057477164,0.0031171914,0.009317199,0.0003434396,0.0000010212336,0.000017279595,0.0000039959436,0.000008289479,0.00003304834,0.9862558,0.0005847541],"about_ca_topic_score_codex":0.0000045290217,"about_ca_topic_score_gemma":0.000014348818,"teacher_disagreement_score":0.97969604,"about_ca_system_score_codex":0.00006485257,"about_ca_system_score_gemma":0.0007071137,"threshold_uncertainty_score":0.99984723},"labels":[],"label_agreement":null},{"id":"W4412492425","doi":"10.1007/s40265-025-02204-x","title":"Managing Pain in Fibromyalgia: Current and Future Options","year":2025,"lang":"en","type":"review","venue":"Drugs","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital; Sinai Health System; University of Toronto; University Health Network; Toronto General Hospital; Women's College Hospital","funders":"","keywords":"Medicine; Pregabalin; Gabapentin; Fibromyalgia; Duloxetine; Analgesic; Psychological intervention; Neuromodulation; Chronic pain; Pharmacotherapy; Intensive care medicine; Anesthesia; Psychiatry; Internal medicine; Alternative medicine","score_opus":0.025462753940830356,"score_gpt":0.35072953547389324,"score_spread":0.3252667815330629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412492425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000042929933,0.9963384,0.000017120856,0.00085258763,0.00023808528,0.0009946658,0.000024011488,0.000047318274,0.0014834682],"genre_scores_gemma":[0.0000022821837,0.997148,0.00019411878,0.0000030257431,0.00010967304,0.00017126983,0.0003112517,0.000035271412,0.0020251323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979912,0.00029497844,0.00045601596,0.00050584885,0.00030497447,0.00044697194],"domain_scores_gemma":[0.99900895,0.00026108604,0.00007800857,0.00045658,0.000034679142,0.00016070582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006998439,0.00035033733,0.0013116653,0.0006668683,0.00006729365,0.000037493028,0.00016406388,0.00028143,0.00018277476],"category_scores_gemma":[0.000065675544,0.00028331697,0.00027971173,0.0007702389,0.00007327077,0.000043349886,0.00016583702,0.0010844525,0.00005287252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000223018,0.000034199293,0.0000032589014,0.30638424,0.000043963428,0.00003716442,0.000055984783,3.7080287e-8,3.6316308e-8,0.00040203737,0.0028626367,0.6901742],"study_design_scores_gemma":[0.00036020228,0.00006453458,0.000023623565,0.14849018,0.0002479685,0.000048822236,0.0001053626,0.00002750738,5.1973302e-8,0.00011281021,0.85032165,0.0001972786],"about_ca_topic_score_codex":0.000017674533,"about_ca_topic_score_gemma":4.8506536e-7,"teacher_disagreement_score":0.847459,"about_ca_system_score_codex":0.00031186928,"about_ca_system_score_gemma":0.00086801226,"threshold_uncertainty_score":0.9999619},"labels":[],"label_agreement":null},{"id":"W4413112966","doi":"10.1007/s40265-025-02201-0","title":"Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management","year":2025,"lang":"en","type":"review","venue":"Drugs","topic":"Diabetes Management and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Medicine; Insulin; Clinical trial; Basal insulin; Intensive care medicine; Type 2 diabetes; Clinical Practice; Diabetes mellitus; Diabetes management; Family medicine; Internal medicine; Endocrinology","score_opus":0.4631296135121979,"score_gpt":0.5785854293964696,"score_spread":0.11545581588427173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413112966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000087576474,0.9788006,0.00080848025,0.0017070358,0.002115047,0.011501625,0.00027632696,0.00010562684,0.004597676],"genre_scores_gemma":[0.00001536536,0.95075184,0.036494084,0.0003100182,0.0014945478,0.0004668921,0.0019015337,0.00008855852,0.008477154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914041,0.001157123,0.0042471965,0.001570637,0.0009267208,0.000694204],"domain_scores_gemma":[0.98568726,0.010010657,0.0010566965,0.0027120332,0.00023270164,0.00030065206],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008609832,0.0005534751,0.0042390325,0.00043782245,0.00010097509,0.00011316983,0.0012514475,0.0007114085,0.000047451424],"category_scores_gemma":[0.008795913,0.00042528793,0.0015889719,0.0007328926,0.000434139,0.0002983934,0.001404051,0.0013320382,0.000050089246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019762942,0.0013645755,0.00010352083,0.07102504,0.0019107307,0.000017885279,0.000017642074,1.3396894e-7,2.7020373e-8,0.0005492653,0.039386835,0.88364804],"study_design_scores_gemma":[0.019505344,0.0010384282,0.000021581585,0.027419845,0.006085499,1.7155573e-7,0.000029606234,0.0010670136,1.6935815e-7,0.000117008174,0.9443824,0.0003329185],"about_ca_topic_score_codex":0.000004350046,"about_ca_topic_score_gemma":0.000003878441,"teacher_disagreement_score":0.90499556,"about_ca_system_score_codex":0.00007129187,"about_ca_system_score_gemma":0.0009985085,"threshold_uncertainty_score":0.9998199},"labels":[],"label_agreement":null},{"id":"W4414195667","doi":"10.1007/s40265-025-02223-8","title":"Update on Medical Treatment of Cushing’s Syndrome","year":2025,"lang":"en","type":"review","venue":"Drugs","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pharmacotherapy; Somatostatin; Disease; Medical treatment; Adverse effect; Medical therapy; Etiology; Glucocorticoid","score_opus":0.024887513794131233,"score_gpt":0.34590200606276056,"score_spread":0.3210144922686293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414195667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007824789,0.97989434,0.0000013830853,0.00019602316,0.00023595967,0.000696088,0.0001345817,0.000035238183,0.018728165],"genre_scores_gemma":[0.0002103548,0.994046,0.000025563675,0.00013011988,0.00004731743,0.0001005305,0.00091808656,0.000023649989,0.004498432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985726,0.00005476728,0.00043253164,0.0003341876,0.00039685104,0.00020909043],"domain_scores_gemma":[0.999066,0.00014714432,0.00012920955,0.00045461784,0.000019250125,0.00018379629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006285554,0.00035752566,0.0020371363,0.00022837186,0.00003097964,0.0000049064092,0.000112013346,0.00027761015,0.00047909236],"category_scores_gemma":[0.000041458316,0.00020879715,0.00062803505,0.00019628921,0.000040991985,0.000014731287,0.000028956954,0.00012620984,0.00026791438],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002295061,0.0010658761,0.000033090146,0.008374613,0.00077869487,0.00076200085,0.000040106224,1.6279374e-8,1.0547595e-9,0.000233765,0.0013231864,0.9873657],"study_design_scores_gemma":[0.0017137425,0.0007461912,0.000020701571,0.022628317,0.002333161,0.00014347372,0.00000879707,7.3611415e-7,2.9397498e-7,0.000056329423,0.97221774,0.00013054458],"about_ca_topic_score_codex":0.00007073158,"about_ca_topic_score_gemma":0.0000039304846,"teacher_disagreement_score":0.9872351,"about_ca_system_score_codex":0.00014489751,"about_ca_system_score_gemma":0.00066493626,"threshold_uncertainty_score":0.8514501},"labels":[],"label_agreement":null},{"id":"W4417078467","doi":"10.1007/s40265-025-02263-0","title":"Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review","year":2025,"lang":"en","type":"article","venue":"Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Tolerability; Discontinuation; Adverse effect; Pharmacovigilance; Clinical trial; Randomized controlled trial; Narrative review; Acute kidney injury","score_opus":0.006647036455436086,"score_gpt":0.26435928212973053,"score_spread":0.25771224567429446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417078467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8257742,0.030427067,0.00009282547,0.024436591,0.00075556536,0.004324219,0.00008080238,0.0000705758,0.11403814],"genre_scores_gemma":[0.84231496,0.023282517,0.001467077,0.005829812,0.000034238536,0.00015827903,0.00012400215,0.000027634786,0.12676147],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913305,0.000060628136,0.0003537109,0.00018588557,0.00014889904,0.00011784891],"domain_scores_gemma":[0.9993189,0.0000643706,0.00012373141,0.00035706724,0.000097886346,0.000038020906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002978162,0.00011056272,0.00043961115,0.000035002355,0.000042431915,0.0000039368565,0.00007148395,0.000020710779,0.0000988003],"category_scores_gemma":[0.00008325763,0.00007394912,0.00010501143,0.00023374267,0.00014162673,0.000038124224,0.00009761287,0.00006484702,0.000007897726],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011960547,0.0020231267,0.050689925,0.029842358,0.0023920638,0.000004767329,0.014766581,0.00000397187,0.0019998043,0.0052417484,0.44976798,0.44207162],"study_design_scores_gemma":[0.0024076265,0.00031867498,0.028097413,0.0074587925,0.00065611914,4.9375376e-7,0.0009061845,0.00001742805,0.0062782182,0.0005758804,0.9531304,0.0001527638],"about_ca_topic_score_codex":0.000021670385,"about_ca_topic_score_gemma":0.000010563573,"teacher_disagreement_score":0.5033624,"about_ca_system_score_codex":0.0000672359,"about_ca_system_score_gemma":0.00007280084,"threshold_uncertainty_score":0.30155578},"labels":[],"label_agreement":null},{"id":"W58682306","doi":"10.2165/00003495-200464050-00002","title":"Treatment of HIV Infection in Pregnant Women","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University; University of Toronto; Montreal General Hospital","funders":"","keywords":"Zidovudine; Medicine; Nevirapine; Lamivudine; Regimen; Pregnancy; Viral load; Clinical trial; Pharmacotherapy; Obstetrics; Pediatrics; Immunology; Internal medicine; Antiretroviral therapy; Human immunodeficiency virus (HIV); Viral disease","score_opus":0.04148333842112486,"score_gpt":0.38624661947773914,"score_spread":0.3447632810566143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W58682306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020015615,0.9899249,0.000009621821,0.00002359024,0.00002698305,0.0009223694,0.00006796114,0.000016186865,0.008808239],"genre_scores_gemma":[0.000054731634,0.9664132,0.000020172449,0.0000011173328,0.000052768497,0.00044221882,0.00020950158,0.00001955541,0.03278676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989443,0.00007429824,0.0004068373,0.00017645386,0.00016327968,0.00023486401],"domain_scores_gemma":[0.9994734,0.000032236316,0.00010102229,0.0002462735,0.00003377402,0.000113312104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008920706,0.00015939612,0.0009544782,0.00040493568,0.000013832989,0.000005574593,0.00004305008,0.00011373012,0.00042767398],"category_scores_gemma":[0.00004498641,0.00010674354,0.00043865966,0.0003004355,0.00003657564,0.000029367711,0.00001693014,0.00013523972,0.0002276896],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008727209,0.00077313144,0.000058079513,0.018060006,0.00013495817,0.000024514147,0.00050829246,1.0810068e-7,3.3679194e-7,0.000058310023,0.00030526117,0.98006827],"study_design_scores_gemma":[0.0008202938,0.0026525236,0.000036973586,0.047233205,0.00013442394,0.000024301631,0.000027440326,0.0000026149826,0.0000055243645,0.000022493226,0.94896835,0.000071847804],"about_ca_topic_score_codex":0.0002937242,"about_ca_topic_score_gemma":0.00002290832,"teacher_disagreement_score":0.97999644,"about_ca_system_score_codex":0.0012405143,"about_ca_system_score_gemma":0.00045368302,"threshold_uncertainty_score":0.468273},"labels":[],"label_agreement":null},{"id":"W7506166","doi":"10.2165/00003495-199300461-00044","title":"A Thesis in Two Parts: Estimating Willingness-to-Pay for Cellulosic Wood Ethanol and Examining the Social Costs of Hydroelectric Production in Quebec, Canada","year":2012,"lang":"en","type":"article","venue":"Drugs","topic":"Forest Management and Policy","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cellulosic ethanol; Production (economics); Hydroelectricity; Willingness to pay; Natural resource economics; Economics; Environmental science; Microeconomics; Engineering","score_opus":0.012770651477598994,"score_gpt":0.25180264966272503,"score_spread":0.23903199818512605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7506166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997618,0.000024797759,0.000024178658,0.0010386211,0.00009307579,0.00036580293,0.000001172804,0.0000052507526,0.00082908396],"genre_scores_gemma":[0.9989042,0.0000017570308,0.0002525825,0.000120187964,0.00010957438,0.000066348366,0.0000019598958,0.000007879699,0.0005354717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993103,0.000046303856,0.00013869857,0.00012451524,0.00012719363,0.00025299937],"domain_scores_gemma":[0.9997378,0.00009479071,0.000063011496,0.000074934236,0.0000023456798,0.00002712874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004164672,0.00007212308,0.00009052372,0.000039051476,0.00007383443,0.000010950024,0.000088328954,0.0000149702855,0.000023064034],"category_scores_gemma":[0.00007254104,0.000052759908,0.000009593744,0.00032848227,0.000035304023,0.0001351622,0.00004905328,0.000060570044,0.0000040629675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048544378,0.00012385129,0.73715043,0.0000927229,0.000015295518,9.692199e-7,0.05861035,0.0061697806,0.0036052724,0.00033993972,0.006830178,0.18701267],"study_design_scores_gemma":[0.0018624516,0.000098131764,0.9122643,0.00021547207,0.00008319091,0.0000018818554,0.004024602,0.05838814,0.011392796,0.0006133414,0.010174499,0.0008812081],"about_ca_topic_score_codex":0.6161035,"about_ca_topic_score_gemma":0.7166261,"teacher_disagreement_score":0.18613146,"about_ca_system_score_codex":0.00020636666,"about_ca_system_score_gemma":0.000019515202,"threshold_uncertainty_score":0.38645294},"labels":[],"label_agreement":null},{"id":"W78203264","doi":"10.2165/10898570-000000000-00000","title":"Pharmacotherapy for Prevention and Treatment of Acute Respiratory Distress Syndrome","year":2010,"lang":"en","type":"review","venue":"Drugs","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; ARDS; Intensive care medicine; Pharmacotherapy; Population; Surfactant therapy; Internal medicine; Lung","score_opus":0.061052418248277084,"score_gpt":0.4031176273432675,"score_spread":0.34206520909499044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W78203264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018452381,0.9946441,0.000051509454,0.000008715336,0.000319295,0.00255033,0.00039786237,0.000029001587,0.00015391305],"genre_scores_gemma":[0.000024066569,0.9954106,0.000321117,0.000040610597,0.00017568644,0.00056288583,0.00033373505,0.00006428186,0.003066983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99885094,0.00003940647,0.00046263408,0.00032195455,0.0001425842,0.0001825033],"domain_scores_gemma":[0.9991167,0.000045759778,0.00032466857,0.00032443006,0.00004708041,0.00014136556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120301615,0.00031005012,0.0014413809,0.00014668118,0.000037472233,0.000009248888,0.00006767458,0.0002775504,0.00009274629],"category_scores_gemma":[0.0000033686065,0.00021728555,0.0005381006,0.00007778297,0.000049113594,0.000038626906,0.000011078768,0.00011120235,0.000006968422],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004652744,0.0001813724,0.0000043491755,0.0050999057,0.00054350955,0.000033361473,0.000060109196,9.579763e-10,0.00026089075,0.000045649827,0.00013941656,0.99358493],"study_design_scores_gemma":[0.0016808133,0.0016188358,0.00000316747,0.002281882,0.0037805676,0.00008692773,0.000008376126,4.4646714e-7,0.00075218163,0.000025308047,0.98959666,0.00016482611],"about_ca_topic_score_codex":0.0000016933416,"about_ca_topic_score_gemma":7.357705e-7,"teacher_disagreement_score":0.99342006,"about_ca_system_score_codex":0.00005503218,"about_ca_system_score_gemma":0.00019991686,"threshold_uncertainty_score":0.8860647},"labels":[],"label_agreement":null},{"id":"W82875543","doi":"10.2165/00003495-200262010-00002","title":"A Critical Review of the Fluoroquinolones","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":347,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Trovafloxacin; Gatifloxacin; Sparfloxacin; Medicine; Moxifloxacin; Chronic bronchitis; Levofloxacin; Lomefloxacin; Gemifloxacin; Ciprofloxacin; Pharmacology; Microbiology; Internal medicine; Antibiotics; Ofloxacin","score_opus":0.07449077231715541,"score_gpt":0.39260944605442294,"score_spread":0.31811867373726754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W82875543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.7239715e-7,0.988601,0.0000019089289,0.0011005033,0.0003148496,0.00063882273,0.000026421887,0.000016336084,0.009299748],"genre_scores_gemma":[0.000011639268,0.99740493,0.00008998397,0.000871137,0.00022529771,0.000006444746,0.000017387372,0.00003702109,0.0013361307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998679,0.00008536306,0.000548127,0.00020605569,0.00029205534,0.00018940016],"domain_scores_gemma":[0.998913,0.00016046758,0.00016313737,0.00056217506,0.000117349795,0.0000839063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016045509,0.00022219706,0.0014551735,0.000047744445,0.000030289097,0.000005122267,0.00023817875,0.00013597199,0.00063824106],"category_scores_gemma":[0.00038731756,0.00012021616,0.00079507835,0.0002820312,0.00017161928,0.000009636717,0.000115522154,0.0003904836,0.00019048706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.95269e-7,0.0000717013,4.3010556e-7,0.31709835,0.000055345685,0.0000067010933,0.000010612251,1.7409718e-9,2.3904244e-7,0.00046311496,0.023153296,0.65913963],"study_design_scores_gemma":[0.00006887879,0.000018870396,0.0000018514697,0.2671234,0.0021842506,0.0000691077,0.0000010426924,0.0000019763588,0.000002539291,0.0000045251427,0.73044246,0.00008109971],"about_ca_topic_score_codex":0.0000016019682,"about_ca_topic_score_gemma":1.8690685e-8,"teacher_disagreement_score":0.70728916,"about_ca_system_score_codex":0.000023454242,"about_ca_system_score_gemma":0.00010925386,"threshold_uncertainty_score":0.6988292},"labels":[],"label_agreement":null},{"id":"W889155653","doi":"10.2165/00003495-200565050-00001","title":"Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Fluticasone propionate; COPD; Exacerbation; Budesonide; Corticosteroid; Placebo; Adverse effect; Population; Oxygen therapy; Formoterol; Pharmacotherapy; Fluticasone; Internal medicine; Salmeterol; Intensive care medicine","score_opus":0.03199389125043568,"score_gpt":0.34635533678960156,"score_spread":0.3143614455391659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W889155653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008562047,0.98624635,0.0000020326327,0.00013430597,0.0002954843,0.003780852,0.00039137257,0.00013561531,0.008157762],"genre_scores_gemma":[0.0018644604,0.9880596,0.00004789025,0.00007490814,0.0015175835,0.00093773357,0.001310468,0.00026213223,0.0059252265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99444234,0.00039325785,0.0012872489,0.0014932837,0.0011203106,0.0012635781],"domain_scores_gemma":[0.9964606,0.00026888473,0.00037218953,0.0015384681,0.0001618809,0.0011979532],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00028184144,0.00101237,0.00280773,0.0010145701,0.00010019005,0.000054523,0.0005838454,0.00047262738,0.00141552],"category_scores_gemma":[0.00018913748,0.0009089571,0.0010952493,0.0012162252,0.00044827638,0.00025260373,0.00049298775,0.0017787073,0.0011723831],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00014723036,0.00038264648,0.00023250117,0.03578254,0.00017645788,0.005313653,0.00006139102,0.0000022233228,9.902093e-7,0.00010101057,0.00016516479,0.9576342],"study_design_scores_gemma":[0.0012291719,0.00004999988,0.012958632,0.017399775,0.0014533111,0.00052654376,0.00007391113,0.00023467648,4.8899557e-7,0.000102072125,0.9651472,0.0008242138],"about_ca_topic_score_codex":0.00005452213,"about_ca_topic_score_gemma":0.000014381794,"teacher_disagreement_score":0.96498203,"about_ca_system_score_codex":0.008361434,"about_ca_system_score_gemma":0.0059690485,"threshold_uncertainty_score":0.9996662},"labels":[],"label_agreement":null},{"id":"W9182150","doi":"10.2165/00003495-200565010-00002","title":"Management of Bronchopulmonary Dysplasia in Infants","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bronchopulmonary dysplasia; Pediatrics; Cerebral palsy; Dexamethasone; Corticosteroid; Adverse effect; Prednisolone; Methylprednisolone; Intensive care medicine; Anesthesia; Surgery; Pregnancy; Internal medicine; Gestational age; Physical therapy","score_opus":0.06658572619596828,"score_gpt":0.4361662911202804,"score_spread":0.3695805649243121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W9182150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004067384,0.976876,4.768283e-7,0.000047168043,0.00009102904,0.001773938,0.000026031505,0.00001983887,0.02112482],"genre_scores_gemma":[0.000022775102,0.99563515,0.00028328045,0.00008193492,0.00013646617,0.00017561058,0.00006335603,0.000060004422,0.0035413953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974121,0.00012310923,0.0008903526,0.00040262207,0.0007179045,0.00045390712],"domain_scores_gemma":[0.9987375,0.00013612772,0.00020606403,0.00064667506,0.00004336538,0.00023022809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005754087,0.00028002032,0.0015276314,0.0006071647,0.000017506505,0.0000044276726,0.00027482375,0.00025913992,0.0003130897],"category_scores_gemma":[0.000035235735,0.00023339875,0.00022848614,0.0006639362,0.00006913728,0.00004403228,0.00020201459,0.0007261564,0.00046304168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004503171,0.000101504746,0.000014394693,0.118509494,0.00006121119,0.00064073334,0.000022274122,9.236211e-8,4.6528488e-8,0.000076550394,0.00020694989,0.88032174],"study_design_scores_gemma":[0.00053113076,0.00006749286,0.00017279103,0.040818777,0.00014757362,0.000035688852,0.00002020602,0.0000025537377,4.5406193e-7,0.000004615204,0.95806533,0.0001333968],"about_ca_topic_score_codex":0.000031605006,"about_ca_topic_score_gemma":0.000003492946,"teacher_disagreement_score":0.9578584,"about_ca_system_score_codex":0.00044052702,"about_ca_system_score_gemma":0.0005490287,"threshold_uncertainty_score":0.95177245},"labels":[],"label_agreement":null},{"id":"W948799663","doi":"10.1007/s40265-013-0017-3","title":"HIV Protease Inhibitors in Pregnancy","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Ritonavir; Atazanavir; Medicine; Lopinavir; Pregnancy; Darunavir; Saquinavir; Protease inhibitor (pharmacology); Drugs in pregnancy; Pharmacology; Viral load; Intensive care medicine; Internal medicine; Immunology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Fetus; Biology","score_opus":0.04838235867481622,"score_gpt":0.38015915827884783,"score_spread":0.3317767996040316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W948799663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005511061,0.9573126,0.000005843792,0.00014161174,0.000045891316,0.0034678723,0.000043575874,0.000040199953,0.038936913],"genre_scores_gemma":[0.000003455618,0.8450132,0.000084638,0.000009298179,0.00017512836,0.0017023492,0.00022045782,0.000042466014,0.15274897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982501,0.00016075712,0.00057300855,0.00032352793,0.0003090185,0.0003835702],"domain_scores_gemma":[0.9990512,0.000048062408,0.00011670681,0.00044281463,0.00006697969,0.00027423777],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016876681,0.0002518857,0.0010230587,0.0004653221,0.000029480807,0.000030189545,0.0001686551,0.0002102256,0.0018137664],"category_scores_gemma":[0.0002965151,0.00017915333,0.00061444705,0.00041465356,0.000058255413,0.00008872777,0.00009232038,0.00074168725,0.0047612283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000017292635,0.00016180877,0.000015308915,0.023525083,0.000040663363,0.00005523996,0.0000673923,2.4579019e-9,3.1609204e-7,0.000046533372,0.09115707,0.8849289],"study_design_scores_gemma":[0.00030325275,0.00021010019,0.0000017426239,0.13854556,0.00009652714,0.000017812346,0.000027488493,0.0000058542123,0.0000027877325,0.000018079369,0.8606406,0.00013023098],"about_ca_topic_score_codex":0.00009588569,"about_ca_topic_score_gemma":0.0000038611174,"teacher_disagreement_score":0.88479865,"about_ca_system_score_codex":0.00016852072,"about_ca_system_score_gemma":0.00041695562,"threshold_uncertainty_score":0.9990987},"labels":[],"label_agreement":null}]}